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Towards retinal repair: analysis of photoreceptor precursor 
cells and their cell surface molecules 
Ya-Ting Han 
UCL, Institute of Child Health 
Abstract 
Photoreceptor cells are the sensory cells of the retina, responsible for detecting light and 
conducting the signals to secondary neurons. Because they cannot be regenerated, loss of 
photoreceptor cells leads to irreversible blindness. Cell transplantation with postmitotic 
photoreceptor precursor cells has been shown as a feasible approach to rescue vision in 
animal models, but the molecular properties of these transplantation-competent cells are not 
understood. The aims of this thesis are to 1) determine the properties of photoreceptor 
precursor cells by transcriptome and proteome analysis; 2) identify cell surface molecules that 
can be used to isolate these cells from cell mixtures and/or that are important for their 
migration and correct integration in development and in a transplantation context. Nrl/CrxGFP 
transgene-labelled photoreceptor precursor cells were separated from other retinal cells by 
flow cytometry and subjected to microarray and mass spectrometry analysis. Bioinformatics 
analysis showed that the photoreceptor precursor cells were enriched in expression of genes 
encoding cell projection proteins. Over 200 cell surface molecule candidates were identified 
and 32 genes encoding confirmed extracellular domains were expressed > 5-fold higher in 
photoreceptor precursors than other retinal cells. These included the stem cell marker Prom1 
(CD133), which was specifically expressed in photoreceptor cells (particularly on their cilia) 
throughout development as well as on transplanted photoreceptors. Together with CD73 and 
CD24, it serves as a specific marker to isolate photoreceptor cells for transplantation. An axon 
guidance molecule Sema7a was shown to be highly expressed in photoreceptor cells. It co-
labels with PlxnC1, rather than the expected receptor Itgb1, in developing retina, as well as 
transplanted migrating photoreceptor cells. Knockout of Sema7a resulted in retinal holes and 
abnormal photoreceptor synapse projection indicating a role of Sema7a in outer retina 
lamination. This study sets the foundation for future work on photoreceptor cell surface 
molecules in development and retinal repair. 
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1 Introduction 
1.1 Eye structure, retinal structure, photoreceptor structure 
Vision is one of the most important sensory inputs to the human brain. It is perceived by the 
eye in which light signals are guided onto the retina (Figure 1.1 A), a 0.2-mm-thick nervous 
tissue which receives light signals and processes images. The retina is an orderly laminated 
structure composed of six types of neurons and one type of glia cells (Figure 1.1 B). 
Photoreceptor cells lie in the outer nuclear layer (ONL) and are the detectors and processors of 
light signals. They absorb and convert the photons into electrical responses and pass them to 
interneurons such as bipolar cells, horizontal cells and amacrine cells. These interneurons, 
located in the inner nuclear layer (INL), relay the signals from photoreceptors to ganglion cells 
which will eventually transmit the signals to brain. There are two types of photoreceptor cells: 
rods for dim light vision and cones for bright light and coloured vision. Both are elegantly 
structured containing the outer segments (OS), the inner segments (IS), the cell body, and the 
synapses (Fig 1.1 C). The OS are essentially the factory of phototransduction and are full of 
membrane disks rich in light-sensing proteins (opsins). Rod OS are longer and feature closed 
individual membrane disks, with a few basal disks open and connected with the ciliary 
axoneme (the inner core microtubule-based cytoskeleton structure of cilia). Cone OS are 
shorter and are formed with open disks that are all connected with the ciliary axoneme. 
Through the connecting cilium the OS are connected with the IS which is responsible for 
metabolism and providing the energy for phototransduction. The connecting cilium is the path 
for opsins and many other shuttle molecules. The IS are connected with the cell bodies which 
contain transcription machinery in the nucleus at the ONL. The cell bodies further project 
synapses which transmit signals to interneurons at the outer plexiform layer (OPL).  
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Figure 1.1 Structures of the eye, 
retina and photoreceptors. (A) 
Structure of a human eye. Light 
goes through the pupil, lens, 
vitreous humour, retina, and hits 
the interphase between the 
retinal pigment epithelium (RPE) 
and the retina, where the 
photoreceptors detect the light 
signal and convert it into 
neuronal signal. (B) Structure of 
the retina. Cone and rod 
photoreceptors have outer 
segments (OS) which associate 
with RPE, connecting cilium (CC) 
which connects the OS and the inner segments (IS), cell bodies which are in the outer nuclear layer (ONL), and synaptic terminus (Syn) at the outer plexiform layer (OPL). The photoreceptors 
detect light signal with their OS and pass neuronal signal to bipolar cells and horizontal cells. The cell bodies of bipolar cells and horizontal cells are in the inner nuclear layer (INL), along with that 
of Müller glial and amacrine cells. Bipolar cells relay the signals from photoreceptors to amacrine and ganglion cells through synaptic contacts at the inner plexiform layer (IPL). Ganglion cells 
further convey the signal to the brain via their long axons toward and along the optic nerve. OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer; 
C, cones; R, rods; B, bipolar cell; H, horizontal cell; M, Müller cell; A, amacrine cell; G, ganglion cell. (C) Structure of the rod and cone photoreceptors. The photoreceptor OS is composed of stacked 
membrane disks which are shed daily and phagocytoed by RPE. OS in rod contain closed individual disks with a few basal disks connected to the ciliary axoneme (Ax, shown in yellow), while cone 
OS are open structures from the plasma membrane with the axoneme extends to the entire length of the OS. Connecting cilium and the structures around the apical surface of IS are important 
for OS biogenesis and opsin transport. The IS contains metabolic machinery which provides the energy that photoreceptors highly demand. The cellular body contain transcription machinery that 
regulates gene expression. The synaptic terminus transmit signals to interneurons. (A) and (B) are modified from (Sung and Chuang 2010; Swaroop, Kim et al. 2010).  
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1.2 Eye formation and development, eye field TFs 
The vertebrate eye originates from the anterior region of the neural plate which is a single 
field of neuroectodermal cells called the eye field. In Xenopus embryos the eye field originates 
from a subset of blastomeres at the 32-cell-stage (Moore and Moody 1999). These 
blastomeres are competent but not destined to form retina, possibly through inhibition of the 
bone morphogenetic protein (BMP) signaling (Moore and Moody 1999). The eventual fate of 
retinogenic cells is established in the neural plate stage when precise levels of Wingless-Int 
(Wnt) signaling are crucial to pattern the presumptive forebrain from which the eyes are 
derived (Cavodeassi, Carreira-Barbosa et al. 2005; Maurus, Heligon et al. 2005). Specification 
of the eye field is synchronized with a confined expression of a group of transcription factors 
within this region, termed the eye field transcription factors (TFs). These TFs include ET (Eye T-
box, or Tbx3), Rx1 (Retina homeobox-1 or Rax), Pax6 (Paired homeobox-6), Six3 (Sine oculis-
related homeobox-3), Lhx2 (Lin 11 Isl 1 Mec 3 homeobox-2), tll (Tailless or Tlx) and Optx2 
(Optic Six gene 2 or Six6).  
Mutations or deletions of Pax6, Six3, Optx2, Rx1, Lhx2, tll result in abnormal or no eye 
formation in many vertebrate species ranging from frog to human (reviewed in (Wawersik and 
Maas 2000)). Haploinsuficiency of PAX6 in human cause aniridia and congenital cataracts 
(Glaser, Jepeal et al. 1994) and mutations in mouse Pax6 results in small eye defects (Hill, 
Favor et al. 1991). On the other hand, Pax6 gain of function results in ectopic lens and retina 
formation in Xenopus (Altmann, Chow et al. 1997; Chow, Altmann et al. 1999). The expanded 
or induced eyes also appear when other eye field TFs like Six3, Rx and Optx2 are over 
expressed in the vertebrate nervous system (reviewed in (Sernagor, Eglen et al. 2006)). 
Interestingly, expression of these eye field TFs are coordinated among themselves in that 
activation of one activates expression of the others and inactivation reduces expression of the 
others. It is therefore proposed in Drosophila (Kumar and Moses 2001) and also been 
demonstrated later in Xenopus (Zuber, Gestri et al. 2003) that it is the coordinated expression 
of these eye field TFs that drives the specification of the eye field. In this model, ET induces 
expression of Rx1 which then induces expression of Pax6. Pax6 then cross talks with Six3 and 
Lhx2 which interactively regulate the expression of each other. Optx2 and tll joined in later to 
cement eye field formation. This model is conserved in mouse as shown by the similar gene 
expression patterns in mice and frogs and morphological defects in all the Rx, Pax6, Lhx2, Six3, 
Six6 and tll knock out (KO) mice (reviewed in (Sernagor, Eglen et al. 2006)). Discrepancies 
remain, however, as the ET homologue in mouse – Tbx3 – does not show abnormalities in the 
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knock out model, whereas knock out of its highly related family member Tbx2 does ((Behesti, 
Papaioannou et al. 2009), and reviewed in (Sernagor, Eglen et al. 2006)). 
Formation of the vertebrate eye cup starts from the neural plate. As the neural plate folds to 
form the neural tube, both sides of the rostral neural plate bulge outwards and form the optic 
vesicles. Once the lips of the neural folds are sealed, the neural ectoderm where the optic 
vesicles are derived from and the surface ectoderm (epithelium) are established. A series of 
interactions between the optic vesicles, the surface ectoderm and the surrounding 
mesenchyme will eventually give rise to the eyes. As the optic vesicles contact the surface 
ectoderm the lens placode is induced. While the lens placode pushes into the optic vesicle, 
invaginates and eventually forms the lens, the optic vesicles folds inwards and forms the 
bilayered optic cup. The outer layer of the optic cup grows into the RPE while the inner layer 
forms the retina.  
1.3 Retinal development 
While the anterior section of the optic cup gradually forms the structures for iris and ciliary 
body, the posterior section continues to develop the neural retina. Cells in this 
neuroepithelium layer are the early multipotential retinal progenitor cells (RPCs) which 
undergo rounds of mitotic division and will eventually exit the cell cycle “giving birth to” the 
different types of retinal cells. The number of mitotic division for RPCs is limited but not fixed, 
and varies according to data from early labeling experiments. Clonal labeling before the onset 
of differentiation showed that the clone size varies from 1 – 16 cells per clone in frog (Holt, 
Bertsch et al. 1988) and 1 – 200 cells in mice (Turner, Snyder et al. 1990). The fate of the RPCs 
is also variable in that a single clone can produce any type of retinal cells (Wetts and Fraser 
1988; Wong and Rapaport 2009).  
Despite this, there is a highly conserved order of cell birth across vertebrate species: retinal 
ganglion cells (RGCs) are always born first, followed by horizontal cells and cones, then 
amacrine cells, rods, and bipolar cells, and Müller glia are born last (Figure 1.2). This was 
shown in mice (Carter-Dawson and LaVail 1979b; Young 1985a), wallaby (Harman and Beazley 
1989), chick (Prada, Puga et al. 1991), monkey (La Vail, Rapaport et al. 1991) and rat (Rapaport, 
Wong et al. 2004). In frog, other than that the birth of rods is shifted before amacrine cells the 
above order remains (Wong and Rapaport 2009). In ferret, rods are born before bipolar cells, 
and Müller cells are born before rods (Dreher and Robinson 1988) (reviewed in (Lamb, Collin et 
al. 2007)). In whichever case, the birth sequence of RGCs followed by horizontal cells followed 
by cones is not changed.  
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In addition, there seem to be two conserved waves of cell birth. Birth of RGCs, horizontal cells 
and cones is the first wave, followed by a period when there is no or very low cell birth. This 
period varies from 4 to 7 days in rat (Rapaport, Wong et al. 2004), 10 to 20 days in monkey (La 
Vail, Rapaport et al. 1991), to 2 to 3 weeks in wallaby (Harman and Beazley 1989). After this 
period, the second wave of cell birth (amacrine cells, rods, bipolar cells, and Müller glia in most 
species, and Müller cells, rods, bipolar cells, and amacrine cells in ferret (Dreher and Robinson 
1988)) appear. 
Figure 1.2 Retinal 
cell birth curves 
of rat. (A) 
Cumulative 
percentage of 
cells in each class 
heavily labelled 
with 3H-TdR along 
development. (B) 
Absolute numbers 
of cells in each 
class heavily 
labelled in the 
mature rat after 
3H-TdR 
administration 
each day between 
E8 and P14. Two 
phases of cell 
genesis are 
apparent, phase 1 
(solid lines) and 
phase 2 (short 
dashed lines) 
except amacrine 
cells (long dashed 
line) exhibit 
intermediate 
properties. RGC, 
retinal ganglion 
cells; Ho, 
horizontal cells; 
Cpr, cone 
photoreceptor 
cells; Am, amacrine cells; RPr, rod photoreceptor cells; BP, bipolar cells; MG, muller cells; E, embryonic day; P, postnatal day. 
Adapted from (Rapaport, Wong et al. 2004)  
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1.4 Photoreceptor development 
Like other retinal cells, photoreceptor cells are derived from the RPCs. Upon their final mitotic 
division, some RPCs “give birth to” RPC daughter cells that are committed to a photoreceptor 
fate. These postmitotic photoreceptor precursors continue to grow and mature into fully 
differentiated photoreceptor cells.  
1.4.1 From progenitors to precursors 
Although it is not very clear how progenitors are exactly regulated to exit cell cycles and 
commit to photoreceptor precursors, several signalling pathways (eg. Wnt, Hedgehog, Notch, 
and FGF) and many homeodomain and basic Helix Loop Helix (bHLH) TFs are known to play in 
part (reviewed in (Agathocleous and Harris 2009)). The Notch-Delta signalling pathway is 
probably the most well-studied mechanism (reviewed in (Perron and Harris 2000)). Delta is a 
ligand for Notch, and is under the control of bHLH proneural proteins (NEUROD1, 
NEUROD4/MATH3, Neurogenin 2, ATOH7/MATH5, ASCL1/MASH1). Notch promotes RPC 
maintenance via signalling to the bHLH TFs HES1 and HES5 which downregulate the proneural 
proteins. Cells with initial higher levels of Delta enhance Notch signalling in their neighboring 
cells. The neighboring cell therefore has lower level of proneural proteins and Delta. This lower 
Delta signals back to the original cell to produce lower Notch, but even higher proneural 
proteins and Delta. Through this amplification, the cells with high Delta and proneural activity 
will differentiate into photoreceptors. However, the roles of the proneural proteins are still 
largely undefined. 
The progenitor has a moving cell body during the cell cycle (Baye and Link 2007; Del Bene, 
Wehman et al. 2008). In G1 interphase, the cell body moves towards the vitread surface where 
the cell undergoes S phase. After DNA replication, the cell body migrates back towards the 
ventricular surface and undergoes M phase there. This process is termed as interkinetic 
nuclear migration because it is mainly the nucleus, the main part of the cell body, which 
migrates within the cytoplasm of the elongated neuroepithelial progenitor cells (Frade 2002; 
Baye and Link 2008). The daughter cells will either continue the cycle if born as progenitors or 
exit the cell cycle if born as precursors. In the latter situation, the cell body will migrate 
towards its final position during the maturation process.  
1.4.2 From precursors to mature photoreceptors 
1.4.2.1 The development steps towards maturation 
The newly born photoreceptor precursor is in a bipolar form pointing to the vitread and 
ventricular side respectively (Figure 1.3). The ventricular side projects a short process linking 
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the soma of the precursors to the future outer limiting membrane (OLM) which is formed from 
adherent junctions between Müller cells and photoreceptor IS. Even at embryonic stages, 
some of the processes began to protrude from the ONL and show enlargement at the ends in 
mice (Hinds and Hinds 1979). Ribosomes, mitochondria, even centriole could be found in these 
bulbous protrusions (Figure 1.3). The soma of the precursors are quite adjacent to the OLM, 
with that of cone precursors even nearer (Figure 1.4 (Reviewed in (Lamb, Collin et al. 2007))). 
It was found in ferret that the other side of the young precursors projects a longer process 
linking them directly to the IPL, and passing through the OPL without connecting initially 
(Johnson, Williams et al. 1999). The OPL at this time begins to form with horizontal cells 
located in the vicinity. Although the photoreceptors will eventually connect with the horizontal 
cells, initial terminals of photoreceptors are at the two discrete sub-layers of IPL, probably 
contacting with amacrine or ganglion cells (Figure 1.4). The terminals are morphologically 
similar to functional synapses and express synaptophysin (Figure 1.4) and synaptotagmin 
(Johnson, Williams et al. 1999). After about two postnatal weeks in ferret, with continued 
maturation of horizontal cells and OPL, the vitread process of photoreceptors retracts from the 
IPL and begins to make synaptic contacts with the horizontal cells at OPL (Johnson, Williams et 
al. 1999). Bipolar cells, whose maturation coincide with the retraction of the photoreceptor 
terminal processes, joined in the contacts slightly later (Figure 1.4, and reviewed in (Lamb, 
Collin et al. 2007)). This phenomenon of connection with the IPL from photoreceptors before 
they retract to contact OPL did not seem to be well noticed in the literature.  
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Figure 1.3 Electron micrograph of embryonic mouse retina. (Right) E17 retina shows ventricular process and an 
enlarged bulbous protrusion of a future photoreceptor cell (cell 16, delineated with dashed red line). The 
protrusion (arrows) contains ribosomes and mitochondria and is surrounded by future villous processes from the 
pigment epithelial cells. x6,000; (Middle) E15 retina shows a ventricular process and protrusion of a future 
photoreceptor cell (cell 17). x4,700; (Left) Higher magnification of the protrusion of cell 17. x14,000. The 
protrusion contains mitochondria, ribosomes, granular endoplasmic reticulum, and a centriole, and is surrounded 
by a few layers of membrane from adjacent pigment epithelial cells. PE, pigment epithelium; VL, ventricular layer. 
Modified from (Hinds and Hinds 1979).  
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Figure 1.4 Ferret photoreceptor maturation stages (a) Around birth, photoreceptors project a vitread process to 
the inner plexiform layer (IPL); (b) Two weeks later, the vitread process retract and bipolar cells form between 
photoreceptors and the IPL; (c) Four weeks later, photoreceptors develop inner segments (IS) and outer segments 
(OS). A, amacrine cell; B, bipolar cell; C, cone photoreceptor cell; G, ganglion cell; H, horizontal cell; ILM, inner 
limiting membrane; OLM, outer limiting membrane; OPL, outer plexiform layer; R, rod photoreceptor cell. 
Adapted from (Lamb, Collin et al. 2007).  
 
 
 
Figure 1.5 Ferret rods project to the IPL. Rod opsin: green; synaptophysin: red.(h) P1, (i) P15. Adapted from 
(Johnson, Williams et al. 1999).  
While the vitread process is synapsing with OPL, the ventricular process of photoreceptors 
extends and elaborates the inner and outer segment (Figure 1.4). Other than the single study 
in ferret, the developmental process of photoreceptor maturation after their birth is largely 
undefined and needs clear investigation. Morphogenesis of mice OS is not fully synchronized 
to reach maturation until around 3 weeks after birth (LaVail 1973). During this period, the 
primitive cilium buds out of the plasma membrane and extends with its apical end ballooning 
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along as visualized by EM (Olney 1968). At P8 – 10, long and highly disorganized disks formed 
(De Robertis 1960), which will stack perpendicularly to the ciliary stalk eventually. The rod disk 
stack increases nearly linear to the length of the OS (LaVail 1973). At around P23, the final 
complete number of photoreceptors (around 70 % of total number of retinal cells) yields 30 
times more rods than cones in the mouse (18 – 20 times in human).  
The photoreceptor cells begin to express some phototransduction genes and photoreceptor-
morphogenesis genes around one week after birth. In ferret, expression of recoverin, vGluT1, 
and rhodopsin proteins has been detected within the first postnatal week (Johnson, Williams 
et al. 1999). In human, S opsin begins to be transcribed around foetal week (Fwk) 12 followed 
by rhodopsin, M opsin and L opsin transcripts at Fwk15 (reviewed in (Swaroop, Kim et al. 
2010)). In mouse, mRNA of S opsin begins to express around E13 (Chen, Tucker et al. 1994), 
followed by the transcription of rhodopsin around P2 and M opsin around P6 (Akimoto, Cheng 
et al. 2006). Protein of rhodopsin and S-opin are not expressed until around P6 (Morrow, 
Belliveau et al. 1998) and P5 (Szel, van Veen et al. 1994) in rat. 
1.4.2.2 The transcriptional networks regulating the development of precursors 
A complex transcription factor network is involved in regulating the development from RPC to 
precursors to mature photoreceptors. Six key regulators show master roles during this process. 
The mammalian ortholog of the Drosophila paired-type homeodomain orthodenticle (Otd), 
Otx2, is probably the earliest regulator of photoreceptor lineage. Conditional knock out of Otx2 
in retinal progenitors converts rods and cones into amacrine-like cells while ectopic expression 
of Otx2 leads to increased production of rods (Nishida, Furukawa et al. 2003). Although 
necessary for photoreceptor commitment, postnatal bipolar-cell-specific knock out of Otx2 
shows severe bipolar cell impairment (Koike, Nishida et al. 2007) demonstrating the multi 
functional role of Otx2. 
Specification of the photoreceptor lineage by Otx2 is probably executed via its activation of 
another Otd ortholog, the cone-rod homeobox protein Crx (Furukawa, Morrow et al. 1997). 
Different from Otx2, Crx expression starts in post-mitotic cells which have just exited the cell 
cycle (Garelli, Rotstein et al. 2006) rendering it the earliest photoreceptor marker. During 
mouse retinal development, Crx mRNA expression starts at E12.5 and peaks at P6 (Furukawa, 
Morrow et al. 1997), coinciding with the onset of cone cell birth and rod maturation 
respectively (Chen, Wang et al. 1997; Furukawa, Morrow et al. 1997). Crx binds and 
transactivates the conserved TAATCC/A sequence of photoreceptor-specific genes rhodopsin, 
cone opsin, arrestin, and interphotoreceptor retinoid-binding protein (Furukawa, Morrow et al. 
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1997). Retrovirus infection of Crx into P0 rat retina significantly increased the frequency of 
photoreceptor clones and decreased the frequency of amacrine and Müller glial clones 
(Furukawa, Morrow et al. 1997). A similar approach blocking Crx transactivation activity at P0 
showed that the photoreceptors did not form outer segments (Furukawa, Morrow et al. 1997). 
This is further confirmed by Crx-/- mice which lack photoreceptor OS and an electroretinogram 
(ERG) response (Furukawa, Morrow et al. 1999). Northern blot at P10 of the Crx-/-mouse retina 
showed a great reduction of both rod and cone opsins (rod: rhodopsin, cone: Opn1sw (or Blue 
Cone Pigment) and Opn1mw (green/red)), transducin (rod: Gnat1, cone: Gnat2), 
phosphodiesterase (rod: Pdeb, cone: Pdebc), cGMP – gated channel (rod: Cncg), arrestin (rod: 
Sag, cone arrestin), and recoverin transcript levels. These are genes involved in the 
phototransduction pathway and are essential for proper function of photoreceptors. 
Requirement of Crx for their expression demonstrates the indispensible role of Crx in the 
maturation of photoreceptors from precursors. It should be noted that Crx is also expressed in 
retinal bipolar cells (Liu, Shen et al. 2001) and the pineal gland (Furukawa, Morrow et al. 1999). 
However, either forced expression of Crx or blockage of Crx transactivation activity did not 
seem to change the number of bipolar cells when compared with controls (Furukawa, Morrow 
et al. 1997) indicating Crx action is more specific to photoreceptors than Otx2.  
Crx interacts with the neural retina leucine zipper protein Nrl, a member of the Maf family. 
Through interacting with other TFs, Nrl activates rod-specific genes and specifies the fate of a 
photoreceptor to become a rod. Nrl-/- mice retina show excessive cone-like photoreceptors at 
the expense of no rods at all (Mears, Kondo et al. 2001), whereas ectopic expression of Nrl in 
either wild-type or Nrl-/- mice transforms all cones into functional rods (Oh, Khan et al. 2007). 
The Nrl-/- mice do not express rod-specific genes (Rho, Gnat1, Nr2e3, Pdeb), express low levels 
of Rom1, Sag and Recoverin, but high levels of cone-specific opsin (Opn1sw, Opn1mw), 
transducin (Gnat2) and arrestin (Mears, Kondo et al. 2001). Nrl transcript can be detected as 
early as E12.5 and stays on into adulthood (Akimoto, Cheng et al. 2006). Prominent 
phosphorylation of NRL protein is observed at the peak of rod differentiation (Kanda, Friedman 
et al. 2007). Reduced phosphorylation is observed in the hot spot mutation (S50 and P51) form 
of Nrl, accompanied by hyperactivity of Nrl for the rhodopsin promoter with Crx (Kanda, 
Friedman et al. 2007), indicating a fine tuning of the transcriptional activity by phosphorylation.  
Besides the homeodomain and leucine zipper TFs, three ligand-regulated TFs i.e. nuclear 
receptors also play key roles during photoreceptor fate determination process – Nr2e3, Rorβ 
and Trβ2. Nr2e3 and Rorβ are retinoid-related orphan receptors whose physiological ligands 
are still unknown. Directly regulated by Nrl, Nr2e3 suppresses cone gene expression (Chen, 
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Rattner et al. 2005; Cheng, Aleman et al. 2006), and can also co-activate some rod genes 
through additional cooperation with Crx (Cheng, Khanna et al. 2004; Cheng, Aleman et al. 
2006), hence irreversibly pushing rod precursors into rods. Rorβ-/- mice retina are similar to Nrl-
/- mice but the cones do not have outer segments (Jia, Oh et al. 2009). This indicates Rorβ is 
involved in rod development, but is also critical for cone development. Indeed, Rorβ synergizes 
with Crx to initiate S opsin expression (Srinivas, Ng et al. 2006). In response to thyroid 
hormone, Trβ2 regulates M opsin patterning during cone development (Ng, Hurley et al. 2001).  
1.5 Rod photoreceptor cells vs Cone photoreceptor cells 
Constituting the majority of retinal cells, rod photoreceptor cells are very sensitive and can 
respond to single light quanta under dim light (http://webvision.med.utah.edu/). These cells 
are generated over a long time window (E12 to P10) with a birth peak around mouse birth 
(Figure 1.2) (Carter-Dawson and LaVail 1979b; Young 1985a; Rapaport, Wong et al. 2004). 
Cone photoreceptor cells, on the other hand, function under bright light, permit high 
resolution of visual images and mediate colour vision (http://webvision.med.utah.edu/). There 
are fewer cones than rods in retina with a ratio of 1:30 in mice (Carter-Dawson and LaVail 
1979a). Mouse cone cells are generated in a short embryonic period with a birth peak at E13 – 
E14 (Figure 1.2) (Carter-Dawson and LaVail 1979b; Rapaport, Wong et al. 2004). 
Morphologically, mouse rods and cones share a lot of common features yet each type has its 
own characteristics. The cones have conical-shaped shorter outer segments (hence the name 
cones) and stubby inner segments whereas the rods have cylindrically shaped long outer 
segments and slim inner segments (Figure 1.6). With multiple heterochromatin loci, nuclei of 
cones lie in a single row only in the ventricular/outer side of the ONL, whereas the single 
chromocentered rod nuclei stack throughout the ONL in rodents. Synapses of cones, known as 
cone pedicles, are large (8-10 µm diameter), conical, flat end-feet of the cone axons. Synapses 
of rods are small round enlargements of the axons or cell body, called spherules (3-5 µm 
diameter).  
All retinal cells, including the rods and cones, are derived from proliferating RPCs. Marked by 
the expression of Pax6 and Chx10, the RPCs in the mammalian retina have a finite capacity to 
self-renew (Figure 1.7). Although the self-renewal ability of mammalian RPCs is limited (e.g. all 
cells in the mouse neural retina are post mitotic by around postnatal day 11 (Young 1985a)), a 
population of RPCs in lower vertebrates, continue to reside in the ciliary marginal zone (CMZ), 
and have the capacity to generate new retinal neurons throughout life (Hollyfield 1971; 
Raymond 1991; Reh and Levine 1998). Upon expression of Otx2 during mammalian retinal 
development, some progenitor cells are beginning to differentiate toward photoreceptor cells 
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and bipolar cells (Nishida, Furukawa et al. 2003; Zuber, Gestri et al. 2003; Koike, Nishida et al. 
2007). Once Crx expression begins, most of the cells will commit to the photoreceptor cell fate 
and exit the cell cycle, making Crx the earliest marker for photoreceptor cells (Chen, Wang et 
al. 1997; Furukawa, Morrow et al. 1997). Required to maintain their fate, both the rod and 
cone photoreceptor cells will maintain Crx expression throughout their lives (Furukawa, 
Morrow et al. 1997). With the expression of Nrl and its downstream Nr2e3, some of the 
photoreceptor cells will become rod precursor cells, which will develop into rods eventually. 
Others will develop into cone precursor cells which will develop into S-cones or M-cones under 
the regulation of Rxrγ and Trβ2 (Hennig, Peng et al. 2008). The current hypothesis is that 
unless a particular set of regulatory factors gain dominance to guide precursors to gain a rod 
or an M-cone identity, the precursors will differentiate into S-cones as a default pathway 
(Figure 1.7) (Hennig, Peng et al. 2008; Swaroop, Kim et al. 2010). To support this model, 
human mutations within NR2E3 and mouse Nrl mutations showed enchanced S cone 
syndrome (reviewed in (Swaroop, Kim et al. 2010)). Further the Trβ2 knockout mice selectively 
lost M-cones and showed increased S-opsin expression (Ng, Hurley et al. 2001). 
Although these regulators are generally regarded as markers for photoreceptor cells of 
different stages or types, cells, especially the precursor cells may retain the potential to 
differentiate into any photoreceptor cell types. For example, it was found that the embryonic 
precursor cells which are Nrl-positively selected (ie. rod precursor cells) express mRNA of S-
opsin (Oh, Khan et al. 2007). Therefore, depending on if S-opsin is turned off or not, these cells 
could become either rods or S-cones. On the other hand, Nr2e3 was found to be expressed in 
Trβ2-positive cells indicating even mature cones and cone precursor cells express the rod 
marker Nr2e3 (Haider, Demarco et al. 2006). These raise the questions of if the precursors for 
rods and cones are same or not and/or at which developmental stage is plasticity lost.  
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Figure 1.6 Cone and rod morphology. Confocal (Left) and electronic microscope (Right) images of cone (Top) and 
rod (Bottom) photoreceptor cells. COS, cone outer segment; cs, cone sacs; ucs, unoriented cone sacs; ccc, cone 
connecting cilium; cf, ciliary filament; CIS, cone inner segment; mi, mitochondria; ROS, rod outer segment; rs, rod 
sacs; sm, surface membrane; RCC, rod connecting cilium; C1, centriole connected with the connecting 
ciliumyt0426. EM images of rabbit photoreceptor cells from Robertis (1960); Confocal images using transplanted 
CrxGFP labeled mouse photoreceptor cells from Baron, M. 
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Figure 1.7 Cone and rod markers. Key markers for RPCs are Pax6 and Chx10. The photoreceptor precursors (PR 
precursors), including both cone and rod precursors, express Otx2, Crx (regulated by Otx2), and Rorβ. Expression 
of Nrl and Nr2e3, key markers for rod photoreceptor cells, divert the precursors into rod lineage. Expressed in 
cones, Rxrγ and Trβ2 divert the fate of S-cones into M-cones. Dashed line divides the mitotic RPC which are self-
renewable from the remaining postmitotic cells. Yellow area indicate the stage of immature photoreceptor 
precursor cells. RPC, retinal progenitor cell; PR, photoreceptor.    
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1.6 Retinal degeneration and cell transplantation therapy 
285 million people are estimated to be visually impaired worldwide among which 39 million 
are blind and 246 million have low vision. Of these, 1.4 million children below age 15 are 
irreversibly blind for the rest of their lives (World Health Organization website: update June 
2012 http://www.who.int/mediacentre/factsheets/fs282/en/index.html). The leading causes 
of blindness are cataract and various forms of retinal degeneration. Other than glaucoma (the 
2nd leading cause of blindness worldwide) and some forms of vitreoretinal degenerations 
where ganglion cells and the inner retina were affected first, most retinal degenerations are 
characterized by defects in the outer retina where photoreceptor cells or RPE cells are affected 
initially. Retinal degenerations can be inherited, acquired and complex. Inherited retinal 
degenerations are caused by mutations in one or more genes. 203 genes have been identified 
so far (Retina International: update February 5, 2013 http://www.retina-international.org/sci-
news/databases/disease-database/) giving rise to around 27 types of inherited X-linked or 
autosomal dominant or recessive retinal degenerations (RetNet: update February 4, 2013 
https://sph.uth.edu/retnet/sum-dis.htm). Acquired retinal degenerations such as diabetic 
retinopathy are caused by infection, nutrition, injury and other environmental factors. 
Complex retinal degenerations such as age-related macular degeneration (AMD) are caused by 
both genetic and environmental factors.  
Retinitis pigmentosa (RP) is the most common form of inherited retinal degeneration, affecting 
more than 1 million people worldwide with a prevalence of around 1 in 4000 (Hartong, Berson 
et al. 2006). Starting with night blindness, patients with RP gradually lose peripheral vision to 
central vision by middle age and some will eventually suffer complete blindness. This is 
because of the progressive degeneration from the rod-rich peripheral regions to the cone-rich 
central regions. Nearly one third of RP patients also suffer from Usher’s syndrome, Bardet-
Biedl syndrome, and other syndromes in which their non-ocular tissues were also affected 
(Hartong, Berson et al. 2006). 56 genes have been identified so far to cause RP upon mutations 
(Table 1.1). Among these genes, RHO mutations account for 30 to 40% of autosomal dominant 
RP, RPGR mutations account for at least 15% of male sporadic (isolated) RP cases and USH2A 
for 10 to 15% of recessive RP (Retnet: update February 4, 2013 
https://sph.uth.edu/Retnet/sum-dis.htm).   
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Table 1.1 Genes for retinal diseases 
 
 
 
 
 
Other inherited retinal degenerations are less common, but could be more severe. Leber’S 
Congential Amaurosis (LCA) probably represents the most severe retinal disorder. Infants with 
LCA are born blind and lack functional photoreceptor cells. Most common mutations for LCA 
lie in GUCY2D (retinal guanylyl cyclase 1), RPE65 (retinoid isomerohydrolase), CRX (a 
transcription factor), CRB1 (Protein crumbs homolog 1), RPGRIP1 and CEP290. Both RPGRIP1 
ad (23) ar (36) x-linked (3)
 BEST1  ABCA4  OFD1  ABHD12  ARL6 ALMS1 CEP290 TTC21B CEP290  CRX
 CA4  BEST1  RP2  CDH23  BBS1 NPHP1 WDR19 TMEM67  IMPDH1
 CRX  C2ORF71  RPGR  CIB2  BBS2 SDCCAG8 ATD1 RPGRIP1L  OTX2
 FSCN2  C8ORF37  CLRN1  BBS4 NPHP4 IFT80 CC2D2A  AIPL1
 GUCA1B  CERKL  DFNB31  BBS5 ICCB1 DYNC2H1 TMEM216  CABP4
 IMPDH1  CLRN1  GPR98  BBS7 NPHP1  CEP290
 KLHL7  CNGA1  HARS  BBS9 TTC21B  CRB1
 NR2E3  CNGB1  MYO7A  BBS10 ARL13B  DTHD1
 NRL  CRB1  PCDH15  BBS12 INPP5E  GUCY2D
 PRPF3  DHDDS  USH1C  CEP290 AHI1  IQCB1
 PRPF6  EYS  USH1G  INPP5E KIF7  KCNJ13
 PRPF8  FAM161A  USH2A  LZTFL1 TCTN1  LCA5
 PRPF31  IDH3B  MKKS OFD1  LRAT
 PRPH2  IMPG2  MKS1  NMNAT1
 RDH12  LRAT  SDCCAG8  RD3
 RHO  MAK  TRIM32  RDH12
 ROM1  MERTK  TTC8  RPE65
 RP1  NR2E3  RPGRIP1
 RP9  NRL  SPATA7
 RPE65  PDE6A  TULP1
 SEMA4A  PDE6B
 SNRNP200  PDE6G
 TOPORS  PRCD
 PROM1
 RBP3
 RGR
 RHO
 RLBP1
 RP1
 RPE65
 SAG
 SPATA7
 TTC8
 TULP1
 USH2A
 ZNF513
 JBTS(13)
 LCA/RP 
(20)
Retinitis pigmentosa (56) Usher 
syndrome 
Bardet-Biedl 
syndrome ALMS (1)  SLSN (5)  JATD(5)
This table only illustrates the major diseases and genetic heterogeneity and is not an exhaustive gene list. ad, 
autosomal dominant; ar, autosomal recessive;  ALMS, Alstrom syndrome; SLSN, Senior–Løken syndrome; JATD, 
Jeune asphyxiating thoracic dystrophy; JBTS, Joubert syndrome; LCA/RP, Leber congenital amaurosis/retinitis 
pigmentosa. Numbers in brackets indicating number of genes in this category. Venn diagrams showing the 
number of common and different genes among RP ad, RP ar and RP x-linked (left), RP ad, RP ar, RP x-linked and 
Usher syndrome (top right), and RP ad, RP ar, RP x-linked and Bardet-Biedl syndrome (bottom right). Gene data 
obtained from Retnet: https://sph.uth.edu/Retnet/sum-dis.htm updated on Feb 04, 2013 except ALMS, SLSN, 
JATD and JBTS which are obtained from (Rachel, Li and Swaroop 2012) 
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and CEP290 are cilium proteins involved in retinitis pigmentosa GTPase regulation and 
ciliogenesis and ciliary transport process respectively. GUCY2D protein is involved in 
resynthesis of cGMP for dark state recovery after phototransduction. CRB1 protein is 
expressed in the apical membrane of the adherent junctions in the ONL of the retina playing a 
role in photoreceptor morphogenesis. RPE65 protein catalyzes production of 11-cis retinal and 
is involved in retinal pigment regeneration. Other inherited disorders that mark macular 
degeneration and loss of central vision include Stargardt disease (mutations found in ABCA4 
(Allikmets, Singh et al. 1997; Jonsson, Burstedt et al. 2013), ELOVL4 (Zhang, Kniazeva et al. 
2001; Vasireddy, Wong et al. 2010)), Best macular degeneration (mutations in VMD2 
(Petrukhin, Koisti et al. 1998; Atchaneeyasakul, Jinda et al. 2008)) and Sorsby fundus dystrophy 
(mutations in TIMP3 (Jacobson, Cideciyan et al. 2002)).  
Usually affecting older adults, AMD is the primary cause of visual impairment in developed 
countries and ranks the 3rd cause of global blindness with a prevalence of 8.7% (World Health 
Organization: http://www.who.int/blindness/causes/priority/en/index.html). In advanced 
AMD patients, the retina detaches from the RPE because of accumulation of drusen – 
extracellular materials that contain proteins and lipids – between Bruch’s membrane and the 
RPE (dry AMD) or because further blood vessels grow up from the choroid behind the retina 
(wet AMD). Other than genes that may contribute to AMD such as ABCA4 (Allikmets, Shroyer 
et al. 1997), complement system proteins factor H (CFH), factor B (CFB) and factor 3 (C3) 
(Sivaprasad and Chong 2006), HtrA serine peptidase 1 (HTRA1) (Dewan, Liu et al. 2006; Yang, 
Camp et al. 2006), age-related maculopathy susceptibility 2 (ARMS2) (Rivera, Fisher et al. 2005; 
Kanda, Chen et al. 2007), aging, smoking (Thornton, Edwards et al. 2005), obesity (Adams, 
Simpson et al. 2012), light exposure (Sui, Liu et al. 2013) and oxidative stress (Ugurlu, Asik et al. 
2013) have all been associated with AMD.  
Photoreceptor cells require a large supply of energy and relevant proteins to be transported to 
the OS for phototransduction and produce lots of metabolic wastes which are transported 
back to the IS or phagocytized by RPE along with the shedded disks. Disturbance of this 
balanced system or defects in photoreceptor morphogenesis will lead to photoreceptor death 
and consequently retinal degenerations. These retinal degenerations are usually irreversible 
and effective treatments are few. With advances in our understanding of the etiology and 
technology innovation, some therapies begin to offer promise in slowing down the 
degeneration or even restoring vision to some degree (Table 1.2). Implantation of a retinal 
prosthesis which transmit light stimuli to the brain through optic nerve showed improved 
vision in three RP patients (Yanai, Weiland et al. 2007), or further showed improved vision as 
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well as long term safety in 30 blind patients with end-stage outer retina degeneration 
(Humayun, Dorn et al. 2012). Vitreoretinal surgery (Heussen, Fawzy et al. 2008) and radiation 
therapy (Kishan, Modjtahedi et al. 2013) also showed some effects in treating wet/neovascular 
AMD. Many pharmaceutical drugs have been used to slow down the process of AMD via 
neuroprotective pathway, inhibiting angiogenisis, visual cycle and complement pathways with 
anti-angiogenic drugs currently the most effective (Zhang, Zhang et al. 2012). For inherited 
disorders where the genes are mutated, gene therapy can effectively cure the disease by 
delivering a correct therapeutic gene into the affected tissue (Thrasher, Casimir et al. 1995). In 
retinal disorders, administration of adeno-associated virus (AAV) construct expressing RPE65 in 
LCA2 patients showed significant improvement in visual function (Bainbridge, Smith et al. 2008; 
Maguire, Simonelli et al. 2008). Although the currently safest viral vectors (AAV) were used in 
clinic, their long term immunotoxicity remains to be monitored. Indeed there was a mild 
increase in serum neutralizing antibodies to AAV2 two weeks to three months after injection in 
two subjects although the levels returned to baseline levels after a year (Simonelli, Maguire et 
al. 2010). Three years follow up showed that the patients retained the visual function that had 
been achieved a few months after injection and did not experience serious adverse events 
related to the vector (Testa, Maguire et al. 2013). For genes too large for viral vectors such as 
ABCA4, DNA nanoparticle package showed successful delivery and improvement of the dark 
adaption recovery and reduced lipofuscin granules in a Stargardt mouse model (Han, Conley et 
al. 2012).  
Despite these advances, none of the above therapies can provide new functional RPE or 
photoreceptors cells, which are the key issue for outer retinal degeneration. In addition, these 
therapies are disease-specific and cannot be used in all the outer-retinal degenerations, except 
the retinal prosthesis implant which only provides artificial vision. Cell transplantation, on the 
other hand, supplements the recipients with new correct functional cells and could potentially 
be used in any of the above retinal degenerations. The question is, can the transplanted cells 
integrate (the process in which the donor cells correctly mature and stabilize their position in 
the ONL (for photoreceptor cells) or the RPE layer (for RPE) of the retina and make appropriate 
connections with recipient neural circuits) and properly function after transplantation. For 
degeneration related to RPE loss/dysfunction, the first clinical trial of human ES cell derived 
RPE showed positive results in treating dry AMD and Stargardt disease (Schwartz, Hubschman 
et al. 2012). For degeneration due to photoreceptor loss, a long journey was made and only 
findings in recent years are promising.  
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Table 1.2 Therapies for outer (RPE, ONL, OPL) retinal disorders 
Therapeutic 
approach 
Subtype disease Reference 
Pharma-
ceutical 
complement pathway 
inhibitors: POT-4, ARC1905, 
Eculizumab, FCFD4514S 
AMD Zhang, Zhang, and 
Weinreb 2012* 
visual cycle inhibitors: 
Fenretinide, ACU-4429 
AMD Zhang, Zhang, and 
Weinreb 2012* 
anti-angiogenic agents: 
rapamycin/sirolimus, pigment 
epithelium-derived factor, … 
wet AMD Zhang, Zhang, and 
Weinreb 2012* 
neuroprotective agents: 
brain-derived neurotrophic 
factor, ciliary neurotrophic 
factor, glial cell-derived 
neurotrophic factor, 
AL-8309B 
AMD Zhang, Zhang, and 
Weinreb 2012* 
FGF     
anti-VEGF agents wet AMD Ambati and Fowler, 
2012* 
Gene therapy RNAi (suppress mutant RHO 
expression while introduce a 
resistant Rho gene) 
RP (RHO) Rossmiller, Mao, and 
Lewin 2012* 
viral vectors:lenti, AAV RP (RHO), 
Neovascular 
AMD (PEDF), LCA 
(RPE65) 
Rossmiller, Mao, and 
Lewin 2012*; 
Campochiaro, 
Nguyen, Shah et al. 
2006; Bainbridge, 
Smith et al. 2008 
DNA nanoparticle Stargardt disease 
(ABCA4) 
Han, Conley et al. 
2012 
Cell therapy RPE AMD, Stargardt 
disease, 
Lu, Malcuit et al. 2009 
PR blindness due to 
PR loss 
MacLaren, Pearson et 
al. 2006 
Vitreoretinal 
surgery 
 wet AMD Heussen, Fawzy et al. 
2008 
Radiation 
therapy 
  wet AMD Kishan,  Modjtahedi, 
Morse, and Lee 2013 
Retinal 
prosthesis 
implant 
Functional electrical 
stimulation 
RP Yanai et al. 2007 
Argus II Retinal Prosthesis 
System (microchip) 
end-stage outer 
retinal 
degeneration 
Humayun, Dorn, et al. 
2012 
 
 
*A review. RP: retinitis pigmentosa; AMD: age-related macular degeneration. PR:photoreceptor; RPE:retinal 
pigment epithelium; RHO: rhodopsin; PEDF:pigment epithelium- derived factor; RPE65:Retinal pigment 
epithelium-specific 65 kDa protein; ABCA4: ATP-binding cassette sub-family A member 4 
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The earliest effort was made 50 years ago in which whole fetal rat retinas were transplanted 
into the anterior chamber of the maternal parent recipients (Royo and Quay 1959). Although 
they survived for months, the donor retina did not show any connections with the host 
environment. Similarly, transplanted rat embryonic retinal sheets or aggregates of embryonic 
retinal neurons were unable to interact properly with the host rat retinas (Zhang, Arner et al. 
2003), although they were able to express some markers for retinal cells such as calbindin (for 
horizontal and amacrine cells), neuronal nitric oxide synthase (NOS, for a subpopulation of 
amacrine cells), and protein kinase C (PKC, for bipolar cells) (Zhang, Arner et al. 2003). The 
embryonic tissues or aggregates were then dissociated into single cells and injected into the 
subretinal space or vitreous cavity of the host animal eye. Transplanted human or mouse 
retinal progenitor cells (Coles, Angenieux et al. 2004; Klassen, Ng et al. 2004) or brain-derived 
rat neural progenitor cells (Takahashi, Palmer et al. 1998) showed better interaction with the 
host mouse or rat retina in that they migrated into all retina layers and developed 
morphological similarities to various retinal cell types. But expression of photoreceptor-only 
genes and specific migration into the ONL after transplantation into adult recipients was very 
inefficient (Takahashi, Palmer et al. 1998; Van Hoffelen, Young et al. 2003; Sakaguchi, Van 
Hoffelen et al. 2004). Similarly transplantation using mature retinal cells also showed very low 
integration. The integration efficiency, however, was significantly increased when the 
postnatal retinal cells were transplanted (MacLaren, Pearson et al. 2006). Furthermore the 
integrated mouse retinal cells were able to respond to light in the recipient mouse eyes after 
transplantation (MacLaren, Pearson et al. 2006). Using different stages of retinal cells from an 
NrlGFP transgenic line which labels only photoreceptor cells that have exited the cell cycle, it 
was concluded that it is the immature postmitotic photoreceptor precursor cells that have the 
highest integration efficiency (MacLaren, Pearson et al. 2006).  
Due to the nature of mouse retina genesis, the birth peak of rods and cones are in postnatal 
period (~P0) and embryonic period (~E14) respectively. Despite their much higher integration 
rate, the postnatal mouse photoreceptor precursors mainly give rise to rods and rarely give 
rise to cones (Lakowski, Baron et al. 2010). The embryonic mouse photoreceptor precursors on 
the other hand, labeled with a CrxGFP transgenic reporter give rise to significantly more cones, 
with a cone/rod ratio similar to the in vivo situation after transplantation (Lakowski, Baron et 
al. 2010). However, the integration efficiency is around 10 fold lower than that of postnatal 
precursors (Lakowski, Baron et al. 2010). These populations (postnatal and embryonic) both 
have attributes of a desired transplantable cell population, i.e. high integration and production 
of both cones and rods. To enrich cell populations which have these desirable attributes, it is 
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important to elucidate and understand the molecular properties of both early and late 
precursor cells which can then be used as criteria to screen for ideal cell populations. 
Specifically, ideal cell populations need to be identified that achieve high level in rod, or cone, 
or rod and cone integration. 
Regarding the sources of donor cells, current research in mouse models uses directly 
dissociated cells from retinal tissues at a confined period of developmental time such as the 
peak of precursor generation. This is not a viable option for clinical cell transplantation as 
unlike blood, which the donors can regenerate after donation, people do not have the ability 
to form a new retina after donation of their retina. In addition, the majority of both rods and 
cones in human development are born during foetal week 12 to 32 which is not a feasible 
period to obtain donor cells. However, recent studies show that it is possible to obtain 
photoreceptor-like cells (Lamba, Karl et al. 2006; Osakada, Ikeda et al. 2008; Osakada, Ikeda et 
al. 2009; West, Gonzalez-Cordero et al. 2012) or even the whole optic-cup (Eiraku, Takata et al. 
2011) or retina-like structures (Aoki, Hara et al. 2009) from embryonic stem (ES) cells or 
induced-pluripotent stem (iPS) cells with certain induction protocols. After transplantation, the 
human ES cell-derived “photoreceptors” express photoreceptor markers and show visual 
responses in ERG analysis (Lamba, Gust et al. 2009). However, both the retina and the induced 
cell cultures contain cells of different types and stages. For effective and safe cell 
transplantation it will be important to select only the transplantation-competent 
photoreceptor precursors and eliminate cells of other types and stages.  
1.7 Why surface molecules of photoreceptor cells 
Two research questions emerged along with the concept that cells at the precursor stage 
integrate best: one is WHY do cells of this stage rather than other stages integrate better; the 
other is HOW to isolate this population of cells from a cell mixture. While the former question 
is important for our understanding of these cells, the latter is a practical issue for cell 
transplantation. Both need to be clearly addressed for cell therapy.  
Imagining the integration process of a single cell, it is highly likely that this is an interaction 
process between the migrating cell and its neighbouring cells and the environment. Hence 
physical stimuli, chemicals, secreted as well as cell surface proteins from neighbouring cells 
and the environment will influence the migration process (such as Reelin which guides 
migration of projection neurons from ventricular zone to the neocortical plate along the radial 
array in the developing mouse neocortex (Hirotsune, Takahara et al. 1995; Jossin and Cooper 
2011)). And there is no doubt that complex mechanisms and various events are happening 
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within the migrating cell. However, it is the molecules that are on the surface of that cell that 
actually provide the physical contact, build the bridge, and conduct the communication with 
other cells and environment, which eventually guide the cell to reside at a particular position 
and ensure that it is permitted to stay there. Finding out what these surface molecules are and 
what they do, therefore, is crucial to address the “why” question.  
Identifying these cell surface molecules may also help to explain the different behavior of the 
early and late precursor populations. As the two donor cell populations are transplanted 
straight away after isolation from the developing retina and are left in similar recipients for the 
same length of time, the environment would be largely the same. Therefore it is the different 
properties of these transplanted cells which make the differences. As integration is a process 
in which donor cells interact with the host environment, differences on the cell surface should 
contribute greatly to the interaction process. As soon as the cells are entering the environment, 
say at the time of injection into the subretinal space, there will probably be some initial 
contacts made through cell surface molecules. As the transplanted cells need to migrate from 
the subretinal space into the ONL, cells which have appropriate cell surface molecules will 
probably be able to connect or “talk” with the host environment and can initiate the migration 
process. Whereas cells which do not have this surface signature will probably not be 
recognized by the host environment, hence may not be able to bridge or connect with the host. 
These cells may remain at the site of injection and may cause unwanted degeneration 
eventually.  
The current approach to select photoreceptor cells from cell mixtures is genetically tagging 
fluorescent proteins using photoreceptor-specific transcription factor transgenes and sorting 
photoreceptors out via expression of the fluorescent protein. This method, although valid in 
scientific research, cannot be applied in clinical practice as genetically tagged fluorescent 
protein is not desirable for patients. In addition, the TFs are expressed in photoreceptors from 
birth to death, and do not specifically label a particular stage. These problems can be solved if 
specific cell surface molecules are identified. On one hand, serving as markers themselves, cell 
surface molecules allow cell isolation by specific antibody affinity to their extracellular domains 
without the need of transgenic reporters. On the other hand, as shown in leukocyte 
differentiation, different clusters of cell surface antigens show different patterns of expression 
along development (Zola, Swart et al. 2005). Therefore, it is possible to label a particular stage 
of the photoreceptor cell through a combination of different cell surface markers.  
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1.8 Approaches for screening cell surface molecules 
There are several ways to provide the pool for identification of cell type specific surface 
antigens. Traditional decoy immunization strategy uses the cells to immunize lymph node cells 
which are then fused with mouse myeloma cells to produce hybridomas. These hybridomas 
secrete monoclonal antibodies which can be further characterized and validated. This method 
was used for ES cells for which around 70 surface molecules are identified but few are new 
molecules (Choi, Kim et al. 2008).  
The second is the classical transcriptome profiling strategy in which RNA microarray is 
performed to identify genes that are transcribed in the given cell population or compared 
against other cell populations. Total RNA of the cells were extracted, their cDNA synthesized 
and hybridised with a gene chip which contains all the genes of that species. Transcribed genes 
will give a signal on the chip and can be detected. Data obtained from the microarray, however, 
often contains tens of thousands of genes, the majority of which are probably not surface 
molecules. Screening only the surface molecules therefore can be highly time-consuming, and 
whether the protein is present on the cell surface or not remains to be established. Despite 
these considerations, RNA microarray remains the largest pool for identifying interesting 
candidates. Some surface markers for definitive endoderm cell population were identified 
using this strategy (Yasunaga, Tada et al. 2005). 
The third method is the proteomic approach which directly identifies and quantifies proteins in 
the sample using Mass Spectrometry (MS). Proteins were directly extracted from the cells and 
digested into small peptides. The peptides were then ionized and their mass evaluated. By 
putting together the fragmented peptides of each protein, the mass and sequence of the 
protein can be determined. This usually produces a much smaller but more accurately targeted 
candidate protein data set than microarray. The problem with this assay is that proteins with 
smaller molecular weight or lower abundance are often masked by proteins with higher 
abundance during MS analysis. However, this might be improved by cell fractionation through 
which the abundance of desired proteins could be increased. The ideal cell fraction that cell 
surface proteins lie in seems to be the membrane fraction which can be obtained via 
ultracentrifugation or chemical enrichment using combinations of detergents and other 
reagents.  
In this thesis, I used both the microarray and MS methods for the following reasons: 1) the full 
transcriptome data and proteome data for photoreceptor precursor cells can be obtained; 2) 
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both the RNA and the protein level are covered; 3) the microarray and MS data probably 
provides the fullest pool for cell surface molecules to be screened for.  
1.9 Hypothesis and aim 
During photoreceptor maturation, two processes project in opposing directions along 
developing photoreceptor precursors: one is the vitread process which will synapse with 
interneurons in the OPL, and the other is the ventricular process which will develop into IS, CC 
and OS within the interphotoreceptor matrix in the subretinal space, part of the OS embedding 
into the RPE. As the processes extend, the cell also seeks the final position for its cell body in 
the ONL and moves towards there. Cones, and not rods, are known to undergo a late 
migration so that their cell bodies become located at the outer edge of the ONL (Rich, Zhan et 
al. 1997). Once the processes are fully established, the position and orientation of the whole 
cell becomes fixed within the ONL. As the surface of the processes and the cell body interact 
with the surrounding environment directly, I hypothesize that cell surface molecules enriched 
there play fundamental roles for the correct localization of the photoreceptors. Furthermore, 
the same cell surface molecules which are important for the localization of precursors in the 
developing retina might also be important for the migration and integration of transplanted 
precursors in the recipient retina. And of wide clinical significance the cell surface molecules 
can be used as tools to isolate the photoreceptor precursor cells. I therefore, aim to discover 
these photoreceptor-specific cell surface molecules and examine their function during 
photoreceptor precursor maturation and integration.  
As mentioned earlier, the postnatal photoreceptor precursor cells possess high integration 
efficiency (MacLaren, Pearson et al. 2006; Lakowski, Baron et al. 2010) and the embryonic 
photoreceptor precursor cells can give rise to cones after transplantation (Lakowski, Baron et 
al. 2010). It will be useful to find out what unique molecular properties these cell populations 
possess. This will not only help us to understand these cells better, but will also facilitate the 
clinical application of cell therapy. To reveal the most unique properties of photoreceptor 
precursor cells, I plan to compare them with other retinal cells of the same stage. This is 
because photoreceptor cells and other retinal cells are all derived from RPCs and they probably 
share more common properties than that of other cell types. Furthermore, I will compare the 
properties of the early and late photoreceptor precursor cells to see if I can identify reasons 
for the different behavior of these cells after transplantation.  
I plan to identify the properties of these cells by analyzing transcriptome data from microarray 
experiments as this will also provide a large enough pool to screen for cell surface molecules. I 
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will also search for cell surface proteins directly through proteome data obtained from mass 
spectrometry.  
This thesis, therefore, has the following objectives:  
1) To understand the properties of embryonic and postnatal photoreceptor precursor 
cells by comparing their transcriptome expression profiles with other retinal cells of 
the same stage and comparing CrxGFP or NrlGFP labeled photoreceptor cells of 
different stages.  
2) To identify cell surface molecules on photoreceptor precursors through bioinformatics 
analysis of proteomic and transcriptomic data.  
3) To confirm expression profiles of identified molecules in photoreceptor cells by 
detecting their mRNA and protein in the developing mouse retina. 
4) To test if/where these molecules are expressed on transplanted photoreceptor 
precursor cells as they interact with the host environment by immunohistochemistry 
(IHC). 
5) To explore the potential interaction partners in the retina of identified molecules, and 
via over-expression or knock out/down experiments aim to demonstrate the function 
for selected molecules in photoreceptor integration and correct orientation after 
transplantation or during photoreceptor development. 
6) To validate the performance of selected cell surface molecules as tools to isolate 
photoreceptor precursor cells for transplantation experiments. 
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2 Materials and methods 
2.1 Mice 
The homozygous NrlEGFP transgenic mouse line (referred to as NrlGFP) (mouse strain SV129) 
(Akimoto, Cheng et al. 2006) was a gift from Anand Swaroop (University of Michigan, USA). The 
Crx-GfpAP transgenic mouse line (referred to as CrxGFP) (mouse strain C57BL/6)  (Samson, 
Emerson et al. 2009) was provided by C. Cepko’s laboratory as a heterozygous line and now 
has been maintained as a homozygous line. The wildtype CD1 mice were used as a GFP 
negative control in flow cytometry (FCM) analysis. All animals were maintained in University 
College London (UCL) animal facilities and experiments performed in accordance with the 
Animals (Scientific Procedures) Act 1986 and the ARVO Statement for the Use of Animals in 
Ophthalmic and Vision Research. For timed matings, light-cycle synchronised animals were set 
up for over-night mating and female checked for vaginal plugs on the following morning. The 
day of plug discovery was counted as embryonic day (E) 0.5.  On the given day of development, 
embryos were removed from the uterus of sacrificed pregnant mice. Postnatal mice are 
collected from either timed-mating pairs or non-timed-mating pairs. For non-timed-mating 
pairs, once pregnancy was confirmed, the cage of a pregnant female was gently checked 
around the date of birth.  
2.2 Dissection of the eye and the retina 
2.2.1 Dissection and dissociation of retinal cells 
The whole embryos and the postnatal and adult eyes were collected from sacrificed animals 
into Earle's Balanced Salt Solution (EBSS) on ice in a procedure room. Eyes from the postnatal 
and adult mice were enucleated with forceps (Dumostar 11cm straight tweezer, Dumont #55). 
The eyes from the embryos and the postnatal and adult mice were dissected in EBSS under a 
Zeiss Stemi SV-6 dissection microscope. After removal of the optic nerve, the eye was pulled 
apart from the hole of the optic nerve revealing the RPE, retina and lens. The RPE and lens 
were carefully removed and only neural retina tissues were collected for dissociation. Single 
retina cell suspension was prepared using the Papain Dissociation System (Worthington 
Biochemical, Lorne Laboratories, UK).  
2.2.2 Dissection of eyes for embedding 
While the lens from embryonic and postnatal eyes were maintained during embedding for IHC, 
lens from adult eyes were generally removed as they might damage the retina tissue during 
cryosectioning. To do this, a hole was punctured on the corneal using a 25G needle, then the 
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cornea was removed with dissection scissors cutting around it starting from the hole, and the 
lens removed with forceps.  
2.3 Cell sorting and Flow cytometry analysis 
2.3.1 Fluorescence-activated cell sorting (FACS) 
For microarray, Mass Spectrometry (MS) and quantitative PCR (qPCR) analysis which compared 
the GFP-positive and GFP-negative cells, two-way sorting which collected both GFP-positive 
and negative cells were performed with a Beckman Coulter MoFloTM XPD cell sorter. 
Dissociated retinal cells were prepared at a concentration of 20-40 million/ml in DMEM or 
DMEM/F-12 medium containing 3% fetal bovine serum (FBS) before sorting and were collected 
in a FACS tube (or 15 ml falcon tube) containing 0.5 ml (or 1 – 3 ml for 15 ml falcon tube) 
DMEM or DMEM/F-12 medium with 20 – 50 % serum (or no serum for MS samples) as the 
serum will be diluted during sorting. FACS-gates were determined according to cell size, cell 
complexity, and non-GFP retinal cells using stage-matched wild-type retina cells (Figure 2.1). 
Purity of the sorted GFP-positive cells was checked by re-running a few sorted cells at the end 
of the sort and was typically >90%.  
For microarray and qPCR analysis, around 20 – 30% CrxGFP-positive cells and around 20% 
CrxGFP-negative cells were collected for E15.5 retinal cells (Figure 2.1 A2 and A3). Around 75% 
CrxGFP-positive cells and around 13% CrxGFP-negative cells were collected for P4 retinal cells 
(Figure 2.1 B2 and B3). Previous experience showed that a minimum of 2 million cells per 
sample was required for microarray analysis. As the cell numbers were low for the E15.5 
retinal preparations, several rounds of sorting and collection were performed. Each E15.5 
sample was collected from several litters, each P4 GFP-positive sample was from two pups 
(four retinas) and each P4 GFP-negative sample was from four pups (eight retinas). Cells from 
different rounds or litters were merged as indicated (Appendix Table 2.1). The sorted GFP 
positive and negative cell pellets were temporarily frozen at -80°C after centrifugation at 328 g 
for 15 min at 4°C and removal of the medium. A similar procedure was performed for the 
NrlGFP-sorted retinal cells for Mass Spectrometry analysis.  
2.3.2 Flow cytometry analysis 
For cell surface marker expression analysis without collection of cells, Papain dissociated live 
retinal cells were adjusted to 1×106 cells per 100 μl 1% bovine serum albumin (BSA) in 
Phosphate Buffered Saline (PBS, isotonic, pH 7.3, Oxoid, UK) and blocked on ice for one hour, 
followed by a 30 min antibody incubation on ice. Cells were then washed in PBS, stained with 
DAPI/Topro3 and subjected to analysis in the LSRII analyser machine (BD Biosciences). The 
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following antibodies were used: PerCPCy5.5-conjugated anti-CD80 (0.1 µg, BioLegend), APC-
conjugated anti-CD83 (0.25 µg, BioLegend), PE-conjugated anti-CD276 (0.5 µg, BioLegend), 
eFluor450-conjugated anti-CD73/NT5E (1.2 µg, eBioscience), PECy7-conjugated anti-CD24 (0.2 
µg, BD Biosciences), APC-conjugated anti-Prominin-1 (0.06 µg, eBioscience). Background 
signals of the fluorochrome were visualized using a corresponding isotype control for each 
antibody (PerCPCy5.5 Armenian Hamster IgG, APC Rat IgG1 κ, PE Rat IgG2a κ were from 
BioLegend; APC Rat IgG1 κ and eFluor450 Rat IgG1 κ were from eBioscience, PECy7 Rat IgG2b κ 
was from BD). Live cells are selected for analysis based on cell size, cell complexity, and 
negative staining of DAPI or Topro3. At least 10, 000 healthy cells were analysed during sorting 
using the software FACSDiva (BD Biosciences). The data were then analyzed and plotted in 
FlowJo 8.6.3. Gates for the antibodies in plots were set according to background signals from 
isotype controls and no-antibody controls. Gates for GFP were set according to retina cells 
from wild type animals of corresponding stages.  
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Figure 2.1 FAC-sorting of GFP positive and 
negative retinal cells. Panel A: E15.5 CrxGFP 
retinal cells; Panel B: P4 CrxGFP retinal cells; 
Panel C: P4 wildtype retinal cells; Column 1: 
Retinal cell population selected and debris 
excluded by gating with forward scatter (FSC, 
cell size) and side scatter (SSC, cell 
complexity). Column 2: Two-way sorting 
scatter plot of GFP-positive cells (right) and 
GFP-negative cells (left). Column 3: 
Histogram plot of GFP-positive cells (right) 
and GFP-negative cells (left). 
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2.4 Microarray and bioinformatics analysis 
Cells were immediately frozen into -80°C after FACS and triplicates of three million cells per 
sample were prepared for RNA extraction (Appendix Table 2.1). RNA of the sorted cells was 
extracted using the RNAeasy mini kit (Qiagene). The concentration and quality of the RNA was 
examined using NanoDrop and Bioanalyser and all samples showed equivalent high quality, 
including the E15.5 sample which later emerged as an outlier in the microarray analysis 
(described in section 2.4.1). cDNA was synthesized for each GFP positive and negative mRNA 
sample and hybridized with Affymetrix Mouse Gene 1.0ST chip (a whole transcript array that 
cover 26,166 total RefSeq transcripts) (performed by UCL genomics). Quality control of the 
array was analyzed to identify possible outliers (see section 2.4.1, performed by UCL genomics). 
The data was compared between groups and gene lists were generated for significant 
differentially expressed genes using analysis of variance (ANOVA) statistical model (Table 2.1 
and Table 2.2, performed by UCL genomics). Functional bioinformatics analysis of the array 
gene lists were performed in Database for Annotation, Visualization and Integrated Discovery 
(DAVID) v6.7 (Dennis, Sherman et al. 2003; Huang da, Sherman et al. 2009) to extract the 
biological theme of the gene lists or to search for genes of particular functions (section 2.4.2). 
Table 2.1 Crx array significant differentially expressed gene numbers (excluding outlier) 
Comparison Criteria Total 
E15.5 GFP+ vs. P4 GFP+ FDR<=0.05 3236 
E15.5 GFP- vs. P4 GFP- FDR<=0.05 1215 
E15.5 GFP+ vs E15.5 GFP- FDR<=0.05 103 
P4 GFP+ vs. P4 GFP-  FDR<=0.05 4487 
E15.5 GFP+ vs. P4 GFP+ FDR <= 0.05, FC +/-2.0 1303 
E15.5 GFP- vs. P4 GFP- FDR <= 0.05, FC +/-2.0 538 
E15.5 GFP+ vs E15.5 GFP- FDR <= 0.05, FC +/-2.0 71 
P4 GFP+ vs. P4 GFP-  FDR <= 0.05, FC +/-2.0 1628 
 
Table 2.2 Crx array significant differentially expressed gene numbers (including outlier) 
Comparison Criteria Total 
E15.5 GFP+ vs. P4 GFP+ FDR<=0.05 2665 
E15.5 GFP- vs. P4 GFP- FDR<=0.05 618 
E15.5 GFP+ vs E15.5 GFP- FDR<=0.05 37 
P4 GFP+ vs. P4 GFP-  FDR<=0.05 2622 
E15.5 GFP+ vs. P4 GFP+ FDR <= 0.05, FC +/-2.0 1286 
E15.5 GFP- vs. P4 GFP- FDR <= 0.05, FC +/-2.0 396 
E15.5 GFP+ vs E15.5 GFP- FDR <= 0.05, FC +/-2.0 31 
P4 GFP+ vs. P4 GFP-  FDR <= 0.05, FC +/-2.0 1384 
 
FDR, false discovery rate; FC, fold change. 
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2.4.1 Microarray quality control analysis 
The quality of the CrxGFP array was analysed by UCL genomics using Partek Genomics Suite in 
2010 September and Array Quality Metrics 3.8.0 under R (R is an open source free software 
environment for statistical computing and graphics) version 2.13.0 (2011-4-13) in 2011 
October. Analysis in Partek was performed with the 12 samples all together and one possible 
outlier was identified (sample number 3, Crx E15.5 GFP+ve 3 as shown in Appendix Table 2.1). 
Analysis in R was performed as pairwise comparison between E15.5 CrxGFP+ve vs CrxGFP-ve, 
P4 CrxGFP+ve vs CrxGFP-ve, CrxGFP+ve E15.5 vs P4, and CrxGFP-ve E15.5 vs P4. Sample 3 was 
detected as an outlier by distance between arrays in E15.5 CrxGFP+ve vs CrxGFP-ve 
comparison, distance between arrays and box plots in CrxGFP+ve E15.5 vs P4 comparison, but 
not as an outlier by box plots and MA plots in E15.5 CrxGFP+ve vs CrxGFP-ve comparison and 
MA plots in CrxGFP+ve E15.5 vs P4 comparison. Results of the quality control analysis here 
presented the analysis from Partek for all 12 samples and the analysis from R for distance 
between arrays, box plots, density plots, and MA plots for the E15.5 CrxGFP+ve vs CrxGFP-ve 
comparison and box plots for CrxGFP+ve E15.5 vs P4.  
The raw array data were first processed in Expression Console from Affymetrix. All quality 
control (QC) parameters from Affymetrix fell within the thresholds, thus passing initial QC. 
After data export, the raw data were uploaded into Partek Genomics Suite and normalized 
using Robust Multichip Average (RMA). Overall grouping/separation of the arrays was checked 
using Principal Component Analysis (PCA). PCA is a dimension reduction and visualisation 
technique that is here used to project the multivariate data vector of each array into a two-
dimensional plot, such that the spatial arrangement of the points in the plot reflects the 
overall data (dis)similarity between the arrays. PCA plots of the 12 samples showed that 
sample 3 was away from all other samples (Figure 2.2 Left). After removal of sample 3, the 
remaining samples clustered as expected (Figure 2.2 Right). Then the signal intensity 
distribution of the normalized arrays was analysed in box plots (Figure 2.3). Normally one 
expects the boxes to have similar positions and lengths (or widths if transposed). Here sample 
3 showed an overall lower intensity. Further examination of histogram of array signal intensity 
showed that sample 3 is slightly different from the others (Figure 2.4). The bulge at the upper 
end of the intensity range for sample 3 indicated signal saturation and the diminishing right tail 
indicated lack of signal. From these analyses in Partek, it seems that sample 3 showed lower 
signal intensity and the signals that can be detected were saturated.  
Further analysis was performed in R to determine if sample 3 was an outlier or not. Pairwise 
comparison was performed as the samples were originally paired for such purposes. Distances 
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between arrays were firstly compared and outliers were detected as arrays whose sum 
distance to all other arrays was exceptionally large. Both E15.5 CrxGFP+ve vs CrxGFP-ve 
comparison and CrxGFP+ve E15.5 vs P4 comparison showed that sample 3 was an outlier. Here, 
as an example, the heatmap of E15.5 CrxGFP+ve vs CrxGFP-ve comparison showed clearly that 
while the other five samples were near and clustered together, sample 3 was far from the 
others (Figure 2.5).  Array intensity distributions were also examined using box plots (Figure 
2.6) and outlier detection performed by computing the Kolmogorov-Smirnov statistic Ka 
between each array's distribution and the distribution of the pooled data. While sample 3 was 
not detected as an outlier in E15.5 CrxGFP+ve vs CrxGFP-ve comparison, it was an outlier in 
CrxGFP+ve E15.5 vs P4 comparison. MA plot examination of individual array quality showed 
that although sample 3 seem to have different background (trend in the lower range of A) and 
saturation of the measurements (trend in the upper range of A) in the plot (Figure 2.7), it had 
the same Hoeffding's statistic Da as sample 6 (D=0.06) and did not pass the outlier detection 
threshold Da >0.15. Finally the density plot of standard deviation versus rank of the mean 
showed a hump on the right hand of the x-axis for the red dots indicating a saturation of the 
intensities rather than the trend being approximately horizontal (Figure 2.8). This agreed with 
the MA plots (Figure 2.7) and histograms (Figure 2.4) of the array signal intensity analysis 
indicating saturation of the array signals.   
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Figure 2.2 PCA plots of the array samples. (Left) Sample 3 (one of E15.5 CrxGFP+ve) falls far from the other 11 samples. (Right) Sample 3 removed from the analysis Yellow indicate CrxGFP+ve, 
purple indicate CrxGFP-ve, pyramids indicate E15.5, balls indicate P4.     
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Figure 2.3 Box plots of normalized array signal intensity distributions. Sample 3 shows an overall lower intensity. 
Red indicates CrxGFP+ve, blue indicates CrxGFP-ve. Each box corresponds to one array.  
   
 
Figure 2.4 Smoothed histograms of array signal density estimates. Sample 3 appears to be out-of-line with the 
others. Red indicates CrxGFP+ve, blue indicates CrxGFP-ve. Each line corresponds to one array. 
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Figure 2.5 Heatmap of the distances between the six embryonic arrays. The color scale is chosen to cover the 
range of distances encountered in the dataset. Patterns in this plot can indicate clustering of the arrays either 
because of intended biological or unintended experimental factors (batch effects). The distance dab between two 
arrays a and b is computed as the mean absolute difference (L1-distance) between the data of the arrays (using 
the data from all probes without filtering). In formula, dab = mean | Mai - Mbi |, where Mai is the value of the i-th 
probe on the a-th array. Outlier detection was performed by looking for arrays for which the sum of the distances 
to all other arrays, Sa = Σb dab was exceptionally large. One such array was detected, and it is marked by an 
asterisk, *. 
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Figure 2.6 Box plots of array signal intensity distribution (pairwise comparisons in R). (Top) E15.5 CrxGFP+ve vs 
CrxGFP-ve, (bottom) CrxGFP+ve E15.5 vs P4. Each box corresponds to one array.  
 
Figure 2.7 MA plots of array samples. M and A are defined as: M = log2(I1) - log2(I2); A = 1/2 (log2(I1)+log2(I2)), 
where I1 is the intensity of the array studied, and I2 is the intensity of a "pseudo"-array that consists of the 
median across arrays. Outlier detection was performed by computing Hoeffding's statistic Da on the joint 
distribution of A and M for each array.  
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Figure 2.8 Variance mean dependence density plot. Density plot of the standard deviation of the intensities 
across arrays on the y-axis versus the rank of their mean on the x-axis. The red dots, connected by lines, show the 
running median of the standard deviation. After normalisation and transformation to a logarithm(-like) scale, one 
typically expects the red line to be approximately horizontal, that is, show no substantial trend.  
2.4.2 Functional bioinformatics analysis of microarray genes by DAVID 
Gene lists which compared the GFP+ve and GFP-ve cells of the same stage excluding the 
outlier were analysed further. Significant genes which expressed more than 2-fold higher in 
the GFP+ve vs GFP-ve comparison (i.e. genes specific to Crx/NrlGFP+ve) and GFP-ve vs GFP+ve 
comparison (i.e. genes specific to Crx/NrlGFP-ve) from the Crx array and a previous NrlP4 array 
were subjected to functional analysis in DAVID.  Affymetrix probe IDs of the genes were 
uploaded onto DAVID and converted into IDs that DAVID uses internally (DAVID ID). Depending 
on the input gene sets, the percentage of DAVID ID varies from 75 % (E15.5 Crx-ve) to 97 % 
(E15.5 Crx+ve) for the six gene sets (Table 3.1). These percentages could roughly be considered 
as the percentage of genes that are annotated from different databases (NCBI’s Entrez, 
Uniprot, Affymetrix, Mouse Genome Informatics (MGI), etc.) as the algorithm to extract 
annotations are based on these IDs despite not all of them might be annotated. The DAVID IDs 
were subjected to DAVID Functional Annotation Chart analysis. The Chart provides a table of 
annotations with genes of similar function enriched under the same annotation. Here Gene 
Ontology (GO) annotations were analysed further. GO terms are a controlled vocabulary of 
terms describing gene and gene product characteristics and are widely used in online 
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databases to annotate genes. Default settings of the GO categories1 in DAVID were used, total 
GO chart records were retrieved for each gene set (Table 3.1), and these records were 
analysed for each gene sets. Depending on the gene sets, further statistical significance 
thresholds were set for the total GO chart records to allow only the most significant GO 
annotations to be extracted for biological themes (see table within Figure 3.3 for numbers of 
these GO terms). 
To represent the biological theme of the gene lists, the GO annotations were pulled out and 
the corresponding percentage of genes annotated with these terms were plotted as bar charts 
as shown in Chapter 3 Figure 3.3, 3.4 and 3.6. Note, this analysis represent annotations rather 
than the absolute numbers of genes; a single gene often has multiple annotations.  
To search for genes encoding cell surface proteins from the microarray gene list via the 
annotation approach, I went through the GO terms for each gene list and picked up all the 
terms which are cell surface related (see also Chapter 3, section 3.2.5.2, and Appendix table 
3.4 for GO terms selected). The genes which are annotated with these terms were pulled out 
from the DAVID analysis results. These genes were then referred back to the original 
microarray gene lists to extract their corresponding information such as gene name/symbol 
and expression fold changes and were compared between different arrays to obtain common 
and different genes. This gave the results of the cell surface related gene lists as shown in 
Chapter 3 Table 3.3. These analyses were performed in Matlab. 
2.5 RNA extraction and PCR 
RNA isolation: Retinal tissues or FACS sorted cells were lysed in TRIZol reagent (Invitrogen) and 
total RNA extracted according to the manufacturer’s instructions. Air dried RNA was dissolved 
in 30 – 50 µl RNase-free water, treated with Turbo DNase (Ambion), analysed on a 
spectrophotometer for concentration (NanoDrop ND-1000), and stored at -80°C.  
cDNA generation: 1 µg RNA and 1 µl random hexamer primers (0.5 µg/µl, Promega) were 
mixed, heated to 70°C for 10 min and  immediately cooled on ice. 4 µl MMLV-RT buffer (5X, 
Promega), 2 µl dNTP mix (10 mM, Promega), 1 µl RNase Inhibitor (Promega), 1 µl MMLV 
reverse transcriptase (Promega), and corresponding volume of Nuclease-free water were 
added to the denatured RNA mixture (final volume 20 µl). The reaction mixture was incubated 
                                                          
1
 Default settings of the gene ontology categories refer to the “FAT” format of Biological Process, 
Cellular Component and Molecular Function in DAVID, and statistic significance value p<=0.1.  
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at 42°C for 1 hour followed by 10 min at 95°C to denature the cDNA and deactivate the reverse 
transcriptase.  
PCR: Primers were designed with Primer3 aiming for a melting temperature (Tm) around 60°C 
and spanning an exon-exon junction where applicable (Table 2.3). The PCR reaction mixture 
(Table 2.4 top) and thermo-cycler programme (Table 2.5 top) were set up according to 
manufacturer’s recommendation (Bioline, BIO-21040).  
Table 2.3 Reverse-transcription PCR primers 
Primers Sequence Tm Amplicon size (bp) 
Prominin-1 GAAAAGTTGCTCTGCGAACC 60 594 
CTTGTTGCTTGTTTGCTGGA 
Cd276 ACAGGAAGATGCTTCGAGGA 60 411 
TAACAGCAGCGCTGTCAAAG 
Cd80 TGAGCCTAGGAGGTGCCTAA 60 330 
TTCCCAGCAATGACAGACAG 
Cd83 TCCAGCTCCTGTTTCTAGGC 59 344 
TCCTGTCACCTTCAGAACCA 
GAPDH TTCCAGTATGACTCCACTCACG 60 491 
GGATGCAGGGATGATGTTCT 
Cd73 CAA ATC CCA CAC AAC CAC TG 60 158 
TGC TCA CTT GGT CAC AGG AC 
Real-time quantitative PCR: TaqMan® Gene Expression Assays which contain the PCR primers 
and a TaqMan® probe with a FAM™ dye label (FAM = 6-carboxy-fluorescein) and minor groove 
binder (MGB) moiety on the 5' end, and non-fluorescent quencher (NFQ) dye on the 3' end,  
were purchased from Applied Biosystems for each gene investigated (Prom1, Sema7a, Cdhr1, 
Sv2b). Gapdh FAM™ was used as the internal control. The PCR reaction mixture (Table 2.4 
bottom) (TaqMan® Fast Univ PCR Master Mix, 4352046) and thermo-cycler programme (Table 
2.5 bottom) were set up according to manufacturer’s recommendation. Each sample was 
triplicated in a 96-well plate and ran on 7500 Fast Real-time PCR System. The data was 
analysed with Applied Bioscience’s 7500 System software.  
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Table 2.4 Polymerase chain reaction mixture 
Reagent Volume 
Template DNA 1 µl 
dNTPs (2mM, Promega) 2.5 µl 
10x NH4 buffer (Bioline)  2.5 µl 
MgCl2 (50mM, Bioline)  0.75 µl 
Forward primer (25 µM)  1.5 µl 
Reverse primer (25 µM) 1.5 µl 
Taq DNA polymerase (5U/μl)  0.1 µl (0.5U) 
Nuclease-free H2O  to 25 µl total volume 
TaqMan® q-PCR 1x well 
mQ water 4.7 µl 
2x Master Mix buffer 6 µl 
assay (probe+FAM, quencher) 0.6 µl 
cDNA 0.7 µl 
Final volume total 12 µl per well 
 
Table 2.5 PCR thermocycler programme 
95°C 2 min Denature 
95°C 30 sec  
58°C 30 sec 30 cycles 
72°C 45 sec   
72°C 5 min Final elongation 
TaqMan® q-PCR   
95°C 20 sec  
95°C 3 sec 60 cycles 
60°C 30 sec   
 
2.6 Immunohistochemistry 
2.6.1 Immunohistochemistry of eye cryosections 
Eyes or embryos were fixed in 4% paraformaldehyde/PBS (PFA), rinsed in PBS, equilibrated in 
30% sucrose, embedded in optimal cutting temperature (OCT) compound (RA Lamb), and 
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frozen at -80°C. Sections were cut vertically (with the optic nerve in parallel with the section 
plane) in 12 or 18 µm thickness with a cryostat (Leica CM1900 UV), collected onto SuperfrostTM 
plus glass slides (VWR, Cat No. 631-0108) and stored at -80°C. Upon immunohistochemistry, 
the sections were air dried on bench for 45 min, washed in 37°C PBS 10 min, incubated with 
blocking solutions (PBS containing 10 % (v/v) fetal bovine serum and 1 % (w/v) bovine serum 
albumin (BSA),and 0.1 % (v/v) Triton X-100 when needed) for 1hr at room temperature before 
antibody incubation. Each slide was incubated with 100 – 200 µl antibody-containing blocking 
solutions and was covered with a Parafilm to prevent flow or dry out of the solutions. For 
antibody conditions see Table 2.6 and Table 2.7. The sections were washed in PBS for at least 3 
X 10 min following antibody incubations. Nuclear dye Hoechst 33342 (Sigma, 1:2000 to 1:5000) 
was either added into the secondary antibody blocking solution or added into PBS and 
incubated with slides for 10 min at room temperature after secondary antibody incubation 
followed by PBS wash. The slides were then mounted with Citifluor AF-1 (Electron Microscopy 
Science) and sealed with glass coverslips (Scientific Laboratories Supplies Ltd, 22X50 mm, 
thickness No. 1.5) using nail-polish.  
2.6.2 Immunocytochemistry of dissociated cells 
Round coverslips (Scientific Laboratories Supplies Ltd, thickness No. 1.5) were washed with 
Industrial methylated spirit (IMS) and water and then sterilized by baking in the oven for 4 hr 
at 180°C. The sterilized coverslips were put into a sterile 24-well plate and coated with 400 µl 
poly-L-lysine per well (Sigma, P4707). After 2 hrs incubation at 37°C, the poly-L-lysine was 
removed and the coverslips were washed with PBS three times. The dissociated retinal cells 
were then seeded onto the coverslips (20,000 cells per well of 24-well plate) and incubated 
with medium at 37°C for around 2 hrs. After removal of the medium, the coverslips were fixed 
with 4 % PFA for 10 min and rinsed with PBS three times. The coverslips were then removed 
from the wells and sequentially incubated with 50 µl blocking solutions, antibody solutions, 
and Hoechst 33342 solutions with the cell side facing down toward the solution droplets 
placed on parafilm. The coverslips were then mounted on to SuperfrostTM plus glass slides with 
Citifluor AF-1 and sealed with nail-polish. 
2.6.3 Antibodies and peptides 
The antibodies and peptides used for immunohistochemistry were listed in Table 2.6 (primary 
antibodies) and Table 2.7 (secondary antibodies).  
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2.6.4 Microscopy and image processing 
For quantification of the number of integrated cells after transplantation and epifluorescent 
images, retinal sections were viewed on a Zeiss Axioplan 2 and images captured via a Jenoptik 
C14 digital camera using OpenLab (Improvision) and dissociated retinal cells were viewed on 
an Olympus IX71. Confocal images or image stacks were acquired with a Zeiss LSM 710 using 
ZEN 2009 (Zeiss). Hoechst33342 or AlexaFluor405 was excited by a 405 nm diode laser, GFP or 
AlexaFluor488 by a 488 nm Argon laser, AlexaFluor594/568 by either a 561 nm diode laser or a 
594 nm HeNE laser, and AlexaFluor647 or DyLight™ 649 by a 633 nm laser. The objectives used 
were 20x Plan Apochromat Dry, 25x LD LCI Plan Apochromat Multi-immersion, 40x C-
Apochromat Water immersion, and 63x Plan-Apochromat Oil immersion and transmitted light 
illumination with differential interference contrast (DIC) prism was often used. Images were 
processed in Photoshop CS4 (Adobe) or ImageJ (open source) and presented in Illustrator CS4 
(Adobe). Quantification of multi-color labeled cells or signal intensity of the images was 
performed in ImageJ.  
 
 
44 
  
Table 2.6 Primary antibodies 
Primary antibody Clonality Host (Isotype) Company Catalogue No. Dilution 
Incubation 
condition 
Prominin-1 (clone 13A4) monoclonal Rat (IgG1, κ)  eBioscience 17-1331-81 1:300 4°C, O/N 
GFP, Alexa Fluor® 488 Conjugate polyclonal 
Rabbit IgG 
fraction Invitrogen A-21311  1:500 4°C, O/N 
Chx10  polyclonal Sheep  Chemicon ab9016 1:1000 4°C, O/N 
recoverin  polyclonal Rabbit  Millipore AB5585 1:1000 4°C, O/N 
Rxrγ polyclonal Rabbit  Abcam ab15518 1:300 4°C, O/N 
Sema7a  polyclonal Rabbit  Abcam ab23578 1:1000 4°C, O/N 
Sema7a peptide N/A synthetic Abcam ab30844 4 µg/ml 4°C, O/N 
Itgb1 (CD29)  monoclonal Hamster  eBioscience 14-0291 1:300 4°C, O/N 
Plexin C1 (CD232)  polyclonal Sheep  R&D systems AF5375 1:200 4°C, O/N 
Pcdh15 polyclonal Rabbit  The Scripps Research Institute, USA N/A 1:200 4°C, O/N 
Bassoon (SAP7F407) monoclonal Mouse (IgG1) Enzo Life Sciences 
ADI-VAM-
PS003 1:2000 4°C, O/N 
Dystrophin (C-terminus) monoclonal Mouse Novocastra NCL-DYS2 1:20 4°C, O/N 
acetylated tubulin  monoclonal  mouse (IgG2b) Sigma T7451 1:1000 4°C, O/N 
γ-tubulin  monoclonal  mouse (IgG1)  Sigma T5326 1:200 4°C, O/N 
polyglutamylated tubulin (GT335) monoclonal mouse (IgG1κ) Enzo Life Sciences ALX-804-885 1:500 4°C, O/N 
CENPF monclonal mouse (IgG2aκ) Abcam ab90 1:200 4°C, O/N 
 
 
  
The isotype is IgG if not stated otherwise.  Anti-Pcdh15 antibody is a kind gift from U. Mueller, The Scripps Research Institute, USA. Anti-acetylated tubulin, anti-γ-tubulin , anti-
polyglutamylated tubulin (GT335), anti-CENPF (Abcam, ab90, 1:200) antibodies are kind gifts aliguots from Prof Philip Beale (UCL Institute of Child Health) 
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Table 2.7 Secondary antibodies 
Secondary antibody Fluorochrome Host Company Catalogue No. Dilution Incubation condition 
Anti-rabbit  
Alexa Fluor® 647 Goat  Invitrogen A-21245 1:500 30 min - 1 hr, RT 
 Alexa Fluor® 594 Goat  Invitrogen A-11037   
 Alexa Fluor® 488 Goat  Invitrogen A-11008   
 Alexa Fluor® 405 Goat  Invitrogen A-31556   
Anti-sheep Alexa Fluor® 568 Donkey Invitrogen A-21099   
 Alexa Fluor® 488 Donkey Invitrogen A-11015   
Anti-goat Alexa Fluor® 594 Rabbit Invitrogen A-11080   
Anti-mouse Alexa Fluor® 594 Goat  Invitrogen A-11032   
Anti-mouse IgG, IgM Alexa Fluor® 488 Goat  Invitrogen A-10680   
Anti-mouse IgM (µ chain) Alexa Fluor® 594 Goat  Invitrogen A-21044   
Anti-hamster (Armenian) DyLight™ 649  Goat  BioLegend 405505   
Anti-rat Alexa Fluor® 594 Goat  Invitrogen A-11007   
 
 
The target isotype is IgG if not stated otherwise.  
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2.7 Hematoxylin and eosin staining for frozen sections 
Frozen slides were thawed at room temperature for 20 min and baked at 37°C for 30 min 
followed by standard hematoxylin and eosin (HE) staining procedure. Briefly, the slides were 
immersed in distilled water (dH2O) 1 min to remove OCT followed by immersion in 
Hematoxylin solution (Mayer’s, Sigma) for 2 min and dH2O for 2 min. The slides were then put 
under running tap water for 5 min followed by immersion in aqueous 1% Eosin (Acros Organics) 
for 1 min and under running tap water again for 5 min. The slides were then dehydrated by 
immersion in 70% ethanol 2 min, 95% ethanol 2 min, 100% ethanol 2 min two times and 
histoclear (National Diagnostics, Hessle) 5 min sequentially. The slides were mounted with DPX 
(a mixture of distyrene, a plasticizer, and xylene, BDH) and left in hood overnight until dry. 
Images were taken with a Zeiss Axiophot 2. 
2.8 Western blot 
Mouse retina was extracted with RIPA buffer for Western blot. 0.2 ml RIPA buffer were used 
for every 8 adult retina. The retina tissues were triturated with a pestle and incubated on ice 
15 min to lyse and spun down at 14000 rpm 4°C 15 min. The supernatant were collected into a 
fresh tube and stored at -80°C. Protein concentration was quantified using Pierce BCA protein 
assay kit (Thermo Scientific Catalogue# 23227). 96-well plates were used and absorbance at 
595 nm was read with a Bio-rad Model 680 microplate reader. 40 µg protein samples were 
mixed with 5 µl 5X loading buffer, boiled at 100°C for 5 min just before loading and resolved in 
SDS-PAGE (10% resolving gel, 5% stacking gel) at 100 v for around 2 hrs.  
The gels were then transferred to nitrocellulose membranes (GE Healthcare, Life Sciences, 
WhatmanTM Protran BA83, Cat#10402495) using Trans-Blot® SD Semi-Dry Transfer Cell (BIO-
RAD) at 18v for 1hr. The membranes were blocked in blocking solutions (PBS containing 0.5% 
Tween and 2% milk) at room temperature for 1 hr, followed by primary antibody incubation at 
4°C overnight, PBS wash 3X 10 min, HRP secondary antibody incubation 1hr room temperature, 
PBS wash 3X 10 min, and ECL (GE Healthcare) developing using Amersham HyperfilmTM. 
Primary antibodies used here were the same as the ones in Immunohistochemistry but using 
lower concentrations (Sema7a 1:4000, PlxnC1 1:1000, Itgb1 1:4000, β-actin 1:10000 (mouse)). 
HRP secondary antibodies were used at 1:4000 dilution (donkey anti sheep HRP (Abcam, 
ab6900) for PlxnC1, goat anti rabbit HRP (Dako, REF P0448) for Sema7a, rabbit anti hamster 
(Abcam, ab5745) for Itgb1, and rabbit anti mouse HRP (Dako, REF P0260) for β-actin). 
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2.8.1 Western blot solutions 
10% SDS solution: 100 g SDS dissolved in 1L Milli-Q water keep stirring until the solution 
becomes clear. 
10% Ammonium persulfate (APS): 2 g APS dissolved in 20 ml Milli-Q water. 
RIPA Lysis buffer: 50 mM Tris-HCl pH7.4, 150 mM NaCl, 1 mM PMSF (omitted in my current 
solution as n/a), 1 mM EDTA, 1% Triton X-100, 0.1% SDS, 1% Sodium Deoxycholate, 1 tablet of 
protease inhibitor mixture (Roche, Complete Mini, REF11836153001) per 10 ml buffer.  
5X protein loading buffer: For a total volume of 10 ml, 2.5 ml 20% SDS, 500 µl 1M DTT, 2.5 ml 
1M Tris-HCl pH 6.8 and 2.5 ml Glycerol was mixed with 0.1 g (w/v) bromophenol blue. Store at 
-80°C until use. 
10X Western Running buffer: 30 g Tris base, 144 g glycine and 10 g SDS were dissolved in 1L 
Milli-Q water. 
Transfer buffer: For 500 ml transfer buffer: 50 ml 10X Western Running Buffer, 100 ml 100% 
methanol and 350 ml dH2O. 
0.5% (v/v) PBS-Tween: 5 ml Tween-20 dissolved in 1L PBS. 
2.9 Transplantation of photoreceptor cells 
Collection of CrxGFP-positive cells was performed via FACS similar to as described in section 
2.3. Cells were collected directly into 15 ml falcon tubes with DMEM medium contain 50% 
serum which will be diluted to around 10% after cell sorting. The cells were then centrifugated 
at 157 g (900 rpm) for 10 min at 4°C and the medium removed. Cells were resuspended in 1 ml 
of 10% serum containing DMEM medium and transferred into 1.5 ml eppendorf tubes and 
transported on ice to the Institute of Ophthalmology for injection. Cells were centrifuged again 
(157 g (940 rpm), 10 min) and medium removed. Appropriate amounts of injection medium 
(5.26% DNase in EBSS) was added to the cell pellet to concentrate the cells into 200, 000 
cells/µl. The cell suspension was transferred on ice into a round bottomed microtube. 1 µl cell 
suspension was injected into the subretinal space between the RPE and ONL of each eye of the 
anesthetised host mice (performed by Dr. Rachael Pearson) and as described (MacLaren, 
Pearson et al. 2006). Recipient mice were sacrificed 3 days to 1 month after injection and their 
eyes collected for immunohistochemistry or imaging and quantification as described in section 
2.2.2 and 2.6.1.  
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2.10 Mass Spectrometry 
After collection of the GFP positive and negative cells from the FACS cell sorter, the cells (5 
million minimum) were lysed and membrane proteins extracted using membrane protein 
extraction lysis buffer (Mem-PER® Pierce). Briefly, the membrane proteins were solubilized 
using a detergent and the hydrophobic proteins were separated from hydrophilic proteins 
through phase partitioning after centrifugation and 37°C incubation. The membrane protein 
concentration was determined according to a standard curve produced using BSA and 
bicinchoninic acid assay (BCA assay) through a spectrophotometer UV mini 1240 (Shimadzu). 
Between 200 to 400 μg proteins per sample were submitted for liquid chromatography/mass 
spectrometry (LC/MSe) analysis using the ElectroSpray Ionisation-Quadrupole – Time-of-Flight 
(ESI-QTOF) mass spectrometer (performed by Dr Wendy Heywood and Dr Kevin Mills from 
Biological Mass Spectrometry Center, ICH, UCL). S. cerevisiae enolase 1 (Eno1_Yeast) has 
always been included in the samples as a positive quality control. The data were run against 
the mouse database and an all species database for any proteins not described yet in mouse.  
2.11 shRNA construction and molecular cloning 
For genes of particular interest such as Sema7a, I attempted to evaluate its effect via knocking 
down with shRNAs (see Chapter 4, section 4.2.5 and Appendix 4.1). Four shRNAs sequences 
were synthesized (Appendix 2.1, Appendix figure 4.1.2 A) with two of the target sequences 
based on Origene products and two target sequences designed using Dharmacon siDESIGN 
Center. The sequences were annealed and ligated with the backbone of mU6 pro vector which 
was digested with BbsI/XbaI (NEB). The ligations were transformed into competent DH5α 
(Invitrogen, 18265-017), five colonies for each ligation were randomly picked and minipreped. 
Correct ligations were confirmed with AscI/SnaB1 (NEB) digestion for 400 bp products. The 2nd 
colonies of each shRNA ligation were midi-preped and sent to UCL for sequencing (primer 
M13R2). 
Annealing: the shRNA sequences were resuspended into 1ug/ul and equal amounts of both 
strands were mixed together. The mixture were heated at 95 °C for 3min and cooled down on 
the bench.  
Ligation: 50 -100 ng vector and 5 ng inserts (for molar ration 3:1 between inserts and vector) 
were incubated with ligase (Promega, T4 DNA ligase, M180A, 28521916) and ligation buffer 
over night at room temperature.  
Transformation: add 10 µl ligation reaction into 50 µl DH5α, incubate on ice for 10 – 15 min 
followed by 30 sec heat shock at 42°C and immediately on ice for 2 min, spread the 
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transformed cells onto pre-warmed lysogeny broth (LB) Agar plates (with 50 µg/ml ampicillin) 
and incubate at 37°C overnight with plates facing down.  
Mini or Midi preparation: single colonies from Agar plates (or around 3 ml mini culture for 
midi culture) were seeded into 5 ml LB broth containing 50 µg/ml ampicillin (or 50 ml LB broth 
for midi culture) near flame and cultured in a shaker at 187 rpm 37°C overnight. The plasmid 
DNA was then purified using Qiagen kits (QIA prep Spin Miniprep kit, Cat 27104; Qiagen 
Plasmid Midi Kit, Cat 12143).  
2.12 shRNA transfection of cell lines 
Human Embryonic Kidney (HEK) 293 cell line and mouse osteoblastic precursor (MC3T3) cell 
line were tested for the knocking down efficiency of Sema7a expression using a Sema7a 
expression vector (Sema7a mouse cDNA clone ORF with C-terminal GFP tag, OriGene, Catalog 
No. MG209876) co-transfected with the shRNA sequences (see Appendix 4.1). Expression of 
exogenous Sema7a was evident as shown by the GFP expression in cells transfected only with 
the expression vector and not the shRNA sequences. The cells were seeded at 1.2 – 1.5 x 105 
cells per well in 6-well plates the day prior to transfection and were transfected when they 
reach ~ 70% confluence. For each well to be transfected, 500 ng DNA (mixed into 50 µl PBS) 
were well mixed (by pipetting) with 6 µl lipofectamine 2000 (Invitrogen, 11668-027) (which is 
also mixed into 50 µl PBS) and incubated for 20 min at room temperature prior addition to the 
cell. The cells were incubated with the above transfection mixture for 4 – 6 hr or overnight 
before changing back to growth medium (DMEM (for HEK293 cells) or MEM alpha (for MC3T3 
cells) media + 10 % FBS). Cells were examined for morphology and GFP expression under 
microscope and RNA was harvested 24 – 48 hr after transfection and subject to PCR and qPCR 
analysis.  
2.13 Statistical analysis 
Statistical analysis for standard deviation, Student’s t-test (a parametric significance test), 
generation of bar chart, histogram and dot plot, were performed in Excel 2010 (Microsoft). 
Generation of box plot and Mann-Whitney test (a non-parametric significance test) were 
performed in SPSS 16.0 (IBM). The p value in DAVID analysis refers to Benjamini value unless 
stated otherwise.  
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3 Transcriptome analysis of photoreceptor precursors 
3.1 Introduction 
Despite much effort in the field of retina transplantation, demonstration of efficient 
integration and visual function of transplanted cells was minimal (reviewed in (West, Pearson 
et al. 2009)). In 2006, it was shown that donor cells, if isolated from an ontogenetic stage when 
they have just committed to the photoreceptor fate, rather than from the early proliferating 
stage of stem/progenitor cells, are able to efficiently integrate into the adult recipient retina, 
form functional synapses with other retinal neurons and improve vision after transplantation 
(MacLaren, Pearson et al. 2006). This was demonstrated using donor cells isolated from an 
NrlGFP transgenic line which only labels postmitotic rod photoreceptor cells (Akimoto, Cheng 
et al. 2006; MacLaren, Pearson et al. 2006). Nrl is a transcription factor which specifies rod fate 
(see Chapter 1, section 1.4.2.2) and its transcript is detected at E12 from the onset of rod 
differentiation (Akimoto, Cheng et al. 2006). The NrlGFP line showed GFP expression in a few 
cells (with long exposure) at E12 and stronger progressive expression from E16 onwards 
(Akimoto, Cheng et al. 2006).  Further work with sorted postnatal NrlGFP labeled rod precursor 
cells showed around 4-fold higher integration rates than unsorted retinal cells (Pearson, 
Barber et al. 2012). These data showed that the postnatal photoreceptor precursor cells are 
potent for efficient transplantation. Yet, it is not understood fully why these cells are of high 
transplantation potential.  
Because cone photoreceptors, although far less than rods in numbers, are responsible for day 
light vision and visual acuity, it is important to understand their properties as well in order to 
better utilize these cells for transplantation. Different from rods which are generated from E12 
to P10, cones are born over a much shorter window prenatally and peak at E14 (see Chapter 1, 
Figure 1.2). As Nrl does not label cones, a CrxGFP transgenic line was developed to label both 
cones and rods (Samson, Emerson et al. 2009). Crx is regarded as the earliest transcription 
factor to lineate and maintain rod and cone fate (Chapter 1, section 1.4.2.2). It is transcribed 
from around E12 and progressively increases till photoreceptor maturation (Furukawa, 
Morrow et al. 1997). CrxGFP expression in the transgenic line was clearly detectable from 
E13.5 and became prominent in postnatal and adult retina  (Lakowski, Baron et al. 2010). At 
E15.5 shortly after the birth peak of cones, Baron observed over 95% CrxGFP+ve cells stain 
positively for a cone photoreceptor specific nuclear receptor, Rxrγ (retinoid X receptor-γ) 
(Figure 3.1 A, (Lakowski, Baron et al. 2010; Baron 2012)) indicating that the CrxGFP+ve cells at 
E15.5 are mainly cones. Transplantation studies using these cells as donor cells found that the 
E15.5 CrxGFP+ve cells gave rise to both cones and rods after transplantation ((Lakowski, Baron 
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et al. 2010), illustrated in Figure 3.1 B). In comparison, the P4 CrxGFP+ve cells only gave rise to 
rods after transplantation (Lakowski, Baron et al. 2010). However, the integration efficiency of 
the postnatal cells was 10-fold higher than the embryonic cells (median 5610 range 754 – 
15402 integrated cells per eye for P3 vs median 334 range 42 – 1466 integrated cells per eye 
for E14.5 (Lakowski, Baron et al. 2010)). As the recipient environments are the same, the 
different behavior of the embryonic and postnatal photoreceptor precursor cells after 
transplantation must due to their intrinsic properties which remains unknown on this respect. I, 
therefore, intend to understand the property changes of the photoreceptor precursors from 
less transplantation-favorable status (E15.5) to more transplantation-favorable status (P4), and 
to understand why early precursors (E15.5) can give rise to both cones and rods but late 
precursors (P4) only give rise to rods. 
One way to understand the properties of photoreceptor precursors is to analyze their 
transcriptomes. Then by comparing their transcriptome with other cell types, molecular 
features that are photoreceptor specific may be identifed. Other retinal cells of the same stage 
as the photoreceptor precursor cells are the best subject for such comparison. Also 
differentiated from multipotential RPCs, other retinal cells may share more common features 
with photoreceptor cells as opposed to other cell types hence their comparison with 
photoreceptor cells may reveal the most unique feature of photoreceptor cells. Further, by 
comparing the photoreceptor-specific transcriptomes of the early and late precursors I expect 
to elucidate some molecular properties that determine their different transplantation behavior.   
Most previous microarrays were performed on full retina of postnatal stages without 
distinguishing between photoreceptor cells and other retinal cells (Dorrell, Aguilar et al. 2004; 
Hackam, Qian et al. 2004; Zhang, Xu et al. 2005; Liu, Wang et al. 2006; Punzo, Kornacker et al. 
2009). Blackshaw et al microdissected ONL from retina cryostat sections and performed serial 
analysis of gene expression (SAGE) study of E12.5 to P6.5 and adult mice ONL and identified 
rod-specific genes (Blackshaw, Fraioli et al. 2001) and genes expressed in RPCs and developing 
PR/interneurons (Blackshaw, Harpavat et al. 2004). Although postnatal ONL mainly contains 
rods and cones, microdissection cannot exclude the remaining progenitor cells and processes 
from Müller glia cells in ONL and possibly processes from other inter neurons at OPL. Further 
in embryonic stages ONL/ONBL is not easily identifiable and contains more progenitor cells, 
which cannot be separated from photoreceptor cells by microdissection. To compare the 
transcriptomes of photoreceptor precursor cells of different stages and vs other retinal cells, I 
aimed to conduct a microarray using E15.5 and P4 retinal cells taking advantage of the newly 
developed CrxGFP line (Figure 3.1 C) (Samson, Emerson et al. 2009). As CrxGFP labels bipolar 
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cells and all photoreceptor cells including both cones and rods, FACS allows direct comparison 
of photoreceptor cells versus other retinal cells. 
Previously in our lab a microarray was conducted using the NrlGFP-sorted P4 retinal cells by 
my colleague Jorn Lakowski although functional bioinformatics analysis wasn’t performed. This 
allows comparison of rod precursors vs non-rod retinal cells. With this data, I also planned to 
compare the NrlGFP cells with CrxGFP cells. As CrxGFP positive cells should be constituted of 
rods, cones, and bipolar cells while NrlGFP positive cells should only contain rods, comparison 
of NrlGFP and CrxGFP positive cells might reveal genes which are specific to cones. In both 
array experiments, the photoreceptor precursor population was compared with its 
corresponding non-photoreceptor-precursor retinal cell population to produce a pair of 
photoreceptor-specific gene set and non-photoreceptor retinal gene set (see workflow in 
Figure 3.1 B and C) which will be analysed and compared further.  
Usage of the Nrl/CrxGFP transgenic line has greatly facilitated our research on retinal cell 
transplantation by enriching photoreceptor cells, but cannot be used in the clinic as it is not 
suitable to use such similar system for humans. Furthermore Nrl and Crx are expressed 
throughout the lifespan of photoreceptor cells; hence they do not allow stage-selection for the 
precursor cells only. It is therefore necessary to identify new markers that can be used to 
isolate photoreceptor cells without genetic modification and that only isolate stage specific 
precursor cells. Therefore, I aimed to screen out photoreceptor-specific cell surface molecules 
from these microarray data. Not only can these surface molecules be used to identify 
signatures and isolate the photoreceptor cells, but also they may help to understand the 
integration process of the migrating cells in the developmental context and transplantation 
environments.  
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Figure 3.1 Early vs late photoreceptor precursors and work flow (A) The majority of CrxGFP+ve cells is Rxrγ+ve. 
Adapted from (Baron 2012). (B) Early and late photoreceptor precursors behave differently. Early photoreceptor 
precursors (embryonic day 15, E15) labelled by CrxGFP give rise to both cones and rods after transplantation, but 
show low integration (~ median 640 cells) (Lakowski, Baron et al. 2010). Late photoreceptor precursors (postnatal 
day 4, P4) labelled by CrxGFP or NrlGFP show high integration (~ median 5600 cells) (Lakowski, Baron et al. 2010), 
but only give rise to rods. (C) Workflow of microarray analysis for early and late CrxGFP positive and negative 
retinal cells. (D) Workflow of analysis for the three available microarray datasets.  
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3.2 Results 
3.2.1 Expression profiles of transgenic lines and generation of gene lists 
Before my preparation of the microarray based on CrxGFP-sorted retinal cells, two other RNA 
microarray databases were also available for analysis: 1) comparison of P4 NrlGFP positive and 
negative cells prepared by Jorn Lakowski from our lab (referred to as the NrlP4 array). 
Generation of the gene list from the NrlP4 array data was prepared by UCL genomics with 
Bioconductor and R. 11,850 genes were significant differentially expressed between P4 NrlGFP 
positive and negative cells (p < 0.05). I intend to analyse this data using the same method as 
that of the CrxGFP-based array (see work flow of the analysis in Figure 3.1 D). 2) Comparison of 
NrlGFP wild-type cells with Nrl-knockout-GFP cells along development (E16, P2, P6, P10 and 
P28) deposited in Gene Expression Omnibus (GEO) from Anand Swaroop’s group (Akimoto, 
Cheng et al. 2006) (referred to as Swaroop array). This data is used to identify genes showing 
dynamic temporal expression profiles. Requested by my supervisor Jane Sowden, UCL 
genomics identified 2,067 genes showing more than 2-fold expression changes during 
development from this array and generated box plots to show the developmental expression 
profiles (Lakowski, Han et al. 2011). I used this dataset to search for cell surface molecules and 
to check for developmental expression profiles of interested genes. Work flow of the analysis 
was shown in Figure 3.1 D.   
3.2.1.1 GFP expression profiles of transgenic reporter lines 
I first examined the retinal expression profiles of the transgenic GFP mouse lines by IHC to 
assess their cell expression specificity. These were CrxGFP, NrlGFP, and Fgf15GFP which is a 
line labelling RPCs in the early embryonic retina ((Decembrini, Cananzi et al. 2011) 
Supplementary figure S1). As a member of fibroblast growth factor (FGF) family, Fgf15 is 
expressed in brain from early stages of neurulation (E8.5) to postnatal period (Gimeno, Brulet 
et al. 2003). From E9.5 Fgf15 transcript was detected in the neural epithelium of the optic 
vesicles (Gimeno, Brulet et al. 2003) and was highly expressed at E14 and E16 in outer nuclear 
blast layer (ONBL) of the retina and stayed until P0 (Blackshaw, Harpavat et al. 2004). Cell 
specificity of the Fgf15GFP line in later retinal development was uncharacterized. If it 
specifically labels RPCs, it could be used for microarray comparison with the photoreceptor cell 
lines to understand why photoreceptor precursor cells can integrate after transplantation but 
progenitor cells cannot.  
Agreeing with previous studies (Samson, Emerson et al. 2009; Lakowski, Baron et al. 2010), 
CrxGFP labeled a portion of ONBL cells located at the outermost two or three rows of ONBL 
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cells at E15.5 (Figure 3.2 A1 – A3). Retaining the high expression at the outer edge of ONBL, 
CrxGFP expression expanded to seven or eight rows in the P4 ONBL (Figure 3.2 B1 – B3). 
Expression of NrlGFP was also evident at P4 agreeing with the previous study (Akimoto, Cheng 
et al. 2006). While CrxGFP expression at E15.5 and P4 and NrlGFP expression at P4 seemed 
comparable for the number of photoreceptors at these stages, expression of Fgf15GFP was in 
both RPCs and other retinal cells at E15.5 (Figure 3.2, D2 and E2). I then examined Fgf15GFP 
expression relative to an RPC marker Chx10 (ceh-10 homeo domain containing homolog (C. 
elegans)) and a cone photoreceptor marker Rxrγ. IHC against Chx10 showed that Fgf15GFP not 
only recognized Chx10+ve cells (filled arrowheads, Figure 3.2 D1 – D3), but also Chx10-ve cells 
(empty arrowheads, Figure 3.2 D1 – D3). Fgf15GFP was also expressed in Rxrγ+ve cells (filled 
arrowheads, Figure 3.2 E1 – E3). (Note although labeling the same cell, Fgf15GFP was 
expressed in the cytoplasm thus it did not colocalize with Chx10 and Rxrγ which were in the 
nucleus.) This showed clearly that Fgf15GFP not only labeled RPCs, but also non-progenitor 
cells including photoreceptor cells. Flow cytometry analysis showed that while only ~ 34% 
GFP+ve cells were detected in the E15.5 CrxGFP retinal cells (Figure 3.2 G), ~ 98% GFP+ve cells 
were detected in the E15.5 Fgf15GFP retinal cells (Figure 3.2 H) showing that the Fgf15GFP 
labeled nearly all the retinal cells an not only the progenitor cells. Taken together, the 
Fgf15GFP population was not considered useful for microarray analysis as a line to provide 
RPCs as it also coexpressed with the CrxGFP photoreceptor population; the CrxGFP strain, 
however, remains a good line to label photoreceptor cells.  
3.2.1.2 Generation of gene lists from microarray  
CrxGFP-sorted cells from E15.5 and P4 retina were collected by FACS (see Chapter 2 section 2.3 
for cell sorting and Figure 2.1 for sorting gate) and subjected to microarray analysis (referred 
to as the CrxE15 array and CrxP4 array respectively or Crx array together) (see Chapter 2 
section 2.4 for microarray analysis). In brief, a total of 19 litters E15.5 embryos (~133 embryos) 
and 24 P4 retinas were used for sorting to collect the GFP+ve and GFP-ve cells. A minimum of 3 
million cells per RNA sample and three RNA samples per cell type (E15.5 Crx+ve, E15.5 Crx-ve, 
P4 Crx+ve, and P4 Crx-ve) were prepared and hybridized to arrays (see Chapter 2 section 2.3 
section 2.4 for methods and Appendix Table 2.1 for sample preparation summary). Analysis of 
the raw microarray data and generation of the gene lists showing significantly altered 
expression levels were performed by UCL genomics. The array was considered successful but 
one possible outlier sample was identified (see Chapter 2 section 2.4). Significant differentially 
expressed genes between pair-wise comparisons were identified using Partek (Table 2.1 and 
2.2). Gene lists which exclude the outlier and compared between GFP+ve and GFP-ve cells 
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were used for further analysis. 4,487 genes were differentially expressed between P4 CrxGFP 
positive and negative cells while 103 genes were differentially expressed between E15.5 
CrxGFP positive and negative cells, and 3,236 genes were differentially expressed between 
E15.5 CrxGFP positive and P4 CrxGFP positive cells (False Discovery Rate (FDR) <=0.05) (Table 
2.1).  
For the NrlP4 array data, I divided the total differentially expressed genes into NrlGFP+ve gene 
set and NrlGFP-ve gene set and performed gene ontology analysis and cell surface marker 
search on both sets (Work flow of the analysis was shown in Figure 3.1 D). The NrlP4 and Crx 
array gave direct comparisons between photoreceptor precursors and other retinal cells, so I 
mainly analysed these two arrays in order to understand the photoreceptor precursor cells and 
find out markers specific to them. The Swaroop array was constantly referred back to check for 
developmental expression patterns of a particular gene under examination. Table 3.1 shows a 
summary of differentially expressed genes and comparison with the previously conducted P4 
NrlGFP array experiment (Lakowski, Han et al. 2011).  
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Figure 3.2 Expression profiles of CrxGFP, NrlGFP, and Fgf15GFP transgenic lines in the retina (continues).  
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Figure 3.2 Expression profiles of CrxGFP, NrlGFP, and Fgf15GFP transgenic line in the retina – continued. (A1 – E3) 
Confocal images of CrxGFP retina at E15.5 (A1 – A3) and P4 (B1 – B3), NrlGFP retina at P4 (C1 – C3), and Fgf15GFP 
retina at E15.5 (D1 – E3) stained with Chx10 (D1) and Rxrγ (E1). Fgf15GFP labels nearly all the embryonic retinal 
cells and does not differentiate between progenitor cells and other cells. Solid arrowheads denote Chx10 or Rxrγ 
positive, empty arrowheads denote Chx10 or Rxrγ negative. Red: Chx10 or Rxrγ; Green: GFP; Blue: Hoechst 33342. 
Scale bar 25 µm. RPE: retina pigment epithelium; INBL: inner neuroblastic layer; ONBL: outer neuroblastic layer. 
(F – H) Flow cytometry represents the percentage of GFP+ve cells (top two quadrants) in the E15.5 retina of wild 
type (F), CrxGFP (G), and Fgf15GFP (H) mouse. X-axis: Forward scatter represent cell size; Y-axis: GFP intensity.  
 
 
Table 3.1 Microarray gene numbers and DAVID analysis of the GFP+ve and GFP-ve gene sets 
Array group 
Affy ID 
(p<0.05) 
Affy ID 
(p<0.05, FC>2) 
DAVID 
ID 
ID % 
GO chart 
records 
Cell surface 
related genes 
E15.5 Crx+ve 85 63 61 97% 94 9 
E15.5 Crx-ve 18 8 6 75% 16  
P4 Crx+ve 2147 627 556 89% 210 127 
P4 Crx-ve 2340 1001 825 82% 430  
P4 Nrl+ve 5626 978 901 92% 328 197 
P4 Nrl-ve 6224 1786 1450 81% 651  
 
  
FC: fold change; Affy ID: Affymetrix probe ID, only genes with statistically significant (p<0.05) expression differences and more than 2-
fold expression changes were selected for further DAVID analysis; DAVID ID: an internal ID that DAVID use to identify unique 
gene/protein records; ID %: percentage of DAVID ID out of input Affymetrix ID; GO chart records: total number of gene ontology 
terms significantly enriched in the gene lists than random gene lists generated from the genome; Cell surface related genes: total 
number of genes annotated with cell-surface-related GO terms; P4: postnatal day 4; E15.5: embryonic day 15.5; +ve: GFP positive; -
ve: GFP negative.  
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3.2.2 Analysis of photoreceptor precursors vs other retinal cells  
I expect that photoreceptor precursor transcriptomes will show different properties from 
other retinal cells of the same stage. To examine what the differences are, I extracted the 
biological themes of each gene set based on annotation databases of all genes currently 
annotated (NCBI’s Entrez, Uniprot, Affymetrix, MGI). The biological theme is summarized from 
the most significant functional annotations obtained from each gene set (significant 
annotations refer to annotation terms that are significantly enriched in the input gene list 
compared to random gene lists generated from the whole genome). 
Firstly, significantly differently expressed genes with more than 2-fold expression changes 
were pulled out from the new array and previous array datasets and separated into GFP 
positive and negative cell gene sets (Table 3.1). Secondly, these gene sets were subjected to in 
silico functional analysis according to their annotations via online software DAVID v6.7 (Dennis, 
Sherman et al. 2003; Huang da, Sherman et al. 2009) (see Chapter 2, section 2.4.2). Thirdly, 
DAVID Functional Annotation Chart analysis was performed using GO annotation terms (Table 
3.1). Fourthly, the most significantly enriched GO annotations (FDR<0.01) were directly 
compared between the GFP+ve genes and GFP-ve genes in the category of Biological Process 
(BP), Cellular Component, and Molecular Function (MF) (Figure 3.3).  
It is clear that the photoreceptor precursor cells already showed different transcriptome 
properties from other retinal cells by E15.5 (Figure 3.3 A, Appendix figure 3.1). In the CrxE15.5 
array, the photoreceptor precursor cell gene set mainly functioned in transcription, visual 
perception, and photoreceptor or eye development whereas the other retinal cells of the same 
stage mainly functioned in oxygen binding and transport (Figure 3.3 A, Appendix figure 3.1). In 
detail, the BP GO terms of E15.5 CrxGFP+ve cells is abundant in neurological system process, 
transcription regulation, and eye related terms such as visual perception, eye development, 
detection of stimulus, and photoreceptor differentiation (Figure 3.3 A). In contrast, the 
negative cells only enriched oxygen transport process (Figure 3.3 A). Whereas no Cellular 
Component GO term was significantly enriched for E15.5 CrxGFP positive cells, the negative 
cells enriched hemoglobin complex in the retina (Figure 3.3 A). Agreeing with the BP theme, 
the MF GO terms of the E15.5 CrxGFP+ve cells enriched DNA binding and transcription factor 
activity whereas the negative cells enriched oxygen binding and oxygen transporter activity 
(Figure 3.3 A). 
The difference between photoreceptor cells and other retinal cells was further enhanced in 
the CrxP4 array (Figure 3.3 B). While the P4 photoreceptor gene set focused on visual 
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perception (in BP), photoreceptor or eye development (in BP), and plasma membrane and cell 
projection (in Cellular Component), the gene set for other retinal cells function in cell cycle or 
general morphogenesis (in BP), organelle (in Cellular Component), cytoskeleton (in Cellular 
Component) and chromosome (in Cellular Component) (Figure 3.3 B). To show the most 
essential information, GO terms from these categories were further compressed and merged 
to form a more compact chart (Appendix figure 3.1).   
In summary based on the analysis of GO annotations of the expressed genes, photoreceptor 
precursor cells (ie. the GFP+ve cells) demonstrate very different properties from other retina 
cells of the same stage and from the entire genome transcriptome. These cells not only 
established their visual perception and photoreceptor commitment features by embryonic 
stages and maintained such properties, but also gradually evolved their properties and 
developed more specific functions for themselves (note loss of the initial transcription 
properties and appearance of the plasma membrane projection properties reflecting the 
gradual building up of more cell-type specific functions). Whereas other retinal cells only 
showed some non-cell-type specific functions such as cell cycle, DNA and chromosome. These 
data are consistent with the onset of photoreceptor differentiation and the emergence of 
unique properties of these light-sensing cells. The maintenance and changes of photoreceptor 
properties will be discussed further in section 3.2.3. It is interesting to note the emergence of 
plasma membrane projection GO terms such as cilium and synapse in photoreceptor cells and 
not other retinal cells, which will be discussed further in Chapter 5 (section 5.2.1).  
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Figure 3.3 Photoreceptor cell 
transcriptomes show very 
different properties from other 
retinal cells of the same stage 
(continues). (A) Properties of 
genes which show >2 fold 
expression differences 
significantly for E15.5 
CrxGFP+ve cells (green, 
photoreceptor precursors) and 
E15.5 CrxGFP-ve cells (blue, 
other retinal cells) were 
compared in the category of 
biological process (BP), 
molecular function (MF), and 
cellular component (CC). X-axis: 
percentage of the genes 
annotated under each GO term 
out of the whole input gene 
lists. Y-axis: GO terms which 
were most significantly 
enriched in the gene lists 
compared with random gene 
lists generated from the genome. According to the size of the gene sets, the statistic thresholds for the GO terms were set as E15.5Crx+ve p0.01, E15.5Crx-ve p0.01, P4Crx+ve and P4Crx-ve FDR0.01. The table at the 
bottom represents numbers of the most significant GO terms enriched for gene sets analysed here and in Figure 3.6. For gene lists which produced more than 20 GO terms in each category, only the top 20 significant 
terms were presented here and in Figure 3.6. BP: Biological process; CC: cellular component; MF: molecular function; FDR: false discovery rate. *indicate GO terms with FDR<0.01.   
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Figure 3.3 Photoreceptor cell transcriptomes show very different properties from other retinal cells of the same 
stage- continued. (B) Properties of genes which show >2-fold expression differences significantly for P4 
CrxGFP+ve cells (green, photoreceptor precursors) and P4 CrxGFP-ve cells (blue, other retinal cells). Note that 
each protein can be annotated by more than one functional term.  
63 
  
3.2.3 Comparative analysis of early and late photoreceptor precursors  
As the E15.5 photoreceptor cells labelled by CrxGFP produce more cones than the P4 
photoreceptor cells whereas the P4 cells showed much higher integration rates (Lakowski, 
Baron et al. 2010), I next sought to compare these two cell populations to find properties that 
are shared and different between these cells. Understanding this could give us the clue as to 
what the properties of a good transplantable cell population should be like, and what typical 
genes are expressed in such a population. This will guide what kind of cell population should 
be screened for when cells are selected from other sources such as ES cells or iPS cells.  
I directly compared the E15.5 CrxGFP+ve gene set (significant genes which were expressed 
more than 2-fold in the E15.5 CrxGFP+ve vs E15.5 CrxGFP-ve comparison, 63 Affymetrix ID, 60 
known unique genes) with the P4 CrxGFP+ve gene set (significant genes which were expressed 
more than 2-fold in the P4 CrxGFP+ve vs P4 CrxGFP-ve comparison, 627 Affymetrix ID, 538 
known unique genes) and found that 16 genes (17 Affymetrix ID) were specific to E15.5 
CrxGFP+ve cells (Figure 3.4 A, Appendix table 3.1), 494 genes (581 Affymetrix ID) were specific 
to P4 CrxGFP+ve cells (Figure 3.4 A, Appendix table 3.3), and 44 genes (46 Affymetrix ID) were 
shared by both early and late photoreceptor precursors (Figure 3.4 A, Appendix table 3.2). I 
then analyzed the functional annotation of the three gene sets using DAVID and found that the 
common precursor gene set mainly functioned in transcription regulation, visual perception 
and cell projection (Figure 3.4 B). On the other hand, while the E15.5-specific genes mainly 
focused on only a few functions, the P4-specific genes showed a variety of specific functions 
(Figure 3.4 B & C).  
The E15.5 precursor specific genes mainly functioned in transcription regulation, embryonic 
development, and metabolic process (Figure 3.4 B & C). This gene set included five 
transcription factors Meis2, Tcfap2b, Tcfap2a, Nr2f2, Onecut1, four ion transporters and three 
retinol metabolisers (Appendix table 3.1, Figure 3.5 A). The P4 precursor specific genes were 
more diverse and included the transcription factors Nrl, Nr2e3, and Zranb1, as well as a large 
proportion of genes with ion binding activity and enzyme regulator activity (Appendix table 3.3, 
Figure 3.4 B & C, Figure 3.5 B). The P4-specific genes were also enriched for additional visual 
perception genes and genes involved in cell projection, cell junction, and synapses (Figure 3.4 
B & C). 
The 44 common genes between E15.5 and P4 probably contain genes that should be present in 
a transplantable cell population. Indeed, not only did this set contain many essential 
transcription factors for photoreceptors such as Crx, Otx2, but also this set contained genes 
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encoding cell projection proteins such as Cdhr1, Sv2b, Cngb3 etc (Figure 3.5 C, Appendix table 
3.2). Interestingly, while I didn’t find any genes encoding cell projection proteins in the E15.5-
specific gene set, a lot of such genes appeared in the P4-specific gene set. This probably 
correlates with the low integration efficiency of E15.5 precursor cells and the high integration 
efficiency of P4 precursor cells and suggest that the onset of cell projection gene expression 
and the formation of specialized cell projections may be a feature associated with increased 
cell integration.  
In summary, I have found the stage-specific and common genes for the early and late 
photoreceptor precursor cells. The common genes for transcription, visual perception and cell 
projection are probably desired for a transplantation competent photoreceptor population. 
Additional P4 stage-specific genes involved in cell projection, ion binding, and enzyme 
regulation may be associated with increased integration efficiency for the transplanted late 
precursor cells.  
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Figure 3.4 Functional comparisons of early and late photoreceptor precursor transcriptomes. (A) Venn diagram showing the 
number of common and stage-specific genes in E15.5 and P4 photoreceptor precursors. 16 and 494 genes were specific to E15 
and P4 Crx+ cells respectively; 44 genes were common in both stages. (B) Comparison of the main function of the common and 
stage-specific genes for photoreceptor precursor cells. (C) Gene ontology terms (Y-axis) for (Left) Biological Process and (Right) 
Molecular Function enriched in E15-specific and P4-specific photoreceptor genes. X-axis representing percentage of the genes 
annotated for each term. GO terms which are significantly enriched are presented (p<0.1). Note each protein can be annotated 
by more than one term. 
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Figure 3.5 Examples of stage-specific and common genes from the comparison of E15.5 and P4 Crx-labelled 
photoreceptor gene sets. (A) E15.5-specific genes include transcription regulation and DNA binding genes, and 
genes involved in metabolic processes. (B) P4-specific genes include enzyme regulator and ion binders. (C) 
Common genes between E15.5 and P4 photoreceptor genes include transcription regulation and DNA binding 
genes, and genes involved in cell projection. Normalized expression fold changes between GFP-positive and GFP-
negative cells from the microarray are shown. Red indicates the fold changes at E15.5, blue indicates the fold 
changes at P4.  
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3.2.4 Comparative analysis of NrlGFP and CrxGFP retinal cells  
As NrlGFP labels rods and CrxGFP labels rods, cones, and bipolar cells, I next investigated if 
cone-specific properties could be found by comparing the NrlGFP+ve cells with the CrxGFP+ve 
cells at P4. Initial functional comparison of the two gene sets showed that the two cell 
populations were largely the same (Figure 3.6 A). In the category of BP, the NrlGFP+ve cells 
(Figure 3.6 A, left column, green) were rich in annotations related with visual perception, 
detection or response to stimulus, and photoreceptor development. This is almost identical to 
that of P4 CrxGFP positive cells (Figure 3.6 A, right column, green). The largest cellular 
component genes for both NrlGFP+ve cells and CrxGFP+ve cells were both encoding plasma 
membrane part and cell projection proteins. Of particular interest, both cells frequently 
showed GO terms related with cilium. This feature, however, was not found in the GFP-ve cells. 
The most significant MF GO terms enriched in the GFP+ve cells were also the same being 
phosphoric diester hydrolase activity including Pde genes such as Pde6a, Pde6b, Pde6c, Pde6g 
which hydrolyzes cGMP to 5’-GMP playing an essential role in phototransduction. Sharing of 
the same properties between the NrlGFP+ve cells and the CrxGFP+ve cells indicates that the 
two cell populations were very similar. In contrast although some common properties were 
detected for CrxGFP-ve and NrlGFP-ve cells, the pattern of MF terms and the largest 
proportion of cellular component terms were different for CrxGFP-ve cells and NrlGFP-ve cells 
(Figure 3.6 A, blue).  
To directly compare between the P4 CrxGFP+ve gene set and the P4 NrlGFP+ve gene set, I 
pulled out the top 40 genes which showed the highest expression fold changes from both gene 
sets (Figure 3.6 B). Comparison of the two sets of top genes showed that half of the top genes 
in one set (20 out of 40) were also the top genes for the other gene set. Even for the remaining 
top genes which were specifically expressed within the Crx/NrlGFP+ve populations (20 out of 
40 for each gene set), nearly all of them can be found in the other gene set albeit with smaller 
expression fold changes. There were two genes that were only found in the Crx array gene lists: 
Gabrr3 and Gje1. However, neither has been shown in the literature to be related with cone 
photoreceptor cells: Gabrr3 is a GABA receptor that mediates inhibitory neurotransmission 
and in retina it is located in axon terminals of bipolar cells (Feigenspan and Bormann 1998; 
Schubert, Hoon et al. 2013), whereas Gje1 is a connexin protein found in rods (Eberle, 
Schubert et al. 2011) and lens (Bassnett, Wilmarth et al. 2009; Sonntag, Sohl et al. 2009).  
Further comparison of the full >2-fold gene sets of P4 NrlGFP+ve, P4 CrxGFP+ve and E15.5 
CrxGFP+ve identified 205 genes that were only present in CrxGFP+ve cells (including 16 genes 
in CrxE15.5 alone, 172 genes in CrxP4 alone, and 17 genes in both CrxE15.5 and CrxP4) (Figure 
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3.6 C, Appendix table 3.5). However, no known genes encoding cone specific proteins were 
identified in this set whereas general transcription factors (eg. Meis2, Onecut1, Neurod1, 
Neurod4, Otx2) or genes in bipolar cells such as GABA receptors (eg. Gabrr3, Gabrr1, Gabra1) 
(Feigenspan and Bormann 1998) were present. On the other hand, many known genes 
encoding cone specific proteins such as Cngb3 (Cyclic nucleotide-gated cation channel beta-3), 
Thrb (Thyroid hormone receptor beta), Opn1sw (S opsin), Chrnb4 (Neuronal acetylcholine 
receptor subunit beta-4), Arr3 (cone arrestin), and Pde6c (Cone cGMP-specific 3',5'-cyclic 
phosphodiesterase subunit alpha) were present in the common genes of NrlGFP and CrxGFP 
gene sets rather than in the Crx-specific gene sets (Appendix table 3.5, known/possible cone 
genes are highlighted in bold).  
Taken together, I showed that by comparing the transcriptomes of CrxGFP+ve and NrlGFP+ve 
gene sets 1) the transcriptome functional properties of CrxGFP+ve and NrlGFP+ve were very 
similar; 2) other than some bipolar cell genes and transcription factors specific to CrxGFP+ve I 
did not identify cone-specific properties or genes in the CrxGFP+ve gene set whereas 3) known 
cone-specific genes were present in both CrxGFP+ve and NrlGFP+ve gene sets. The most likely 
explanation is that the abundance of rods in the P4 CrxGFP population masked the properties 
of cones. Alternatively, it could be that the intrinsic molecular properties of rods and cones 
may indeed be very similar in early postnatal stages and these cells could not be distinguished. 
In support of this, Young reported that rods and cones were morphologically indistinguishable 
until P5 in 0.5 µm sections (Young 1985a).  
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Figure 3.6 Comparison of the P4 CrxGFP-sorted cells and NrlGFP-sorted cells (continues). (A) Gene ontology 
properties of the CrxGFP-sorted and NrlGFP-sorted P4 retinal cells were similar in the category of biological 
process (BP), cellular component (CC), and molecular function (MF). Green is GFP+ve and blue is GFP-ve. CrxGFP 
P4 data were the same as Figure 3.3 B. Note each protein can be annotated by more than one term.  
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Figure 3.6 Comparison of the P4 CrxGFP-sorted cells and NrlGFP-sorted cells – continued. (B) The top 40 genes 
from CrxGFP+ve genes and NrlGFP+ve genes share 20 common genes and nearly all the remaining genes can also 
be found in both gene sets although with smaller fold changes. FC: expression fold changes between the CrxGFP 
(Crx) or NrlGFP (Nrl) sorted P4 positive and negative cells. (C) Venn diagram comparing the P4 NrlGFP+ve, P4 
CrxGFP+ve and E15.5 CrxGFP+ve gene sets with 2-fold cut off.  
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3.2.5 Possible candidates as cell surface molecules for photoreceptor precursors 
Next two approaches were used to find cell surface markers for photoreceptor cells from the 
array datasets: one is to manually search for the “cluster of differentiation” (CD) genes in the 
microarray database according to their names, and the other is to pull out the genes which are 
related with cell surface molecules according to their functional annotations. 
It should be noted that with 5,480 transmembrane proteins and 3,129 glycosylated 
transmembrane proteins currently annotated for humans in the UniProt database 
(http://www.uniprot.org/), only around 350 proteins are CD antigens (http://hcdm.org/). 
Therefore, although the CD marker approach gives confirmed cell surface antigens, lots of cell 
surface proteins will be omitted by this approach. The functional annotation approach, on the 
other hand, provides a much bigger candidate pool, but interesting candidates will need to be 
validated individually to determine if they are cell surface antigens or not. This is because 
there are no defined “cell surface molecule” annotation terms which describe proteins with 
extracellular domains or extracellular proteins with domains anchored to the cell plasma 
membrane. GO terms which are related to “cell surface molecule” such as cell projection and 
plasma membrane not only annotate real cell surface proteins, but also proteins which do not 
have extracellular domains but are involved in making the cell projection structure. In addition, 
some annotations may come from electronic protein structure prediction rather than direct 
experimental assay. 
3.2.5.1 CD gene lists 
The CD nomenclature was established to classify monoclonal antibodies generated by different 
laboratories against leukocyte cell surface antigens and antibodies with similar binding 
patterns at various differentiation stages were clustered together (Zola, Swart et al. 2005). 
Molecules assigned with a “CD” number are usually cell-surface glycoproteins, and have 
antibodies available. So far over 350 human CD molecules have been assigned 
(http://hcdm.org/) and are used to define different cell types in the immune system.  
To search for all the CD molecules in the microarray data, the gene symbol of the full 335 
mouse CD molecules were compared with the gene symbol lists from the array data, and the 
common candidates between the CD list and the array lists constitute the CD molecules. A 
further specific search for “CD” in all the array gene lists including the Swaroop array added in 
additional CD molecules which were missed by the gene symbol comparison. This was 
performed for all the GFP positive and negative genes of the three array databases without 
setting the two-fold change threshold (Table 3.2). 40 CD molecules were found in the P4 
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NrlGFP+ve cells, with 10 molecules showing more than two-fold expression changes compared 
with negative cells (above the black line in Table 3.2). 63 CD molecules were found for P4 
NrlGFP-ve cells and 26 genes expressed more than two-fold than the positive cells. 13 CD 
molecules were found in the P4 CrxGFP+ve cells and five expressed two-fold higher than the 
negative cells. 35 CD molecules were in the P4 CrxGFP-ve cells and 19 genes were more than 
two-fold. Only one CD molecule Jam2 was identified in E15.5 CrxGFP+ve cells and one CD 
molecule for the negative cells. A total of ten CD molecules showed more than two-fold 
expression changes from the Nrl and Crx arrays for photoreceptor cells. These are Nt5e (CD73), 
Prom1 (CD133), Lifr (CD118), Sema7a (CD108), Itga3 (CD49c), Sirpa (CD172a), Jag1 (CD339), 
Cd8a (CD8a), Jam2 (CD322), and Prnp (CD230). In addition, seven CD molecules were identified 
in the Swaroop array (CD24a, CD2, CD302, CD53, CD59a, CD80, and CD83). Some of these CD 
markers will be further discussed in the following chapters.  
  
73 
  
Table 3.2 CD markers from Crx, NrlP4, and Swaroop array 
 
  
P4 Nrl+ (40) FC Nrl-v+ P4Nrl- (63) FC Nrl-v+ P4 Crx+ (13) FC P4Crx+v- P4 Crx- (35) FC P4Crx+v-
Nt5e -22.9 Pdgfra 6.5 Nt5e 31.1249 Kit -7.5178
Prom1 -9.19 Kit 6.15 Prom1 9.40123 Hmmr -5.66575
Lifr -6.02 Cxcr4 5.66 Jam2 5.52587 Itga2 -5.40528
Sema7a -5.03 Cd9 5.21 Sema7a 3.64527 Mcam -4.74093
Itga3 -3.89 Abcg2 4.89 Lifr 3.45633 Pdgfra -4.33077
Sirpa -3.71 Cd1d1 4.89 Darc 1.94085 Abcg2 -3.79395
Jag1 -2.81 Plxnc1 4.32 Itga3 1.87802 Plxnc1 -3.62236
Cd8a -2.22 Mcam 4.08 Sirpa 1.77622 Bmpr1b -3.6054
Jam2 -2.2 Hmmr 3.92 Cd164 1.71845 Cd9 -3.36756
Prnp -2.03 Atp1b3 3.18 Jag1 1.49326 Ptprj -3.19075
Cd164 -1.72 Ngfr 3.16 Ly75 1.46569 Cxcr4 -3.15292
Fgfr3 -1.63 Fgfr1 2.95 Ccr6 1.39352 Tlr3 -2.42421
Tspan7 -1.6 Cd200 2.93 Cd4 1.37309 Alcam -2.37286
Cd276 -1.51 Itgav 2.87 Itga6 -2.28179
Igf1r -1.48 Cd24a 2.87 Il1r1 -2.21358
Tfrc -1.39 Itga2 2.87 Cd109 -2.18779
Cd37 -1.37 Lrp1 2.85 Atp1b3 -2.14666
Csf2rb -1.34 Bmpr1b 2.75 Trf -2.08977
Cd320 -1.33 Sema4d 2.62 Thy1 -2.04565
Ly75 -1.31 Itgb1 2.6 Itgav -1.94834
Cd209b -1.26 Ddr1 2.41 Sema4d -1.93483
Cd4 -1.25 Gstm7 2.38 Cd44 -1.89469
Siglece -1.24 Ptprj 2.36 Ptprj -1.88747
Fasl -1.23 Il4ra 2.13 Fgfr1 -1.87736
Insr -1.23 Trf 2.11 Cdh2 -1.78236
Cd247 -1.22 L1cam 2.03 Itgb1 -1.74768
Fut4 -1.22 Cdh2 1.99 Ddr1 -1.64655
Entpd1 -1.21 Itga4 1.91 Pvrl3 -1.60783
Icam2 -1.21 Alcam 1.9 Atp1b3 -1.5615
Cd3d -1.21 B3gat1 1.9 Vcam1 -1.54913
Tnfsf13b -1.2 Cd151 1.86 Adam17 -1.54468
Itgal -1.2 Cd99l2 1.85 F3 -1.49366
Tnfrsf17 -1.2 Cd59a 1.75 Pvr -1.39178
Insr -1.19 Gypc 1.62 Ngfr -1.32807
Cd209a -1.19 Tnfrsf12a 1.57 Cd97 -1.18495
Cd22 -1.18 F11r 1.52
Itgax -1.18 Thy1 1.48
Cd3g -1.17 Alk 1.47 E15.5 Crx+ (1) FC E15Crx+v- E15.5 Crx- (1) FC E15Crx+v-
Bsg -1.16 Cd47 1.43 Jam2 1.54415 Bmpr1b -2.2096
Cd8b1 -1.15 Pdgfrb 1.43
Cd44 1.41
Cd72 1.41 Swaroop Array (7)
Vcam1 1.35 CD24a antigen
Cd109 1.35 CD2-associated protein
Ace 1.34 CD302 antigen
Tlr3 1.34 CD53 antigen
Fgfr4 1.34 CD59a antigen
F3 1.33 CD80 antigen
Sdc1 1.33 CD83 antigen
Itga6 1.32
Cd68 1.3
Il1r1 1.28
Pvrl3 1.27
Fgfr2 1.27
Nrp1 1.27
Itga5 1.27
Ncam1 1.25
Adam17 1.25
Cd38 1.22
Csf1r 1.21
Pvrl2 1.2
Cd2bp2 1.2
Itgam 1.19
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3.2.5.2 Cell surface-related gene lists 
To increase the size of the cell surface marker candidate pool, I also used the functional 
annotation approach in DAVID. This approach will yield a much higher number of candidates 
and only genes of the GFP+ve cells with more than two-fold higher expression compared to 
GFP-ve cells were analysed.  All the annotation terms which are related with cell surface 
molecules were selected and screened (including cell projection terms such as cilium and 
synapse, see Appendix table 3.4 for all GO terms used), and all the genes annotated with these 
terms were pulled out and merged to form one gene list named as cell surface-related genes.  
197 cell surface-related genes were identified for P4 NrlGFP+ve cells, 127 genes for P4 
CrxGFP+ve cells and nine genes for E15.5 CrxGFP+ve cells. These three cell surface-related 
gene sets were then compared to identify common and cell population-specific genes (Table 
3.3). Eight genes were common to all three populations and one gene was common to CrxP4 
and CrxE15.5 positive cells. These nine genes may include cell surface molecules that could be 
used to select both early and late photoreceptor precursors. 89 genes were common to CrxP4 
and NrlP4 positive cells, and no genes were found common to CrxE15.5 and NrlP4 positive cells. 
The CrxP4 and NrlP4 common genes should be able to serve as the pool of cell surface markers 
for late photoreceptor precursors. Unfortunately no CrxE15.5 specific genes were found to 
specifically select for embryonic photoreceptor precursors. 29 genes were specific to CrxP4 
positive cells and cone specific cell surface markers could come from these genes. 100 genes 
were specific to NrlP4 positive cells which was unexpected. Considering that the NrlP4 array 
generated more genes than the CrxP4 array initially, the NrlP4 specific genes identified might 
actually come from differences between arrays rather than having real biological meanings.  
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Table 3.3 Cell surface-related gene lists 
 
 
 
Common CrxE15+CrxP4+NrlP4+ cell surface related genes (8)
GeneID GeneSymbol GeneName FC NrlP4-v+ FC1 CrxE15+v- FC2 CrxP4+v- FC3 Crx+E15vP4 FC4 Crx-E15vP4
10503464 Cngb3 cyclic nucleotide gated channel beta 3 -12.6 26.0673 12.9657 -1.32521 -2.66432
10350530 Pdc phosducin -84.4 16.5561 43.7619 -12.2548 -4.63625
10414663 Rpgrip1 retinitis pigmentosa GTPase regulator interacting protein 1 -33.4 5.75074 21.604 -6.26463 -1.66757
10407337 Hcn1 hyperpolarization-activated, cyclic nucleotide-gated K+ 1 -8.17 5.18522 7.23023 -5.12108 -3.67262
10474141 Slc1a2 solute carrier family 1 (glial high affinity glutamate transporter), 
member 2
-2.48 4.15551 8.43913 -2.41959 -1.19143
10427496 Egflam EGF-like, fibronectin type III and laminin G domains -14.7 4.13253 9.67583 -2.75206 -1.1754
10600604 Dmd dystrophin, muscular dystrophy -12.3 3.13276 11.581 -3.04372 1.21455
10564646 Sv2b synaptic vesicle glycoprotein 2 b -8.17 2.75689 16.9575 -3.62394 1.69731
Common CrxE15+CrxP4+ cell surface related genes (1)
GeneID GeneSymbol GeneName FC NrlP4-v+ FC1 CrxE15+v- FC2 CrxP4+v- FC3 Crx+E15vP4 FC4 Crx-E15vP4
10363224 Fabp7 17.3043 26.1714 -3.16354 -2.0917
Common CrxP4+NrlP4+ cell surface related genes (89)
GeneID GeneSymbol GeneName FC NrlP4-v+ FC1 CrxE15+v- FC2 CrxP4+v- FC3 Crx+E15vP4 FC4 Crx-E15vP4
10352928 Rp1h retinitis pigmentosa 1 homolog (human) -122 1.35926 44.6873 -49.0212 -1.49109
10530503 Cnga1 cyclic nucleotide gated channel alpha 1 -34.1 1.11251 36.0885 -40.8715 -1.25996
10540984 Rho rhodopsin -127 -1.04559 34.1121 -44.2423 -1.24041
10540991 --- --- -29.4 1.06174 31.3976 -33.492 -1.13256
10587639 Nt5e 5' nucleotidase, ecto -22.9 2.25786 31.1249 -17.8497 -1.29485
10459475 Cplx4 complexin 4 -15.7 -1.04124 27.3017 -34.7447 -1.22222
10484261 Cerkl ceramide kinase-like -11.2 3.12629 16.1369 -4.13472 1.24837
10536209 Gngt1 guanine nucleotide binding protein (G protein), gamma 
transducing activity polypeptide 1
-42.2 1.81586 15.3593 -12.1606 -1.43769
10419015 Pcdh21 protocadherin 21 -27.1 4.21158 14.3479 -4.55181 -1.3361
10368021 D230044M03Rik RIKEN cDNA D230044M03 gene -14.1 1.05596 10.667 -8.89136 1.13613
10439483 Cdgap CDC42 GTPase-activating protein -5.5 1.73977 9.85156 -7.52304 -1.32856
10529824 Prom1 prominin 1 -9.19 1.24535 9.40123 -4.24424 1.77866
10547858 Gnb3 guanine nucleotide binding protein (G protein), beta 3 -6.36 2.78104 9.28214 -3.76594 -1.12832
10462887 Pde6c phosphodiesterase 6C, cGMP specific, cone, alpha prime -13 12.758 9.09732 1.07249 -1.3076
10495712 Abca4 ATP-binding cassette, sub-family A (ABC1), member 4 -9.58 1.39594 8.07413 -6.2773 -1.08528
10410995 Rasgrf2 RAS protein-specific guanine nucleotide-releasing factor 2 -10.6 2.42242 7.69304 -5.85925 -1.84499
10543591 Opn1sw opsin 1 (cone pigments), short-wave-sensitive (color blindness, 
tritan)
-42.2 1.46211 7.35149 -6.23974 -1.241
10352586 Ush2a Usher syndrome 2A (autosomal recessive, mild) homolog 
(human)
-24.8 2.28418 7.01788 -3.4602 -1.12623
10466248 Stx3 syntaxin 3 -8.69 1.61114 6.96566 -6.73011 -1.55666
10495259 Gnat2 guanine nucleotide binding protein, alpha transducing 2 -10.9 6.57846 6.78718 -1.04271 -1.01065
10388465 Doc2b double C2, beta -11.7 2.71129 6.75295 -3.03904 -1.22017
10354897 Trak2 trafficking protein, kinesin binding 2 -2.91 1.85247 6.61963 -5.01534 -1.40352
10593947 Cplx3 complexin 3 -4.08 1.91689 6.21274 -4.11427 -1.26943
10482968 Pla2r1 phospholipase A2 receptor 1 -7.57 1.15555 5.93668 -5.09318 1.00871
10366073 Cep290 centrosomal protein 290 -7.01 1.35788 5.92009 -3.28442 1.32742
10436666 Jam2 junction adhesion molecule 2 -2.2 1.54415 5.52587 -2.86082 1.25089
10472549 Bbs5 Bardet-Biedl syndrome 5 (human) -7.46 1.35512 5.47092 -4.40103 -1.09012
10598309 Cacna1f calcium channel, voltage-dependent, alpha 1F subunit -14.6 1.21519 5.36359 -4.31375 1.02319
10497713 Pex5l peroxisomal biogenesis factor 5-like -8 1.32106 4.92491 -3.46657 1.07541
10543791 Podxl podocalyxin-like -11.2 1.90941 4.76013 -1.97798 1.26037
10473880 Lrp4 low density lipoprotein receptor-related protein 4 -12.8 -1.18694 4.65252 -6.71325 -1.21567
10593767 Chrnb4 cholinergic receptor, nicotinic, beta polypeptide 4 -7.57 1.75116 4.6459 1.17311 3.11231
10482030 Stom stomatin -2.46 -1.08347 4.35805 -4.66603 1.01195
10462303 Kcnv2 potassium channel, subfamily V, member 2 -20.7 2.01156 4.32865 -2.71686 -1.26255
10596737 Gnat1 guanine nucleotide binding protein, alpha transducing 1 -18.8 1.15297 4.24634 -4.09312 -1.11137
10593668 Dmxl2 Dmx-like 2 -4.06 1.39853 4.16733 -3.16686 -1.06278
10598359 Syp synaptophysin -4.66 1.51843 3.87938 -2.88935 -1.13093
10344935 Kcnb2 potassium voltage gated channel, Shab-related subfamily, 
member 2
-2.1 1.06275 3.76165 -1.49339 2.37015
10380571 Gngt2 guanine nucleotide binding protein (G protein), gamma 
transducing activity polypeptide 2
-7.36 2.04152 3.75887 -2.42316 -1.31607
10560919 Atp1a3 ATPase, Na+/K+ transporting, alpha 3 polypeptide -3.18 -1.23102 3.75012 -6.15319 -1.33288
10593671 Dmxl2 Dmx-like 2 -3.78 1.31459 3.70081 -2.84735 -1.01143
10585778 Sema7a sema domain, immunoglobulin domain (Ig), and GPI membrane 
anchor, (semaphorin) 7A
-5.03 -1.05654 3.64527 -3.12341 1.23306
10382376 Ttyh2 tweety homolog 2 (Drosophila) -2.95 1.81247 3.58817 -3.51552 -1.77577
10594144 Bbs4 Bardet-Biedl syndrome 4 (human) -4.14 1.26758 3.54791 -2.16995 1.28987
10392415 Rgs9 regulator of G-protein signaling 9 -6.11 1.55203 3.52891 -3.53079 -1.55286
10585484 Chrna5 cholinergic receptor, nicotinic, alpha polypeptide 5 -7.78 1.01644 3.47781 -1.87292 1.82686
10422822 Lifr leukemia inhibitory factor receptor -6.02 1.28228 3.45633 -4.20741 -1.56092
10508052 Grik3 glutamate receptor, ionotropic, kainate 3 -2.66 1.3637 3.44141 -2.531 -1.00294
10583847 Bbs9 Bardet-Biedl syndrome 9 (human) -5.31 -1.20228 3.37727 -4.54105 -1.11837
10600994 Arr3 arrestin 3, retinal -8.75 1.03877 3.33913 -3.24265 -1.00875
10507500 Slc6a9 solute carrier family 6 (neurotransmitter transporter, glycine), 
member 9
-3.86 1.1708 3.23292 -3.23045 -1.16991
10421934 Klhl1 kelch-like 1 (Drosophila) -5.17 1.16602 3.22274 -1.05694 2.61498
10603051 Ap1s2 adaptor-related protein complex 1, sigma 2 subunit -2.25 1.22257 3.1968 -2.15248 1.21479
10552857 Slc17a7 solute carrier family 17 (sodium-dependent inorganic phosphate 
cotransporter), member 7
-32.4 1.32034 3.17132 -2.62905 -1.09457
10386951 Hs3st3b1 heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 -5.86 1.30514 3.15196 -2.13828 1.12943
10348321 Dgkd diacylglycerol kinase, delta -2.53 1.44176 3.04502 -2.07896 1.0159
10357164 Epb4.1l5 erythrocyte protein band 4.1-like 5 -2.91 1.15452 2.98192 -1.94708 1.32652
10509441 Ece1 endothelin converting enzyme 1 -3.14 1.30382 2.97518 -2.22003 1.02787
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10363921 Pcdh15 protocadherin 15 -5.46 3.09258 2.87036 -6.92572 -7.46191
10512129 B4galt1 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, 
polypeptide 1
-4.41 -1.39769 2.82217 -3.83449 1.02869
10424607 Ptp4a3 protein tyrosine phosphatase 4a3 -9.78 -1.00227 2.81157 -2.68694 1.04876
10474619 Fmn1 formin 1 -2.1 -1.15986 2.79725 -1.42099 2.2832
10504234 Unc13b unc-13 homolog B (C. elegans) -2.87 -1.23641 2.78021 -2.13542 1.60974
10456096 Pde6a phosphodiesterase 6A, cGMP-specific, rod, alpha -13.5 1.28197 2.74065 -2.43282 -1.13798
10457357 Mpp7 membrane protein, palmitoylated 7 (MAGUK p55 subfamily 
member 7)
-2.35 1.48422 2.73373 -2.01633 -1.09472
10497842 Bbs7 Bardet-Biedl syndrome 7 (human) -3.89 -1.02996 2.64062 -2.5832 1.05286
10444890 Ier3 immediate early response 3 -5.78 1.16517 2.6323 -1.80359 1.25259
10397683 Ttc8 tetratricopeptide repeat domain 8 -3.32 1.19381 2.63163 -2.31089 -1.04831
10476512 Snap25 synaptosomal-associated protein 25 -3.16 1.25319 2.55632 -2.3121 -1.13347
10405253 Cplx2 complexin 2 -3.94 1.39799 2.55392 -1.87899 -1.02854
10584901 Dscaml1 Down syndrome cell adhesion molecule-like 1 -4.11 -1.1683 2.50649 -2.68727 1.08971
10481349 Ntng2 netrin G2 -5.03 1.88705 2.45379 -1.47233 -1.13228
10457359 Mpp7 membrane protein, palmitoylated 7 (MAGUK p55 subfamily 
member 7)
-2.08 1.2649 2.43801 -2.04372 -1.06033
10510482 Clstn1 calsyntenin 1 -2.35 1.00629 2.30346 -2.56083 -1.11873
10467258 Fer1l3 fer-1-like 3, myoferlin (C. elegans) -4.69 1.11361 2.29186 -2.58363 -1.25538
10436947 Kcne2 potassium voltage-gated channel, Isk-related subfamily, gene 2 -2.14 1.44492 2.27596 -1.8501 -1.17455
10565910 Plekhb1 pleckstrin homology domain containing, family B (evectins) 
member 1
-5.03 1.2541 2.27326 -4.14376 -2.28601
10595805 Rasa2 RAS p21 protein activator 2 -2.19 1.2491 2.22509 -1.53475 1.16069
10567964 Cln3 ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-
Vogt disease)
-6.02 1.0286 2.22478 -2.16838 -1.00253
10603598 Rpgr retinitis pigmentosa GTPase regulator -2.01 -1.098 2.20675 -2.0735 1.16856
10517521 Epha8 Eph receptor A8 -2.45 1.38766 2.19087 -1.71495 -1.08622
10367775 Stxbp5 syntaxin binding protein 5 (tomosyn) -2.41 1.69705 2.17653 -2.03053 -1.58321
10577792 Plekha2 pleckstrin homology domain-containing, family A 
(phosphoinositide binding specific) member 2
-14.7 1.28646 2.17432 -1.902 -1.12534
10587194 Gnb5 guanine nucleotide binding protein (G protein), beta 5 -3.53 1.03198 2.11965 -2.63795 -1.28433
10479379 Slco4a1 solute carrier organic anion transporter family, member 4a1 -8.88 1.01852 2.10709 -1.77365 1.16639
10592001 St14 suppression of tumorigenicity 14 (colon carcinoma) -2.13 1.05532 2.06456 -1.85796 1.05295
10469335 Stam signal transducing adaptor molecule (SH3 domain and ITAM 
motif) 1
-2.19 1.25798 2.06329 -1.46586 1.11891
10519069 Plch2 phospholipase C, eta 2 -6.77 1.28334 2.0309 -1.96427 -1.24124
10483822 Ttc30a2 tetratricopeptide repeat domain 30A2 -2.73 -1.07089 2.02147 -2.19464 -1.0138
CrxP4+ alone cell surface related genes (29)
GeneID GeneSymbol GeneName FC NrlP4-v+ FC1 CrxE15+v- FC2 CrxP4+v- FC3 Crx+E15vP4 FC4 Crx-E15vP4
10436416 Gabrr3 1.56298 47.1376 -30.1713 -1.00042
10590623 Cxcr6 2.07137 6.18301 -3.5795 -1.19917
10399046 Vipr2 -1.01688 4.90671 -4.45678 1.11953
10440621 Grik1 1.02031 4.28654 -6.07252 -1.44542
10503866 Gabrr1 -1.04233 3.44093 -2.86596 1.25144
10519815 Cacna2d1 1.42311 3.2895 -1.23462 1.87222
10408268 Scgn 1.21635 3.13135 -2.81532 -1.09359
10415228 Cpne6 1.19314 3.02101 -3.21398 -1.26935
10496192 Tacr3 1.94921 2.98331 -3.31982 -2.16907
10503334 Gem 1.04369 2.92072 -2.59492 1.07843
10410408 Adcy2 1.70573 2.87769 -3.3475 -1.98421
10459671 Dcc 1.7565 2.86387 2.30614 3.76003
10385297 Gabra1 1.54053 2.85675 -10.3722 -5.59335
10485979 Gjd2 -1.1969 2.69682 -4.48856 -1.39059
10418053 Kcnma1 -1.09801 2.67229 -4.41711 -1.50538
10601595 3110007F17Rik 1.34439 2.64575 -1.63947 1.20038
10372503 Lgr5 -1.11738 2.55332 -1.77645 1.60603
10503659 Epha7 -1.04798 2.37221 -2.15222 1.1551
10403796 Amph -1.1379 2.28951 -3.52346 -1.35245
10360349 Cadm3 1.68219 2.27022 -1.57632 -1.16802
10548118 Prmt8 2.65199 2.24071 -1.50301 -1.77889
10601588 3110007F17Rik 1.29496 2.21928 -1.43976 1.19032
10512949 Abca1 1.20781 2.17968 -8.58166 -4.7553
10548905 Eps8 1.43357 2.17568 -1.90381 -1.25443
10593628 Rab39 1.32043 2.16936 -1.23456 1.33077
10426292 Alg10b -1.08455 2.16388 -1.59711 1.46943
10553301 Ldha -1.11543 2.07221 -2.21213 1.04488
10563820 Svip 1.52172 2.04565 -1.34358 1.00054
10439362 Stxbp5l -1.31005 2.00723 -2.06766 1.27177
NrlP4+ alone cell surface related genes (100)
GeneID GeneSymbol GeneName FC NrlP4-v+
10388098 Aipl1 aryl hydrocarbon receptor-interacting protein-like 1 -12.7
10489872 Kcnb1 potassium voltage gated channel, Shab-related subfamily, 
member 1
-6.23
10560491 Klc3 kinesin light chain 3 -5.78
10523260 Shroom3 shroom family member 3 -4.92
10478907 Pard6b par-6 (partitioning defective 6) homolog beta (C. elegans) -4.41
10378964 Sez6 seizure related gene 6 -4.38
10523579 Arhgap24 Rho GTPase activating protein 24 -4.35
10517842 Crocc ciliary rootlet coiled-coil, rootletin -4.23
10432190 Adcy6 adenylate cyclase 6 -4.11
10453636 Svil supervillin -3.97
10390117 Itga3 integrin alpha 3 -3.89
10476021 Sirpa signal-regulatory protein alpha -3.71
10397835 Slc24a4 solute carrier family 24 (sodium/potassium/calcium exchanger), 
member 4
-3.61
10510767 Nphp4 nephronophthisis 4 (juvenile) homolog (human) -3.53
10483819 Ttc30b tetratricopeptide repeat domain 30B -3.46
10378549 Rtn4rl1 reticulon 4 receptor-like 1 -3.43
10425335 Syngr1 synaptogyrin 1 -3.41
10464858 Bbs1 Bardet-Biedl syndrome 1 (human) -3.32
10591978 Hnt neurotrimin -3.32
10594679 Tln2 talin 2 -3.29
CrxE15 
(total 9)
NrlP4 
(total 197)
CrxP4 
(total 127)
0
29
1 0
8
89
100
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10587023 Rab27a RAB27A, member RAS oncogene family -3.23
10573956 Slc6a2 solute carrier family 6 (neurotransmitter transporter, 
noradrenalin), member 2
-3.14
10427816 Pdzd2 PDZ domain containing 2 -3.12
10555935 Cckbr cholecystokinin B receptor -3.12
10547807 Eno2 enolase 2, gamma neuronal -3.1
10373986 Ap1b1 adaptor protein complex AP-1, beta 1 subunit -2.97
10488060 Jag1 jagged 1 -2.81
10593384 Dixdc1 DIX domain containing 1 -2.77
10377725 Dlg4 discs, large homolog 4 (Drosophila) -2.73
10409345 Cltb clathrin, light polypeptide (Lcb) -2.71
10548585 Csda cold shock domain protein A -2.69
10521626 Cc2d2a coiled-coil and C2 domain containing 2A -2.68
10352777 Slc30a1 solute carrier family 30 (zinc transporter), member 1 -2.62
10555460 Stard10 START domain containing 10 -2.62
10566457 Apbb1 amyloid beta (A4) precursor protein-binding, family B, member 
1
-2.62
10392152 Scn4a sodium channel, voltage-gated, type IV, alpha -2.6
10520173 Accn3 amiloride-sensitive cation channel 3 -2.6
10573954 Capns2 calpain, small subunit 2 -2.6
10464612 Cabp4 calcium binding protein 4 -2.58
10469404 Cacnb2 calcium channel, voltage-dependent, beta 2 subunit -2.51
10488762 Snta1 syntrophin, acidic 1 -2.51
10487906 Slc23a2 solute carrier family 23 (nucleobase transporters), member 2 -2.5
10383289 Baiap2 brain-specific angiogenesis inhibitor 1-associated protein 2 -2.48
10412773 Slc4a7 solute carrier family 4, sodium bicarbonate cotransporter, 
member 7
-2.46
10483439 Lrp2 low density lipoprotein receptor-related protein 2 -2.43
10575120 Sntb2 syntrophin, basic 2 -2.43
10595382 Lca5 Leber congenital amaurosis 5 (human) -2.43
10565634 Myo7a myosin VIIa -2.41
10345571 Cnga3 cyclic nucleotide gated channel alpha 3 -2.39
10460498 Slc29a2 solute carrier family 29 (nucleoside transporters), member 2 -2.36
10419854 Slc7a8 solute carrier family 7 (cationic amino acid transporter, y+ 
system), member 8
-2.33
10529741 Rab28 RAB28, member RAS oncogene family -2.33
10580733 Bbs2 Bardet-Biedl syndrome 2 (human) -2.33
10364239 Slc19a1 solute carrier family 19 (sodium/hydrogen exchanger), member 
1
-2.3
10387568 Tnfsf12-tnfsf13 tumor necrosis factor (ligand) superfamily, member 12-member 
13
-2.3
10448925 Cacna1h calcium channel, voltage-dependent, T type, alpha 1H subunit -2.3
10518019 Ddi2 DNA-damage inducible protein 2 -2.3
10546056 Rab43 RAB43, member RAS oncogene family -2.3
10547888 Gpr162 G protein-coupled receptor 162 -2.3
10489377 Serinc3 serine incorporator 3 -2.28
10514000 Mpdz multiple PDZ domain protein -2.28
10588577 Cish cytokine inducible SH2-containing protein -2.28
10460356 Gpr152 G protein-coupled receptor 152 -2.27
10540659 Ttll3 tubulin tyrosine ligase-like family, member 3 -2.23
10579776 Arhgap10 Rho GTPase activating protein 10 -2.23
10361887 Perp PERP, TP53 apoptosis effector -2.22
10467068 Sgms1 sphingomyelin synthase 1 -2.22
10532784 Svop SV2 related protein -2.22
10538993 Cd8a CD8 antigen, alpha chain -2.22
10571560 Mtnr1a melatonin receptor 1A -2.22
10575844 Cdh13 cadherin 13 -2.22
10443598 Dnahc8 dynein, axonemal, heavy chain 8 -2.2
10455259 Arhgap26 Rho GTPase activating protein 26 -2.2
10517587 Alpl alkaline phosphatase, liver/bone/kidney -2.17
10591643 Rab3d RAB3D, member RAS oncogene family -2.17
10382393 Dnaic2 dynein, axonemal, intermediate chain 2 -2.14
10408227 Hfe hemochromatosis -2.14
10411156 Scamp1 secretory carrier membrane protein 1 -2.13
10418506 Stab1 stabilin 1 -2.11
10540952 Ift122 intraflagellar transport 122 homolog (Chlamydomonas) -2.11
10368806 Smpd2 sphingomyelin phosphodiesterase 2, neutral -2.1
10464167 Adrb1 adrenergic receptor, beta 1 -2.1
10474545 Slc12a6 solute carrier family 12, member 6 -2.1
10607806 Ofd1 oral-facial-digital syndrome 1 gene homolog (human) -2.1
10386652 Aldh3a2 aldehyde dehydrogenase family 3, subfamily A2 -2.08
10533929 Scarb1 scavenger receptor class B, member 1 -2.07
10564960 Furin furin (paired basic amino acid cleaving enzyme) -2.07
10404792 Phactr1 phosphatase and actin regulator 1 -2.04
10443730 Abcg1 ATP-binding cassette, sub-family G (WHITE), member 1 -2.04
10577757 Adam9 a disintegrin and metallopeptidase domain 9 (meltrin gamma) -2.04
10354979 Als2 amyotrophic lateral sclerosis 2 (juvenile) homolog (human) -2.03
10355456 Mreg melanoregulin -2.03
10476314 Prnp prion protein -2.03
10483824 Ttc30a1 tetratricopeptide repeat domain 30A1 -2.03
10607366 Shroom2 shroom family member 2 -2.03
10531274 Btc betacellulin, epidermal growth factor family member -2.01
10424965 Ppp1r16a protein phosphatase 1, regulatory (inhibitor) subunit 16A -2
10451213 1700027N10Rik RIKEN cDNA 1700027N10 gene -2
10468344 Col17a1 collagen, type XVII, alpha 1 -2
10535043 Pdgfa platelet derived growth factor, alpha -2
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3.2.5.3 Genes of top interests 
The above analysis produced 227 genes of potential interest as encoding cell surface (or cell 
surface-related) molecules. Ideally, all these genes should be examined individually. To 
efficiently select only the most interesting cell surface candidates, I prioritized genes in two 
non-exclusive groups. Group one: genes common to all three populations (8 genes) and genes 
common to E15.5 and P4 CrxGFP positive cells (1 gene) (Figure 3.7, Table 3.3). These genes 
may include cell surface molecules which are shared by both early and late photoreceptor 
precursors. Group two: genes with more than five-fold expression changes in the 
photoreceptor cells (Figure 3.7). This allows selection of the most photoreceptor-specific genes. 
Notably, the above nine genes common to early and late photoreceptor cells also satisfied this 
standard. For the rest, 54 of the 89 common genes in CrxP4+ve and NrlP4+ve cells, two genes 
in CrxP4+ve alone and three genes in NrlP4+ve alone satisfied the five-fold standard. These 
genes may include cell surface markers for late rod or cone precursors. These two groups of 
genes gave a total of 68 candidates which were then sifted and examined individually in 
Uniprot to determine the presence of extracellular domains or GPI-anchors as well as their 
functions and cellular localization (Table 3.4). 32 of them have confirmed extracellular domains 
or are GPI-anchored. Based on their function and cellular location, I further selected 13 genes 
which locate in cilium or synapse regions or function in cell migration or adhesion as these 
features may be important for effective transplantation (Table 3.5).  
Of the 13 selected surface markers, Pcdh21/Cdhr1, Ush2a, Prom1 and Pcdh15 were annotated 
to be related with cilium (Table 3.5). Pcdh15, Ush2a, Sv2b, Slc17a7, Chrna5, Chrnb4, and 
Gabrr3 were annotated to be related with synapses. Podxl, Sema7a, Ntng2 and Jam2 were 
annotated to be related with cell migration, adhesion, axon guidance or outgrowth. The 
pathways in which the 13 candidates are involved and their interacting molecules were also 
identified (Table 3.5). Prom1 interacts with Cdhr1 in cilium. Sv2b interacts with laminin in 
extracellular matrix-receptor interaction pathways. Sema7a interacts with Itgb1 and PlexinC1 
in axon guidance pathways. And Jam2 interacts with Jam3, Jam2, Magl1, Itga4, and Itgb1 in 
tight junction and leukocyte transendothelial migration. The interacting molecules of our 
selected cell surface markers were also detected in our microarrays (Table 3.5).  
All the 13 genes selected showed much higher expression in photoreceptor cells than other 
retinal cells at P4 according to the microarrays (Figure 3.8). Other than Slc17a7 and Gabrr3 the 
expression fold changes of the 13 genes were not widely different between the NrlGFP-sorted 
and CrxGFP-sorted P4 retinal cells. Except Sema7a, most of the 13 genes also showed slightly 
higher expression in the E15.5 photoreceptor cells than other retinal cells. These indicate the 
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specificity of these cell surface markers to photoreceptor cells. Other than Chrnb4, all 
remaining genes showed higher expression in late photoreceptor cells than early 
photoreceptor cells indicating the higher demands of the cell surface molecules for late 
photoreceptor precursors (Figure 3.8). The absolute expression levels of these genes were also 
high in the microarrays. Other than Gabrr3 which was absent in the NrlP4 array, the log2 
intensity of the remaining genes were all above 8.7 for NrlP4+ve cells (data not shown). In the 
Crx array, the minimum log2 intensity of the 13 genes was 4.8 in E15.5 CrxGFP+ve cells and 6.3 
in P4 CrxGFP+ve cells demonstrating high expression (Figure 3.9).  
 
 
Figure 3.7 Flowchart for sifting through the cell-surface related candidate genes. The 227 cell surface related 
candidate genes were furthered filtered through a five-fold expression changes which gave 68 candidate genes. 
The 68 candidates were individually examined for presence of extracellular domains or GPI-anchor which gave 32 
candidates. The 32 candidates were further examined for functions involved in cilium, synapses, migration and 
adhesion and yields 13 candidates of high interests.  
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Table 3.4 Extracellular domains, function and location of 68 prioritized cell surface candidates  
 
 
Common CrxE15+CrxP4+NrlP4+ cell surface related genes (8 -> 8)
GeneSymbol Extracellular Domains Function Location
Cngb3 231-242, 316-351, 431-
568
cGMP actived opening of cation channel multipass mem, OS
Pdc na visual phototransduction cilium
Rpgrip1 na disk morphogenesis cilium
Hcn1 157 – 162, 230 – 237, 
311 – 333, 356 – 360
cAMP actived hyperpolarization ion channel multipass mem, apical dendrites
Slc1a2 143 – 238 terminate postsynaptic action of glutmate by removing them from 
synaptic cleft
multipass mem,axolemma 
Egflam na ribbon synapse formation ECM, synapse
Dmd na synaptic transmission, signaling, anchors ECM to cytoskeleton synapse, peripheral mem pr, cytoskeleton, 
sarcolemma
Sv2b 132 – 148, 204 – 205, 
259 – 277, 412 – 535, 
587 – 592, 650 – 653
synaptogenesis, control secretion synapse, ribbon synapses, cell junction, synaptic 
vesicle mem
Common CrxE15+CrxP4+ cell surface related genes (1-> 1)
GeneSymbol Extracellular domain Function Location
Fabp7 na transport of hydrophobic gland cytoplasm
Common CrxP4+NrlP4+ cell surface related genes (89-> 54)
GeneSymbol Extracellular domain Function Location
Rho 1 – 36, 99 – 113, 177 – 
202, 277 – 284
image-forming vision, postnatal PR viability multipass mem, IS, OS 
Rp1h soluble fraction? PR differentiation cilium, IS, cell bodies of PR
Gngt1 na GTPase activity, replacement of GDP by GTP, G protein-effector 
interaction
lipid-anchor, cytoplasmic side, rod OS
Opn1sw 1 – 31, 95 – 108, 172 – 
197, 272 – 279
visual pigments, increase spectral sensitivity multi-pass mem, cones
Cnga1 178 – 190, 254 – 291, 
387 – 470
cGMP actived opening cation channel multipass mem, OS
Slc17a7 85 – 116, 162 – 169, 230 
– 236, 324 – 341, 400 – 
401, 457 – 469
Mediates the uptake of glutamate into synaptic vesicles at 
presynaptic nerve terminals of excitatory neural cells
synapse, synaptic vesicle mem, synaptosome
Pcdh21/Cdhr1 22 – 701 may be required for structural integrity of OS single-pass mem, cilium, OS base, opposite CC
Ush2a 35 – 5033 involved in hearing and vision,  required for integration into the 
basement mem. interact with collagen IV and fibronectin
single-pass type I mem protein, stereocilium mem, 
apical and basement mem, high in basement mem, 
synaptic terminals of PR
Nt5e Signal peptide 1 – 28, 
GPI-anchored
hydrolyzes extracellular nucleoties into mem permeable 
nucleosides
GPI-anchor
Kcnv2 185 – 269, 366 – 391, 
449 – 461, 483 – 488
Modulates channel activity by shifting the threshold and the half-
maximal activation to more negative values 
multi-pass mem
Gnat1 na amplifies and transduces visual impulse, GTP-binding, nucleotide-
binding
OS, CC
Cplx4 na regulate synaptic vesicle exocytosis lipid-anchor, synapse, synaptic terminal
Plekha2 na Binds specifically to phosphatidylinositol-3,4-diphosphate 
(PtdIns3,4P2), but not to other phosphoinositides. May recruit 
other proteins to the plasma membrane.
peripheral mem, nucleus, cytoplasm
Cacna1f 12 ex domains give rise to long-lasting calcium currents multi-pass mem, INL, ONL
D230044M03Rikna na na
Pde6a na catalyse guanosine cyclic phosphate into guanosine phosphate, 
transmits and amplifies visual signal
lipid-anchor, cytoplasmic side
Pde6c na catalyse guanosine cyclic phosphate into guanosine phosphate lipid-anchor, cytoplasmic side
Lrp4 21 – 1725 Potential cell surface endocytic receptor, which binds and 
internalizes extracellular ligands for degradation by lysosomes.
single-pass mem, 
Doc2b na stimulate mem fusion by modifying mem curvature, binds 
calcium/phospholipids
peripheral mem, synapse, synaptic vesicle, 
cytoplasm
Cerkl na Hu:no detectable ceramide-kinase activity Hu:necleolus, may shuttle, moderate expression in 
retina
Podxl 22 – 404 migration, regulation of both adhesion and cell morphology and 
cancer progression
 single-pass type I mem protein, microvillus, 
lamellipodium
Gnat2 na amplifies and transduces visual impulse, GTP-binding, nucleotide-
binding
rod OS,mem
Rasgrf2 na synaptic plasticity by contributing to the induction of long term 
potentiation, calcium-regulated nucleotide exchange factor 
actvating Ras and RAC1
peripheral mem,ER mem
Ptp4a3 na stimulate progression from G1 to S phase, enhances cell 
proliferation, motility and invasive activity
early endosome
Abca4 43 – 546, 1397 – 1558 photoresponse, transport retinal multi-pass mem, rims of rods
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Prom1 20 – 107, 180 – 434, 509 
– 794
binds cholesterol, regulate disk morphogenesis and MAPK and Akt 
pathways
multi-pass mem, cilium
Slco4a1 124 – 142, 195 – 224, 
296 – 309, 403 – 422, 
474 – 582, 641 – 673
Mediates the Na+-independent transport of organic anions such 
as the thyroid hormone T3 (triiodo-L-thyronine) and of 
taurocholate
multi-pass mem
Arr3 na May play a role in an as yet undefined retina-specific signal 
transduction. Could binds to photoactivated-phosphorylated 
red/green opsins.
IS, OS
Stx3 284 – 289 potentially docking synaptic vesicles single-pass type IV mem, apical plasma mem
Pex5l na Interacts with RAB8B peripheral mem, cytoplasm
Chrna5 451 - 467, 30 - 254? 305 - 
316?
binds acetylcholine and opens an ion-conducting channel multi-pass mem, synapse, postsynaptic cell mem
Pla2r1 27 - 1396 phospholipase receptor, may affect MAPK single-pass type I mem, 
Chrnb4 21 – 235, 286 – 297, 485 
– 495
binds acetylcholine and opens an ion-conducting channel multi-pass mem, synapse, postsynaptic cell mem, 
Bbs5 na BBSome complex, ciliogenesis cilium, basal bodies
Gngt2 na GTPase activity, replacement of GDP by GTP, G protein-effector 
interaction
lipid-anchor, cytoplasmic side
Cep290 na localization of ciliary and phototransducin proteins cilium, nucleus, centrosome
Plch2 na produce DAG and IP3 plasma mem
Gnb3 na GTPase activity, replacement of GDP by GTP, G protein-effector 
interaction
G-protein complex
Rgs9 na inhibits signal transduction by increasing GTPase activity of G 
protein alpha subunits
G-protein complex
Lifr 44 - 828 Signal-transducing molecule. May have a common pathway with 
IL6ST. The soluble form inhibits the biological activity of LIF by 
blocking its binding to receptors on target cells.
Isoform 1: Cell membrane; Single-pass type I 
membrane protein. Isoform 2: Secreted. 
Cln3 59 - 98, 299 - 357 Battenin Lysosome membrane; Multi-pass membrane 
protein
Hs3st3b1 54 - 390 sulfotransferase 1 family, enzyme single-pass type II mem protein, Golgi
Ier3 105 - 153 May play a role in the ERK signaling pathway by inhibiting the 
dephosphorylation of ERK by phosphatase PP2A-PPP2R5C 
holoenzyme
single-pass type II mem, Golgi
Cdgap/Arhga
p31
na GTPase-activating protein for RAC1 and CDC42, required for cell 
spreading, polarized lamellipodia formation and cell migration
migration, lamellipodium, focal adhesion
Pcdh15 27 - 1381 Calcium-dependent cell-adhesion protein. Required for inner ear 
neuroepithelial cell elaboration and cochlear function. Probably 
involved in the maintenance of normal retinal function
single-pass type I mem (heavy glycosalation), 
stereocilium, OS, 
Bbs9 na BBSome complex, ciliogenesis cilium mem, cytoplasm
Klhl1 na May play a role in organizing the actin cytoskeleton of the brain 
cells
cytoskeleton
Sema7a Sema domain and Ig-
like C2-type domain, 
GPI-anchored
Axon guidance, may play an imortant role in the nervous system 
and in modulating immune function
GPI-anchor
Ntng2 Laminin EGF-like 
domains, GPI-anchored
Migration, promotes neurite outgrowth of both axons and 
dendrites. Interacts with LRRC4
GPI-anchor
Plekhb1 na binds transducins.Interacts with MYO1C mem-associated. Highly in OS
Cplx3 na regulate synaptic vesicle exocytosis lipid-anchor, synapse, synaptic terminal
Atp1a3 99 – 121, 299 – 310, 783 
– 792, 857 – 908, 961 – 
975
catalytic component of Sodium/potassium-transporting ATPase multi-pass mem, across plasma mem
Trak2 na Hu:regulate endosome-to-lysosome trafficking of mem cargo, 
including EGFR
Cytoplasm, early endosome
Jam2 29 - 236 processes of lymphocyte homing to secondary lymphoid organs tight junction, single-pass type I mem
CrxP4+ alone cell surface related genes (29->2)
GeneSymbol Extracellular domain Function Location
Gabrr3 24 - 266, 321 -311 Hu: mediates neuronal inhibition by binding to GABA Hu: synapse, postsynaptic cell mem, multi-pass 
mem
Cxcr6 1 – 41, 99 – 112, 174 – 
196, 269 – 284
Receptor for the C-X-C chemokine CXCL16 multi-pass mem
NrlP4+ alone cell surface related genes (100-> 3)
GeneSymbol Extracellular domain Function Location
Aipl1 na protein trafficking and/or protein folding and stabilization cytoplasm, nucleus
Kcnb1 na mediate voltage-dependent potassium ion permeability of 
excitable mem
multi-pass mem
Klc3 na microtubule-associated force-producing protein that may play a 
role in organelle transport
Elongating spermatid tail midpiece. Localized in 
outer dense fibers (ODFs) and associates with 
mitochondria 
ECM: extracellular matrix; OS: outer segment; IS: inner segment; PR: photoreceptor; mem: membrane; Hu: Human; CC: 
connecting cilium; ER: endoplasmic reticulum; INL: inner nuclear layer; ONL: outer nuclear layer. Extracellular domain 
positions are either directly provided by Uniprot or estimated by positions of transmembrane domains and N-linked 
glycosylation sites which are known or predicted to be extracellular. 
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Table 3.5 Pathways and interacting molecules of 13 selected surface markers 
 
 
 
 
 
Gene 
Symbol
Gene Name Note Pathway Genes in 
pathway
Expression in 
microarray (FC)
Prom1 prominin 1 cilium Cilium (Yang et al. 2008), Transcriptional 
misregulation in cancers (Kegg pathway)
Pcdh21 
(Yang et al. 
2008)
NrlP4+ve Pcdh21 -27.1
Pcdh21/
Cdhr1
protocadherin 21 / 
cadherin-related family 
member 1
cilium Cadherin signaling pathway (Panther 
pathway), Wnt signaling pathway (Panther 
pathway)
Prom1 (Yang 
et al. 2008)
NrlP4+ve Prom1 -9.19
Pcdh15 protocadherin 15 adhesion, 
stereocilium, 
heavy 
glycosalation
Cadherin signaling pathway  (Panther 
pathway), Wnt signaling pathway  (Panther 
pathway) 
Ush2a Usher syndrome 2A 
(autosomal recessive, 
mild) homolog (human)
apical and 
basement mem
Cilium (Yang et al. 2010; Liu et al, 2007)
Sv2b synaptic vesicle 
glycoprotein 2 b
synapse ECM-receptor interaction (Kegg pathway) laminin NrlP4-ve Lamb1-1 1.82, 
Lama1 3.1, Lama2 1.23, 
Lama5 1.18, Lamb2 
3.01, Lamc1 1.37, Sv2c 
2.45
Slc17a7 solute carrier family 17 
(sodium-dependent 
inorganic phosphate 
cotransporter), member 7
synapse Ionotropic glutamate receptor pathway 
(Panther pathway), Metabotropic glutamate 
receptor group III pathway (Panther 
pathway)
Chrna5 cholinergic receptor, 
nicotinic, alpha 
polypeptide 5
synapse Nicotinic acetylcholine receptor signaling 
pathway (Panther pathway) 
Chrnb4 cholinergic receptor, 
nicotinic, beta 
polypeptide 4
synapse Nicotinic acetylcholine receptor signaling 
pathway (Panther pathway) 
Gabrr3 Hu:Gamma-aminobutyric 
acid receptor subunit rho-
3
Hu: synapse na
axon guidance Axon guidance (Kegg pathway) Itgb1 NrlP4-ve Itgb1 2.6
plexin C1 NrlP4-ve Plxnc1 4.32
Jam2 tight junction Jam3 NrlP4-ve Jam3 3.23
Jam2 NrlP4+ve Jam2 -2.2
MagI1 NrlP4-ve Magi1 2.69
Itga4 NrlP4-ve Itga4 1.91
Itgb1 NrlP4-ve Itgb1 2.6
Podxl podocalyxin-like migration na
Ntng2 netrin G2 nuerite 
outgrowth
Axon guidance mediated by Slit/Robo 
(Panther pathway), Axon guidance mediated 
by netrin (Panther pathway)
Interacting molecuesPhotoreceptor surface markers
Leukocyte transendothelial migration (Kegg 
pathway), Cell adhesion molecules (Kegg 
pathway)
Tight junction (Kegg pathway), Cell adhesion 
molecules (Kegg pathway)
junction adhesion 
molecule 2
sema domain, 
immunoglobulin domain 
(Ig), and GPI membrane 
anchor, (semaphorin) 7A
Sema7a
ci
li
u
m
sy
n
ap
se
m
ig
ra
ti
o
n
/a
d
h
e
si
o
n
OS, outer segment; CC, connecting cilium; mem, membrane; PR, photoreceptor cells 
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Figure 3.8 Expression fold changes of selected cell surface markers from microarray. (Top) Table of the 
normalized expression fold changes of selected markers between different comparisons from the microarrays. 
(Bottom) Chart of the normalized expression fold changes. NrlP4 +v- : P4 NrlGFP+ve vs NrlGFP-ve; CrxE15 +v-: 
E15.5 CrxGFP+ve vs CrxGFP-ve; CrxP4 +v-: P4 CrxGFP+ve vs CrxGFP-ve; Crx+ E15vP4: CrxGFP+ve E15.5 vs P4; Crx- 
E15vP4: CrxGFP-ve E15.5 vs P4.  
 
 
 
Gene Symbol NrlP4 +v- CrxE15 +v- CrxP4 +v- Crx+ E15vP4 Crx- E15vP4
Prom1 9.19 1.24535 9.40123 -4.24424 1.77866
Cdhr1 27.1 4.21158 14.3479 -4.55181 -1.3361
Pcdh15 5.46 3.09258 2.87036 -6.92572 -7.46191
Ush2a 24.8 2.28418 7.01788 -3.4602 -1.12623
Sv2b 8.17 2.75689 16.9575 -3.62394 1.69731
Slc17a7 32.4 1.32034 3.17132 -2.62905 -1.09457
Chrna5 7.78 1.01644 3.47781 -1.87292 1.82686
Chrnb4 7.57 1.75116 4.6459 1.17311 3.11231
Gabrr3 1.56298 47.1376 -30.1713 -1.00042
Sema7a 5.03 -1.05654 3.64527 -3.12341 1.23306
Jam2 2.2 1.54415 5.52587 -2.86082 1.25089
Podxl 11.2 1.90941 4.76013 -1.97798 1.26037
Ntng2 5.03 1.88705 2.45379 -1.47233 -1.13228
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Average Stdev Average Stdev Average Stdev Average Stdev
Prom1 8.35821 0.028157 8.041653 0.095672 10.4437 0.14913 7.210867 0.219296
Cdhr1 6.47519 0.33671 4.400827 0.172311 8.66163 0.417646 4.818857 0.107789
Pcdh15 7.288985 0.363191 5.66017 0.399457 10.08096 0.38391 8.559717 0.231177
Ush2a 5.5172 0.567001 4.325523 0.188166 7.308053 0.328018 4.49702 0.109593
Sv2b 8.271455 0.035645 6.808413 0.340741 10.12903 0.08853 6.045163 0.134221
Slc17a7 4.870175 0.033524 4.46927 0.332747 6.26472 0.290027 4.599633 0.094689
Chrna5 6.55776 0.352464 6.53424 0.169071 7.463047 0.155706 5.66487 0.147782
Chrnb4 9.149725 0.454054 8.341417 0.239726 8.919387 0.632958 6.703427 0.044324
Gabrr3 4.7679 0.194723 4.123593 0.309595 9.683003 0.279764 4.124197 0.035193
Sema7a 5.576905 0.010981 5.65625 0.229596 7.220027 0.292322 5.354 0.069338
Jam2 9.545925 0.073475 8.91911 0.090159 11.06237 0.087387 8.596153 0.093131
Podxl 6.53793 0.482912 5.604807 0.162006 7.52196 0.608996 5.27096 0.259737
Ntng2 5.81083 0.100862 4.89469 0.115697 6.368927 0.350208 5.07392 0.015219
Gene Symbol E15+ve E15-ve P4+ve P4-ve
 
Figure 3.9 Absolute expression levels of selected cell surface markers from Crx microarray. (Top) Table of the 
normalized absolute microarray expression levels of selected markers. (Bottom) Chart of the normalized 
expression levels. Error bar represent standard deviation (Stdev) from three independent samples except 
CrxE15.5+ve which includes two independent samples. E15+ve: E15.5 CrxGFP+ve; E15-ve: E15.5 CrxGFP-ve; P4 
+ve: P4 CrxGFP+ve; P4-ve: P4 CrxGFP-ve;  
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3.2.6 Quantitative RT-PCR validation of selected genes 
To validate the microarray expression of the candidate genes, I performed qPCR for four genes 
of particular interest namely Prom1, Sema7a, Cdhr1 and Sv2b. Prom1 was reported to interact 
with Cdhr1 in the cilium at the basement of outer segment involving outer segment formation 
(Yang, Chen et al. 2008). Sema7a is involved in axon guidance and cell migration interacting 
with Itgb1 and PlxnC1 (Pasterkamp, Peschon et al. 2003; Pasterkamp, Kolk et al. 2007; Scott, 
McClelland et al. 2009; Messina, Ferraris et al. 2011). Sv2b was detected in ribbon synapses of 
the mouse retina, in particular both rod and cone terminals (Rich, Zhan et al. 1997), interacting 
with laminins (Wang, Janz et al. 2003; Morgans, Kensel-Hammes et al. 2009). Knock out of 
Sv2b in mice reduced neurotransmission between photoreceptor cells and bipolar cells as well 
as the expression levels of synaptic vesicle proteins synaptotagmin, synaptophysin, and the 
vesicular glutamate transporter V-GLUT1 (Morgans, Kensel-Hammes et al. 2009). The qPCR 
expression trends of the four genes agree with the microarray and showed even greater 
expression fold changes between photoreceptor cells and other retinal cells (Figure 3.10). 
Expression of Sema7a was also higher in the E15.5 photoreceptor cells than other retinal cells 
according to qPCR despite the microarray indicating slightly higher expression in other retinal 
cells. Expression of Prom1 was also examined in NrlGFP-sorted retinal cells, which showed 
similar expression fold changes as CrxGFP-sorted cells (around 20-fold, Figure 3.10 A, B, F). The 
expression levels of the four genes in photoreceptor cells as well as the expression fold 
changes between photoreceptor cells and other retinal cells were all higher in postnatal stages 
than embryonic stages, agreeing with the microarray data (Figure 3.10 F).  
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Figure 3.10 qPCR relative expression levels and fold changes of representative markers. Relative expression levels 
of Prom1 (A, B), Sema7a (C), Cdhr1 (D), and Sv2b (E) from CrxGFP or NrlGFP sorted E15.5 and P4-5 retinal cells. 
Error bar represent standard deviation of three independent samples. (F) Expression fold changes between 
comparisons for Prom1, Cdhr1, Sv2b and Sema7a. E15.5 Crx+v-: E15.5 CrxGFP+ve vs CrxGFP-ve; P4 Crx+v-: P4 
CrxGFP+ve vs CrxGFP-ve; P5 Nrl+v- : P5 NrlGFP+ve vs NrlGFP-ve (only performed for Prom1); Crx+ E15.5vP4: 
CrxGFP+ve E15.5 vs P4; Crx- E15.5vP4: CrxGFP-ve E15.5 vs P4.  
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3.3 Discussion 
Despite intensive microarray study in the retina (Dorrell, Aguilar et al. 2004; Hackam, Qian et al. 
2004; Zhang, Xu et al. 2005; Liu, Wang et al. 2006; Punzo, Kornacker et al. 2009), rarely has this 
specifically focused on photoreceptor cells. Microdissection of ONL had been performed 
(Blackshaw, Fraioli et al. 2001), but contamination from progenitor cells and processes of other 
retinal neurons was not controlled. With the development of GFP-tagged photoreceptor 
transcription factor transgenic lines, specific isolation of photoreceptor cells from the retina is 
possible. Using these transgenic lines Akimoto et al has profiled the gene expression pattern of 
NrlGFP labelled rod photoreceptor cells and Nrl-knockout-GFP labelled “cone-like-rod” cells 
during development (Akimoto, Cheng et al. 2006). They also compared the GFP-sorted cells 
with the whole retina but not with none-photoreceptor retina cells, and hence were less likely 
to identify photoreceptor-specific properties and genes. During the course of my study, two 
photoreceptor microarrays after FACS selection of photoreceptor vs other retinal cells were 
reported: one is on P4 rod cells using a rhoEGFP transgenic line (Eberle, Schubert et al. 2011) 
and the other is on E17.5 photoreceptor cells using a bacterial artificial chromosome (BAC)-
Crx-EGFP line (Muranishi, Sato et al. 2010). The latter studies identified 744 and 168 genes that 
were upregulated more than 2 fold in the EGFP+ve cells respectively though only limited 
transcriptome analysis was performed and the array data from only one of these was 
deposited in public databases. The embryonic photoreceptors I studied are from E15.5 retina 
which is the earliest time point so far used for photoreceptor microarray. Thirdly, comparison 
of the E15.5 and P4 photoreceptor microarray revealed specific genes and properties that may 
be associated with efficient integration and formation of cones after transplantation.   
The rod-specific genes reported in the rhoEGFP study (rhodopsin, Pde6b, Gngt1, recoverin) and 
the cell surface markers it reported (Cd73, Cnga1, Gje1, and Pcdh15) (Eberle, Schubert et al. 
2011) were also present in my study. The BAC-Crx-EGFP study identified 168 genes at E17.5 
showing more than 2-fold higher expression in CrxGFP+ve cells than CrxEGFP-ve cells 
(Muranishi, Sato et al. 2010) whereas I only identified 63 genes at E15.5. This is probably 
because more transcripts are expressed at later developmental stages than earlier stages as I 
found 627 genes showing more than 2-fold higher expression in CrxGFP+ve cells at P4. 
However, I do not exclude the possibility of different sensitivity between my array and 
Muranishi’s array. Similar to the E17.5 photoreceptor array, most of the E15.5 transcripts are 
transcription factors such as Otx2, NeuroD1, Neurod4, Meis2. The genes encoding cone specific 
proteins reported in the E17.5 array were also present in the E15.5 array (such as Thrb and 
Opn1sw but not Rxrγ). In addition, I also found Cngb3 and Pde6c, which are more recently 
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known as cone-specific, present in the E15.5 array (as well as the CrxP4 array) and will be 
discussed further in section 3.3.1. 
3.3.1 The properties of photoreceptor precursor cells 
By comparing the CrxGFP or NrlGFP positive versus negative cells, I was able to find the unique 
transcriptional properties of the photoreceptor precursor cells. Genes within these cells are 
particularly the ones encoding proteins involved with visual perception, detection to stimulus, 
and photoreceptor development. These are expected transcriptional properties specifically 
belonging to photoreceptor cells, and hence demonstrate the accuracy of the microarray 
analysis. Interestingly, I also found significant enrichment of genes encoding cell projection 
proteins, in particular genes encoding proteins associated with cilia, which were significantly 
enriched in the P4 photoreceptor cells, but not other retinal cells of the same stage. The cilium 
is a very specialized structure on many polarized cells. Much cilia work to date focuses on 
intracellular molecules which are involved in the genesis of cilium, yet functions, working 
mechanisms, and detailed subcellular locations of many cilium cell surface molecules are still 
poorly defined. Some of these molecules will be further studied in Chapter 5 (section 5.2).  
Photoreceptor precursors at embryonic stages showed some commitment to photoreceptor 
differentiation, but remain largely unspecified. One of the major molecular activities of these 
cells was transcription regulation which agrees well with the early status of these cells and the 
E17.5 Crx-EGFP array study (Muranishi, Sato et al. 2010). Similarly, the E15.5-specific 
photoreceptor genes produced by further secondary comparison of the E15.5 versus P4 
photoreceptor-specific gene sets were highly focused on transcription regulation, embryonic 
development, and metabolic process, and not many transcripts showed specific cellular 
localization. In contrast, the P4-specific genes showed a highly spread-out pattern in many 
specific functions such as ion binding (eg. Cadm3, Ppp2r3a, Galnt4, Clstn1), channel activity (eg. 
Grik1, Grik3, Chrna5, Chrnb4), lipid binding (eg. Snx14, Cpne6, Fabp12, Nr3c1, Arhgap29), 
transcription factor binding ((eg. Dcc, Ncoa2, Kat2b, Hipk3, Nlk), phosphoric diester hydrolase 
activity (eg. Pde6a, Pde6b, Plcl1, Smpdl3a), and so on. Importantly, the P4-specific genes 
enriched lots of cell projection transcripts for cilia and synapses (eg. Gnat1, Rp1, Bbs4/5/7/9, 
Rpgr, Ttc30a2, Pcdh15, Ttc8, Cnga1, Plekhb1, Arr3, Cep290). The limited transcriptional 
properties of the E15.5 photoreceptor cells and their lack of specific genes encoding cell 
projection proteins may be associated with their low integration efficiency after 
transplantation. In contrast, appearance of large amounts of various new transcripts, 
especially the enrichment of many genes encoding cell projection proteins, along with other 
diversified detailed functions and properties probably enable the P4 precursor cells more 
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readily incorporated into the host environment, hence showing higher integration efficiency 
after transplantation.  
In addition to the stage specific genes, the above secondary comparison also revealed 
common genes and properties for the early and late photoreceptor precursors. This not only 
included the expected genes encoding photoreceptor-specific transcription regulation factors 
(Crx) and sensory perception proteins (Pdc), but also many genes encoding cell projection 
proteins. Genes in this set seem to be of particular interest as both genes specific to cone 
photoreceptor cells and genes encoding cell projection proteins can be found here such as 
Thrb, Pde6c and Cngb3. Pde6c encodes the cone-specific alpha subunit of cGMP 
phosphodiesterase thus playing essential role in cone phototransduction. Mutations of Pde6c 
have been associated with early onset of cone disorders including progressive cone dystrophy 
(Thiadens, den Hollander et al. 2009), achromatopsia (Chang, Grau et al. 2009; Grau, Artemyev 
et al. 2011) and cone-rod dystrophy (Huang, Zhang et al. 2013). Containing three extracellular 
domains, Cngb3 is specifically involved in the electrical response and cation channel opening of 
cones (Gerstner, Zong et al. 2000) and its deficiency is associated with retinal disorders 
characterised by the loss of cones (Kohl, Baumann et al. 2000; Sundin, Yang et al. 2000; Xu, 
Morris et al. 2011). Cngb3 mutations were also found in patients with cone-rod dystrophy  
(Huang, Zhang et al. 2013). In our array, Cngb3 showed much higher expression fold-changes 
in the E15.5 CrxGFP+ve and CrxGFP-ve comparison than in the P4 comparison and will be 
discussed further in Chapter 5 (section 5.2.1).  
3.3.2 Cell surface markers for photoreceptor precursor cells 
I used two approaches to search for photoreceptor cell surface markers. By searching for CD 
molecules, I found 10 CD markers expressed more than two-fold in photoreceptor cells 
compared with other retinal cells from the Crx and Nrl array. By searching with functional 
annotations in these arrays, I found 227 candidates with two-fold higher expression in 
photoreceptor cells. Applying more stringent criteria including more than five-fold expression 
changes, containing confirmed extracellular domains, and function in cilium/synapses/ 
migration/adhesion prioritized 13 markers of particular interests. These 13 candidates not only 
showed high expression fold changes between photoreceptor cells and other retinal cells, but 
also high absolute expression levels in photoreceptor cells. The axon guidance molecule 
Sema7a was rarely reported in retina and was studied further in Chapter 4 as a candidate 
molecule possibly involved in photoreceptor migration and ONL organization. The cilia protein 
Prom1 was studied further in Chapter 5 for the cilia property of photoreceptor cells which may 
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be involved in photoreceptor orientation, and in Chapter 6 as a biomarker to label 
photoreceptor cells for transplantation along with CD73 and CD24.   
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4 The role of cell surface molecule Sema7a on migrating 
photoreceptor cells in the retina 
4.1 Introduction 
The mature retina is a laminated neural tissue, organised in three layers of neurons separated 
by two plexiform layers composed of axons and synapses. This complex structure develops 
from the pseudostratified neuroepithelium of the embryonic optic cup. Multipotential RPCs 
from this single layer of optic cup gradually differentiate into different neurons which orient 
themselves and migrate into their destined positions and finally form all the confined layers. 
However, the molecular mechanisms governing layer formation are not well understood. Some 
semaphorins were recently shown to be involved in the correct lamination of the inner retina 
(Matsuoka, Chivatakarn et al. 2011; Matsuoka, Nguyen-Ba-Charvet et al. 2011). For example, 
Sema6a is expressed in the IPL and GCL directing lamina-specific neurite arborisation of 
tyrosine hydroxylase (TH)-expressing dopaminergic amacrine cells, intrinsically photosensitive 
RGCs (ipRGCs) and calbindin-positive cells via interaction with PlexinA4 (Matsuoka, Nguyen-Ba-
Charvet et al. 2011). Sema5a and Sema5b are transiently expressed in the ONBL of the 
postnatal retina as repulsive molecules to prevent neurite mistargeting of the majority of RGCs, 
amacrine cells, and bipolar cells via interaction with PlexinA1 and PlexinA3 (Matsuoka, 
Chivatakarn et al. 2011). However, no molecules have been reported to be involved in the 
correct lamination of the outer retina, in particular the photoreceptor layer. I, therefore, am 
interested in finding out cell surface molecules with such functions. This is because although 
there will be other signals in play such as secreted proteins, chemical and physical stimuli, 
presence or absence of the proteins at the surface of the migrating cell will almost certainly be 
a major influence on cell migration and development of the laminated retinal structure. 
Furthermore, identifying the cell surface molecules that mediate the migration and integration 
process of the cells following transplantation and correct orientation and organisation within 
the ONL may aid efforts to repair the retina via photoreceptor transplantation in diseases 
causing photoreceptor degeneration. My colleagues have previously shown that subretinally 
transplanted photoreceptor precursor cells can migrate into the ONL and differentiate into 
correctly integrated photoreceptors (MacLaren, Pearson et al. 2006; Lakowski, Baron et al. 
2010; Pearson, Barber et al. 2012). However the processes and mechanisms involved are not 
understood.  
The semaphorins were discovered in 1993 as a family of membrane-associated and secreted 
proteins (Kolodkin, Matthes et al. 1993). Over 20 members have been identified so far. 
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Although some of them have been shown to be involved in immune cell regulation (Suzuki, 
Okuno et al. 2007), organ morphogenesis (Behar, Golden et al. 1996), tumor suppression 
(Tomizawa, Sekido et al. 2001), and vascularization (Serini, Valdembri et al. 2003; Gu, Yoshida 
et al. 2005), the semaphorins were largely known for their function in axon guidance and 
synapses formation. Therefore, the semaphorins seems to be good candidates as cell surface 
molecules involved in organisation of photoreceptors within the ONL. However, not many 
semaphorins were known to be expressed in the eye. In addition to Sema6a and Sema5a/5b 
mentioned above, earlier it was also found that Sema4a is expressed in the GCL, INL and RPE 
and its deficiency results in disorganized outer segments of photoreceptor cells (Rice, Huang et 
al. 2004). Yet, semaphorins expressed in the photoreceptor cells remained unknown.  
In my microarray screen for cell surface molecules which are highly transcribed in 
photoreceptor cells, Sema7a was identified as being of potential interest because of its 
involvement in axon guidance and higher expression in photoreceptor cells than other retinal 
cells (Chapter 3, Table 3.2 to Table 3.5). Although it has been reported in other systems there 
is little information about Sema7a in the retina, except one in situ hybridization study showed 
Sema7a expression in RGC at E15 and further in IPL, lens, and lens epithelium at E19 
(Pasterkamp, Kolk et al. 2007). A total of 17 semaphorins were identified in our arrays (Table 
4.1). Three semaphorins were found to be expressed higher in photoreceptor cells: Sema3f, 
Sema4b and Sema7a, with Sema7a showing more than 5-fold higher expression in rod 
photoreceptor cells (5.03 FC) and Sema3f and Sema4b showing less than 2-fold higher 
expressions (1.79FC and 1.31FC respectively). I also found 14 semaphorins more highly 
expressed in other retinal cells which include Sema6a (6.87FC), Sema5a (5.28FC), Sema5b 
(3.25FC), Sema3a (3.1FC), Sema4g (2.95FC), Sema4d (2.62FC), Sema4a (2.43FC), Sema6d 
(2.14FC), and Sema4f (2.1FC).  
All semaphorin family members contain a relatively conserved N terminus extracellular 
semaphorin (sema) domain and a class-specific C terminus which differs in membrane 
anchorage and additional sequence motifs. Based on these overall structures as well as 
phylogenetic tree analyses, the semaphorins were grouped into eight classes (Figure 4.1 A) 
(Semaphorin-Nomenclature-Committee 1999). Class 1 and 2 are invertebrate semaphorins 
which include Sema-1a, Sema-1b, and Sema-2a. Class 3 to 7 are expressed in vertebrates 
which include Sema3 A-F, Sema4 A-G, Sema5 A-B, Sema6 A-C, and Sema7A. The 8th class are 
the viral semaphorins which are named as Class V. Other than the viral and the class 2 and 3 
semaphorins which are secreted, all other semaphorins are associated with membranes. Of 
these, while class 1, 4, 5 and 6 semaphorins contain a transmembrane domain in their C 
93 
 
terminus, Sema7a is attached to the membrane via a glycosylphosphatidylinositol (GPI)-anchor. 
Structure of Sema7a without the GPI-anchor mimics the viral semaphorin A39R secreted by 
smallpox virus (Liu, Juo et al. 2010).  
 
Table 4.1 Semaphorins expressed in the Crx and Nrl array 
Name P4 Nrl- vs. + E15.5 Crx+ vs. - P4 Crx+ vs. - Crx+ E15.5 vs. P4 Crx- E15.5 vs. P4 
Sema7a -5.03 -1.05654 3.64527 -3.12341 1.23306 
Sema3f -1.79 1.30482 1.55983 -1.12193 1.06552 
Sema4b -1.31         
Sema6a 6.87 -1.4142 -3.70638 2.05435 -1.27575 
Sema5a 5.28 -1.35661 -4.70013 -1.11271 -3.85511 
Sema5b 3.25         
Sema3a 3.1 -1.38269 -2.58841 4.59939 2.45692 
Sema4g 2.95         
Sema4d 2.62 -1.7785 -1.93483 1.09753 1.00885 
Sema4a 2.43 -1.26067 -1.49504 1.12616 -1.05305 
Sema6d 2.14         
Sema4f 2.1         
Sema3e 1.89 -2.33023 -2.2827 1.10998 1.13309 
Sema6b 1.62         
Sema3b 1.24         
Sema4c 1.24         
Sema3d 1.2         
 
 
 
Initially identified as a ligand-receptor pair through an in vitro binding assay, Sema7a was 
shown to bind to PlexinC1 (PlxnC1) (Tamagnone, Artigiani et al. 1999). However, two later 
experiments in olfactory neurons and activated T cells respectively suggested that Sema7a 
may actually bind to integrin β1 (Itgb1) or integrin α1β1 rather than PlxnC1 to promote axon 
outgrowth (Pasterkamp, Peschon et al. 2003) or induce inflammation (Suzuki, Okuno et al. 
2007). Interestingly, a later crystallographic analysis of the Sema7a mimic A39R alone showed 
that the proposed integrin binding site – a three amino acid RGD motif (arginine-glycine-
aspartic acid)– was actually buried and unlikely to be recognized by integrins (Liu, Juo et al. 
2010), which indicates either Sema7a does not bind to integrins directly or it has a different 
conformation when binding to integrins. Crystallography of Sema7a/PlexinC1 complex showed, 
however, clearly that Sema7a inserts its 4c-4d loop into the groove of PlexinC1 and forms 
Semaphorins in green indicates expression higher in photoreceptor cells, in blue indicate higher in other retinal cells. 
Expression fold changes were presented for P4 Nrl- vs. +, P4 NrlGFP-ve vs P4 NrlGFP+ve; E15.5 Crx+ vs. -, E15.5 
CrxGFP+ve vs E15.5 CrxGFP-ve; P4 Crx+ vs. -, P4 CrxGFP+ve vs P4 CrxGFP-ve; Crx+ E15.5 vs. P4, CrxGFP+ve E15.5 vs P4; 
Crx- E15.5 vs. P4, CrxGFP-ve E15.5 vs P4.  
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several salt bridges (Figure 4.1  B and C) (Liu, Juo et al. 2010). The interaction interface 
extends between residues 202-376 of the Sema domain. It also showed that Sema7a has a 
homodimer interface within residues 250-405 in human (248-403 in mouse) and proposed that 
Sema7a may form homodimers which then interact with PlxnC1 and induce PlxnC1 
dimerization (Figure 4.1 B) (Liu, Juo et al. 2010). Therefore, it remains perplexing as to which 
receptors Sema7a interact with in vivo. It is possible that in different systems Sema7a might 
interact with different receptors or both receptors but under different mechanisms.   
In this chapter I analysed expression of Sema7a protein in the retina and colocalisation with its 
two putative receptors, PlexinC1 and integrinβ1. I sought to find out which receptor Sema7a is 
interacting with in the retina and to investigate the hypothesis that Sema7a interactions are 
important for orienting and organising developing photoreceptor precursors within the ONL.  
 
Figure 4.1 Semaphorin 
classes and Sema7a 
structure. (A) Semaphorin 
classes. Adapted from 
(Semaphorin-
Nomenclature-Committee 
1999) (B) Illustration of 
Sema7a dimers interacting 
with PlexinC1. Adapted 
from (Liu, Juo et al. 2010).  
(C) Crystallography 
structure of Sema7a 
dimers with PlexinC1. PSI, 
domains found in Plexins, 
Semaphorins and Integrins. 
Adapted from (Liu, Juo et 
al. 2010).  
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4.2 Results 
4.2.1 Conservation of Sema7a 
Based on current genome annotations, the amino acid sequence of human SEMA7A was 
compared with chimpanzee, dog, cattle, rat, mouse, chicken, and zebrafish to assess 
conservation. Other than the homologues from chicken and zebrafish which showed less than 
50% sequence identity, all other mammalian homologues showed over 80% sequence identity 
(and mouse showed 89.6% identity) (Table 4.2). Like other semaphorins, Sema7a has a signal 
peptide (44 amino acid, aa) and a sema domain (~ 436 aa) on the N terminus (Figure 4.2). On 
its C terminus, Sema7a has a 39 aa Plexin repeat, an 86 aa Ig-like C2-type immunoglobin 
domain, and an Alanine lipidation site for GPI-anchor. There are five glycosylation sites on the 
extracellular domains, four of them on the sema domain and one on the Ig domain. There is 
also the RGD motif within the sema domain predicted for cell attachment or integrin binding. 
All these structural features are conserved from human to mouse (Figure 4.2). For the lower 
vertebrate animals, although they maintain the sema domain albeit in a smaller form, several 
structure elements or features that have emerged in mammals do not seem to be conserved in 
these species such as the signal peptide, the RGD motif, the lipidation site, and the 
glycosylation sites (Figure 4.2).  
Table 4.2 Sema7a pairwise alignment score 
Gene Identity (%) 
Species Symbol Protein DNA 
H.sapiens Human SEMA7A   
vs. 
P.troglodytes 
Common 
chimpanzee 
SEMA7A 98.8 99.2 
vs. C.lupus 
Dog (Gray 
wolf) 
SEMA7A 90.3 89.1 
vs. B.taurus Cattle SEMA7A 84.2 86.7 
vs. 
M.musculus 
House mouse Sema7a 89.6 87.9 
vs. 
R.norvegicus 
Brown rat Sema7a 89.4 87.5 
vs. G.gallus 
Chicken (Red 
Junglefowl) 
SEMA7A 49.7 59 
vs. D.rerio Zebrafish sema7a 38 46.4 
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Figure 4.2 Domain organization of Sema7a from Human to Zebrafish. The total number of amino acid residues is 
shown on the right (uniprot/NCBI) near protein accession number. The percentage of sequence identity with 
human is shown under species names (performed in NCBI blast).  
4.2.2 Sema7a expression in the mouse retina 
According to the qPCR analysis (Chapter 3, Figure 3.10), the Sema7a transcript is more than 10-
fold and 20-fold higher in CrxGFP FACS sorted photoreceptor cells than other retinal cells at 
E15.5 and P4 respectively in the mouse retina. I next examined Sema7a protein localisation in 
the adult and developing retina.  
IHC in adult mouse retina showed Sema7a was highly localised in the IS of photoreceptor cells 
and in the OPL. It was also found as clustered dots on the surface of photoreceptor cell bodies 
although the levels were lower than the process regions. Sema7a expression was also found in 
INL and IPL of the inner retina, but the levels were lower than that of the outer retina. In the 
GCL, however, high levels of Sema7a expression was found on some ganglion cells at the cell 
bodies and/or the axons (Figure 4.3 A top row).  
Specificity of the Sema7a antibody was demonstrated by pre-incubation of the antibody with 
the peptide that it was raised against in blocking solution before it was incubated with the eye 
sections. The peptides successfully bind all the antibodies in the solution and no signals can be 
detected from the sections (Figure 4.3 A middle row), similar with the control where primary 
antibody was omitted (Figure 4.3 A bottom row). Further, Sema7a antibody only recognized 
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the expected 75 KD band and the glycosylated form of the adult retina lysates in western blots 
(Figure 4.3 D and Appendix figure 4.2).  
I then went on to examine the developmental expression profile of Sema7a in retina using the 
CrxGFP transgenic mice which labels the photoreceptor cells (Figure 4.3 B). With higher 
expression at the apical regions of the developing photoreceptor cells, Sema7a protein can be 
detected in the whole E15.5 retina. Slightly higher expression remained in the apical region of 
the ONBL in the early postnatal days (Figure 4.3 B, P1 and P4), and the expression level in the 
whole retina seems to increase along development. Interestingly, I noticed some individual 
cells showed particular high levels of Sema7a expression at P4, and some of them were also 
CrxGFP+ve and appeared as if they were migrating in the retina (Figure 4.3 B, P4, arrow heads).   
As the retina began to form different layers from P8 onwards, Sema7a expression seems to be 
particularly higher at the regions where the borders of the layers are going to form (Figure 4.3 
B’, P8 and P21). It is highly expressed at the segment regions of the photoreceptor layer, the 
synapse regions between the photoreceptor layer and bipolar/amacrine cell layer (ie. the OPL), 
as well as the synapse regions between the INL and GCL (ie. the IPL). Sema7a co-staining with 
Prom1 which localises at the basement of the OS (see Chapter 5 for study of Prom1) showed 
that Sema7a expression was below Prom1 demonstrating that Sema7a localises in the inner 
segments (Figure 4.3 C).  
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Figure 4.3 Sema7a 
expression in the retina 
(continues). (A) Sema7a 
IHC with blocking 
peptide on adult eye 
sections. The wild-type 
(WT) 6 – 8 weeks adult 
eye sections were 
incubated alone with 
Sema7a antibody (top 
row), or pre-incubated 
with the Sema7a 
peptide followed by co-
incubation with Sema7a 
antibody (middle row), 
or without the Sema7a 
antibody (bottom row). 
Scale bars represent 25 
µm except in inserts 
which represent 5 µm. 
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Figure 4.3 Sema7a expression in the retina- continued. (B) Sema7a expression profile in CrxGFP retinal sections 
along development (E15.5 – P4). Inserts in the P4 retina represent Z-projections. Arrow heads indicate 
Sema7a+ve CrxGFP expressing cells. Scale bars represent 25 µm except in inserts of top row (E15.5) which 
represent 5 µm.  
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Figure 4.3 Sema7a expression in the retina- continued. (B’) Sema7a expression profile in CrxGFP retinal sections 
along development (P8 – P21). (C) Sema7a costain with Prom1 in adult mouse retina. Scale bars represent 25 µm. 
(D) Western of Sema7a, PlexinC1, and Integrinβ1 from adult mouse retina lysates. Expected sizes of Sema7a, 
PlexinC1, and Integrinβ1 are 75 KD (100 KD if glycosylated), ~200 KD and 40KD respectively. Full image of 
Western blot in Appendix figure 4.2. 
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4.2.3 Sema7a receptors’ expression profiles in the mouse retina  
IHC of Itgb1, one of the Sema7a receptors, during eye development shows that the protein 
was expressed highly in peripheral tissues of retina, but not within the retina (Figure 4.4). It 
was also expressed in some vascular cells in the retina, but did not seem to be expressed on 
any neurons.  
PlxnC1, the other receptor of Sema7a, was clearly expressed in the retina throughout 
development (Figure 4.5). It was expressed in both the photoreceptor cells and other retinal 
neurons. At later stages, its expression became higher in the inner retina, particularly the IPL, 
and seemed to form an increasing gradient from outer retina to inner retina, in contrast to the 
distribution of Sema7a which appeared higher in the outer and lower in the inner retina (see 
Figure 4.3). In adults, expression of PlxnC1 clearly showed the sublayers of the IPL.  
To assess the relative localization of Sema7a and its receptors directly, I co-labelled Sema7a 
and its receptors using different fluorochromes on the same sections (Figure 4.6). Agreeing 
with the single labelling experiments, no co-localization between Sema7a and Itgb1 was 
observed. However, PlxnC1 largely colabelled with Sema7a in early postnatal stages. Punctate 
dots which showed colocalization of both markers on the boarder of cell bodies were clearly 
observed. The majority of the cells in the P4 retina were positive for both PlexnC1 and Sema7a, 
including the Sema7a-high expression cells. Despite the overall colocalization, there were a 
few punctate dots on some cells in the ONBL that showed single immunostaining of either 
Sema7a or PlexnC1 alone (solid or empty arrow heads) showing presence of domains on the 
cell surface where the two molecules did not colocalize. The colocalizations in the adults seem 
to be less than that of the postnatal stages (Appendix figure 4.1). At the segment region of 
photoreceptor cells where Sema7a strongly immunostained, PlxnC1 signals were weak. And in 
the IPL I observed strong signals from PlxnC1 but not Sema7a. Where there were 
colocalizations between Sema7a and PlxnC1, they are shown as punctate dots on the cell 
bodies of photoreceptor cells or horizontal cells. Hence, I conclude that Sema7a did not colabel 
with Itgb1, but largely colabels with PlxnC1 as punctate dots on the surface of cell bodies of 
many retinal cells including photoreceptor cells.   
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Figure 4.4 Itgb1 expression profile 
along retina development. Itgb1 
Immunohistochemistry on E15.5, P4, 
P8 CrxGFP eyes and adult WT eyes. 
Scale bars represent 25 µm.    
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Figure 4.5 PlxnC1 expression 
profile along retina development. 
PlxnC1 Immunohistochemistry on 
E15.5, P4, P8, P10 CrxGFP and 
adult WT eyes. Scale bars 
represent 25 µm.   
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Figure 4.6 Sema7a co-staining with its receptors in P4 retina. Top row: Sema7a does not colable with Itgb1. Bottom row: Sema7a largely colabels with PlxnC1. Despite the overall co-localization of Sema7a with PlxnC1, 
single domains of Sema7a (solid arrow heads) or PlxnC1 (empty arrow heads) staining also exist on the retinal cells as the inserts show in the bottom row. Scale bars represent 25 µm.   
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4.2.4 Sema7a is expressed on migrating and integrated transplanted cells 
4.2.4.1 Sema7a is expressed on the surface of dissociated retinal cells before transplantation 
As Sema7a can be cleaved by caspase-9 (Ohsawa, Hamada et al. 2009) or possibly by 
phosphatidylinositol-specific phospholipases which cleave GPI anchors (Sharom and Lehto 
2002; Sharom and Radeva 2004), I examined if Sema7a is still expressed on the surface of 
retina cells after dissociation. Retinal cells of both E15.5 and P4 from CrxGFP mice were 
examined after microdissection and papain dissociation (see method in Chapter 2, section 
2.2.1). At E15.5, Sema7a was expressed on the cell surface of both CrxGFP+ve cells and 
CrxGFP-ve cells (Figure 4.7) (n = 311 retinal cells examined, 12.2% was Sema7a+veCrxGFP+ve 
and 85.2% was Sema7a+veCrxGFP-ve). At P4, Sema7a expression remained on both CrxGFP+ve 
and CrxGFP-ve cells (n = 77 retinal cells examined, 59.7% was Sema7a+veCrxGFP+ve and 35.1% 
was Sema7a+veCrxGFP-ve). Some cells showed particular high localized expression of Sema7a 
at specific regions of the cell which looks like developing processes (Figure 4.7, 3rd and 4th row).  
I also examined the Sema7a receptors on dissociated P4 retinal cells (Figure 4.8). Itgb1 was 
only found to be expressed in a few CrxGFP-ve cells and not in any CrxGFP+ve cells (n = 106 
retinal cells examined, 16% was Itgb1+veCrxGFP-ve and 0% was Itgb1+veCrxGFP+ve). PlxnC1, 
however, were expressed in both the CrxGFP-ve and CrxGFP+ve cells (n= 183 cells examined, 
36.1% was PlxnC1+veCrxGFP+ve and 36.6% was PlxnC1+veCrxGFP-ve) and the expression 
levels seem to be slightly higher in the CrxGFP-ve cells. The expression of Sema7a and its 
receptors on dissociated retinal cells agree with their expression on retinal sections. As unlike 
retinal sections in which the cells might be cut open the dissociated cells remain intact, this 
confirmed that Sema7a and its receptors are expressed on the cell surface and can still be 
maintained after dissociation. Immuno-staining of the dissociated cells also showed that the 
expression of Sema7a could be enriched at particular regions of the cell surface, possibly the 
lipid rafts of the plasma membrane where GPI-anchored proteins were enriched (Sharom and 
Lehto 2002).  
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Figure 4.7 Sema7a expression on dissociated retinal cells. E15.5 (top two rows) and P4 (bottom three rows) 
retinal cells from the CrxGFP (green) mouse strain were dissociated and stained with Sema7a (red) and Hoechst 
(blue). Solid arrow heads indicate CrxGFP+ve cells; empty arrow heads indicate CrxGFP-ve cells. Scale bar 
represent 10 µm.  
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Figure 4.8 Itgb1 and PlxnC1 expression on dissociated retinal cells. P4 retinal cells from the CrxGFP (green) mouse 
strain were dissociated and stained with Itgb1 or PlxnC1 (red) and Hoechst (blue). Solid arrow heads indicate 
CrxGFP+ve cells; empty arrow heads indicate CrxGFP-ve cells. Scale bar represent 10 µm.  
 
4.2.4.2 Sema7a is expressed on migrating and integrated cells after transplantation 
Earlier my colleagues have established that the transplanted postnatal photoreceptor 
precursor cells labelled with NrlGFP or CrxGFP can migrate and correctly integrate into the 
host ONL after subretinal injection (MacLaren, Pearson et al. 2006; Lakowski, Baron et al. 2010; 
Pearson, Barber et al. 2012). Here I took advantage of this system to assess if Sema7a is 
expressed during the migration of transplanted photoreceptor cells into the ONL. After 
subretinal injection of the NrlGFP or CrxGFP labelled postnatal photoreceptor cells (performed 
by Dr Rachael Pearson), the majority of the cells stay in the SRS between the ONL and the RPE 
(Figure 4.9 A). A small proportion of the injected cells migrate away from the SRS and go 
through the outer and inner segment regions of the host retina, and finally integrate and 
correctly localise into the host ONL. I here define the cells at the SRS as cells that cannot or 
that have not yet migrated; cells at the inner or outer segment (IS/OS) as migrating cells; and 
cells at the ONL as migrating or migrated cells (Figure 4.9 A). By comparing Sema7a expression 
on these cells of different migration ability, it might be possible to infer if Sema7a is involved in 
migration.  
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Eyes of the host animals were analyzed for Sema7a expression at 3 – 12 days after 
transplantation of P4 CrxGFP sorted photoreceptor precursors (n = 8 eyes, N = 6 animals). I 
clearly observed high Sema7a expression around the cell surface of the transplanted cells 
(Figure 4.9 E). Strikingly nearly all the migrating/migrated GFP+ve cells expressed Sema7a: 100% 
GFP cells at ONL (mean ± SD = 100% ± 2%, median = 100%, range = 85 – 100%) and 93% GFP 
cells at IS/OS (mean ± SD = 93% ± 13%, median = 100%, range = 60 – 100%) (Figure 4.9 B, C and 
E). However, only about half of the GFP cells at the SRS express Sema7a (mean ± SD = 53% ± 
22%, median = 50%, range = 10 – 100%). This highly associates Sema7a expression with 
migration and correct localisation. Furthermore, while there was no big difference of Sema7a 
expression on migrating cells (ie GFP cells at IS/OS and ONL) on different days after 
transplantation, there was a clear decrease of Sema7a expression on GFP cells at the SRS as 
time proceeds (Figure 4.9 D). This implies that cells that cannot migrate might lose Sema7a 
expression eventually. 
Interestingly, I found that migrating GFP cells in the segment region or ONL which have not yet 
shown the morphology of mature photoreceptor cells expressed very high level of Sema7a 
(Figure 4.10 top row). Whereas when the cells developed mature photoreceptor cell 
morphology such as segments or processes, their Sema7a expression was reduced back to host 
or endogenous levels (Figure 4.10 bottom row).  
I then examined the expression of Sema7a receptors on these transplanted eyes (Figure 4.11). 
Similar to the colocalization I observed in development, PlxnC1 again colocalized with Sema7a 
on the surface of the transplanted migrating cells. Because of the close interaction between 
Sema7a and PlxnC1 (Liu, Juo et al. 2010) and our resolution limit, it is hard to determine if the 
PlxnC1 signal came from neighbouring cells or the migrating cell itself. On the other hand, 
Itgb1 only labelled a few scattered vascular cells of the host retina which were far away from 
the transplanted cells. Together these data suggest a role for Sema7a in photoreceptor 
migration and that PlxnC1/Sema7a interactions may be involved.  
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Figure 4.9 Sema7a 
expression on 
transplanted eyes 
(continues). FACS 
sorted P4 CrxGFP 
precursor cells were 
injected into the 
subretinal space (SRS) 
between the ONL and 
the RPE, and Sema7a 
expression was 
analysed 3 to 12 days 
post injection.  (A) 
Illustration of position 
of transplanted 
photoreceptor cells 
after injection. The 
majority of the cells 
are located at the SRS; 
a small proportion of 
the cells migrate through the outer and inner segment (IS/OS) region and move into the outer nuclear layer (ONL). Cells at the SRS are defined as potential cells to migrate; cells at the IS/OS are 
defined as migrating cells; and cells at the ONL are defined as migrating or migrated cells. Dot plot (B) and table (C) representing proportion of Sema7a+ve transplanted photoreceptor cells at 
these positions at 3 to 12 days post injection (n= 8 eyes, 56 confocal stacks). (D) Time-course of Sema7a-expressing transplanted cells. The proportion of Sema7a+veGFP+ve out of the total 
transplanted GFP+ve cells in the SRS, IS/OS and ONL region were counted at 3 days, 6 days and 12 days after transplantation. Error bars represent standard deviation.  
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Figure 4.9 Sema7a expression on transplanted eyes- continued. 
(E) Images of the transplanted photoreceptor cells which are 
at the SRS (top row), at the IS/OS (middle row), and at the 
ONL (bottom row). Scale bars represent 25 µm except in 
inserts which represent 5 µm. 
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Figure 4.10 Sema7a high and low 
expression cells after 
transplantation. (Top row) High 
Sema7a expression on transplanted 
cells before they show mature 
photoreceptor morphology. 
(Bottom row) sema7a expression 
return to endogenous levels on 
transplanted cells which show 
mature photoreceptor morphology 
such as segments. Solid arrow 
heads indicate cell body of the 
photoreceptor cell; empty arrow 
heads indicate the process and 
segments of the photoreceptor cell. 
Scale bars represent 25 µm except 
in inserts which represent 5 µm.  
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Figure 4.11 PlxnC1 and Itgb1 expression on transplanted eyes. (Top row) PlxnC1 was highly expressed on/adjacent to transplanted migrating cells (n = 57 GFP+ve cells counted). (Bottom row) 
Itgb1 was not expressed on any cells near the transplanted cell (n = 58 GFP+ve cells counted). Arrow heads indicate the transplanted CrxGFP+ve cells. Scale bars represent 25 µm.  
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4.2.5 Requirement for Sema7a during outer nuclear layer development 
Finally two approaches were taken to more directly assess if Sema7a is required for ONL 
development: 1) using shRNA to knock down Sema7a expression in cells following 
transplantation and in the postnatal developing retina; 2) examination of eyes from Sema7a 
knockout mice.  
Preliminary trials for the shRNA experiment with four shRNA sequences on cell lines, however, 
did not achieve satisfactory knockdown of expression from a Sema7a-IRES-GFP vector (see 
Appendix 4.1 for details) and future experiments will test more oligos. I also examined eyes 
from Sema7a knockout mice kindly provided by Alex Kolodokin’s group, which generated the 
Sema7A null mice and first showed the axon outgrowth effect of Sema7a in olfactory bulb 
(Pasterkamp, Peschon et al. 2003). The Sema7a null mouse line appeared grossly normal and 
was generated through homologous recombination and Cre recombinase excision of the first 
exon and its upstream 1.1kb DNA which leads to loss of the first 59 amino acids of Sema7A 
including the signal peptide (Pasterkamp, Peschon et al. 2003). Eyes at P8/9 were selected for 
analysis as at this time point retinal lamination and ONL organisation is ongoing. The Sema7A 
knockout P8/9 eyes (n = 3) showed loss of Sema7a expression and reduced level of PlxnC1 
expression by 50% (Figure 4.12, A and B). Itgb1 expression, however, remained similar 
between the knockout and the wild type animals. In the eyes where there was no Sema7a 
expression, holes (regions where cells were missing) were frequently observed in the ONL 
(Figure 4.12 A and C, arrowheads) (mean ± SD = 51.7 ± 7.1 holes per slide with six 18µm 
sections on each slide, n = 3 eyes.) although the thickness of ONL looks normal. While the 
photoreceptor ribbon synapse proteins bassoon and dystrophin showed precise punctate 
location within the OPL of the wild-type retina, they projected abnormal processes into the INL 
and ONL in the retina of Sema7a knockout out mice. On the other hand, the bipolar cell 
dendritic tip marker metabotropic glutamate receptor 6 (mGluR6) and rod bipolar cell marker 
PKCα showed normal distribution in the knockout retina (Figure 4.12 D). These data indicate 
that Sema7a is important for the normal synapse formation for photoreceptor cells during 
retina development.  
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Figure 4.12 Sema7a 
knockout mouse retina 
(continues). (A) 
Expression of Sema7a 
(top row), PlxnC1 (middle 
row), and Itgb1 (bottom 
row) in the retina of wild 
type (left) and sema7a 
knockout (right) mice. 
Scale bars represent 25 
µm. (B) Quantification of 
the expression of Sema7a, 
PlxnC1, and Itgb1 based 
on the mean intensity of 
the signals from confocal 
images. Each column 
represents the average of 
the mean intensity of 20 – 
30 confocal slices and the 
error bar represent 
standard deviation. The 
expression in the retina 
are significantly different 
between the knockout 
and wild type animals for 
Sema7a (p = 1.52 X 10
-32
) 
and PlxnC1 (p = 1.07 X 10
-
24
), but not significantly 
different for Itgb1 (p = 
0.404) based on students’ 
t-test. (C) Hematoxylin 
and eosin stain of the 
retina of wild type (left) 
and sema7a knockout 
(right) mice. 
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Figure 4.12 Sema7a knockout mouse retina- continued. (D) Expression of Bassoon, Dystrophin, PKCα, and mGluR6 
in the retina of wild type and sema7a knockout mice. Scale bars represent 25 µm.  
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4.3 Discussion 
Previously Sema7a has been reported to function in axon/dendrite branching, cell migration 
and immune responses (Holmes, Downs et al. 2002; Pasterkamp, Peschon et al. 2003; Suzuki, 
Okuno et al. 2007; Fukunishi, Maruyama et al. 2011; Messina, Ferraris et al. 2011). Its 
transcripts are highest in the brain, and lower in heart, thymus, spleen, testis and ovary. In the 
immune system, Sema7a concentrates at the lipid rafts of the immunological synapse of T cells 
upon their activation and interacts with Itgb1 to stimulate macrophages to produce 
proinflammatory cytokines (Suzuki, Okuno et al. 2007; Suzuki, Kumanogoh et al. 2008). It is 
also expressed in the skin keratinocytes to promote attachment, spreading and dendrite 
outgrowth of melanocytes (Scott, McClelland et al. 2008). Here I report for the first time that 
Sema7a was highly expressed in photoreceptor cells. I showed that while also expressed in 
other retinal cells, Sema7a expression level was particularly high in the synapses and segment 
region of mature photoreceptors where the border of ONL lies. During development Sema7a 
expression remains high in these apical and basal regions of photoreceptor cells where the 
processes are about to protrude and layers about to be defined. Upon loss of Sema7a 
expression, I showed that the photoreceptor synapses but not the processes of bipolar cells, 
showed abnormal extended processes. Considering the involvement of Sema5a/b and Sema6a 
in the stratification of the inner retina (Matsuoka, Chivatakarn et al. 2011; Matsuoka, Nguyen-
Ba-Charvet et al. 2011), this semaphorin might be the one that is involved in the 
photoreceptor layer formation of the outer retina.  
Sema7a function in the nervous system was initially reported to promote axon growth and 
branching of the olfactory bulb neurons (Pasterkamp, Peschon et al. 2003). Accumulating 
evidence also showed that Sema7a is involved in the migration of neurons such as the thalamic 
neurons (Fukunishi, Maruyama et al. 2011) and GnRH-1 neurons (Messina, Ferraris et al. 
2011).Interestingly, I also observed particularly high expression of Sema7a on the migrating 
photoreceptor cells after cell transplantation as well as on some photoreceptor cells within the 
developing P4 to P8 retina during normal retina development. This could indicate a role for 
Sema7a in the migration of the photoreceptor cells. To directly assess how Sema7a might 
affect the migration of the photoreceptor cells, further shRNA experiments testing more oligos 
to reduce Sema7a expression in transplanted cells will be needed.  
Sema7a was reported in other systems mainly interacting with Itgb1 (Pasterkamp, Peschon et 
al. 2003; Suzuki, Okuno et al. 2007; Scott, McClelland et al. 2008; Messina, Ferraris et al. 2011). 
In the olfactory bulb and the skin systems, Sema7a was expressed on the olfactory fibers and 
the keratinocytes while Itgb1 was expressed on the interacting receptor cell GnRH-1 neurons 
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and melanocytes to promote their migration and axon/dendrite spreading (Scott, McClelland 
et al. 2008; Messina, Ferraris et al. 2011). Although PlxnC1 was also expressed on these 
receptor cells, it seems it inhibited the spreading and migration role of Sema7a (Scott, 
McClelland et al. 2008; Messina, Ferraris et al. 2011). I, however, found that Itgb1 was not 
expressed in the retina, in particular not in any adjacent retinal cells that interact with the 
Sema7a-expressing photoreceptor cells. Therefore it seems unlikely for Itgb1 to interact with 
Sema7a in the retina. On the other hand, I observed abundant expression of PlxnC1 in the 
retina, which initially was widespread and overlapped with Sema7a. More interestingly, there 
were high levels of colocalisation of Sema7a and PlxnC1 on retinal cells during early postnatal 
development, although such colocalisation was reduced in later stages as Sema7a became 
more highly expressed in the outer retina and PlxnC1 became more highly expressed in the 
inner retina. In the photoreceptor transplantation experiments, I also observed such 
colocalisation of Sema7a and PlxnC1. Therefore my data suggests that it is more likely that 
Sema7a might actually interact with PlxnC1, rather than Itgb1, to be possibly involved in cell 
migration and ONL formation in the retina. Further, PlxnC1 expression level was reduced in the 
Sema7a-/- mouse retina while Itgb1 level was unaffected. Crystallography showed interaction 
between Sema7a and PlxnC1 (Liu, Juo et al. 2010) but not yet for Sema7a/Itgb1.  
Considerable progress has been made in defining the molecular basis of axon guidance 
patterning in neural circuits formation. One common form of regulation is the graded 
expression of pairs of axon guidance cues and their receptors in projection neurons or their 
targets. For example, in the olfactory system, Semaphorin 3A (SEMA3A) and neuropilin 1 
(NRP1) are expressed in an opposite anterior-posterior gradient giving each class of olfactory 
sensory neurons (OSN) unique amounts of SEMA3A and NRP1 (Imai, Yamazaki et al. 2009). This 
allows axons of the OSN to be sorted based on the expression levels of SEMA3A and NRP1 as 
the axons progress to the olfactory bulb (Imai, Yamazaki et al. 2009). Further SEMA3F and its 
receptors NRP2 and plexin A3 (PLXNA3) are expressed complimentarily as a dorsal-ventral 
gradient in the olfactory epithelium (Takeuchi, Inokuchi et al. 2010). In this way, the early 
arriving axons release SEMA3F to repel late arriving NRP2–PLXNA3-positive axons to more 
ventral regions allowing establishment of the dorsal-ventral patterning of olfactory axons 
(Takeuchi, Inokuchi et al. 2010; Pasterkamp 2012). In the visual system, Sema6a and 
Sema5a/5b and their plexin receptors are expressed complimentarily on adjacent layers of 
different retinal cell types with the semaphorins constraining neurites from mistargeting via 
repulsive interaction with the plexins to regulate the lamination of the inner retina (Matsuoka, 
Chivatakarn et al. 2011; Matsuoka, Nguyen-Ba-Charvet et al. 2011). The retina data of Sema7a 
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presented here does not support a repulsive mechanism as the expression of Sema7a and 
PlxnC1 overlaps and even colocalises. Sema7a and PlxnC1 do show some degree of 
complimentary expression patern on different cell types in more mature stages. However 
during early development when the retinal cells are still mobile, Sema7a and PlxnC1 
expression largely overlaps in the whole retina. Therefore, Sema7a and PlxnC1 seem to be less 
confined in their expression in the retina than other semaphorins and plexins. It is possible 
that at the time when migration of a particular retinal cell is required, Sema7a will be highly 
expressed on its surface and this will induce the expression of PlxnC1 on its surrounding 
neighbouring cells no matter if they are the same type of cells or not. I, however, could not 
exclude the possibility that the colocalized PlxnC1 signal detected is from that Sema7a-
expressing cell rather than the surrounding cells. Possible functions of such interactions 
between Sema7a and PlxnC1 could be (non-exclusively) 1) guiding/limiting migration of the 
photoreceptor precursor cell to the correct location within developing retina; 2) keeping 
photoreceptor cells together in ONL; and 3) preventing progenitors/precursors from 
overshooting the OPL.  
During development of olfactory sensory neurons, Sema7a can be cleaved by the Apaf-
1/caspase-9 pathway whose deficiency disrupted axonal projections, synaptic formation and 
maturation of these neurons (Ohsawa, Hamada et al. 2010). It may therefore be possible that 
the colocalisation of Sema7a and PlxnC1 I detected comes from a secreted (or fragmented) 
form of Sema7a which binds to PlxnC1. However, I showed clear cell surface expression of 
Sema7a on dissociated retina cells indicating membrane localisation and Sema7a alone 
labelled domains were detected in the Sema7a/PlxnC1 costaining experiments. Furthermore I 
did not detect any of the cleaved fragments of Sema7a in retina western blot like those shown 
in the Sema7a cleavage by caspase-9 in the aged olfactory bulb (Ohsawa, Hamada et al. 2010). 
These data instead indicate that in the retina Sema7a acts as a GPI-anchored cell surface 
molecule rather than any other form to interact with neighbouring cells.      
4.4 Conclusions 
• I report the first semaphorin, Sema7a, identified in photoreceptor cells. Sema7a is 
expressed in developing photoreceptors and then in the inner segments and synapses 
of mature photoreceptors, whereas expression of the putative receptor plexinC1 is 
initially widespread and then becomes most highly expressed in the inner retina.  
• Unlike other systems describing Sema7a/Itgb1 interactions (Pasterkamp, Peschon et al. 
2003; Suzuki, Okuno et al. 2007; Scott, McClelland et al. 2008; Messina, Ferraris et al. 
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2011), Sema7a colabels with PlexinC1, but not Itgb1, as punctate dots on the surface 
of retinal cell bodies during development.  
• Sema7a is highly expressed on transplanted migrating photoreceptors cells, and 
colabels with PlexinC1 (but not Itgb1).  
• In Sema7a-/- mice retina where Sema7a expression was lost, PlxnC1 level was also 
reduced (but not Itgb1). Loss of Sema7a leads to ONL lesions/holes and over-extended 
processes of photoreceptor synapses revealed by expression of photoreceptor ribbon 
synapse proteins bassoon and dystrophin. 
• I propose that Sema7a/PlxnC1 interactions may be important for photoreceptor 
integration and ONL formation.  
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5 The cilia and cilia surface proteins of photoreceptor precursor 
cells  
5.1 Introduction 
From the transcriptome analysis in Chapter 3, I noticed that the postnatal photoreceptor 
precursor cell transcriptome showed a very unique transcriptome property compared to other 
retinal cells – expression of genes associated with the cilium – a feature highlighted in both the 
Crx array and Nrl array (Figure 3.3, Figure 3.6). The cilium is a special filiform extrusion of the 
plasma membrane and varies in its morphology and microtubule composition according to cell 
types. Nearly all the polarized cells (including neurons) are ciliated 
(http://www.bowserlab.org/primarycilia/cilialist.html; (Alberts, Johnson et al. 2008; Louvi and 
Grove 2011)). However, as other retinal neurons did not enrich this feature or at least not at 
this stage from the transcriptome analysis, the cilium transcripts seem to be a unique feature 
for the photoreceptor precursor cells among all the cells in the retina. Little is known about the 
photoreceptor cilia in early developmental stages, although there are many studies on mature 
photoreceptor OS which is part of the specialized photoreceptor cilia as re-appreciated in 
recent years (Liu, Zhang et al. 2010). The first rudimentary OS “disk”(saccule) appears around 
P7-8 under EM (De Robertis 1960; Olney 1968; Morrow, Furukawa et al. 2005) and the OS 
become recognizable under light microscope by P10 (Olney 1968). The cilium feature I noticed 
from photoreceptor precursor transcriptome is at P4, which is before OS formation. On the 
other hand, embryonic photoreceptor precursor transcriptome did not enrich this feature 
(Figure 3.3 A, Appendix figure 3.1). The common properties of the E15.5 and P4 photoreceptor 
cells do include some plasma membrane and cell projection annotations (Figure 3.4 B), but 
many more cilium-related annotations were enriched in the P4 precursor cells than the E15.5 
photoreceptor cells (Figure 3.3, Figure 3.6, and Appendix figure 3.1). I, therefore, want to know 
if there is a difference in cilium properties between the embryonic and postnatal 
photoreceptor precursor cells and to better understand the postnatal photoreceptor cilia prior 
to OS formation.  
Despite being a tiny organelle, deficiency of cilium is to be blamed for numerous human 
pleiotropic disorders. Here I mention several that also show neural defects in the eye. Bardet–
Biedl syndrome (BBS), for example, showing symptoms of retinitis pigmentosa, rod-cone 
dystrophy, anosmia, cognitive disabilities, polydactyly, cystic kidneys, obesity, male 
hypogonadism and congenital heart defects (Forsythe and Beales 2013), are characterised by 
autosomal recessive inheritance of BBS genes whose proteins localize within the cilium and are 
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involved in subcellular targeting of other ciliary proteins (Beales, Warner et al. 1997; Fliegauf, 
Benzing et al. 2007; Forsythe and Beales 2013). Usher syndrome (USH), another 
heterogeneous disease displaying hearing loss, vestibular system dysfunction and progressive 
retinitis pigmentosa, are characterized by absence or abnormality of the USH proteins which 
are involved in intraflagellar transport (IFT) and rhodopsin transport in photoreceptor cilia 
(Wolfrum and Schmitt 2000; Reiners, Nagel-Wolfrum et al. 2006) as well as playing a 
developmental role in sterocilia for the cochlear hair cells (Fliegauf, Benzing et al. 2007; Liu, 
Bulgakov et al. 2007). Similar to Jeune asphyxiating thoracic dystrophy, Joubert syndrome, 
Alstrom syndrome and Senior–Løken syndrome, ciliopathies showed vision impairment among 
other symptoms (Fliegauf, Benzing et al. 2007; Louvi and Grove 2011; Rachel, Li et al. 2012). 
Joubert syndrome is associated with retinal dystrophy since childhood (Sturm, Leiba et al. 
2010). Alstrom syndrome patients lost vision in young adulthood demonstrating retinitis 
pigmentosa with cone-rod degeneration (Malm, Ponjavic et al. 2008). Senior–Løken syndrome 
showed severe visual loss from early childhood (Stone, Cideciyan et al. 2011). Genes involved 
in these retina-related ciliopathies were listed in Chapter 1 Table 1.1.  
Although the cilia structure and morphology varies according to cell types, nearly all cilia types 
share the basic structural units composed of a basal body, transition zone, axoneme, and 
ciliary membrane (Figure 5.1). Located at the bottom of the cilium, the basal body is made up 
of the centriole and pericentriolar proteins and is where the transition zone and axoneme are 
anchored. The transition zone is where the triplet microtubules of the centriole are converted 
into the doublet microtubule structure of the axoneme. The axoneme contains nine pairs of 
peripheral microtubule doublets. Depending on cell types, it may contain additional central 
microtubules and dynein motors. The photoreceptor cilium lacks these additional structures 
and is thus defined as a primary immotile cilium. It is extended from the inner segment and 
includes the connecting cilium and the outer segment (Figure 5.1). Axoneme from the 
connecting cilium extends into the outer segment. In rods the extended axoneme stops at the 
base of the outer segment where the few open disks are located. In cones where all the disks 
are open as continuous delineated foldings of the connecting cilium plasma membrane, the 
axoneme extends the whole length of the outer segment (Figure 1.1, Figure 5.7 A, (Mustafi, 
Engel et al. 2009)). The connecting cilium is important for OS biogenesis and opsin transport as 
turnover products from OS and newly synthesized opsins and other proteins from IS are 
shuttled through it. Around 109 molecules of rhodopsin are estimated to be transported in the 
connecting cilia in the human retina every day (Hildebrandt and Otto 2005). Proteins which 
need to be transported to the OS are first recruited near the basal bodies where they further 
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pass the transition fiber and are then loaded onto the IFT complex at the transition zone 
(Emmer, Maric et al. 2010). The loaded IFT particles interact with the dyneins and kinesins 
which shuttle along the axoneme to send cargos to the OS or bring recycled products back to 
the base of the connecting cilium. Disruption of the IFT machinery leads to photoreceptor 
degeneration (Tsujikawa and Malicki 2004; Boldt, Mans et al. 2011).   
Protruding from the cell surface and mainly non-motile, functions of the primary cilia are 
thought to be to sense and amplify environmental signals. Indeed, several signalling pathways  
including the sonic hedgehog (SHH) pathway (Huangfu, Liu et al. 2003), platelet-derived 
growth factor receptor (PDGFR) pathway (Schneider, Clement et al. 2005),  and planar cell 
polarity (PCP) pathways (Ross, May-Simera et al. 2005) are shown to be mediated through cilia. 
But this may not be the only function of the immotile primary cilia. Some studies suggest that 
they might also be involved in cell migration. It was found that the primary cilia of the 
migrating fibroblasts orient in the direction of cell migration (Albrecht-Buehler 1977) and that 
primary cilia align toward the scratch made in a wound healing assay (Schneider, Cammer et al. 
2010). However it remains unexplored if such orientation or guidance also holds for the 
primary cilia of neural cells (Louvi and Grove 2011), in particular the photoreceptor precursor 
cells that I am interested in. Despite much being known about the structure of the mature 
specialised outer segment bearing photoreceptor cilia, little is known about when the 
photoreceptor cilia begin to form and how their development progresses.   
To date, knowledge about the cilium is mainly based on molecules inside the organelle, such as 
the BBS proteins and IFTs. Little is known about the surface molecules at the cilium membrane. 
Directly interacting with the environment, the cilium surface proteins are likely to reveal more 
information about the function and mechanisms of this organelle and the cell. For example, 
studies of the cyclic nucleotide-gated (CNG) channel proteins revealed that primary cilia also 
use cAMP (Barzi, Berenguer et al. 2010) and cGMP signalling pathways (Meyer, Angele et al. 
2000) in both vertebrate and invertebrate and the cilia may provide a unique compartment to 
localize these signalling for specific cellular functions (Johnson and Leroux 2010). In addition, 
study of the cilium-related cell surface proteins may also provide more therapy targets for 
disease related with ciliopathies.  
In this chapter, I aim to investigate the hypothesis that the nascent primitive photoreceptor 
cilium is important for integration/orientation of developing photoreceptor cells in the ONL. I 
aim to find out: 
1) Which cilium related genes are enriched in photoreceptor precursor cells?  
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2) Is there a difference in cilium gene expression between the E15.5 and P4 photoreceptor 
precursor cells? The latter show ~10-fold higher integration efficiency compared with the 
former after cell transplantation (Lakowski, Baron et al. 2010).  
3) Are cilium-related cell surface proteins expressed in the photoreceptor precursor cells and 
what are their subcellular locations?  
4) Are the cilium-related cell surface proteins expressed in the migrating transplanted 
photoreceptor precursor cells?  
Taking together, answers to these questions might reveal how important cilium and cilium-
related cell surface proteins are in photoreceptor cell development as well as in establishment 
of cell transplantation based therapy.   
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Figure 5.1 Mature rod connecting cilium and cilium protein location. Most cilium proteins are intracellular. The 
cell surface cilium proteins Prom1 (red) locates at the basement of OS interacting with Cdhr1 (green) (Yang, Chen 
et al. 2008) while Usherin (pink) locates at the apical inner segment recess that wraps around the connecting cilia 
(periciliary membrane complex) (Liu, Bulgakov et al. 2007). Other cilia surface molecules which are present in 
photoreceptor cilia include somatostatin receptor 2a and 3 in newt (Grigoryan, Vasilaki et al. 2003), and possibly 
polycystin 2 the mutation of which leads to photoreceptor degeneration in rat(Feng, Wang et al. 2009).  
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5.2 Results 
5.2.1 Photoreceptor precursors are enriched with cilium-related genes  
To find out what cilium genes are enriched in photoreceptor precursor cells, I uploaded all the 
genes with more than 2-fold higher expression in the photoreceptor gene sets from the E15.5 
CrxGFP, P4 CrxGFP, and P4 NrlGFP array to DAVID. Genes which were annotated to be related 
with cilium (see Appendix table 3.4 for cilium-related GO terms used) were pulled out and 
compared between the Nrl and Crx array (Table 5.1, Figure 5.2 A). Expression of three genes 
Cngb3 (synonyms Cng6), Pdc, and Rpgrip1 were enriched in all three cell populations. CNG ion 
channels depolarize cilium potential to amplify cAMP signals and lack of this amplification 
leads to severely blunted odorant responsiveness in mice (Hengl, Kaneko et al. 2010). Cngb3 
(protein name Cyclic nucleotide-gated cation channel beta-3) encodes the beta subunit of a 
CNG cation channel protein which upon activation leads to opening of the cone cation channel 
and causes an electrical response (Gerstner, Zong et al. 2000). Loss or mutation of Cngb3 is 
associated with achromatopsia (Kohl, Baumann et al. 2000; Sundin, Yang et al. 2000; Xu, 
Morris et al. 2011), a retina disorder characterised by inability to distinguish colours and low 
visual acuity. Cngb3 expression was 26-fold higher in the E15.5 CrxGFP+ve cells than the E15.5 
CrxGFP-ve cells. Such a difference agrees with the concept that embryonic photoreceptor cells 
are mainly cones. As development proceeds and rods outnumber cones, the difference is 
decreased. Nevertheless, its absolute expression in photoreceptor cells is still increased from 
E15.5 to P4 by 1.3-fold indicating the continued requirement of Cngb3 by cones.  
Also showing higher expression in E15.5 photoreceptor cells than other retinal cells are Pdc 
and Rpgrip1, although their expression fold changes were even higher in the P4+ve vs P4–ve 
comparison and the P4+ve vs E15.5+ve comparison indicating more demand of these genes in 
the rods. Pdc (protein name Phosducin) is involved in regulating phototransduction by 
interaction with transducin subunits in the OS (Lee, Ting et al. 1992). Rpgrip1 (protein name X-
linked retinitis pigmentosa GTPase regulator-interacting protein 1, RPGR-interacting protein 1) 
forms stable polymers to tether RPGR in the photoreceptor connecting cilium. It is required for 
normal outer segment disk morphogenesis and its deficiency is a known cause of LCA (Zhao, 
Hong et al. 2003). Rpgrip1 protein is located between the axonemal microtubules and the 
plasma membrane in the connecting cilium of photoreceptor cells (Zhao, Hong et al. 2003). 
18 cilium annotated genes were shared between the P4 CrxGFP+ve and NrlGFP+ve cells and 17 
genes were present only in the NrlP4 array probably because of its higher sensitivity (Table 5.1). 
Therefore a total of 35 cilium annotated genes were enriched in the postnatal photoreceptor 
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precursor cells. Many of these proteins are known to be located in different regions of the 
mature photoreceptor cilia such as the OS disks (eg. Rho, Opn1sw, Arr3), the axoneme (eg. 
Ttll3, Dnaic2), the transition zone (eg. Cep290) and the basal body (eg. BBS5) (Table 5.2). Most 
of these proteins are intracellular, particularly the ones at basal bodies, transition zones, and 
rod OS disks. But some are located on the plasma membrane and contain extracellular 
domains (highlighted as bold in Table 5.1).  
In summary, expression of 38 cilium-related genes was found to be enriched in the 
photoreceptor precursor cells, among which 23 are associated with retinal diseases (Table 5.2). 
As well as the higher expression fold changes in the P4 photoreceptor cells than other retinal 
cells, three cilium genes also showed much higher expression in the E15.5 photoreceptor cells 
than other retinal cells (Figure 5.2 B, Table 5.1) suggesting cilium development as early as 
embryonic stages. It should be noted, however, that all 38 cilium related genes identified 
showed higher expression in P4 photoreceptor cells than E15.5 photoreceptor cells (Figure 5.2 
B, Table 5.1). In addition, many more genes were enriched in the P4 photoreceptor cells than 
the E15.5 photoreceptor cells (35 genes vs 3 genes). This shows that the postnatal 
photoreceptor precursor cells are indeed more enriched with expression of cilium-related 
genes than the embryonic photoreceptor precursor cells.  
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Table 5.1 Cilium-related gene lists from array 
 
 
 
  
 
 
 
CrxE15 + vs. - CrxP4 + vs. - NrlP4 + vs. - Crx+ E15 vs. P4
Cngb3 cyclic nucleotide gated channel beta 3 26.0673 12.9657 12.6 1.32521
Pdc phosducin 16.5561 43.7619 84.4 12.2548
Rpgrip1
retinitis pigmentosa GTPase regulator 
interacting protein 1 5.75074 21.604 33.4 6.26463
Rp1h retinitis pigmentosa 1 homolog (human) 1.35926 44.6873 122 49.0212
Cnga1 cyclic nucleotide gated channel alpha 1 1.11251 36.0885 34.1 40.8715
Rho rhodopsin -1.04559 34.1121 127 44.2423
Prom1 prominin 1 1.24535 9.40123 9.19 4.24424
Opn1sw
opsin 1 (cone pigments), short-wave-sensitive 
(color blindness, tritan) 1.46211 7.35149 42.2 6.23974
Ush2a
Usher syndrome 2A (autosomal recessive, mild) 
homolog (human) 2.28418 7.01788 24.8 3.4602
Cep290 centrosomal protein 290 1.35788 5.92009 7.01 3.28442
Bbs5 Bardet-Biedl syndrome 5 (human) 1.35512 5.47092 7.46 4.40103
Gnat1
guanine nucleotide binding protein, alpha 
transducing 1 1.15297 4.24634 18.8 4.09312
Bbs4 Bardet-Biedl syndrome 4 (human) 1.26758 3.54791 4.14 2.16995
Bbs9 Bardet-Biedl syndrome 9 (human) -1.20228 3.37727 5.31 4.54105
Arr3 arrestin 3, retinal 1.03877 3.33913 8.75 3.24265
Pcdh15 protocadherin 15 3.09258 2.87036 5.46 6.92572
Bbs7 Bardet-Biedl syndrome 7 (human) -1.02996 2.64062 3.89 2.5832
Ttc8 tetratricopeptide repeat domain 8 1.19381 2.63163 3.32 2.31089
Plekhb1
pleckstrin homology domain containing, family B 
(evectins) member 1 1.2541 2.27326 5.03 4.14376
Rpgr retinitis pigmentosa GTPase regulator -1.098 2.20675 2.01 2.0735
Ttc30a2 tetratricopeptide repeat domain 30A2 -1.07089 2.02147 2.73 2.19464
Klc3 kinesin light chain 3 5.78
Crocc ciliary rootlet coiled-coil, rootletin 4.23
Nphp4 nephronophthisis 4 (juvenile) homolog (human) 3.53
Ttc30b tetratricopeptide repeat domain 30B 3.46
Bbs1 Bardet-Biedl syndrome 1 (human) 3.32
Rab27a RAB27A, member RAS oncogene family 3.23
Cc2d2a coiled-coil and C2 domain containing 2A 2.68
Stard10 START domain containing 10 2.62
Slc4a7
solute carrier family 4, sodium bicarbonate 
cotransporter, member 7 2.46
Lca5 Leber congenital amaurosis 5 (human) 2.43
Myo7a myosin VIIa 2.41
Cnga3 cyclic nucleotide gated channel alpha 3 2.39
Bbs2 Bardet-Biedl syndrome 2 (human) 2.33
Ttll3 tubulin tyrosine ligase-like family, member 3 2.23
Dnaic2 dynein, axonemal, intermediate chain 2 2.14
Ttc30a1 tetratricopeptide repeat domain 30A1 2.03
1700027N10Rik RIKEN cDNA 1700027N10 gene 2
CrxP4+ve alone (0)
NrlP4+ve alone (17)
CrxE15+ve 
CrxP4+ve NrlP4+ve 
common (3)
CrxP4+ve NrlP4+ve 
common (18)
Expression Fold Change
Array Gene Symbol Gene Name
Bolded genes encode cell surface proteins 
129 
 
Table 5.2 Cilium-related gene function, location and associated retinal diseases
 
Gene 
Symbol Function Location Retinal disease
Cngb3 cGMP actived opening of cation channel multipass mem, OS
recessive achromatopsia Pingelapese; recessive, 
progressive cone dystrophy
Pdc visual phototransduction cilium na
Rpgrip1 disk morphogenesis cilium
recessive Leber congenital amaurosis; recessive 
cone-rod dystrophy
Rp1h PR differentiation CC, IS, cell bodies of PR na
Cnga1 cGMP actived opening cation channel multipass mem, OS recessive retinitis pigmentosa
Rho image-forming vision, postnatal PR viability multipass mem, IS, OS 
dominant retinitis pigmentosa; dominant 
congenital stationary night blindness; recessive 
retinitis pigmentosa
Prom1
binds cholesterol, regulate disk morphogenesis and MAPK 
and Akt pathways multi-pass mem, cilium, base of rod OS
recessive retinitis pigmentosa with macular 
degeneration; dominant Stargardt-like macular 
dystrophy; dominant macular dystrophy, bull's-eye; 
dominant cone-rod dystrophy
Opn1sw visual pigments, increase spectral sensitivity multi-pass mem, cone OS dominant tritanopia
Ush2a
involved in hearing and vision,  required for integration into 
the basement mem. interact with collagen IV and 
fibronectin
single-pass type I mem protein, 
stereocilium mem, apical and basement 
mem, high in basement mem, synaptic 
terminals of PR
recessive Usher syndrome, type 2a; recessive 
retinitis pigmentosa
Cep290 localization of ciliary and phototransducin proteins
cilium transition zone, nucleus, 
centrosome
recessive Senior-Loken syndrome; recessive 
Joubert syndrome; recessive Leber congenital 
amaurosis; recessive Meckel syndrome
Bbs5 BBSome complex, ciliogenesis cilium basal bodies recessive Bardet-Biedl syndrome
Gnat1
amplifies and transduces visual impulse, GTP-binding, 
nucleotide-binding OS, CC
dominant congenital stationary night blindness, 
Nougaret type; recessive congenital stationary 
night blindness
Bbs4 BBSome complex, ciliogenesis cilium mem, cytoplasm recessive Bardet-Biedl syndrome
Bbs9 BBSome complex, ciliogenesis cilium mem, cytoplasm recessive Bardet Biedl syndrome
Arr3
May play a role in an as yet undefined retina-specific signal 
transduction. Could binds to photoactivated-phosphorylated 
red/green opsins. IS, OS na
Pcdh15
Calcium-dependent cell-adhesion protein. Required for 
inner ear neuroepithelial cell elaboration and cochlear 
function. Probably involved in the maintenance of normal 
retinal function
single-pass type I mem (heavy 
glycosalation), stereocilium, OS, 
recessive Usher syndrome, type 1f; recessive 
deafness without retinitis pigmentosa; digenic 
Usher syndrome with CDH23
Bbs7 BBSome complex, ciliogenesis cilium mem, cytoplasm recessiveBardet Biedl syndrome
Ttc8/Bbs8 BBSome complex, ciliogenesis cilium mem, cytoplasm
recessive Bardet-Biedl syndrome; recessive 
retinitis pigmentosa
Plekhb1 binds transducins.Interacts with MYO1C mem-associated. Highly in OS na
Rpgr PR integrity, ciliogenesis
centrosome, cilium basal body and 
axoneme
X-linked retinitis pigmentosa, recessive; X-linked 
retinitis pigmentosa, dominant; X-linked cone 
dystrophy 1; X-linked atrophic macular dystrophy, 
recessive
Ttc30a2
polyglutamylation of axonemal tubulin; anterograde 
intraflagellar transport cilium na
Klc3
microtubule-associated force-producing protein that may 
play a role in organelle transport
Elongating spermatid tail midpiece. 
Localized in outer dense fibers (ODFs) and 
associates with mitochondria na
Crocc
Rootletin,structural component of the ciliary rootlet; 
contributes to centrosome cohesion before mitosis
In ciliated cells, associated with ciliary 
rootlets. In non-ciliated cells, localized 
between, around and at the proximal 
ends of the centrioles. na
Nphp4
organization of apical junctions in kidney cells; may not 
strictly required for ciliogenesis
cilium basal body; centrosome; tight 
junction
recessive Senior-Loken syndrome; recessive 
nephronophthisis, juvenile
Ttc30b
polyglutamylation of axonemal tubulin; anterograde 
intraflagellar transport cilium na
Bbs1 BBSome complex, ciliogenesis cilium, basal bodies recessive Bardet-Biedl syndrome
Rab27a cytotoxic granule exocytosis in lymphocytes
 Lipid-anchor. Melanosome; Late 
endosome; Lysosome na
Cc2d2a
in tectonic-like complex acting as a barrier that prevents 
diffusion of transmembrane proteins between the cilia and 
plasma membranes. Required for ciliogenesis and sonic 
hedgehog/SHH signaling
cilium transition zone between basal body 
and axoneme
recessive retinitis pigmentosa and mental 
retardation; recessive Joubert syndrome
Stard10 Phospholipid transfer protein cilium flagellum; cytoplasm; membrane na
Slc4a7
Electroneutral sodium- and bicarbonate-dependent 
cotransporter
multi-pass membrane protein; apical cell 
membrane; stereocilium na
Lca5 minus end-directed microtubule transport cilium axoneme and basal body recessive Leber congenital amaurosis
Myo7a
outer PR disks renewal; regulation of opsin transport; 
ditribution and migration of RPE melanosomes and 
phagosomes; RPE65 transport
inner and base of OS and synaptic ending 
region; cytoskeleton
recessive Usher syndrome, type 1b; recessive 
congenital deafness without retinitis pigmentosa; 
recessive atypical Usher syndrome (USH3-like)
Cnga3
Cyclic nucleotide-gated cation channel alpha-3; essential for 
the generation of light-evoked electrical responses in the 
red-, green- and blue sensitive cones multi-pass membrane protein; OS recessive achromatopsia
Bbs2 BBSome complex, ciliogenesis cilium, basal bodies recessive Bardet-Biedl syndrome
Ttll3
Tubulin monoglycylase generating side chains of glycine on 
the gamma-carboxyl groups of glutamate residues within 
the C-terminal tail of alpha- and beta-tubulin cilium axoneme; cytoskeleton na
Dnaic2 Dynein intermediate chain 2, axonemal cilium axoneme na
Ttc30a1
polyglutamylation of axonemal tubulin; anterograde 
intraflagellar transport cilium na
1700027N10
Rik/Rsph9
Radial spoke head protein 9 homolog, component of the 
axonemal radial spoke head appears to interact with the 
projections from the central pair of microtubules cilium axoneme, radial spoke na
Retnet last updated July 25, 2013 (last access 31 July 2013) for retinal diseases. Uniprot last updated July 24, 2013 (last acess 31 
July 2013) for protein fucntion and location. CC, connecting cilium; OS, outer segment; IS, inner segment; mem, membrane; na, 
not available 
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Figure 5.2 Cilium-related genes comparison and expression fold changes (A) Venn diagram showing the number 
of common and different cilium-related genes in E15.5 Crx+ve, P4 Crx+ve cells and P4 Nrl+ve cells (B) Histogram 
of expression fold changes of the common cilium-related genes.  
 
5.2.2 Cilium development in photoreceptor cells 
To test if there is any cilium-related difference between the E15.5 and P4 photoreceptor cells 
at the protein level, I examined the IHC of three proteins which are established cilium markers 
in other systems. Acetylated α-tubulin (AcTub) marks the axoneme (Fliegauf, Benzing et al. 
2007) and has been used as a cilia marker in mouse embryonic fibroblasts, embryonic nodes 
and perineural mesenchyme tissues etc (Garcia-Gonzalo, Corbit et al. 2011). CenpF is a 
centromere protein that is transiently associated with the outer kinetochore plate of 
chromosomes for their segregation in M phase (Liao, Winkfein et al. 1995; Zhu, Mancini et al. 
1995; Yang, Guo et al. 2003) and relocalizes at different phases of cell cycle (Zhu, Mancini et al. 
1995; Yang, Guo et al. 2003; Pooley, Moynihan et al. 2008). In differentiated cells CenpF is 
found to localize at the centrosome (Moynihan, Pooley et al. 2009; Bolhy, Bouhlel et al. 2011) 
which is composed of centrioles which form basal bodies in interphase to assemble primary 
cilia (Kobayashi and Dynlacht 2011). Upon ablation of the CenpF protein, the centrosomal 
proteins which CenpF colocalize with redistribute and the nucleation, anchoring and 
repolymerization of centrosome specific microtubules are disrupted (Moynihan, Pooley et al. 
2009). GT335 is a monoclonal antibody raised against glutamylated tubulins and specifically 
recognizes polyglutamylation which is a unique posttranslational modification that is highly 
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abundant in cilia. It stains the basal bodies and the axonemes of nearly all ciliated cells such as 
human nasal epithelia cells (Million, Larcher et al. 1999), mouse tracheal cilia (Ikegami, Sato et 
al. 2010), mouse and sea urchin sperm flagellar microtubules and basal bodies (Kann, Soues et 
al. 2003), lung ciliated cells axonemes and basal bodies (Kann, Soues et al. 2003).  
At E15.5, AcTub expression was detected mainly at the apical region of the ONBL and the 
bottom of the INBL (Figure 5.3 A). By P4, AcTub was expressed all over the retina, but was 
particularly high in the apical region of the photoreceptor layer (Figure 5.3 B). CenpF was 
weakly expressed also at the apical region of the ONBL in E15.5 retina (Figure 5.3 C). At P4, 
CenpF expression at the apical region of the ONBL was much higher and was more specifically 
localized at the interphase between the apical protrusion and the remaining of the cell body 
(Figure 5.3 D) although expression in the inner INBL was also observable. Similar to CenpF and 
AcTub, GT335 was also weakly expressed at the apical region of the ONBL at E15.5 and more 
highly expressed there at P4 (Figure 5.3 E, F). So clearly these cilium markers were expressed in 
E15.5 retina, but were more highly expressed in P4.  
It is also noticeble that while location of these cilium markers were not so different at E15.5 
(all at the tip of the protrusion), their location in the cilium at P4 differs slightly. While GT335 
expression spread into the axoneme and the basal bodies of the cilia, CenpF expression was 
only confined at the bottom of the cilia where the centrosome locates and AcTub stained the 
thin axoneme structures of cilia. Such differences probably reflect the more developed 
structure of the cilia. 
Therefore, I conclude that the cilium marker proteins began to localise in photoreceptor cells 
as early as E15.5, but much more abundant expression as well as more defined localization was 
seen in P4 when the cilium structure is more developed. This indicates cilium began to form as 
early as E15.5 and was more established by P4. This agrees well with the early electron 
micrographs showing protrusions (and even centrioles in the protrusions) in some 
photoreceptor cells (Chapter 1, Figure 1.3) (Hinds and Hinds 1979) and the microarray analysis 
that a few cilium related genes can already be detected at E15.5 but much more were enriched 
at P4 and that cilium was a feature for the P4 photoreceptor cells.  
However these cilium markers are located within the cell. Because I am interested in cell 
surface proteins as these have the potential to interact with other extracellular molecules to 
organise cell location or affect migration, I went on to examine if the cilium-related cell surface 
proteins show the same expression pattern.  
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Figure 5.3 Cilium markers expression in mouse retina (continues). Confocal images of AcTub (panel A and B), 
CenpF (panel C and D), and GT335 (panel E and F) on E15.5 and P4 CrxGFP retina. Cilium markers (red), CrxGFP 
(green), Hoechst 33342 (Hst, blue). Scale bars represent 25 µm except in inserts which are 5 µm.  
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Figure 5.3 Cilium markers expression in mouse retina- continued. Confocal images of AcTub (panel A and B), 
CenpF (panel C and D), and GT335 (panel E and F) on E15.5 and P4 CrxGFP retina. Cilium markers (red), CrxGFP 
(green), Hoechst 33342 (Hst, blue). Scale bars represent 25 µm except in inserts which are 5 µm.  
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5.2.3 Prom1 is expressed in the cilium regions of photoreceptor cells throughout retinal 
development 
Despite involvement with the protruding cilium structure, not all the cilium proteins I pulled 
out above from the transcriptome analysis (Table 5.1) are located on the cell surface or have 
extracelluar domains. The BBS proteins, for example, are located within the cell at the bottom 
of the cilium region around the basal bodies. And pericentriolar marker Cep290 only shows a 
centrosome localization (Valente, Silhavy et al. 2006; Otto, Hurd et al. 2010). In fact, only 9 out 
of the 38 proteins above are annotated to contain extracellular domains. These are Cngb3, 
Cnga1, Rho, Opn1sw, Prom1, Ush2a, Pcdh15, Slc4a7 and Cnga3 (Table 5.1 and Table 5.2, 
highlight in bold). The CNG proteins, Rhodopsin and opsins have been well studied and are 
involved in phototransduction. In the case of Rhodopsin, although it is annotated to contain 
four extracellular domains, these domains are probably only extracellular when the protein is 
at the base of the OS where new disks remain open. The most common presence of Rhodopsin, 
however, is on membranes of mature rod OS disks which are inside the cell. The CNG proteins 
and S-opsin, located on the open disks of cone OS, are true cell surface molecules. In Chapter 3, 
I prioritized some cell surface protein candidates (Table 3.5) which included Prom1, 
Cdhr1/Pcdh21, Pcdh15 and Ush2a implicated in cell projection and showed high level up 
regulation (> 5-fold). Prom1 was reported to locate at the basement of outer segments 
interacting with Cdhr1 for OS formation (Yang, Chen et al. 2008) (see Figure 5.1 for locations of 
Prom1, Cdhr1 and Ush2a/Usherin in rod cilia). Pcdh15 and Ush2a mutations are associated 
with Usher syndromes which initially affected photoreceptor cells followed by RPE pathology 
in the eye (Jacobson, Cideciyan et al. 2008). As Prom1 and Pcdh15 showed higher expression 
levels from the microarray (Figure 3.9) and their antibodies were available, I first examined the 
retina development expression profile of these two proteins.  
From E15.5 to P4, Prom1 showed intense polarised staining at the apical regions of the 
developing photoreceptor layer where the cilia will develop (Figure 5.4, A, B, C, A2, B2, C2). 
The discrete punctate distribution of Prom1 along development at the cilium region colocalizes 
with the CrxGFP signals there (Figure 5.4, inserts in row A and row C). A lower level of Prom1 
staining within the developing neuroblastic layer at these stages was also detected, but the 
expression was more diffuse and seemed to be outlining the cell borders (Figure 5.4, A2, B2, 
and inserts in row A and C). At later stages when the photoreceptor cells are matured, Prom1 
expression was confined to the basement of the outer segments and no expression was 
observed in other retinal cell types (Figure 5.4, row D and E). Quantitative PCR showed that 
Prom1 transcripts showed more than 5 – 8 folds higher expression after birth relative to its 
expression in embryonic stages (Figure 5.4, F).  
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Therefore, Prom1 seemed to label the nascent cilia in photoreceptor precursor cells, and in the 
mature rod photoreceptor cells at the bottom of rod OS disks near the top of the connecting 
cilium.  
 
 Figure 5.4 Prom1 expression profile during retinal development. (A – E) Confocal images of Prom1 IHC in CrxGFP 
mouse eye sections along development, scale bar represent 25 µm; (F) Prom1 qPCR in retinal development, error 
bar represents standard deviation of three independent samples.  
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5.2.4 Pcdh15 is expressed in cilium and synapses of photoreceptor cells as well as other 
retinal cells throughout retinal development 
In embryonic stages, Pcdh15 showed intense punctate staining at the apical regions of the 
developing ONBL (Figure 5.5, row A), similar to Prom1. But unlike Prom1, strong punctate 
staining near the bottom of the INBL was also observed for Pcdh15. After birth while it 
maintained the high expression at the outer edge of the photoreceptor cells, Pcdh15 was also 
expressed at the emerging OPL where photoreceptor synapses locate (Figure 5.5, row B, C and 
D). In addition, it was also expressed in the inner retina including the INBL/INL and GCL (Figure 
5.5, row B to E) whereas expression in these regions was not observed for Prom1. When the 
retina was fully developed by P21, Pcdh15 expression in the photoreceptor apical regions was 
mainly in the outer segments and filled the whole structure (Figure 5.5, row E and inserts) in 
contrast to Prom1 which was only confined at the bottom of the OS.  
Therefore, the cell surface molecule Pcdh15 is expressed in the photoreceptor cilia during 
development and in particular the outer segments. This, in addition to Prom1, provides a 
further cell surface marker to study the photoreceptor cilium. However, it should be noted 
that Pcdh15 is also expressed in the photoreceptor synapses regions and other retinal cell 
types. 
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Figure 5.5 Pcdh15 expression profile in CrxGFP retinal sections along development. (A - E) Confocal images of 
Pcdh15 IHC in CrxGFP mouse eye sections along development. (C3) shows the enlarged image of the inserts for (C 
– C2). Scale bar represent 25 µm for all except (C2) for 50 µm, (C3) for 10 µm, and the inserts for (B – B2) and (E – 
E2) for 5 µm.  
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5.2.5 Prom1 is expressed on migrating transplanted photoreceptor cells 
Because Prom1 more specifically labeled the photoreceptor cilia than Pcdh15, I examined if 
this cilium-related cell surface marker is involved in the migration of transplanted 
photoreceptor cells. P4 CrxGFP+ve cells were FACS sorted and injected into the SRS of adult 
wildtype mouse eyes. 3 to 12 days after injection, eyes of the host animals were collected and 
analysed for Prom1 expression. The transplanted photoreceptor cells which can migrate away 
from the SRS to the segment region or ONL clearly expressed Prom1 (Figure 5.6). Interestingly, 
while the transplanted cells at the segment region mostly show Prom1 expression all over the 
cell body (Figure 5.6 A2, B2, n = 76 GFP+ve cells counted), transplanted cells in the ONL 
seemed have higher enrichment of Prom1 in particular directions/regions (Figure 5.6 C2, n = 
38 GFP+ve cells counted), although the directions/regions varied in different cells.   
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Figure 5.6 Prom1 expression on transplanted photoreceptor cells. All confocal Z-projections. (A – A3) 3 days after 
transplantation; (B – B3, and C – C3) 6 days after transplantation. Prom1 (red), CrxGFP (green), Hoechst 33342 
(Hst, blue). Dashed line or arrow heads indicate Prom1 expression on transplanted cells. Scale bar represent 25 
µm. N = 76 GFP+ve cells counted in segment region and n = 38 GFP+ve cells counted in ONL.  
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5.3 Discussion 
I noticed that the postnatal photoreceptor cells featured the cilium property according to the 
gene ontology analysis of the transcriptome study in Chapter 3 (Figure 3.3, Figure 3.6). Here in 
this chapter, I confirmed that these cells indeed enriched expression of many cilium related 
genes (Table 5.1). These genes are mainly retinitis pigmentosa genes, nucleotide channel or 
binding proteins, opsins or arrestins, and BBS proteins. In addition, all these genes showed 
higher expression in postnatal photoreceptor cells than embryonic photoreceptor cells (Figure 
5.2 B, Table 5.1). And all their expressions were higher in photoreceptor cells than other retinal 
cells at the postnatal stage (Figure 5.2 B, Table 5.1). Three of these genes also showed much 
higher expression in photoreceptor cells than other retinal cells at the embryonic stage 
indicating cilium development as early as E15.5. I, therefore, propose that cilium genesis starts 
at E15.5 if not earlier and is quite developed as a feature structure for the photoreceptor cells 
by P4 – well before establishment of the outer segment. Further examination of the E15.5 and 
P4 retina using established cilium markers has confirmed this observation. Not only were the 
cilium markers detected at E15.5, but also more abundant protein expression as well as more 
defined localization was observed at P4 (Figure 5.3).  
To explore the cilium property further, I examined two cilium surface molecules Prom1 and 
Pcdh15. Prom1 belong to the prominin family. Prominin family includes prominin-1, prominin-
2 and prominin-like proteins and contains a conserved region of around 800 amino acid 
residues. They are pentaspan membrane proteins with two large extracellular glycosylated 
loops (over 250 residues, Prom1: 180 – 434 and 509 – 794,) and two small cytoplasmic loops, 
with the N-terminal domain (Prom1: 20 – 107) extruding out of the cell and C-terminal inside 
(Fargeas, Florek et al. 2003) (see Figure 5.7 B for Prom1 protein structure). The 115-KDa 
glycoprotein prominin-1 is expressed in a CD34bright subset of human hematopoietic stem and 
progenitor cells (Miraglia, Godfrey et al. 1997) and many epithelial cells and has been regarded 
as a surface marker for stem cells (Boivin, Labbe et al. 2009). In the context of retina, Prom1 
protein has previously been reported to be expressed in photoreceptor cells (Maw, Corbeil et 
al. 2000; Yang, Chen et al. 2008; Zacchigna, Oh et al. 2009), and our data agrees with this 
(Figure 5.4, and (Lakowski, Han et al. 2011)). Transcripts of Prom1 were nine fold higher in the 
photoreceptor cells than other retinal cells from our arrays (Figure 3.8) and in the ONBL or ONL 
throughout development except a few cells in INL also showed Prom1 expression in postnatal 
stages (Jaszai, Fargeas et al. 2011). The protein of Prominin-1 preferentially localizes to the 
apical surface of polarized cells and specifically associates with plasma membrane protrusions 
such as microvilli and microvilli-related structures of neuroepithelium and other epithelial cells 
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(Weigmann, Corbeil et al. 1997; Corbeil, Roper et al. 2000), filopodia, lamellipodia, and 
microspikes of CHO cells (Weigmann, Corbeil et al. 1997), and plasma membrane protrusions 
of fibroblasts and hematopoietic stem cells (Corbeil, Roper et al. 2000). In mature 
photoreceptor cells, prominin-1 was previously described to be concentrated in the plasma 
membrane evaginations at the base of the OS of rods (Maw, Corbeil et al. 2000; Yang, Chen et 
al. 2008; Zacchigna, Oh et al. 2009), and possibly spreads into the entire OS of cones (Jaszai, 
Fargeas et al. 2007). Our Immunohistochemistry of Prom1 in retina showed the same 
specificity toward the cilia region of the developed photoreceptor cells, ie at the basement of 
rod OS (Figure 5.4, and (Lakowski, Han et al. 2011)) and the entire cone OS (Figure 6.6 A’ in 
chapter 6).  
Furthermore, I showed that similar to our Immunohistochemistry of the established cilium 
markers, this cilium surface protein was also expressed in the apical protrusions of 
photoreceptor cells as early as E15.5. This is before birth when rod ciliogenesis was proposed 
to start in a recent study (Sedmak and Wolfrum 2011). The embryonic expression of the cilium 
markers and cilium surface proteins therefore highly indicate the cone cilia genesis at this 
stage. Early identification of centriole in the apical protrusion of E15 photoreceptor cells by 
electron microscopy images also agrees with this hypothesis (Hinds and Hinds 1979). Studies 
about initiation of cone ciliogenesis have been lacking except one study in tree shrew 
suggesting cone ciliogenesis starts around E20 (Knabe and Kuhn 1997). Our observation 
therefore provides mammalian evidence suggesting mouse cone ciliogenesis starts at least at 
E15.5. As rod ciliogenesis coincides with the birth peak of rods at P0 in mice, it is plausible that 
cone ciliogenesis may also coincide with the birth peak of cones at E14.5.  
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Figure 5.7 Model of photoreceptor cell cilia development and cilium surface proteins Prom1 and Pcdh15 location 
(A) Development of cilia and photoreceptor cells. (B) Structure and localisation of Prom1 on developing 
photoreceptor cells. (C) Structure and localisation of Pcdh15 on developing photoreceptor cells. E, embryonic day; 
P, postnatal day; OS, outer segment; CC, connecting cilium; IS, inner segment; OLM, outer limiting membrane; 
ONL, outer nuclear layer; OPL, outer plexing layer; Extracellular, extracellular side of the cell; PM, plasma 
membrane; N, N-terminus; C, C-terminus. 
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My colleagues showed that the E14.5 photoreceptor cells gave the maximum integration of 
cones and postnatal photoreceptor cells gave around 10 fold higher integration of rods after 
transplantation (Lakowski, Baron et al. 2010). The presence of cilia structures on E15.5 cones 
and the abundant and more defined cilia structures on P4 rods interestingly match the 
integration properties of the transplanted photoreceptor cells. It is therefore tempting to 
propose that the presence of cilia structures on photoreceptor cells might play a role in the 
integration of transplanted photoreceptor cells in the host environment. The primary cilia of 
fibroblasts were reported to align toward the direction of migration possibly helping 
fibroblasts to migrate (Albrecht-Buehler 1977; Schneider, Cammer et al. 2010). Our finding 
that the cilium surface protein Prom1 was directionally/regionally enriched on transplanted 
migrating photoreceptor cells (Figure 5.6) further supports this possibility. Interestingly while 
cells migrating in the ONL showed directional/local enrichment, cells in the segment region did 
not show such enrichment (Figure 5.6). It might be possible that the orientation roles of 
photoreceptor cilia only function after cells migrated in the ONL which might provide some 
directional cues that the cilia can sense and use to orient the cells. While before cells migrated 
in the ONL, the cilium surface molecules could be all over the cell body to search for such 
directional cues.  
In addition to the intensive punctate staining at the apical protrusion, I also observed relatively 
weak expression of Prom1 around the cell body of photoreceptor cells in early development. 
Expression around the whole cell body was also observed on photoreceptor precursor cells 
after dissociation (Lakowski, Han et al. 2011) and after transplantation (Figure 5.6). The all 
around expression on developing photoreceptor cell bodies gradually diminished as more 
expression was concentrated to the apical regions as development proceeds. This observation 
has not been reported before. This may imply the translocation of this surface molecule from 
around the cell body to the cilium region. How this translocation works and whether it is 
coupled with the genesis of cilium will be worth further investigation. It is less likely to be 
based on direct interaction with the cytoskeleton, because neither studies which disturbed the 
actin-bundling protein villin and profoundly altered cytoskeletal architecture of epithelial 
microvilli abolished the preferential microvilli localization of prominin (supplementary data in 
(Roper, Corbeil et al. 2000)) nor did deletion of the C-terminal domain of Prom1 – the potential 
cytoskeleton interaction domain – impaired Prom1’s microvilli specification in epithelial cells 
(Corbeil, Roper et al. 1999). Interestingly, when mild cholesterol depletion was applied to 
Prom1-transfected MDCK cells (using methyl-β-cyclodextrin), Prom1 was redistributed from 
microvilli to the entire apical plasma membrane (Roper, Corbeil et al. 2000). Indeed, Prom1 
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directly interacts with cholesterol (Roper, Corbeil et al. 2000) and is enriched in the 
cholesterol-based Lubrol lipid rafts (Roper, Corbeil et al. 2000; Corbeil, Roper et al. 2001). 
Although this may only explain the specification of Prom1 from microvilli to apical surface, it is 
possible that transportation of Prom1 from the Golgi complex and around the cell body to the 
apical surface may also involve cholesterol.  
I also examined another cilium cell surface molecule Pcdh15. Pcdh15 is a single-pass type I 
membrane protein (see Figure 5.7 C for cartoon of Pcdh15 protein structure), usually heavily 
glycosylated. It is a calcium-dependent cell-adhesion protein, required for inner ear 
neuroepithelial cell elaboration (Lefevre, Michel et al. 2008) and cochlear function (Alagramam, 
Murcia et al. 2001). It can be found in the stereocilium of hair cells (Alagramam, Murcia et al. 
2001; Kazmierczak, Sakaguchi et al. 2007; Lefevre, Michel et al. 2008) as well as photoreceptor 
cilia (Reiners, Marker et al. 2005). Interestingly there are two orthologues of Pcdh15 in 
zebrafish with Pcdh15a necessary for integrity of the stereociliary bundle while Pcdh15b knock 
down results in clumped photoreceptor outer segments positioned perpendicular to RPE 
(Seiler, Finger-Baier et al. 2005). PCDH15 (USH1F) mutation in human is associated with Usher 
syndromes (Jacobson, Cideciyan et al. 2008). Mouse Pcdh15 localizes in rod and cone outer 
segments and synapses and costains with peanut agglutinin (PNA), as well as in connecting 
cilium (Reiners, Marker et al. 2005). It also colocalizes with harmonin (USH1C) at the base of 
the photoreceptor outer segment where newly synthesized disk membranes are present 
(Reiners, Marker et al. 2005). Our Immunohistochemistry of Pcdh15 showed expression in the 
cilia (in particular OS) and synapses region of photoreceptor cells (Figure 5.5) which agrees 
with previous findings, but also expression in other types of retinal cells. As previous 
Immunohistochemistry in retina for Pcdh15 did not show the inner retina (Reiners, Marker et 
al. 2005), I do not know if that antibody also labels inner retina cells. It is possible that either 
murine Pcdh15 indeed labels other retinal cells or our antibody has non-specific effects. 
Although also expressed in the synapses of photoreceptor cells, Pcdh15 remains an interesting 
cilium surface molecule because its expression in the cilia is within the whole outer segment 
and is different from Prom1 (Figure 5.5). Interestingly, a PCDH15 mutation is associated with 
increased total cholesterol levels as well as high plasma triglycerides concentration and 
apolipoprotein B levels in Finnish dyslipidemic patients with hyperlipidemia (Huertas-Vazquez, 
Plaisier et al. 2010). This again links cholesterol with cilium surface molecule, but whether 
Pcdh15 affects the cholesterol levels in photoreceptor cells and cilia requires further 
investigation.  
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To sum, based on some early electron microscopy images of developing photoreceptors 
(Robertis 1960; Hinds and Hinds 1979) as well as my own immunohistochemical staining of 
retina with cilium markers and cilium cell surface protiens, a simple cartoon was drawn to 
illustrate the process of cilia development and the cell surface protein location along this 
process (Figure 5.7). Initially the apical region of the cell gradually buds out. The bud continues 
to grow into the primitive cilium which is filled with vesicular materials at the apical end. The 
apical region of the primitive cilium expands as the vesicles accumulate and grow. These 
vesicles gradually remodel and reorient themselves into stacked disks vertical to the growing 
axis of the buds and finally form the outer segment. More recent investigation in ciliogenesis 
further revealed that IFT proteins were associated with ciliary apparatus as early as 
appearance of the primary ciliary vesicle and electron dense centriolar satellites around P0 
(Sedmak and Wolfrum 2011). However studies so far are mainly in rods, and little is known 
about the cones which are born early and which might use a different mechanism because 
their disks are the continuous invagination of the plasma membrane rather than closed disks. 
Expression of Prom1 is mainly at the apical protrusions of the cilia in embryonic and early 
postnatal stages, but is specifically at the base of rod OS and the whole of cone OS disks 
(Figure 5.7 B). Expression of Pcdh15 is in both the apical protrusion (the whole OS surface in 
the case of mature photoreceptor cells) as well as the synapse region of the photoreceptor 
cells throughout development (Figure 5.7 C).   
5.4 Conclusions 
 I identified 38 cilium annotated genes enriched in photoreceptor precursor cells from 
the transcriptome analysis, among which 23 are known to be associated with retinal 
diseases.  
 Nine cilium cell surface molecules were identified. Two of them Prom1 and Pcdh15 
were examined in detail and both showed high expression in the cilia, although Pcdh15 
was also expressed in the photoreceptor synapses and other retinal cells. Prom1 
specifically labeled the cilia (cone OS and base of rod OS) in photoreceptor cells in 
retina and was also expressed on the migrating photoreceptor cells after 
transplantation.  
 I found three cilia annotated genes showed higher transcript levels in photoreceptor 
precursor cells compared with other retinal cells at E15.5 from the transcriptome 
analysis and observed protein expression of cilium markers (AcTub, CenpF and GT335) 
and cilium cell surface proteins (Prom1 and Pcdh15) at E15.5, which indicates possible 
cone ciliogenesis at this stage.   
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 I found 38 cilia genes showed higher transcript levels in photoreceptor precursor cells 
compared with other retinal cells at P4 and all 38 genes showed higher transcript 
expression in P4 than E15.5 photoreceptor precursors. More abundant expression and 
more defined localization of cilium proteins (ie. the above cilium markers and cilium 
cell surface proteins) were also seen in P4 than E15.5. I speculate such differences in 
the cilium property may correlate with the higher integration rate of the postnatal 
photoreceptor precursor cells compared with the embryonic photoreceptor precursor 
cells after transplantation. In support of this, the migrating photoreceptor cells express 
the photoreceptor cilium specific cell surface protein Prom1 after transplantation.  
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6 Cell surface molecules can be used to select photoreceptor 
precursors for cell transplantation 
6.1 Introduction 
As demonstrated in mice, transplantation of rod photoreceptor cells is a feasible approach to 
restore vision if the donor cells are from the early postnatal stages (MacLaren, Pearson et al. 
2006; Pearson, Barber et al. 2012). As a means of therapy for human, the corresponding stage 
of donor cells would have to come from fetal tissue of 13 to 28 wks in pregnancy, which is not 
ideal. With much more availability and easy access, ES cells or induced pluripotent stem cells 
(iPS cells) offer this therapy more promising sources. Several groups have demonstrated that 
given certain conditions, these cells are able to differentiate into retinal cells including 
photoreceptor cells (Lamba, Karl et al. 2006; Osakada, Ikeda et al. 2008; Meyer, Shearer et al. 
2009; Eiraku, Takata et al. 2011). However, these cultures are mostly heterogeneous 
containing cells of different types and developmental stages. To obtain homogeneous correctly 
staged photoreceptor precursor cells, cell selection strategy has to be applied to these cultures. 
Although photoreceptor cells have been selected using GFP-tagged transgenic genes in 
research, this is not desirable for human therapy.  
It is known that in the immune system, during development as differentiation proceeds 
different types of cells begin to present different cell surface antigens to interact with 
neighboring cells or the environment, and monoclonal antibodies raised against these surface 
antigens are termed as the “CD” markers (Zola, Swart et al. 2005) (although the antigen itself 
or the gene that encodes the antigen are often referred to the CD name as well). The end 
result is that each type of cell in the immune system has a unique pattern of expressed CD 
markers along development. Using combinations of antibodies against these antigens, cells of 
a particular type and stage are successfully enriched. As the photoreceptor cells are able to 
correctly position themselves in the ONL during development, these cells must also express 
cell surface markers helping them to interact with the surroundings. In addition, the 
transplanted photoreceptor precursor cells can correctly migrate from SRS to ONL which is a 
process that probably involves lots of interactions between the cell and its environment and 
thus will require the presence of cell surface molecules. Therefore, if I can identify the 
photoreceptor specific cell surface marker profile, these markers could be used to enrich and 
isolate these cells by cell sorting using antibodies recognising cell surface molecules without 
any genetic manipulation. Previously in Chapter 3, I have developed ways to identify cell 
surface markers based on microarray analysis (section 3.2.5) and also listed all the CD markers 
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identified from the different arrays (Table 3.2). In this chapter, I will evaluate the potential of 
using some of these markers to isolate live photoreceptor precursor cells in flow cytometry 
and test the feasibility of using cell surface molecules to prepare donor cells for 
transplantation experiments.  
With my supervisor Jane Sowden, I selected several CD markers (CD73/Nt5e, CD24, CD80, 
CD83, CD276, and Prom1/CD133) for analysis from the combined data sets:  NrlGFP P4 array 
(generated by Jorn Lakowski), the previously reported Swaroop array (Akimoto, Cheng et al. 
2006) and the CrxGFP P4 array (produced as part of this thesis). CD73, CD24, CD80, CD83 and 
CD276 were initially focussed on based on the array data existing before the start of my study. 
My identification protocol also confirmed the presence of these molecules (Table 3.2 and 
Table 3.3). In addition I found Prom1/CD133 quite interesting as it was found to be highly 
enriched in human retina (Carter, Dick et al. 2009). These markers were chosen because they 
showed dynamic developmental expression profiles in the Swaroop array (Figure 6.1 A – F) and 
(i) potentially can label photoreceptor precursors at specific developmental stages; and (ii) 
may label cones specifically or cones as well as rods.  
To assess if the antigens were present on the cell surface in order to be useful for live cell 
selection, I plan to examine their protein expression using fluorochrome-conjugated antibodies 
in flow cytometry using live retinal cells. For each marker under examination, the retina was 
collected after microdissection of the mouse eye and subjected to Papain treatment to obtain 
dissociated single retinal cells (see Chapter 2, section 2.2.1). These live cells were directly 
incubated with the antibody after blocking (without fixation) and analysed in flow cytometry 
machine. My colleague Jorn Lakowski had successfully tested CD73 and CD24 with this 
approach and my aim was to examine the remaining markers in combination with CD73/CD24 
with the same approach. Most of the markers were examined for several timepoints 
throughout development so that their expression profiles along retina development can be 
obtained. 
6.2 Results 
6.2.1 Trials on CD80, CD83 and CD276 
CD80 
In the Swaroop array (Akimoto, Cheng et al. 2006), the mRNA level of Cd80 was very low from 
E16 to P10 but increased at P28 (log2 intensity from around 2 to around 5, Figure 6.1 C). If its 
protein is also expressed in the adult photoreceptor cells but not the younger cells, CD80 could 
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be used as an adult marker to deplete the more matured cells from the mixed cell population. 
Flow cytometry results showed that after subtraction of the background from isotype control, 
however, very few retina cells could be recognized by CD80 except 1 – 2% cells positive for 
CD80 staining at P10 and P20 (Figure 6.2 A). These 1 – 2% cells were further analysed against 
NrlGFP which labels developing and mature rod photoreceptors. Although there was a slight 
increase in the NrlGFP positive population at P10 and P20 (0.1% and 0.6% respectively), the 
CD80 positive cells were mainly in the non-rod retina cells (2% at P20 and 1.3% at P10, Figure 
6.2 B). Because non-rod retina cells also contain cone photoreceptors, to rule out if the CD80 
positive cells might be cone photoreceptors, retina cells from the CrxGFP line were analysed. 
GFP expression in this transgenic line labels both rod and cone photoreceptors. Similar to the 
NrlGFP line, around 2% cells were CD80 positive but were mainly in the CrxGFP negative 
population (Figure 6.2 C) indicating that the CD80 positive cells are not photoreceptor cells.  
CD83 
Transcript of Cd83 was also low in wild type rod precursor cells in the array data (log2 intensity 
around 3, Figure 6.1 D), but sharply increased (log2 intensity 6.8) at P10 in the cone-like rod 
cells where Nrl was knocked out (Akimoto, Cheng et al. 2006). This suggests that Cd83 might 
label cone cells. Therefore, P10 retina cells of the CrxGFP line were analysed in flow cytometry. 
2.4% of the whole retina cells were found being both CD83 positive and CrxGFP positive 
(Figure 6.3 A). This number nearly corresponds to the percentage of cones in the whole retina 
cells. However, intensity of the CD83 signals here was only slightly higher than the background 
and no distinct cell population was identified. In addition, 1.4% retina cells which were 
CD83+ve were CrxGFP-ve showing that CD83 also labels non-photoreceptor retina cells.  
CD276 
Transcript of Cd276 was relatively high in the P4 NrlGFP microarray and was higher in the 
NrlGFP positive population than the negative population (log2 intensity 8.5 vs 7.9, Figure 6.1 E). 
I wanted to know if it could be used to enrich rod precursor cells. After subtraction of the 
background from isotype non-specific binding, there seemed to be a small percentage of 
CD276 binding cells in all time points tested (0.24% at P4, 0.28% at P6, 0.43% at P10, and 0.49% 
at P20, Figure 6.3 B). However, such a percentage is too low to be considered as a marker to 
enrich photoreceptor precursor cells.  
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Validation of CD80, CD83, and CD276 
To examine the mRNA levels of these genes as well as to validate their microarray expression, 
conventional reverse-transcription PCR was performed for retina tissues. Results showed that 
while Cd73 and Prom1 were highly expressed, Cd83 was only detectable at lower level. Cd276 
could be detected at relatively higher levels, but Cd80 was not detected in the retina at all 
although it was detected in activated dendritic cells which were used as a positive control 
(Figure 6.2 D).  
None of the antibodies for CD80, CD83, and CD276 tested identified any distinct cell 
populations nor sufficiently increased the percentage of the expected cell population. To rule 
out the possibility that the antibodies are not working, I examined these antibodies on 
dendritic cells which are known to be able to present the antigens of CD80, CD83, and CD276 
on the cell surface after maturation or lipopolysaccharide (LPS) activation. Results showed that 
over 70% dendritic cells were positive for CD80 and over 30% were positive for CD83 and 
CD276 (Figure 6.3 C) which agrees with their expression levels after LPS activation. This shows 
that all three antibodies were properly functioning. To rule out possible protocol problems in 
flow cytometry analysis with retina cells, two molecules, CD24 and CD73, recently shown in 
the lab to be highly expressed in retinal cells (by Jorn Lakowski), were tested along with the 
three antibodies following the same procedure. Around 45% and 30% retina cells were positive 
for CD24 and CD73 at E18.5 and 3 months respectively (Figure 6.3 C). Therefore, it is highly 
likely that the majority of the antigens of CD80, CD83, and CD276 are not yet present on the 
surface of the retina cells. Further analysis with western blot may reveal if the proteins are 
translated at all. 
In summary, Cd80 with maximum log2 intensity at 5 in microarray analysis labeled around 1% 
non-photoreceptor cells in FCM analysis, but did not label any photoreceptor cells and was not 
detectable by PCR. For Cd83 and Cd276, their log2 intensity in microarray was around 7 and 
their transcripts were detectable in PCR. But in FCM analysis, CD83 labeled non-photoreceptor 
cells as well as photoreceptor cells (both around 2%), while CD276 barely labeled more than 
0.5% cells. Therefore I conclude that none of the three candidates could be used as surface 
markers for positive selection of photoreceptor precursors. However, CD80 and CD276 might 
be used as negative cell surface markers for photoreceptor cells. Indeed CD80 showed high 
expression in ES cells and low expression in neural progenitors during the controlled 
differentiation of ES cells (Wollscheid, Bausch-Fluck et al. 2009). Therefore, when isolating 
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photoreceptor precursor cells from ES cells, CD80 could be a useful negative marker for 
photoreceptors.  
From these preliminary studies, I also found that genes with log2 intensity below 6 in the 
arrays were difficult to be detected by conventional PCR. I therefore prioritized genes with 
log2 intensity higher than 6 in future studies. These include CD73, CD24, and Prom1 which will 
be focused on the following sections.  
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Figure 6.1 Expression levels of candidate genes in Swaroop array and NrlP4 array. The Swaroop array compares NrlGFP+ve cells 
in wildtype (WT) and Nrl-knockout (KO) background at the time point of E16, P2, P6, P10 and 4 wks. The box plots of the 
Swaroop array represent the absolute gene expression levels (ie. the log2 array signal intensity on X-axis) of Cd73, Cd24, Cd80, 
Cd83, Prom1 and Eno2 (A, B, C, D, F and G). The NrlP4 array compares NrlGFP+ve cells (+) and NrlGFP-ve cells (-) at P4. The dot 
plots of the NrlP4 array represent the absolute gene expression levels (ie. the log2 array signal intensity on X-axis) of Cd276, 
Sema7a and Basigin (E, H and I). Each dot represents the expression level of the gene under examination from each array chip. 
WT, wildtype; KO, Nrl knockout; +, NrlGFP+ve; -, NrlGFP-ve.  
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Figure 6.2 FCM analysis of CD80 and PCR analysis of Cd80, Cd83, Cd276, Prom1, Gapdh and Cd73. Representative 
dot plot patterns of CD80 labelled cells compared with forward scatter (FSC, roughly equals cell size) (A), or 
compared with NrlGFP (B) or CrxGFP (C) at each developmental time point. Pink boxes indicate positive signals 
determined using matched isotype control stained cells. When X-axis is NrlGFP or CrxGFP, the top right hand 
quadrants in each plot indicate cells that are double positive for GFP and CD80. (D) PCR analysis of Cd80, Cd83, 
Cd276, Prom1, Gapdh and Cd73 on P4, P10, P28 retinae and activated dendritic cells (DC). 
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Figure 6.3 (A) FCM analysis of CD83 against CrxGFP. (B) FCM analysis of CD276 against FSC. (C) FCM analysis of 
CD80, CD83, CD276 on dendritic cells and CD24 and CD73 on retinal cells at E18.5 and 3 months respectively. 
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6.2.2 Flow cytometry analysis of Prom1, CD73, and CD24 in NrlGFP line  
To evaluate the possibility of using Prom1, CD73, and CD24 to isolate live photoreceptor cells, 
my colleague Jorn Lakowski and I tested the corresponding antibodies in dissociated NrlGFP 
retinal cells using flow cytometry (CD73 and CD24 by Dr Lakowski, Prom1 by Y. Han). Firstly, 
the percentage of retinal cells labelled by each candidate cell surface antigen at different 
developmental time points was established. At E17, only a very small number (2%) of retinal 
cells is stained with CD73 and this increased markedly in the postnatal period to more than 60% 
of all cells persisting into adulthood (Figure 6.4 B, F). By contrast, CD24 showed an inverse 
pattern (Figure 6.4 C, F): more than 80% of cells were labelled at E17 and this decreased in the 
postnatal period to very low levels in the mature retina of less than 8% consistent with its 
reported down regulation in maturing neurons in the central nervous system (Shirasawa, 
Akashi et al. 1993; Nieoullon, Belvindrah et al. 2007). Prom1 (CD133) stained a significant 
number of retinal cells during embryonic and postnatal development (>70%) but levels 
decreased in adulthood (Figure 6.4 D, F).  
By gating for each fluorochrome and GFP, the proportion of each cell surface marker 
population that colabels with NrlGFP was assessed. At E17, very few of the NrlGFP cells 
colabeled with CD73 (Figure 6.4 G) indicating that CD73 is not a marker of the very early stages 
of rod photoreceptor differentiation. By P5, and at later stages, the majority of retinal cells 
(>60%) were colabeled for CD73 and NrlGFP (Figure 6.4 G; top right hand quadrants). 
Conversely, at E17 the vast majority of the CD24+ve cells were NrlGFP-ve (Figure 6.4 H, left 
hand panel; top left hand quadrant, 70%). The proportion of retinal cells that colabeled with 
CD24 and NrlGFP initially increased postnatally so that by P5 more than 40% of all retinal cell 
colabeled and then subsequently declined such that less than 10% of cells colabel after P10 
(Figure 6.4 H; top right hand quadrants). At E17, Prom1 labeled approximately 70% of all cells, 
but the majority of these were NrlGFP-ve (Figure 6.4 I; left hand panel; top left hand quadrant). 
In the postnatal period, Prom1 labeled both GFP+ve cells and GFP-ve cells with approximately 
50% of all cells colabeling for GFP and Prom1 at P5 and more than 60% at P10 decline 
thereafter (Figure 6.4 I). 
CD73 and CD24 were evaluated as a candidate surface marker combination that could define 
postnatal stage photoreceptor precursors as previous qPCR and immunohistochemistry 
analysis indicated that these markers were coexpressed in developing photoreceptors at P4–
P7 but not at earlier or later stages (Lakowski, Han et al. 2011). Here flow cytometry analysis 
confirmed that more than 30% of retinal cells colabeled with CD73 and CD24 at P5, whereas 
negligible levels colabel at embryonic and adult stages (Figure 6.4 J). For easy comparison of 
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the performance of the markers in flow cytometry analysis, I defined two terms to evaluate 
these markers, namely “specificity” and “efficiency”. Specificity refers to the percentage of 
marker labelled cells that are NrlGFP+ve. This parameter evaluates how specifically the 
markers label photoreceptor cells and is particularly useful for cell resources of mixed 
population. Efficiency refers to the percentage of NrlGFP+ve cells that are labelled by the new 
marker(s). This parameter evaluates how many photoreceptor cells can be labelled by the 
markers and is useful when the cell resources are limited. Although when applying to in vitro 
differentiation of stem cells, if cell resources are abundant, efficiency may not represent a 
restricting factor. The majority of CD73 and CD24 double-labelled and CD73 single labelled 
cells expressed the NrlGFP transgene at P5 (98.4 ± 0.3% and 98.8 ± 0.1% respectively; Figure 
6.4 K) showing high specificity. Only 43.3 ± 5.1% of NrlGFP precursors label with both CD73 and 
CD24 at P5 showing lower efficiency compared to single labelling (Figure 6.4 K). The specificity 
and efficiency of the double labelling is illustrated in Figure 6.4 L. 
Therefore, m colleague and I identified three cell surface molecules, CD73, CD24 and Prom1, 
highly expressed in retinal cells in flow cytometry experiments. Each of them shows a unique 
expression pattern against NrlGFP along retinal development. Both single labelling of CD73 and 
double labelling of CD73CD24 can isolate rod photoreceptor cells with high specificity, but the 
CD73CD24 combination add further specificity to a developmental stage around P5 in expense 
of efficiency.  
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Figure 6.4 FCM analysis of Prom1 (ie CD133), CD24, and CD73 in NrlGFP (continues). (A–E) Graph of surface 
marker expression profiles from three independent retinal cell samples derived from NrlGFP mice at E17, P5, P10, 
and P20. (F) Table of the average percentage of viable cells expressing each marker or combination of markers 
and the respective standard deviation (n = 3). (G–I) Representative dot plot patterns of CD73, CD24, and Prom1 
labelled cells compared with NrlGFP expression at each developmental time point. Pink lines demarcate 
detection thresholds for positive signal determined using matched isotype control stained cells. Top right hand 
quadrants in each plot indicate percentage of total cells that are double labelled (from (Lakowski, Han et al. 
2011)).  
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Figure 6.4 FCM analysis of Prom1, CD24, and CD73 in NrlGFP-continued. (J) Representative dot plot patterns of 
double labeled CD73 and CD24 cells from E17 to P20 as labelled in (G). (K) Table of the average percentage of 
NrlGFP cells expressing the markers (Specificity) or percentage of the marker expressing cells that are NrlGFP+ve 
(Efficiency) (n = 3) at P5. (L) Venn diagram showing expression overlap between CD73, CD24, and NrlGFP at P5. 
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6.2.3 Flow cytometry analysis of Prom1, CD73 and CD24 in CrxGFP line 
As NrlGFP does not label cones, I next examined if these markers also label cones by using the 
CrxGFP line which labels cones, rods, and bipolar cells (Furukawa, Morrow et al. 1997; 
Lakowski, Baron et al. 2010). As the three types of cells are different in terms of cell numbers 
in the retina, expression levels of CrxGFP, and probably cell size and cell complexity, they might 
show up as different populations when passing the lasers of the flow cytometry machine and 
being presented in the flow cytometry scatter plot which provides 2-dimentional visual 
separation to these cells. Therefore, using the CrxGFP population might reveal more 
information as to what retinal cells these surface markers label. Further, the specificity and 
efficiency of the surface marker labelling were examined.   
CrxGFP vs NrlGFP 
First I compared the flow cytometry plots of the CrxGFP and NrlGFP line. Similar to the NrlGFP 
line, more CrxGFP-ve cells appear to transfer into the CrxGFP+ve population as development 
proceeds (Figure 6.6 A). However, different from the NrlGFP line which contains only one cell 
population with a slight continuous gradient of GFP intensity (Figure 6.5 A right), the 
CrxGFP+ve cells showed about three distinct differently sized cell populations with increased 
CrxGFP intensity at late postnatal periods (Figure 6.5 A left and Figure 6.6 A). The biggest cell 
population (around 54.6% live retinal cells at P8) is likely to be the rods which roughly cluster 
their CrxGFP levels around 105. On its right is a very small CrxGFP+ve population (around 4.27%) 
with CrxGFP levels higher than 105 and on its left is a median sized CrxGFP+ve population 
(around 18.5%) with maximum CrxGFP levels around 104.4. Considering the size of the 
population and levels of the CrxGFP signals, the weak CrxGFP+ve cells (ie. the left population) 
is likely to be bipolar cells and the strong CrxGFP+ve cells (ie. the right population) to be cones. 
Immunohistochemistry showed that the weak CrxGFP+ve cells locate in INL and are mostly 
positive for PKCα staining indicating they are bipolar cells (Figure 6.5 B). The percentage of the 
possible bipolar cells here in flow cytometry agrees with Young’s autoradiography study that 
around 20% ventricular cells produced postnatally are bipolar cells and this decreased to 10.3% 
in adults (Young 1985a). Percentage of adult mouse rods represent 97% of photoreceptor cells 
while cones represent 3% (Carter-Dawson and LaVail 1979b). The three cell populations also 
expressed different levels of the cell surface markers (Figure 6.6 A).  
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Figure 6.5 CrxGFP+ve cell populations. (A) Flow cytometry analysis comparing the CrxGFP (left, at P8) and NrlGFP 
(right, at P10) retina cells. X-axis GFP intensity, Y-axis forward scatter. (B) Immunohistochemistry of P8 CrxGFP 
retina with rod bipolar cell marker PKCα.  
Prom1  
The developmental pattern of the biggest cell population of the CrxGFP+ve cells (ie. the 
CrxGFP+ve cells with middle intensity, the rods) resembled the NrlGFP profile in terms of 
Prom1 expression (Figure 6.6 A vs Figure 6.4 I). Before maturation, all these rods are labelled 
by Prom1, although in the adult only a portion was Prom1+ve. Prom1 did not label the putative 
bipolar cells (ie. the weak CrxGFP+ve cells) but labelled all the putative cones (ie. the strong 
CrxGFP+ve cells) (Figure 6.6 A). Immunohistochemistry of Prom1 and cone arrestin confirmed 
that Prom1 indeed labelled the cones, specifically at the cone OS (Figure 6.6 A’), agreeing with 
previous finding that Prom1 colabels with another cone marker PNA (Supplemental figures in 
(Zacchigna, Oh et al. 2009)). This shows that Prom1 labelled all the NrlGFP or CrxGFP labelled 
rods and cones in postnatal stages.   
Prom1 also labelled many CrxGFP-ve cells early in development, but this percentage decreased 
as development proceeds and was negligible by adult stage (Figure 6.6 A), similar to the 
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pattern in NrlGFP (Figure 6.4 I). The percentage decrease of the Prom1+veGFP-ve cells 
corresponded to the increase of Prom1+veGFP+ve cells as if the Prom1+ve cells were shifting 
from GFP-ve to GFP+ve throughout development till all the Prom1+ve cells became GFP+ve in 
adult (Figure 6.6 A, Figure 6.4 I). Intriguingly, throughout postnatal development the 
percentage of Prom1 expressing cells in the retina was maintained between 70 – 80 % which 
roughly equals the total percentage of photoreceptor cells in adult retina (Figure 6.4 D, F; 
Figure 6.6 C, D). This suggests Prom1 may label a progenitor/precursor cell population which is 
destined to become photoreceptor cells even before they begin to express NrlGFP or CrxGFP.  
It is notable that at P20 when the photoreceptor cells were fully matured, Prom1 no longer 
labelled the bulk of rod photoreceptor cells in flow cytometry, although it still can label cones 
(Figure 6.6 A). Immunohistochemistry showed that Prom1 was expressed in the adults, but 
was specifically located at the bottom of rod OS and was just above the connecting cilium 
(Figure 6.6 A’, Chapter 5, Figure 5.4 and (Lakowski, Han et al. 2011)). As the connecting cilium 
is prone to damage, it is likely that these delicate structures were broken during the 
dissociation procedure resulting loss of rod OS and proteins around this region.   
Therefore, Prom1 seem to be a photoreceptor specific marker in retina. It not only labels the 
rods and cones from early embryonic development, but also the postnatal rods and cones. Its 
ability to label mature rods was decreased in flow cytometry analysis because of the 
dissociation procedure, but it is still able to label adult cones.  
CD24 
In contrast to Prom1, CD24 labelled all the putative bipolar cells (the median sized relatively 
low CrxGFP-expression population) as well as the CrxGFP-ve cells as shown on P8 (Figure 6.6 A). 
But it also labelled all the cones (the small tight high CrxGFP-expression population) and a 
small portion of rods at this stage. This agrees with the NrlGFP line in which by P10 CD24 
recognized a portion of the NrlGFP+ve cells and a portion of the NrlGFP-ve cells. Later CD24 is 
lost from photoreceptor cells.  
CD73 
CD73, on the other hand, did not label the CrxGFP-ve cells and only labelled the CrxGFP+ve 
cells throughout retinal development. For the CrxGFP+ve cells, CD73 did not label many of 
them at around birth ie only around 3% comparing to over 30% by Prom1 or CD24. But this 
percentage greatly increased to over 30% at P4 and to over 60% between P8 to P12, which 
then decreased to around 47% in matured retina. The majority of these cells were rods which 
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constantly showed high levels of CD73 throughout development. But the small sized high 
CrxGFP signal cells (ie. the possible cones) showed decreased CD73 levels at P20 although their 
CD73 levels were high between P4 to P12. Similar to Prom1, CD73 did not label the medium 
sized CrxGFP+ve cell population with weaker GFP signals (ie the possible bipolar cells). 
Therefore, CD73 seem to label relatively late stages of immature photoreceptor cells (including 
rods and cones) and mature rods, but not early stages of immature photoreceptor precursors 
and mature cones.  
Prom1 CD24 combination 
To find if a combination of these markers are more specific to isolate photoreceptor cells at 
particular developmental stages than single labelling, I combined staining of the CrxGFP retinal 
cells with these markers. Combined analysis of Prom1 and CD24 in the CrxGFP line showed 
that similar to the NrlGFP line there seem to be two cell populations (Figure 6.6 B). Most of the 
cells were positive for Prom1 throughout P0 to P12. About half of the Prom1+ve cells were also 
positive for CD24 between P0 to P8 and the other half was CD24-ve. The majority of the 
CD24+ve cells were Prom1+ve. The CD24+veProm1-ve cells contained about 70% CrxGFP+ve 
cells (likely to be bipolar cells) whereas the CD24-veProm1+ve cells contained 98% CrxGFP+ve 
cells around P8 (data not shown) indicating that CD24 has not labelled many photoreceptor 
cells and labelled more non-photoreceptor cells. The double positive cells (32 – 49% of total 
retinal cells between P0 and P8) although not forming a homogenous population, were mainly 
from the stage before P8. As both markers seemed also to enrich cones, this combination 
could be useful to select cones and rods which are born early.  
Prom1 CD73 combination 
Combined analysis of Prom1 and CD73 showed that these two markers seemed to show a 
rough linear relationship (Figure 6.6 B). Neonatal stages (P0 – P4) saw many Prom1+veCD73-ve 
cells but they seem to migrate into the double positive cells as more CD73 was expressed 
along development. The cells seemed to be relatively homogeneous double negative or double 
positive for both markers in particular between P8 and P12. Combining with the single 
labelling plot, the double negative cells were expected to be mainly GFP-ve cells and bipolar 
cells whereas the double positive cells (17 – 62% of total retinal cells between P4 and P20) 
should be rods and cones. Indeed, consistently 94 – 99% of the double positive cells were 
CrxGFP+ve throughout postnatal development (Figure 6.6 C). Therefore, the combination of 
these two markers seems to purely enrich photoreceptor precursor cells taking into account 
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that Prom1 eliminated the very mature photoreceptor cells and CD73 eliminated the very 
young photoreceptor cells.  
CD73 CD24 combination 
Double labelling with CD73 and CD24 showed that these two markers showed a much smaller 
percentage of overlap in comparison with the other two combinations (12 – 37% of total 
retinal cells between P4 and P8) (Figure 6.6 B). Around 90% of these double positive cells were 
also CrxGFP+ve between P0 and P8 (Figure 6.6 C). This combination, however, seems to 
particularly enrich retinal cells between P4 and P8.  
Prom1 CD24 CD73 combination 
Triple labelling of all three markers at P8 showed that over 98% triple positive cells express 
CrxGFP (Table 6.1). This is slightly lower than CD73 alone or in combination with Prom1 
(probably because of the unspecificity that CD24 brought in), but higher than any other single 
or double labelling. However, only one third of the CrxGFP cells can be triple labelled at P8 
(Table 6.1).  
Table 6.1 Percentage of Triple stain for P8 CrxGFP cells 
 
 
Expression stages 
I then directly compared the developmental profile of these markers with that of CrxGFP 
(Figure 6.6 D and C left). First of all, from all the live retinal cells, CrxGFP expression gradually 
increased from around 40% at P0 to around 90% at P20. CD73 largely resembled the trend of 
CrxGFP along development albeit was constantly 20 – 45% lower with a further 15% decrease 
from P12 to P20. However, at P0 when over 40% retinal cells already expressed CrxGFP, CD73 
barely labelled anything. CD24 showed an opposite trend of CrxGFP despite some fluctuations, 
with relatively high expression (40 – 70%) until P8 followed by a sharp decrease when it barely 
labelled any cells. Prom1 was also high at early stages, but the expression was maintained at 
around 70% from birth to P12 and dropped in mature retinal cells. Therefore when in 
combinations, CD24 and Prom1 enriched P0 – P8 cells, Prom1 and CD73 enriched P4 – P20 
CD24 CD73 Prom1 CD24Prom1 CD73Prom1 CD24CD73 CD24CD73Prom1
Specificity
% of CrxGFP from surface 
marker labelled cells 
(mean ± SD)
84.3±1.69 99±0.058 94.5±1.14 92.8±0.84 99.3±0.1 98.1±0.4 98.6±0.2
Efficiency
% of surface markers from 
CrxGFP labelled cells 
(mean ± SD)
56±13.9 73.5±2.17 81±0.31 39.1±11 70.9±1.15 31.5±9.85 33.0±8.18
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cells, whereas CD73 and CD24 (or triple staining of Prom1, CD73 and CD24) enriched P4 – P8 
cells (Figure 6.6 C, Table 6.1, and Figure 6.7).  
Specificity and efficiency  
I then assessed the specificity of these labelling in the CrxGFP line (Figure 6.6 C). Around 40 – 
50% CD24+ve cells expressed CrxGFP at P0 and P20, and around 70 – 80% between P4 to P12. 
Over 90% CD73+ve cells expressed CrxGFP throughout postnatal development. Although only 
around 40% Prom1+ve cells were CrxGFP+ve at P0, from P4 onwards over 80 – 90% Prom1+ve 
cells were CrxGFP+ve. Double labelling mostly showed higher specificity than single markers. 
Around 90% CD24+veProm1+ve cells were CrxGFP+ve between P4 and P8, although only 
around 60% were CrxGFP+ve at birth and after P12. Nearly all of the CD73+veProm1+ve cells 
were CrxGFP+ve throughout development. The CD73+veCD24+ve cells showed around 80 – 90% 
CrxGFP+ve cells from P0 to P8, but the percentage decreased thereafter.  
Therefore, single labelling with CD73 was highly specific and combination with Prom1 further 
enhanced the specificity. CD73 CD24 combination was also specific at early stages but the 
specificity decreased after P8 probably because of the low expression and low specificity that 
CD24 brought in. Single labelling with Prom1 was also specific except at early stages when 
CrxGFP expression was still low. Prom1 CD73 combination showed higher specificity than 
Prom1 alone but was in expense of loss of early born photoreceptor cells. Prom1 CD24 
combination showed slightly higher specificity than Prom1 alone at early stages but was lower 
than Prom1 alone at stages after P8. Single labelling of CD24 was much less specific than single 
labelling of Prom1 or CD73, but in combination with either of them showed higher specificity 
than CD24 alone. Triple labelling of CD73 CD24 and Prom1 was not more specific than CD73 
alone or double labelling of CD73 and Prom1, but was more specific than other single or 
double labelling (Table 6.1).   
The efficiency analysis shows that Prom1 is the most efficient surface markers among the 
three to isolate photoreceptor cells (Figure 6.6 C). CD73 was only relatively more efficient than 
Prom1 after maturation. CD24 was not a very efficient marker except when neonatal 
photoreceptor cells were desired. Combination of these markers greatly reduced efficiency 
comparing to single labelling, but Prom1+veCD73+ve was still highly efficient for isolation of P8 
photoreceptor cells.  
The expression of Prom1, CD73, and CD24 in relative to CrxGFP and their specificity and 
efficiency was illustrated as venn diagrams in Figure 6.6 E.  
165 
 
 
Figure 6.6 FCM analysis of Prom1, CD73 and CD24 in CrxGFP (continues). (A) Representative dot plot of Prom1, CD73, and 
CD24 labeled cells compared with CrxGFP expression at each developmental time point.  
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Figure 6.6 FCM analysis of Prom1, CD73 and CD24 in CrxGFP- continued. (A’) Immunohistochemistry of Prom1 (red) with Cone arrestin (green) in 6 – 8 wks wild type mouse retina. Hst, Hoechst 
33342; OS, outer segment; IS, inner segment; ONL, outer nuclear layer. Inserts: layout the OS and IS of a cone photoreceptor cell. Scale bars represent 25 µm.  
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Figure 6.6 FCM analysis 
of Prom1, CD73 and CD24 
in CrxGFP- continued. (B) 
Representative dot plot 
of combined analysis of 
Prom1, CD73, and CD24 
in CrxGFP cells at the 
indicated time point.  
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Figure 6.6 FCM analysis of Prom1, 
CD73 and CD24 in CrxGFP- 
continued. (C) Graph showing 
marker+ve percentage of retinal 
cells (left), marker specificity 
(middle), and marker efficiency 
(right) at the indicated time point; 
Error bar represent standard 
deviation of three independent 
sample preparation; (D) 
Expression trend line of the 
surface markers at the indicated 
time point in comparison with 
CrxGFP expression. (E) Venn 
diagram showing expression of 
the three markers relative to 
CrxGFP based on expression 
percentage at P0 (left) and P8 
(right).  
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6.2.4 Cell surface marker flow cytometry analysis summary 
In summary (Figure 6.7): 
 CD80 and CD276 showed very low or no expression in photoreceptor cells in flow 
cytometry analysis and may be used as negative markers.  
 CD83 showed unspecific low expression and may not be useful for selection.  
 CD73 specifically isolate photoreceptor cells from P4 onwards but not early rods and 
cones and mature cones.  
 CD24 labels early photoreceptor cells before P8 but is not specific as also labels the 
possible bipolar cells.  
 Prom1 specifically labels all photoreceptor cells (both rods and cones) in the retina and 
some Nrl/CrxGFP-ve cells during early embryonic development.  
 Prom1 CD73 combination or CD73 alone showed the highest specificity and was also 
relatively efficient in isolating photoreceptor cells among all single and combined 
labelling experiments (Figure 6.7, Table 6.1). This combination can isolate pure 
photoreceptor cells from retina from P4 onwards (Figure 6.7).  
 Prom1 CD24 combination is good to isolate rods and cones which are born early ie 
before P8 and is more specific than Prom1 or CD24 alone for this stage.  
 CD24 CD73 combination labels the fewest photoreceptor cells among all single and 
double labelling, but specifically isolates these cells between P4 to P8, an optimal 
developmental stage for transplantation competent rod precursors.  
 Triple staining of CD73, CD24 and Prom1 resembles that of CD24 CD73 combination 
albeit with less cells.  
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Figure 6.7 Surface marker flow cytometry summary. CD80 and CD276 showed no or very low expression in retinal 
cells in flow cytometry and may be used for negative selection. CD83 showed low unspecific expression for both 
photoreceptor cells and other retinal cells and is not useful. CD73, CD24, and Prom1 showed high expression in 
retina/photoreceptor cells and different developmental profiles. CD24 was high in early photoreceptor cells, 
CD73 was high in late photoreceptor cells, and Prom1 was high throughout photoreceptor development. The 
coloured shapes indicate percentage of total live retinal cells that express the markers (left, Expression in retina) 
or percentage of marker labelled cells that express CrxGFP (right, Specificity) at P0, P4, P8, P12, and P20.  
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6.2.5 Transplantation of photoreceptor precursor cells selected via CD73 and CD24 
Finally to examine if cell surface markers can isolate viable retinal cells for transplantation 
experiments, transplantation with cells sorted using CD73 and CD24 were tested. Postnatal 
day four retina cells which were double positive for CD73 and CD24 in FACS were injected into 
the subretinal space of adult wild-type recipients (performed by Rachael Pearson). The 
transplanted cells were tracked based on GFP expression of the NrlGFP or CbaGFP (which 
labels all retinal cells injected based on GFP expression under the control of a chicken β–actin 
promoter) mice. The CbaGFP line allows comparison of the transplantation efficiency between 
unsorted retinal cells vs cells sorted by NrlGFP or cell surface markers. Three weeks post 
transplantation the recipient eyes were collected and assessed (performed by Jorn Lakowski). 
Large numbers of the transplanted cells had migrated and correctly located into the recipient 
ONL. These cells showed the morphology of mature photoreceptor cells and also expressed 
mature photoreceptor cell markers such as recoverin, retinal guanylate cyclase (RetGC), and 
phosducin (Figure 6.8, experiments performed by J. Lakowski (Lakowski, Han et al. 2011)). In 
addition, the number of integrated cells sorted by CD73 and CD24 (median = 10,899, range 544 
– 32,826, n = 10) was two fold higher than the number of integrated cells sorted by NrlGFP 
(median = 4,649, range 1,953 – 8,206, n = 12) and around 18-fold higher than unsorted cells 
(median = 606, range 131 – 4,032, n = 15) (Figure 6.8, experiments performed by J. Lakowski 
(Lakowski, Han et al. 2011)).  
The same approach was then applied to mouse models of retinal degeneration to assess if 
integration can also be achieved. Transplanting into a degenerating environment is more 
challenging because of the worsened physiological and structural changes in the eye. The 
Prph2rd2/rd2 (Rds) mutant mice and the Crb1rd8/rd8   (Crb1) mutant mice were used. The Rds 
mouse is homozygous for a null mutation in the Prph2 gene and represents a slow rod 
degeneration model LCA. In this model, photoreceptor cells lack the disk structures of outer 
segments and contain reduced amounts of rhodopsin. The Crb1 mutant mice contain a single 
base pair deletion in the Crb1 gene. In this model, the OLM is compromised and retinitis 
pigmentosa and LCA may eventually occur. Similar to transplantation to wild-type recipients 
above, I analysed the degenerating mouse eyes which were collected three weeks after 
transplantation. Rod precursors isolated by CD73CD24 expression clearly integrated into the 
ONL of both Rds (median = 4,406, range 0 – 25,742, n = 8) and Crb1 (median = 1,008, range 
876 – 3,284, n = 4) retina. The Rds mice seem to be quite varied in the number of integrated 
cells (Figure 6.9). Both mutant mice did not show higher integration than the wild type (Figure 
6.9 E).   
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Figure 6.8 Transplantation of CD73 and CD24 sorted cells into wildtype mice. (A – C’’) Confocal Z-projections of 
integrated NrlGFP+ve cells 3 wks after transplantation showing expression of photoreceptor markers recoverin 
(A’), RetGC (B’), and phosducin (C’). (D) CD73 and CD24 sorted cells integrate more efficiently than NrlGFP sorted 
or unsorted cells. Mann-Whitney, p < .05 ((Lakowski, Han et al. 2011) Experiments performed by Lakowski). 
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Figure 6.9 Transplantation of CD73 
and CD24 sorted cells into mutant 
mice. (A – D) Images of CD73CD24 
double-sorted P4 NrlGFP cells 
transplanted into 6-8wks Prph2
rd2/rd2 
(Rds) mutant mice; (A – C) are 
confocal Z-projections, (D) is normal 
microscope image; (E) comparison of 
the total number of integrated P4 
NrlGFP cells in mutant (Rds and Crb1) 
and wild-type recipient retina.   
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6.3 Discussion 
Here six cell surface molecules were tested for their ability to isolate photoreceptor cells. 
Three of them CD80, CD83, CD276 could not enrich photoreceptor cells. CD73 efficiently 
enriched rod photoreceptor cells from retina of late postnatal stages onwards. CD24, although 
not as specific as CD73, only enriched immature photoreceptor cells of early stages and is 
turned off after P10. CD73 CD24 combination, therefore, delineated a narrow window of the 
precursor stage (P4 – P8) from which transplanted cells showed high integration efficiency 
(MacLaren, Pearson et al. 2006). Our transplantation experiments further confirmed that cells 
isolated by this combination are viable and can integrate into the host ONL (either wild type or 
degenerated retina) and mature normally. These experiments prove the concept of using cell 
surface markers to isolate donor cells for retinal transplantations and future experiments will 
test the integration efficiency of cell populations isolated using different marker combinations.  
Prom1 is the 3rd surface marker which I found can efficiently enrich both cones and rods with 
high specificity in flow cytometry. Constantly around 70% of total mouse retinal cells can be 
labelled by Prom1 before P10, agreeing with a magnetic automated cell sorting (MACS) 
analysis where at least 67% of total human retinal cells can be isolated by Prom1 (Carter, Dick 
et al. 2009). Initially suggested as a marker for hematopoietic stem/progenitor cells (Yin, 
Miraglia et al. 1997), Prom1 is found to be expressed mainly in neuroepithelium and some 
embryonic and adult epithelia (Weigmann, Corbeil et al. 1997). It was also reported to label 
around 3% cells of neural or oligodendrocyte progenitor potential in fetal human brain 
dissociates (Uchida, Buck et al. 2000; Wang, O'Bara et al. 2013) as well as some cancer cells (Li, 
Liu et al. 2010; Wang, Chadalavada et al. 2010; Nishida, Hirohashi et al. 2012; Ji, Greening et al. 
2013; Walker, Wierick et al. 2013). IHC analysis in adult mouse retina showed that Prom1 
specifically labels photoreceptor cells (Chapter 5, Figure 5.4) agreeing with previous confocal 
and electron images (Yang, Chen et al. 2008; Zacchigna, Oh et al. 2009). Therefore if cells were 
only isolated from retina, using Prom1 alone may be enough and both rods and cones could be 
enriched. However, when in the context of in vitro differentiated stem cells, combination with 
CD73 and/or CD24 will be necessary. The combination of Prom1 with CD73 further enhanced 
the specificity to all rods, combination of Prom1 with CD24 might be useful to isolate rods and 
in particular cones of prenatal and early postnatal stages, and combination of all three may 
reduce contamination from other types of progenitor or differentiated cells from stem cell 
cultures. 
It is interesting to note that when isolating the gradually maturing photoreceptor cells, CD73 
showed a clear homogeneous level of expression as seen by the round tight cell cluster on the 
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scatter plot whereas Prom1 showed a continuous gradient level of expression. This is possibly 
due to the different localization of Prom1 and CD73 in matured photoreceptor cells. While 
Prom1 was mainly located at the cilium region which could be sheared during dissociation, 
CD73 was expressed mainly on the cell bodies and could be more robust to dissociation.  
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7 Proteomic study of rod precursors and other retinal cells at P4 
7.1 Introduction 
To complement the transcriptome analysis described in Chapter 3, I am interested in directly 
finding out proteins which are highly expressed on the surface of photoreceptor precursor 
cells. This was considered potentially useful as transcripts identified from microarray do not 
always lead to coincident high levels of protein. One method is the proteomic approach which 
identifies individual proteins from protein mixtures by mass mapping and peptide sequencing. 
Because most cell surface proteins are hydrophobic and not suitable for gel-based analysis, a 
technique that couples a mass spectrometer with a liquid chromatography (LC) interface, 
ElectroSpray Ionisation – Quadrupole-Time-of-Flight Mass Spectrometry (ESI-QTOF MS) were 
used. Combination of the electrospray ionisation source with LC also gives greater separation 
of the peptides before they enter the mass spectrometer and reduced effects of ion 
suppression by salts and other co-eluting molecules, thereby providing more accurate 
molecule identification and sequence coverage.  
7.2 Results 
7.2.1 Mass spectrometry of NrlGFP positive population: whole cell vs. membrane 
extraction 
Ideally MS will provide a high-throughput mapping of all the protein candidates from the cell 
lysates. In reality, proteins with lower abundance could be masked by highly abundant 
proteins and cannot be detected. Therefore, I tested if fractionation of the cells by enriching 
the membrane-associated proteins using a membrane protein extraction kit (see section 2.7) 
will improve the number of membrane and cell surface proteins identified.   
Similar to the microarray, I FACS sorted GFP positive versus negative P4 cells from NrlGFP 
mouse retina. Whole cell lysates (prepared by Dr Lakowski) and membrane-enriched proteins 
were separately prepared and submitted for MS analysis. A total of 366 proteins comparing 
with all species were reported for the whole cell lysates of photoreceptor cells, of which 27 are 
known mouse proteins (Appendix Table 7.1, mouse proteins are above the black line on 1st 
page of the table). In contrast, 60 mouse proteins were identified for the membrane fractions 
of photoreceptor cells (Appendix Table 7.2 A). 12 mouse proteins overlap between whole cell 
lysates and the membrane fractions (yellow highlighted in Appendix Table 7.1). All the proteins 
identified by both methods for photoreceptor cells were then submitted to DAVID functional 
chart and their Cellular Component GO terms were analysed. All GO terms with a Benjaminin 
value (a type of modified p value) smaller than 0.05 were compared between the whole cell 
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lysates (red) and the membrane fraction of photoreceptor cells (green) (Figure 7.1). Many GO 
terms appeared in both protein lists, and for these GO terms there were always more proteins 
in the membrane fractionation than the whole cell lysates either by comparing absolute 
protein numbers (dark colours) or the percentage of these proteins of the whole input lists 
(light colours). There were also GO terms that only appeared in the whole cell lysates, but 
these were mainly chromatin or nucleosome proteins. As expected, there were more proteins 
for the membrane-related GO terms in the membrane fraction than the whole cell extraction 
(comparing both absolute protein numbers and percentage). In addition, several GO terms 
which are related to cell surface molecules or membranes including cell projection, 
membrane-bounded vesicle and vesicle only appeared in the membrane fractionated proteins 
and not the whole cell extracted proteins. This shows that enriching the membrane fraction 
from the cells indeed enabled us to identify relatively more cell surface molecules or 
membrane proteins than from the whole cell extraction.  
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Figure 7.1 Cellular component analysis of P4 NrlGFP+ve cell proteomics: whole cell lysates versus membrane 
fraction. Red, whole cell lysates; Green, membrane fraction. X-axis: dark colour, percentage of proteins 
annotated under each GO term; light colour, absolute numbers of proteins annotated under each GO term. Note 
each protein can be annotated by more than one functional annotation term. Y-axis, GO terms. 
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7.2.2 Mass spectrometry of membrane fraction of NrlGFP positive vs. negative 
I then went on to examine for the enriched membrane proteins if there are any differences 
between the photoreceptor precursor cells and other retinal cells. To do this, I compared the 
Cellular Component GO terms of the MS results of the membrane fractions of the P4 NrlGFP 
positive and negative cells (Figure 7.2 A and B, Appendix Table 7.2). 16 GO terms which are 
related with intracellular proteins were present in both NrlGFP positive and negative 
populations, and similar numbers of proteins for these terms were being enriched for both cell 
populations (Figure 7.2 A and B right of the dashed line; Figure 7.2 C). 12 GO terms were found 
only in the photoreceptor precursor population (Figure 7.2 C, GO terms in green). 9 out of the 
12 GO terms are membrane-related, such as cell projection, cytoplasmic membrane-bounded 
vesicle, membrane-bounded organelles, membrane-bounded vesicle etc (Figure 7.2 A, left of 
the dashed line). The term “cell projection” enriched the fewest proteins of the 9 GO terms (8 
proteins vs 36 proteins in “membrane-bounded organelles”) (Figure 7.2 C). In contrast, 7 GO 
terms were found only in the negative population which are mainly chromatin, nucleosome, 
protein-DNA complex, and only one membrane related GO term was enriched which is 
organelle inner membrane (Figure 7.2 B, left of the dashed line; Figure 7.2 C, GO terms in blue). 
This shows that there are more membrane proteins in the photoreceptor precursor cells than 
other retinal cells after membrane fractionation of both cell types.  
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Figure 7.2 Cellular component analysis of membrane proteomics of P4 NrlGFP sorted cells (A) P4 NrlGFP+ve cells 
(B) P4 NrlGFP-ve cells. Dark colour, percentage of proteins annotated under each GO term; light colour, absolute 
numbers of proteins annotated under each GO term. X-axis, GO terms. The dashed line separate the cell-specific 
GO terms (left) from the common GO terms (right); (C) Direct comparison of the cellular component GO terms for 
P4 NrlGFP+ve cells and NrlGFP-ve cells. Green indicates terms only appeared in the photoreceptor precursors and 
blue indicates terms only appeared in other retinal cells. 
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7.2.3 Repeats of membrane fractionation for MS of NrlGFP positive vs. negative 
Our initial trial of ESI-QTOF MS with membrane preparations of sorted retinal cells seems 
indeed to enrich some membrane proteins, although the total number of proteins identified 
was low (60 for rod photoreceptor cells and 39 for non-rod retinal cells) (Run 1, Appendix 
Table 7.2). To confirm the repeatability of the method as well as to see if more cell surface 
proteins could be identified, I performed another run of MS with new FACS sorted retinal cells. 
Membrane proteins of the new sorted cells were again extracted using the same Pierce Mem-
Per kit as before. This time two different precipitation reagents were used, acetone as before 
and also chloroform as the latter is better to remove fat tissues. Using chloroform 31 proteins 
were detected for rods and 34 for non-rod retinal cells (Run 2, Appendix Table 7.3). Using 
acetone 47 proteins were detected for rods and 32 for non-rod retinal cells (Run 3, Appendix 
Table 7.4).  
Comparison of the three runs for the rods shows that while six proteins were common in the 
1st and 3rd run, only two and three proteins were common between the 2nd and 1st, 3rd run 
(Figure 7.3). This suggests that the precipitation method indeed affects the number of proteins 
enriched and that acetone is better to precipitate photoreceptor membrane proteins than 
chloroform. Numbers of proteins identified in non-rod retinal cells were comparable between 
all three runs (Figure 7.3).  
 As common proteins between different runs are probably the most robust proteins present in 
the cells, I examined what these proteins are. There were 13 proteins found to be common in 
at least two runs for the photoreceptor cells, of which lamin B1 (Lmnb1) and heterogeneous 
nuclear ribonucleoproteins A2/B1 (Hnrnpa2b1) could be detected in all three runs (Table 7.1). 
These two proteins were also common proteins found in the non-rod retinal cells. Of the 
remaining 11 common proteins, six proteins were also present in the non-rod retinal cells. 
These include HnrnpK, Voltage dependent anion selective channel protein 1 (Vdac1), Tubulin 
beta 5 chain (Tubb5), Tubb2c, Myristoylated alanine rich C kinase substrate (Marcks), and ATP 
synthase subunit beta mitochondrial (Atp5b). These proteins, although not specific to 
photoreceptor cells, might be important for the development of the whole retina. Five 
proteins were specific to photoreceptor cells from the common proteins, of which Sodium 
potassium transporting ATPase subunit alpha 3 (Atp1a3), Sodium potassium transporting 
ATPase subunit beta 2 (Atp1b2), and Alpha enolase (Eno1) were interesting candidates which 
will be discussed further in the next section.  
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A total of 15 common proteins were found in at least two runs for the non-rod retinal cells 
(Table 7.1). Other than the above mentioned eight proteins which were present in both rod 
and non-rod retinal cells, the remaining proteins were three tubulin chains, one phosphate 
dehydrogenase, one histone protein, one heterogeneous nuclear ribonucleoprotein, and Brain 
acid soluble protein 1 (Basp1) which will also be further discussed below.  
 
 
Figure 7.3 Comparison of three Mass Spectrometry runs of membrane fraction from FAC-sorted retinal cells. 
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Table 7.1 Common proteins from three runs of Mass Spectrometry 
 
 
 
 
 
Run 1 Run 2 Run 3 Run 1 Run 2 Run 3
Lamin B1 31.5536 1.7757 21.4516 Histone H4 113.2583 1.201 10.2123
Heterogeneous nuclear ribonucleoproteins A2/B1 25.3172 0 0 Voltage dependent anion selective channel protein 1 11.4354 9.4427 53.8539
Lamin B1 20.2837 19.1796 79.612
ATP synthase subunit beta mitochondrial 12.2702 4.7696 37.1476
Heterogeneous nuclear ribonucleoprotein K 33.4423 1.1821 Glyceraldehyde 3 phosphate dehydrogenase 235.7324 2.0879
Voltage dependent anion selective channel protein 1 20.6201 2.11 Tubulin beta 5 chain 166.0173 1.0231
Sodium potassium transporting ATPase subunit alpha 3 1.022 11.2294 Tubulin beta 2B chain 2.2063 2.7463
Beta actin like protein 2 0 0 Tubulin alpha 1C chain 186.3768 4.4704
Sodium potassium transporting ATPase subunit beta 2 0 10.6499  Brain acid soluble protein 1 4.2734 0.8403
Tubulin beta 5 chain 130.4988 0 Myristoylated alanine rich C kinase substrate 10.3172 4.1355
Tubulin beta 2C chain 24.1877 6.808 Heterogeneous nuclear ribonucleoprotein K 25.4271 4.8244
Creatine kinase B type 72.1535 5.5526 Heterogeneous nuclear ribonucleoproteins A2/B1 3.2446 23.2192
Alpha enolase 54.6878 1.1967 Heterogeneous nuclear ribonucleoprotein H 2.9709 43.4083
Myristoylated alanine rich C kinase substrate 18.29 1.3756 Tubulin beta 2C chain 15.8904 0
ATP synthase subunit beta mitochondrial 11.4701 7.2057 Tubulin alpha 1A chain 28.1914 29.374
Common in 2 of the 3 runs (11) Common in 2 of the 3 runs (11)
Proteins in photoreceptor cells
Amount (fmoles)
Proteins in other retinal cells
Amount (fmoles)
Common in all 3 runs (2) Common in all 3 runs (4)
Red indicates common proteins found in both photoreceptor cells and other retinal cells. 
Of these proteins, Voltage dependent anion selective channel protein 1 (Vdac1), Sodium potassium transporting ATPase subunit alpha 3 (Atp1a3), Sodium 
potassium transporting ATPase subunit beta 2 (Atp1b2) and Myristoylated alanine rich C kinase substrate (Marcks) are regarded as plasma membrane proteins. 
Red indicates common proteins found in both photoreceptor cells and other retinal cells. 
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7.2.4 Marker candidates from MS of NrlGFP positive vs. negative membrane fractions 
To assess whether any of these proteins are cell surface molecules, I merged the three runs of 
MS of the membrane fractions from the P4 NrlGFP positive and negative cells to give a total of 
123 proteins in P4 NrlGFP positive population and 86 proteins in negative population (Table 
7.2 A). To find out which of these proteins could be possible cell surface molecules, all the 
candidates were examined individually in Mouse Genome Informatics (MGI) 
(http://www.informatics.jax.org/) and UniProt Knowledgebase (http://www.uniprot.org/). As 
for searches of the microarray data as there are no specific annotation terms for cell surface 
proteins, I screened for plasma membrane proteins using the following criteria: proteins which 
are membrane-bound but annotated as located in the intracellular membrane system, such as 
cytoskeleton, nuclear envelope, and subcellular organelles (eg. endoplasmic reticulum, 
microtube, mitochondria, Golgi body, lysosome/vacuole etc) were not considered as surface 
proteins. Proteins which are annotated as located on plasma membranes, or annotated with 
extracellular or cell surface GO terms such as “plasma membrane”, “cell projection”, 
“secreted”, “cell membrane” etc were considered as plasma membrane proteins. Plasma 
membrane proteins identified in this way from each run of the MS were labelled red in 
Appendix Tables 7.2, 7.3, and 7.4. A total of 15 and 9 plasma membrane proteins were 
identified for the rods and non-rod retinal cells respectively (Table 7.2 A and B). Among them, 
four proteins could be detected in both rods and non-rod retinal cells (Table 7.2 B). All the 
plasma membrane proteins were further examined in the database to assess if they contain 
extracellular domains. Plasma membrane proteins whose domain structures were not 
annotated in the databases were also examined using transmembrane domain prediction 
software Tmhmm and MEMSAT, and signal peptide prediction software Signal P. Transcript 
levels of these genes from the Swaroop array and NrlGFP P4 array as well as the molecular 
function and biological process GO terms that these proteins are annotated were also 
examined. Interesting candidates from these examinations are presented in Table 7.3.  
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Table 7.2 Plasma membrane proteins from Mass Spectrometry  
 
 
 
 
  
rods other cells
protein No. protein No. protein No. % of total protein No. % of total
1st run 60 39 8 13.33333 6 15.384615
2nd run 31 34 7 22.58065 3 8.8235294
3rd run 47 32 5 10.6383 4 12.5
Total 123 86 15 12.19512 9 10.465116
Total proteins Plasma membrane proteins
rods other cellsA
rods alone (11) common (4) others alone (5)
Fabp7 Eno1 Serpina3k
Eno2 Marcks Ntsr1
Rab10 Basp1 Syn1
Rab8a Vdac1 Stxbp1
Atp1a1 Slc2a1
Atp1a3
Atp1a2
Atp1b2
V2Rp5
V2Rp2
Plasma membrane proteinsB
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Table 7.3 Surface marker candidates from Mass Spectrometry.  
 
Protein domains/location Extracellular 
domain
E16-P28 NrlGFP P4 NrlGFP +vs- positive negative
BASP1 
family
Brain acid 
soluble 
protein 1
Basp1 negative regulation of gene-
specific transcription, cytoplasm, 
growth cone, nuclear speck, 
plasma membrane, promoter 
binding, specific transcriptional 
repressor activity, transcription 
corepressor activity 
high from E16 to P10  
(log2 around 13),  
decrease at P28 
(log2 around 11).
2-fold higher in 
negative cells 
(log2 at 9.2 and 
10.2)
5.3663 4.2734 Tmhmm: no TMHs; 
MEMSAT:(in) 110-127; 
Signal P: no signal peptide, 
non-secretory protein
Alpha-enolase Eno1 glycolysis, phosphopyruvate 
hydratase complex, plasma 
membrane, magnesium ion 
binding, phosphopyruvate 
hydratase activity, protein binding
low from E16 to P10 
(log2 around 6), 
increase at P28 
(log2 at 10)
2-fold higher in 
negative cells 
(log2 at 11.6 and 
12.6)
54.6878 56.9848 Tmhmm: no TMHs, mainly 
outside; MEMSAT:(in) 106-
124; Signal P: no signal 
peptide, non-secretory 
protein
Gamma-
enolase
Eno2 glycolysis, perikaryon, 
phosphopyruvate hydratase 
complex, photoreceptor inner 
segment, plasma membrane, 
magnesium ion binding, 
phosphopyruvate hydratase 
activity
high at E16 (log2 at 
12.2), decreased at 
P2 (log2 at 11), but 
increased from P6 
to P28 (log2 range 
11.3 – 13.5)
3-fold higher in 
positive cells (log2 
at  9.8 and 8.2)
10.4937 N/A Tmhmm: no TMHs, mainly 
outside; MEMSAT: (in) 106-
124; Signal P: no signal 
peptide, non-secretory 
protein
MARCKS 
family
Myristoylated 
alanine-rich C-
kinase 
substrate
Marcks cell cortex, centrosome, germinal 
vesicle, membrane, actin binding, 
calmodulin binding, protein kinase 
C binding
high in E16 to P6 
and decreased in 
P10 and P28 (from 
13.2 – 11.7)
1.7-fold higher in 
negative cells 
(log2 at 11.3 and 
12.1)
18.29 10.3172 Tmhmm: no TMHs, mainly 
outside; MEMSAT:(out) 275-
291; Signal P: no signal 
peptide, non-secretory 
protein
eukaryotic 
mitochondri
al porin 
family
Voltage-
dependent 
anion-
selective 
channel 
protein 1
Vdac1 anion transport, apoptosis, 
behavioral fear response, learning, 
nerve-nerve synaptic transmission, 
transmembrane transport, plasma 
membrane, pore complex, 
nucleotide binding, voltage-gated 
anion channel activity
N/A N/A 20.6201 53.8539 Multi-pass membrane 
protein locates on plasma 
membrane, mainly 
transmembrane beta 
stranded; Tmhmm: no 
TMHs: MEMSAT: (out) 255-
276; Signal P: signal peptide 
cleavage site 21-22
yes
calycin 
superfamily, 
Fatty-acid 
binding 
protein 
family
Fatty acid-
binding 
protein, brain
Fabp7 cell proliferation in forebrain, 
neurogenesis, prepulse inhibition, 
transport, cell projection, 
cytoplasm, neuronal cell body, 
lipid binding, transporter activity
high from E16 to P6 
(log2 around 12), 
decreased at P10 
(log2 at 9), very low 
at P28 (log2 at 2)
1.37-fold higher in 
positive cells (log2 
at 10.9 and 10.5)
17.6197 N/A Tmhmm: no TMHs; 
MEMSAT: (out) 23-43; Signal 
P: no signal peptide, non-
secretory protein
Ras-related 
protein Rab-
8A
Rab8a protein transport, small GTPase 
mediated signal transduction, 
plasma membrane, GTP binding, 
protein binding
N/A N/A 1.3939 N/A Tmhmm: no TMHs; 
MEMSAT: (out) 7-26; Signal 
P: no signal peptide, non-
secretory protein
Ras-related 
protein Rab-10
Rab10 intracellular protein transport, 
small GTPase mediated signal 
transduction, Golgi apparatus, 
plasma membrane, GTP binding, 
protein binding
N/A 1.42-fold higher in 
negative cells 
(log2 at 9.85 and 
10.35)
3.2215 N/A Tmhmm: no TMHs; 
MEMSAT: (out) 8-27; Signal 
P: conatin signal peptide 
cleavage site between 
residual 23 and 24, non-
secretory protein
Sodium 
potassium 
transporting 
ATPase 
subunit alpha 
3
Atp1a3 basolateral plasma membrane,  
regulation of glucocorticoid 
biosynthetic process, blood 
pressure and the force of heart 
contraction, sodium:potassium-
exchanging ATPase activity
N/A 3.18-fold higher in 
positive cells (log2 
at 12.4 and 10.6)
11.2294 N/A 4 to 5 extracellular 
domains; Tmhmm: 8 TMHs; 
MEMSAT: 8 TMHs; Signal P: 
no signal peptide
yes
Sodium 
potassium 
transporting 
ATPase 
subunit beta 2 
Atp1b2 cytoplasm, cell adhesion, 
sodium:potassium-exchanging 
ATPase activity
N/A 4.35-fold higher in 
positive cells (log2 
at 12.5 and 10.3)
10.6499 N/A 1 extracellular domain (aa. 
68 -290); Tmhmm: 1TMHs; 
MEMSAT: 1TMHs; Signal P: 
no signal peptide
yes
G-protein 
coupled 
receptor 1 
family
Neurotensin 
receptor type 
1
Ntsr1 G-protein coupled receptor protein 
signaling pathway, adult 
locomotory behavior, signal 
transduction, integral to 
membrane, plasma membrane, 
neurotensin receptor activity, G-
protein coupled
N/A N/A N/A 44.2043 Cell membrane, four 
extracellular domains (aa. 1-
64, 122-143, 211-235, 331-
348), Tmhmm: 7 TMHs, 
Signal P: no signal peptide, 
non-secretory protein
yes
serpin 
family
Serine 
protease 
inhibitor A3K / 
Contrapsin / 
SPI-2
Serpina3
k / Mcm2 
/ Spi2
response to cytokine stimulus and 
peptide hormone stimulus, 
extracellular region, serine-type 
endopeptidase inhibitor activity
N/A N/A N/A 16.5039 Tmhmm: no TMHs; 
MEMSAT: 1: (in) 7-23, 2: 72-
90; Signal P: contain signal 
peptide cleavage site 21-22; 
The  serpin-protease 
complex is covalently 
bound and  highly stable 
synapsin 
family
Synapsin 1 Syn1 presynaptic active zone, synaptic 
vesicle membrane, 
neurotransmitter secretion
N/A 1.64-fold higher in 
negative cells 
(log2 at 7.5 and 
8.2)
N/A 68.2297 Tmhmm: no TMHs; 
MEMSAT: no TMHs; Signal 
P: no signal peptide
Sugar 
transporter 
family, 
Glucose 
transporter 
subfamily
Solute carrier 
family 2 
facilitated 
glucose 
transporter 
member 1
Slc2a1 basolateral plasma membrane, 
cytoplasm, cellular response to 
glucose starvation, 
dehydroascorbic acid transporter 
activity, D-glucose transmembrane 
transporter activity
N/A 1.48-fold higher in 
negative cells 
(log2 at 5.7 and 
6.2)
N/A 12.0599 6 extracellular domains; 
Tmhmm: 12 TMHs; 
MEMSAT: 12 TMHs; Signal P: 
no signal peptide
yes
NrlGFP microarray  (Fold change and 
log2 intensity)
NrlGFP MassSpec (P4, 
fmoles)
Sodium 
potassium 
transporting 
ATPase 
subunit
enolase 
family
small 
GTPase 
superfamily, 
Rab family
Family Protein Gene Gene ontology
Tmhmm and MEMSAT are protein transmembrane 
helix prediction program, Signal P is signal peptide 
prediction program. TMH: transmembrane helix 
E16-P28 NrlGFP data from Swaroop array. 
P4 NrlGFP +vs- (ie GFP+ve versus GFP-ve) 
data from Lakowski. 
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7.2.4.1 Plasma membrane proteins identified in both populations 
The four plasma membrane proteins identified from the in silico analysis in rod and non-rod 
populations are Vdac1, Marcks, Basp1, and Eno1. The protein expression levels of Basp1 and 
Eno1 are largely similar between the positive and negative population (Table 7.3). Transcript 
levels of Basp1 and Eno1 were higher in the non-rod retinal cells than rods (Table 7.3). Despite 
this, both genes showed high transcript levels and interesting expression profiles in the rods 
during retinal development. While Basp1 was high in early rod development from E16 to P10 
and decreased in the adult at P28, Eno1 was low between E16 to P10 but increased at P28 
(Appendix Figure 7.1). This indicates that although both proteins may not be specific for rods, 
they may still be involved for rod development at different stages. However, my in silico 
analysis suggests that they do not contain any extracellular domains.  
Marcks showed 1.8-fold higher protein levels in rod photoreceptor cells than the non-rod 
retina cells according to MS (Table 7.3). However, transcript level of Marcks was slightly higher 
in the non-rod retinal cells although its level was also high in the rods from the microarrays 
(Table 7.3). As rod development proceeds, Marcks expression gradually decreased (Appendix 
Figure 7.1) indicating down regulation as the retina matures. Although this protein is described 
as being located on the membrane and may contain a lipid-anchor, being the substrate for 
protein kinase C (Herget, Oehrlein et al. 1995) this protein is more likely to be intracellular 
than extracellular and I didn’t find any evidence suggesting extracellular domains.  
Vdac1 showed high proteins levels from the MS, but its transcript was not detected in the 
microarrays. There are two isoforms for the multi-pass membrane channel protein Vdac1. 
Mitochondrial VDAC-1 (Mt-Vdac1) locates on mitochondrion outer membrane while 
plasmalemmal VDAC-1 (Pl-Vdac1) locates on plasma membrane (Buettner, Papoutsoglou et al. 
2000). Pl-Vdac1 has confirmed extracellular domains. Pl-Vdac1-transfected cells exhibited 
higher rates of ATP release than control groups in response to medium change (Okada, O'Neal 
et al. 2004). On the other hand, cells from the Vdac1 knock out mice released less ATP and 
showed slower regulatory volume decrease after luminal hypotonic challenged cell volume 
increase than wild type cells (Okada, O'Neal et al. 2004). This shows that Vdac1 is associated 
with ATP release which is highly relevant for the high-energy-demanding photoreceptor cells. 
Although there is no information about it in retina yet, Vdac1 could be an interesting protein 
to study. 
These proteins were detected in both rods and non-rod retinal cells, hence are less likely to be 
specific for rods. However because of their higher abundance, they might be important for rod 
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development. Among them only Vdac1 was confirmed to have extracellular domains and could 
possibly be used as a cell surface marker.  
7.2.4.2 Plasma membrane proteins identified only in NrlGFP positive population 
11 plasma membrane proteins were identified to exist only in rod precursor cells and not in 
other retinal cells. These include Gamma-enolase (Eno2), brain Fatty acid-binding protein 
(Fabp7), two Ras-related proteins Rab8a and Rab10, four subunits of sodium potassium 
transporting ATPase alpha 1 (Atp1a1), alpha 2 (Atp1a2), alpha 3 (Atp1a3) and beta 2 (Atp1b2), 
and two Vomeronasal 2 receptors V2Rp5 and V2Rp2. The vomeronasal receptor V2Rp5 and 
V2Rp2 were expressed at very low levels from the MS (less than 2 fmoles, Appendix Table 7.3). 
Although being inferred to locate on plasma membrane and predicted to have extracellular 
domains and signal peptides according to Tmhmm, MEMSAT and Signal P (data not shown), 
little is known about these two proteins other than a role in female mouse sexual receptive 
behaviour (Haga, Hattori et al. 2010).   
10 fmoles Eno2 protein was detected in NrlGFP-positive cells by MS and the transcript levels 
were three fold higher than non-rod retinal cells (Table 7.3). During development Eno2 
transcript level was high at E16 (log2 intensity 12), but decreased at P2 (log2 intensity 11) from 
which transcription gradually increased again (log2 intensity 11 – 13.5) (Appendix Figure 7.1). 
Nrl KO mice showed a similar trend of increase but with higher transcripts levels than wild type 
mice from P2 onwards (log2 intensity 11.8 – 13.8) and lower levels at E16 (Appendix Figure 
7.1). In Zebrafish, endogenous Eno2 mRNA was detected in the developing retina from 2dpf 
and by 12dpf it localized to the retinal ganglion cell, inner and outer nuclear layers including 
rods (Bai, Garver et al. 2007; Bai, Wei et al. 2009). This indicates that Eno2 is probably involved 
in rod development. Then I examined if Eno2 contains any cell surface domains. Although 
Tmhmm and Signal P predicted it did not contain transmembrane helixes (TMHs), extracellular 
domains, or signal peptides, MEMSAT predicted a TMH at residual 106 –124 and an 
extracellular domain. It is also predicted to translocate to the plasma membrane when forming 
dimmers by computational similarity, but there is no experimental data in mammalians yet. It 
is found that the enolase of S. cerevisiae (Lopez-Villar, Monteoliva et al. 2006) and some 
prokaryotic microorganism locates on the cell surface (Bernal, de la Rubia et al. 2004; 
Schaumburg, Diekmann et al. 2004). This protein, therefore, remains an interesting surface 
molecule candidate for photoreceptor cells. Of particular note, antibodies to a neuron-specific 
enolase were found to preferentially label cones (Rich, Zhan et al. 1997).  
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18 fmole Fabp7 protein was detected in the NrlGFP positive cells by MS and the transcript 
levels were slightly higher in rod precursor cells than non-rod retinal cells in microarray (Table 
7.3). With gradually a slight decrease, Fabp7 transcripts levels remain high from E16 to P6 
(log2 intensity around 12), but decreased clearly at P10 (log2 intensity 9) and dramatically at 
P28 (log2 intensity 2) (Appendix Figure 7.1). When Nrl was knocked out, Fabp7 transcript levels 
increased at all time points tested especially at P28 where log2 intensity increased from 2 to 
12 (Appendix Figure 7.1). During chick retina genesis, protein levels of Fabp7 also showed 
three fold decrease from E12 to P33 by ESI-MS (Finnegan, Robson et al. 2008). These clearly 
show that Fabp7 could be highly involved in photoreceptor development. However, there was 
no evidence of extracellular domains for Fabp7 except a transmembrane helix (residual 23-43) 
predicted by MEMSAT. 
Two members of the Rab family, Rab10 and Rab8a, were also found to be present exclusively 
in the NrlGFP positive cells, although the expression levels were low (3 fmole and 1 fmole 
respectively) (Table 7.3). Rab10 was predicted to have a transmembrane helix (residual 8-27) 
and a signal peptide with a possible cleavage site between residual 23 and 24 by MEMSAT and 
Signal P. It is a member of RAS oncogene family, involved in transport, small GTPase mediated 
signal transduction, membrane nucleotide binding, protein binding, and GTP binding. Rab8a 
was predicted to have a transmembrane helix (residual 7-26) and no signal peptides. It 
interacts with Myo5c tubules (Jacobs, Weigert et al. 2009) and EHD1 which regulates 
endocytosis and associates with tubular membranes to facilitate recycling (Sharma, Giridharan 
et al. 2009). Rab8a and Rab8b are essential for ciliary trafficking and their knockouts in 
addition with Rab10 knockdown greatly affected ciliogenesis (Sato, Iwano et al. 2013). Without 
confirmed extracellular domains, these two proteins could not serve as cell surface molecules.  
Four subunits of the sodium potassium transporting ATPase Atp1a1, Atp1a2, Atp1a3 and 
Atp1b2 were exclusively found in the rod photoreceptor cells. This type of ATPase couples the 
catalysis of ATP hydrolysis and the exchange of Na+ and K+ ions to create the electrochemical 
gradient of these ions and provide energy for active transport of nutrients. Although the 
expression levels of Atp1a1 and Atp1a2 were below 1 fmole, Atp1a3 and Atp1b2 showed 
relatively higher expression (around 11 fmoles). Transcript levels of Atp1a3 and Atp1b2 were 
also 3 – 4 folds higher in the rods than other retinal cells. All of these four proteins have 
confirmed extracellular domains. Atp1a3 is a multipass membrane protein and is the catalytic 
component of the ATPase.  Atp1b2 is a single-pass type II membrane protein and is a non-
catalytic component of the ATPase.  
190 
 
Considering all these 11 proteins, Eno2, Atp1a3 and Atp1b2 seem to be the most promising 
candidates as cell surface markers for rod photoreceptor cells.  
7.2.4.3 Plasma membrane proteins identified only in NrlGFP negative population 
Five plasma membrane proteins were identified in MS to exist only in the non-rod retinal cells: 
Neurotensin receptor type 1 (Ntsr1), Serine protease inhibitor A3K (Serpina3k), Synapsin 1 
(Syn1), Syntaxin binding protein 1 (Stxbp1), and Solute carrier family 2 facilitated glucose 
transporter member 1 (Slc2a1). Although both Syn1 and Stxbp1 are involved in synaptic 
transmission, no evidence of TMHs or extracellular domains were found or predicted.  
Serpina3k is a secreted protein that belongs to the serpin family. Its decrease in retina may 
contribute to retinal inflammation in diabetic retinopathy and is thus suggested to have an 
anti-inflammatory and antioxidant effect (Zhang, Hu et al. 2009). Although it is secreted out of 
the cell, serpin binds covalently to proteases and forms a stable complex. Further investigation 
of its specificity and the protease it binds to may tell if serpina3k could serve as a surface 
marker or not.  
Slc2a1 belongs to the glucose transporter subfamily and facilitates glucose uptake. It has six 
confirmed extracellular domains and 12 TMHs. Ntsr1 belongs to the rhodopsin-like G protein-
coupled receptor (GPCR) family that binds to neurotensin which plays important roles in 
neurotransmission and neuromodulation. It can activate phospholipase C, stimulate inositol 
phosphate (IP) production, and is also linked to the Gs-mediated pathway which increases 
intracellular cAMP levels (reviewed in (Hwang, Kim et al. 2009)). It contains four extracellular 
domains including the N-terminal domain and four cytoplasmic domains. There is no report 
about Slc2a1 and Ntsr1 function in retina development yet. If they are specific to non-rod 
retina cells, they could possibly be used as markers to deplete these cells from cell mixtures 
that contain the desired rod precursor cells.  
7.3 Discussion 
By comparing the proteome of rod photoreceptor cells from whole cell lysates versus 
membrane preparations, I have found that membrane fractionation indeed allowed us to 
identify more membrane proteins (Figure 7.1). By comparing the proteome of rod 
photoreceptor cells versus other retinal cells from membrane preparations, I have found that 
rod photoreceptor cells enriched more membrane proteins than other retinal cells (Figure 7.2), 
which was as expected and also agrees with the microarray analysis (Chapter 3, section 3.2.2 
and 3.2.4).  
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I have repeated the membrane preparation MS of sorted retinal cells. The results, however, 
showed high variability. For the photoreceptor cells which are membrane rich, the number of 
proteins detected varied from 60 to 31 between the three runs. Only two proteins can be 
detected in all three runs and 11 proteins common in two runs. It is noticeable that when the 
precipitation reagent was changed from chloroform to acetone for the 3rd run, 6 common 
proteins were detected between the 1st and 3rd run despite they were different biological 
samples. In contrast, only two proteins were common between the 2nd and 3rd run which used 
the same biological sample but different precipitation reagents. In addition, more proteins 
were detected in the 1st and 3rd run which used acetone than the 2nd run which used 
chloroform. This shows that different precipitation reagents will affect the protein yield for MS 
of membrane preparations, at least for photoreceptor cells.  
On the other hand, I also noticed that for other retinal cells which are less membrane rich, the 
numbers of proteins detected were less different between the runs (39 to 32). There were also 
slightly more common proteins detected among the runs for these cells (four common 
proteins in three runs) despite fewer total proteins. The repeatability for these cells was 17.4% 
(ie. 15 common proteins out of 86 total proteins), nearly 2-fold higher than the membrane rich 
photoreceptor cells which was 10.6% (ie. 13 common proteins out of 123 total proteins). 
Because the photoreceptor cells have more membrane proteins, this suggests that the 
variability might be related with the amount of membrane proteins and possibly 
contaminating detergents from the Pierce Mem-Per kit used for solubilisation. In future 
experiments, we could try to dialyse the membrane preparations to see if these detergents 
can be removed from the samples prior to precipitation for MS and to see if the repeatability 
increased. Future experiments could also seek to evaluate the quality of the protein 
preparation prior to MS analysis. Normal procedure which was followed, is to perform a 
protein assay (BCA assay) to determine the concentration of the samples, and to ensure the 
samples are the same concentration and volume before they are loaded for MS. Unlike 
labelling based or in-gel based MS, no other quality control is normally required for direct MS 
with protein mixtures. However, as the protein concentration assay will not determine 
whether the proteins are degraded or not, as peptides will give colour reactions, a useful 
additional quality control step would be to visualise the protein preps on a Coomassie or Silver 
stained gel prior to MS analysis. 
For all the proteins identified from the three runs of the membrane proteomics of the rods and 
non-rod retinal cells, I individually examined them in the protein database to search for cell 
surface protein candidates. 20 proteins were found to be plasma membrane related. Of these 
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plasma membrane proteins, Vdac1, Ntsr1, Slc2a1, Atp1a3, and Atp1b2 were the ones that 
have confirmed extracellular domains and were relatively abundant. Atp1a3 and Atp1b2 were 
only found in the rod membrane proteomics and possibly could be developed as cell surface 
markers for rods. Ntsr1 and Slc2a1 were only found in the non-rod retinal cells and thus might 
be used as a negative marker to deplete these cells from cell mixtures. Vdac1 was abundant in 
both rods and non-rod retinal cells. So although it is not specific to rods, it possibly could serve 
as a general retinal marker for cell cultures which may contain non-retinal cells. Further 
analysis will be required to confirm the different abundance of these proteins in rod and non-
rod cells, for example by Western blot analysis. Notably the identified proteins differed from 
the list of 13 cell surface markers identified from the RNA microarray analysis; and only 10 of 
them showed significantly altered expression pattern at the mRNA level in the microarray.     
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8 Summary and final discussion 
8.1 Properties of photoreceptor precursor cells 
I identified gene expression properties of the photoreceptor precursor cells by comparing their 
transcriptome with other retinal cells of the same stage and comparing different stages of the 
photoreceptor cells. Comparison with other retinal cells of the same stage showed the unique 
properties of photoreceptor precursor cells. This includes the expected properties such as 
visual perception and photoreceptor development as well as notable properties such as the 
enrichment of genes encoding cell projection proteins, and in particular many cilium-related 
genes.  
I found the cilium property to be quite a unique feature for photoreceptor precursor cells in 
comparison with other retinal cells from the functional bioinformatics analysis. By studying the 
expression of some cilium markers and cilium cell surface molecules, I found the cilium 
property of photoreceptor cells is present as early as E15.5. As this is earlier than the recent 
evidence in rods suggesting photoreceptor cilia genesis starts around P0 (which coincides with 
the birth peak of rods) (Sedmak and Wolfrum 2011), it may represent early cone ciliogenesis 
coinciding with the period for the birth peak of cones. If it is indeed early cone ciliogenesis, it 
may represent a property of embryonic photoreceptor precursors (which give rise to cones 
after transplantation) that is important for integration. As there is little literature about cone 
ciliogenesis in mammals and considering the importance of cones, it will be important for 
future work to confirm if these embryonic ciliogenesis are cone specific.  
Consistent with cilium marker expression, the cilium property was more established in P4 
matching the higher integration rate of postnatal photoreceptor precursor cells after 
transplantation. Also many more cilium genes and other genes encoding cell projection 
proteins were expressed in P4 photoreceptor cells than E15.5 photoreceptor cells. Most of the 
cilium-related cell surface molecules, such as Prom1, Pcdh15 were also more highly expressed 
at P4 than E15.5. The cilium study here provided the starting point for further investigation of 
cone ciliogenesis as well as the role of cilium and cilium cell surface molecules in the migration 
and integration processes of photoreceptor cells. 
Using the NrlGFP (rod marker) and CrxGFP (rod and cone marker) mouse strains I attempted to 
identify properties for cone photoreceptor cells. Comparison of the two strains showed that 
GO annotations of the two lines were largely the same at postnatal stages. As the cones are at 
low abundance, transcripts with lower expression level may have been undetected due to the 
limits of the array methodology. Alternatively, these two populations may in fact be largely 
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similar at the early postnatal stages prior to photoreceptor maturation. Surprisingly, I detected 
cone transcripts (Opn1sw) within the NrlGFP population. The embryonic CrxGFP cells showed 
some unique properties. However, none of the genes responsible for these properties seem to 
be particularly related with cones. On the other hand, I found some genes in the common gene 
set between the embryonic and postnatal CrxGFP+ve cells that have cone specific functions, 
such as Cngb3, Pde6c. Furthermore, I did find a total of 205 genes (among which 29 are genes 
encoding cell projection proteins) which are exclusive to the postnatal CrxGFP line despite the 
similarity between the postnatal CrxGFP and NrlGFP cells. Further individual examination of 
these genes may identify more cone-specific genes and may give more clues about cone 
properties.   
8.2 Approaches for screening cell surface molecules 
I performed bioinformatics analysis of the microarray and mass spectrometry data on the 
photoreceptor cells to search for cell surface molecules using several different approaches. 
Initially I searched for all members from several families of proteins which are known to have 
extracellular domains and for which a single member was initially identified as showing a 
significant expression pattern in microarray data. For example, tetraspanin (Tspan) is a family 
of highly conserved transmembrane proteins. It contains four transmembrane domains with 
two extracellular domains (the N and C-termini are within the cell). There are 34 mammalian 
tetraspanin in total and I have found five (Tspan 5, 6, 7, 9 and 33) in the Swaroop array and 13 
(Tspan 1, 2, 5, 6, 7, 9, 10, 12, 14, 15, 17, 18, and 33) in the Nrl array. Of the five Tspan 
identified in both the Swaroop array and NrlGFP array, Tspan 6 is high in P4 NrlGFP negative 
population while Tspan 5, 7, 9, 33 are high in NrlGFP-positive population. Semaphorin is 
another family of proteins which contains extracellular domains and I found 17 of them 
present in the Nrl and Crx array. Similarly members of the solute carrier family, basic 
immunoglobulin superfamily were all present in our arrays (data not shown). This method, 
although exhaustive to search for all members of one particular family, relies on prior 
knowledge of all the families which have members with extracellular domains.  
I then collected the names (both the CD name and the gene name) of all the mouse CD 
molecules and searched for these within the microarray data. Over 100 CD molecules were 
found in our arrays and 10 of them were expressed over two-fold higher in photoreceptor cells 
than other retinal cells. Although these candidates are confirmed cell surface molecules and 
have antibodies available, the number of highly differentially expressed molecules was low. To 
further enlarge the pool of candidates, I used the gene ontology search approach. It has to be 
noted that there are no specific gene ontology terms that define cell surface molecules (or 
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surface molecular domains). There are terms that are often used to annotate cell surface 
molecules such as transmembrane proteins, plasma membrane. However, transmembrane 
proteins can be either trans subcellular organelle membrane or trans plasma membrane. Even 
for trans plasma membrane, the proteins can be either intracellular or extracellular. In 
addition, the cell surface molecules I am seeking for are not uniform – both transmembrane 
proteins which have extracellular domains and proteins for which the whole structure is 
extracellular but are attached to the plasma membrane via some linkers all count. Therefore, it 
is important to go through the whole gene annotations of each gene list and check all the 
terms that may be used to annotate any type of cell surface molecules. This has given 227 cell 
surface molecule candidates which are expressed more than two fold higher in photoreceptor 
cells. This method probably provides the fullest list for photoreceptor cell surface molecules. 
Reassuringly, all the top ten CD molecules and the above mentioned members of known 
protein families with extracellular domains highly expressed in photoreceptor cells were in this 
list. 
I also performed a complementary mass spectrometry analysis with the photoreceptor 
precursor cells. To reduce the extent of cell surface proteins being masked by other high 
abundant proteins, I tried to enrich for the membrane fraction of the cells in which cell surface 
molecules are located. Indeed more membrane-related proteins were identified in the 
fractionation than in the whole cell lysates. Also more membrane-related proteins were in the 
photoreceptor cells than in other retinal cells. This shows that the membrane fractionation 
was successful. However, I did not identify many cell surface molecules and there was not a 
good correlation with the microarray data, likely reflecting the different sensitivities of the two 
techniques – detection of thousands of mRNAs versus detection of tens of proteins. There are 
several possible reasons. Firstly, despite cell fractionation, the abundance of surface proteins 
in the sample may still be too low to be detected by this method initially. Secondly, cell surface 
proteins which are anchored to plasma membrane through lipid linkers might be sheared off 
during the procedure. Thirdly, if the final dissociation of proteins from the membrane is not 
efficient after membrane fractionation, some proteins may not even be released for detection. 
These reasons probably accounts for why cell surface markers such as CD73, Prom1, CD24 etc. 
which I know are present in photoreceptors were not detected by MS in the experiments 
presented here.  
In the future, to search cell surface markers through the mass spectrometry approach, we 
could try to chemically tag cell surface glycoproteins with a linker molecule, such as biocytin 
hydrazide (BH), and enrich the labelled peptides by affinity purification (Wollscheid, Bausch-
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Fluck et al. 2009). Compared with other MS strategies, this method seems to be more 
comprehensive and specific for surface membrane proteomics. The key issue with this method 
is the oxidation of cell surface carbohydrate-containing proteins on living cells followed by BH 
labeling, which needs to be carefully optimized to not only increase candidate capturing, but 
also prevent cell death and side reactions. Considering the high sensitivity/limited viability of 
photoreceptor cells, a substantial amount of effort will be required to optimize the conditions.  
There is another type of analysis called membrane-polysome translation state array analysis 
(TSAA) which we could try in the future. This method separates membrane-bound and 
secreted RNA from cytosolic and nuclear RNA (Kolle, Ho et al. 2009). Basically cells were lysed, 
nuclei removed, and supernatant applied to sucrose gradient. The membrane-bound and 
secreted RNA were separated by ultracentrifugation and then hybridized with Illumina 
microarray chips. This selects only the membranes-associated or secreted RNA from total 
mRNA, therefore produce a data set that is better targeted than normal microarray. It detects 
more genes than MS and also avoids the problems for hydrophobic proteins. The problem 
remains, however, that it cannot differentiate plasma membrane proteins with 
intracellular/subcellular membrane proteins. Therefore bioinformatics analysis is still required 
to select only the cell surface candidates. Although this method analyses the polyribosome-
bound RNA, it is still at RNA level and protein existence still needs to be confirmed.  
8.3 The cell surface molecules  
I have identified 227 cell surface molecule candidates that are expressed more than two fold 
higher in photoreceptor precursor cells than other retinal cells from the Nrl and Crx array. 68 
of them are more than five-fold higher, among which 32 are confirmed cell surface molecules. 
In this thesis, I have intensively studied Prom1, CD73, CD24, and Sema7a.  
8.3.1 Prom1 and isolation of photoreceptor cells for transplantation 
In our microarray databases, Prom1 is highly expressed with log2 intensity over 13 in the 
Swaroop array and between 7 – 11 in the NrlP4 and Crx array (Figure 3.9, Figure 6.1 F). Its 
expression is nine fold higher in P4 photoreceptor precursor cells than other retinal cells 
according to both the NrlP4 array and CrxP4 array and is four-fold higher in P4 than E15.5 
photoreceptor precursors in the Crx array (Table 3.3). Preliminary conventional PCR confirmed 
the presence of Prom1 transcript between P4 to P28 retina tissues (Figure 6.2 D). Quantative 
PCR showed that Prom1 expression is 6 – 8 fold higher from P5 to P21 than E15.5 in retina 
(Figure 5.4 F) and is 20 times higher in photoreceptor cells than other retina cells at P4-5 
(Figure 3.10 A & B). Confocal images of developmental retina also confirmed the expression of 
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Prom1 protein at the cilia region from embryonic stages onwards (Figure 5.4). It is found in 
human that two different frameshift mutations of PROM1 which result in truncated proteins 
that could not be delivered to cell surface, are responsible for the severe autosomal-recessive 
retinitis pigmentosa found in a Pakistan family (Zhang, Zulfiqar et al. 2007) and an India 
consanguineous pedigree respectively (Maw, Corbeil et al. 2000). Further an R373C missense 
mutation of PROM1 was reported to cause autosomal-dominant macular degeneration in 
three pedigrees of Stargardt disease 4, bull’s-eye macular dystrophy, and cone-rod dystrophy 
(Yang, Chen et al. 2008). Knockout or mutant Prom1 transgenic mice exhibited 
underdeveloped and disorganized disk membranes in both rods and cones (Yang, Chen et al. 
2008; Zacchigna, Oh et al. 2009) as well as mislocalized rod and cone opsins and shortened 
cone OS and increased photoreceptor apoptosis (Zacchigna, Oh et al. 2009). All these suggest 
that Prom1 plays important roles in OS morphogenesis and sorting of opsin proteins.  
I found that Prom1 is also expressed on transplanted photoreceptor cells (Figure 5.6). 
Interestingly while Prom1 expression was all over the cell body surface before the cells 
entered the host ONL, it is localised into specific regions of the cell surface once the cells are in 
the ONL. During normal retina development, I also observed Prom1 expression all over the cell 
body in embryonic stages, and a gradual reduction of overall expression but increased apical 
expression as development proceeds. Based on these expression patterns, I propose that the 
overall expression and the foci expression may represent two stages for photoreceptor 
migration with the former function more of a spreading out and searching for cues and the 
latter orienting and migration in the retina. The exact mechanism of how Prom1 translocates 
from the cell body to the cilium is still unknown, but cholesterol is likely to be involved. Further 
study of loss of function of Prom1 in migrating transplanted cells may indicate if Prom1 plays 
roles in the migration of photoreceptor cells.  
Flow cytometry analysis with conjugated anti-Prom1 antibody using dissociated retina cells 
from Nrl/CrxGFP mouse showed that, firstly Prom1 labelled all the NrlGFP labelled cells and 
the “strong” CrxGFP+ve cells, secondly Prom1 did not stain the “weak” CrxGFP+ve population, 
thirdly Prom1 stained some Nrl/CrxGFP-ve cells in early development but much less in late 
development (Figure 6.4 and 6.6). As immunostaining of Prom1 showed clearly that Prom1 
stains specifically to the outer layer of the retina where photoreceptor cells lie and does not 
stain the inner retina (Figure 5.4 in this thesis, Figure 3 in (Lakowski, Han et al. 2011)), I 
propose that the weak CrxGFP+ve cells which Prom1 did not stain in flow cytometry (Figure 6.6 
A) are likely to be bipolar cells (as discussed in Chapter 6, section 6.2.4); the GFP-veProm1+ve 
cells in early development (Figure 6.6 A) are likely to be cells destined to become 
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photoreceptor cells/ progenitor cells as these GFP-veProm1+ve cells gradually decreased while 
the GFP+veProm1+ve cells correspondingly increased (as discussed in Chapter 6, section 6.2.4).  
Prom1 did not label many adult photoreceptor cells in flow cytometry and showed a decreased 
gradient there. Conversely, confocal images of adult mouse eye cryosections showed clearly 
that Prom1 stains specifically between the inner and outer segments of adult rod 
photoreceptor cells (Figure 5.4). This agrees with previous confocal and electron microscopy 
images which showed Prom1 localization at the membrane evaginations of the base of rod 
photoreceptor outer segments (Yang, Chen et al. 2008; Zacchigna, Oh et al. 2009) and 
coexpression of Prom1 with Recoverin, Rhodopsin, and PNA both in sections and dissociated 
cells (Supplemental figures in (Zacchigna, Oh et al. 2009; Lakowski, Han et al. 2011)). It was 
shown in neocortex neuroepithelial (NE) cells that the Prom1-enriched-apical midbodies can 
be released into the neural tube fluid as NE cells divide (Dubreuil, Marzesco et al. 2007). 
However, these processes are observed mainly around E10.5 and E11.5 and no later than 
E14.5 (Dubreuil, Marzesco et al. 2007) whereas the mouse retina I studied were from E15.5 
onwards and I did not notice this phenomenon. The decrease of Prom1 expression in adult 
photoreceptor cells in flow cytometry however, considering its gradient pattern, is most likely 
to be caused by damage of the cilia region of adult photoreceptor cells during the dissociation 
procedure as normally the more mature the photoreceptors are, the more delicate and 
thinner the cilia regions will be. Our flow cytometry also showed that the total Prom1+ve cells 
were consistently between 70 – 80% of the whole retinal before P10. This agrees with a 
reported MACS analysis where at least 67% of the total human retinal cells are labelled by 
Prom1 from post-mortem tissues (Carter, Dick et al. 2009). Further, the transplanted cells 
which migrate and integrate into the host retina indeed express Prom1 (Figure 5.6 in this 
thesis, and Figure 6 in (Lakowski, Han et al. 2011)). Taken together, these data indicate that 
Prom1 labels all the cone and rod photoreceptor cells in the retina from the early stages of 
development. Because it labels the rod and cone precursor cells, and not photoreceptor cells 
which lost their cilia during dissociation, it serves very well to select desired photoreceptor 
cells for transplantation.  
Prom1, together with two other cell surface molecules CD73 and CD24 that my colleague and I 
showed labelled photoreceptor cells from the retina (Figure 6.4, Figure 6.6 – 6.9 in this thesis, 
(Lakowski, Han et al. 2011)), may be used in combination to isolate photoreceptor populations 
for transplantation. Firstly, all three markers labelled a relatively large proportion of 
photoreceptor cells on their own. Secondly, all three markers showed different expression 
profiles. CD73 did not label early photoreceptor precursors (before P4) and adult cones, but 
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labelled late photoreceptor precursors (P4 onwards) and adult rods. CD24 did not label 
photoreceptor cells older than P12, but labelled early rod and cone precursor cells (embryonic 
to P8) as well as bipolar cells. Prom1 specifically labelled all the photoreceptor cells since their 
birth, although its expression was reduced in adult photoreceptor cells. As each marker has a 
different expression profile, different combinations give rise to different photoreceptor 
populations. For example, a combination of Prom1 and CD24 may enrich embryonic to P8 
photoreceptor cells (in particular cones), a combination of CD24 and CD73 enriched P4 to P8 
photoreceptor cells, and a combination of CD73 and Prom1 enriched P4 to P12 pure 
photoreceptor cells. Future comparisons of the transplantation behaviour of these 
photoreceptor cells from different combinations will determine which population gives the 
highest number of integrated cells and cone photoreceptor cells.  
Further to confirm if the combinations of all three markers labels photoreceptor cells 
specifically in different cell mixtures, it will be necessary to examine marker combinations on 
other types of cells which express these markers as well as stem cell sources of donor cells for 
transplantation. For example, high expression of both CD73 and CD24 was detected by flow 
cytometry on immortalized human amniotic epithelial cells (Zhou, Koike et al. 2013) and 
Prom1 also labels hematopoietic progenitor cells and epithelial cells (reviewed in (Corbeil, 
Roper et al. 2001)). Currently the three markers define photoreceptor cells if donor cells are 
isolated only from the developing retina. If the donor cells are derived from differentiated 
stem cell cultures, they may not be sufficient and further markers will be required to define 
the retinal context and increase stringency. It will be important to examine the expression 
profiles of the remaining cell surface molecules from our candidate list so that more retinal or 
photoreceptor-specific cell surface markers can be found.  
8.3.2 Sema7a and retinal stratification 
8.3.2.1 Sema7a 
In this thesis I intensively studied Sema7a, a GPI-anchored semaphorin much studied in the 
olfactory bulb and other systems, but not in the retina. This is a migration related cell surface 
molecule. The transcript was highly expressed in photoreceptor cells according to the 
microarrays and qPCR (Figure 3.8 – 3.10). The protein was initially expressed in the whole 
retina but became more highly expressed in the outer retina, especially in the segments and 
synapses of photoreceptor cells (Figure 4.3). On the other hand, while the receptor Itgb1 did 
not show much expression in the retina, the other receptor PlxnC1 showed initial widespread 
expression in the retina followed by higher expression in the inner retina (Figure 4.4 – 4.6). 
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PlxnC1 also colabeled with Sema7a on the surface of photoreceptor cells in normal 
development as well as on migrating photoreceptor cells after transplantation (Figure 4.6, 
4.11). In Sema7a-/- mice retina where Sema7a expression was lost, expression of PlxnC1 was 
also reduced (Figure 4.12). This indicates that Sema7a is interacting with PlxnC1 in the retina 
which is different from the Sema7a/Itgb1 interactions in many other systems (Pasterkamp, 
Peschon et al. 2003; Suzuki, Okuno et al. 2007; Scott, McClelland et al. 2008; Messina, Ferraris 
et al. 2011).  
Study of Sema5a/5b and Sema6a shed the first light on the regulation of the layer formation of 
the inner retina (Matsuoka, Chivatakarn et al. 2011; Matsuoka, Nguyen-Ba-Charvet et al. 2011) 
while stratification of the outer retina is still virtually unknown. I here report the first 
semaphorin, Sema7a, expressed in the outer retina and in particular photoreceptor cells, and 
whose loss leads to Bassoon and Dystrophin in photoreceptor synapses over shooting into the 
ONL/INL. This indicates Sema7a may prevent over extension of photoreceptor synapses. This is 
likely to be achieved via interaction with PlxnC1, but the exact mechanism of this process need 
to be examined further.  
Sema7a and PlxnC1 are also expressed on migrating transplanted photoreceptor cells as well 
as on some migrating-like cells in the developing retina and loss of Sema7a leads to holes in 
the ONL. These indicate additional roles of Sema7a and PlxnC1 in photoreceptor migration and 
possibly ONL formation. Further examination of the Sema7a knockout or knockdown 
photoreceptor cells in the developmental context as well as the transplantation context might 
help to answer these questions.  
Because Sema7a is also expressed at lower levels in other retinal cells, it does not seem to be a 
specific marker to isolate photoreceptor cells from the retina for transplantation. However, it 
might be used in combination with other markers as a retinal cell marker.  
8.3.2.2 Retina lamination 
Although well known for its layered structure, little is known about the molecular mechanism 
that control the stratification of the retina. To form the synaptic layers, neurites must first be 
guided to the correct plexiform layer, then to the correct sublamination layer (where it applies) 
and thirdly to establish synaptic contacts with the correct partner. For example, following 
Sema5a/5b’s repulsive guidance to constrain neurites in IPL, Sema6a and PlxnA4 guide a small 
subset of neurites to the correct sublamination of IPL. Yet, molecules that mediate direct 
synapse formation remain unidentified in the retina. These are likely to be short-range 
adhesive cues like the sidekicks and DSCAMs found in Drosophila (Yamagata, Weiner et al. 
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2002; Yamagata and Sanes 2008) but are largely unidentified in mammals. Further, Sema6a is 
only expressed in a small number of inner retinal cells and Sema5a/5b only functions in the 
early postnatal stages of retina to establish IPL lamination indicating additional stratification 
cues must exist.  
Not only establishment of the synaptic layers need to be further investigated, but also 
formation of the nuclear layers remains enigmatic. For example, how do cell bodies of 
photoreceptor cells stack into such a regular layer of ONL? What makes cone photoreceptor 
cells stay only in the apical region of the ONL? What controls photoreceptor cells to not 
migrate into other cell layers? Similar questions also apply to other inner retinal cells. This 
thesis provided some preliminary evidence suggesting Sema7a’s involvement in some of these 
processes. But it cannot be the only one involved and other molecules need to be identified.  
In the microarray analysis, I also found Sema3f and Sema4b more highly expressed in 
photoreceptor cells and 14 other semaphorins (mostly Sema3s, Sema4s and Sema6s) more 
highly expressed in inner retinal cells. Sema3s have been recently implicated in the control of 
synaptic specificity in mammalian cortical–thalamic–striatal circuits (Ding, Oh et al. 2011) and 
spinal reflex circuitry (Sema3e with PlxnD1) (Pecho-Vrieseling, Sigrist et al. 2009) and cortex 
and hippocampus (Sema3f with Nrp2 or PlxnA3) (Tran, Rubio et al. 2009). Our future work will 
focus on these molecules. Understanding the molecular mechanisms regulating retinal neuron 
migration and retinal layer formation will not only facilitate the cell transplantation approach, 
but may also shed light on the design of more strategies in general neural injuries and diseases.  
8.4 The photoreceptor cilium and its implications in retinal repair 
The tiny organelle cilium has been under intensive study over the last decades, but 
understanding of the development of photoreceptor cilia remains limited. The work in this 
thesis suggests that the nascent cilium, prior to OS formation, may be important during 
photoreceptor development for ONL organisation. Current knowledge about photoreceptor 
cilium mainly focuses on ciliopathy genes that cause retinal degeneration and that the 
organelle itself is critical for protein transport between the OS and IS. As a primary sensory 
organelle, the photoreceptor cilia may function more than just as a sorting machine. Primiary 
cilia in other cell types such as fibroblasts (Schneider, Cammer et al. 2010) and endothelial cells 
(Jones, Adapala et al. 2012) have been indicated to function in orientation and migration; it is 
possible that the photoreceptor cilia may also have such functions. Study in this thesis found 
that the postnatal photoreceptor precursor cells which have high integration potential are 
featured with cilia properties and the transplanted migrating photoreceptor cells express the 
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cilium protein Prom1. These indicate that the cilia may be involved in the migration of 
transplanted photoreceptor cells. Future work will examine this hypothesis in detail.  
Firstly, whether there is an association between intact photoreceptor cilia and integration 
efficiency need to be evaluated. Since Prom1 locates at the base of rod OS which are just 
above the connecting cilium, Prom1 could be used as an indicator for cilia intactness. As all 
early postnatal NrlGFP cells are labelled by Prom1, if use of a harsher digestion protocol yields 
NrlGFP+veProm1-ve cells, these cells are most likely to have lost the Prom1-labelled cilia 
region leaving the cilia impaired. Comparison of the integration efficiency of these cells with 
the NrlGFP+veProm1+ve cells may tell us if there is an association between cilia and 
integration efficiency. Since over time cells may replenish the lost cilia, it will be important to 
analyse a time course of cells following transplantation.  
Secondly, if there is association between cilia and integration efficiency, what exact role cilia 
may play in the migration of photoreceptor cells will need to be further examined. It has to be 
noted that the role of cilia in transplanted migrating photoreceptor cells may not be exactly 
the same as the new born photoreceptor cells in a developmental context. Unlike the new 
photoreceptor cells which are born in the ONL, the transplanted cells need to migrate all the 
way from SRS through the interphotoreceptor matrix into ONL. It is quite possible that these 
cells may be orientated and guided during this migration process. Whether cilium is playing 
such a role can be assessed by comparing the migration path of the transplanted cells which 
have cilia and which do not have cilia. Again the Prom1 and NrlGFP combination may help to 
answer this question.  
On a separate note, this thesis also observed expression of cilia markers at embryonic stages. 
Since rod ciliogenesis was proposed to start not until around P0 (Sedmak and Wolfrum 2011), I 
speculate that such early expression of cilia markers indicates ciliogenesis of cones. Different 
from rods, the axoneme of cones extends the whole length of OS thus probably making cilia 
even more critical for cones than for rods. Not much is known about cone ciliogenesis so far. 
Our future work is to further examine the apical protrusions of photoreceptor cells in 
embryonic stages at more time points using cone markers combining with cilia markers in 
immunohistochemistry. Electron microscopy will provide more solid evidence as to if cilia are 
really forming. Immunogold labelling with cone markers will probably give a firm conclusion on 
my speculation. As embryonic photoreceptor cells give rise to cones after transplantation but 
the integration efficiency is low, detailed investigation of the embryonic photoreceptor 
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precursor cells and their subcellular structure may also shed light on how to increase the 
integration efficiency of embryonic photoreceptor cells and the number of cones to be formed.  
8.5 Cell transplantation and retinal repair 
8.5.1 Transplantation efficiency 
Since the start of cell transplantation being tested for retinal repair, the integration efficiency 
have been low with a typical number of 1,000 – 5,000 new cells per eye (MacLaren, Pearson et 
al. 2006; West, Pearson et al. 2008; Lakowski, Baron et al. 2010; Pearson, Barber et al. 2010; 
West, Pearson et al. 2010; West, Pearson et al. 2012). On-going optimizations have been 
performed to increase the integration efficiency including disruption of the host OLM (West, 
Pearson et al. 2008; Pearson, Barber et al. 2010), providing neurotrophic growth factors to the 
host environment (West, Pearson et al. 2012), preselection of donor cells (Lakowski, Baron et 
al. 2010; Pearson, Barber et al. 2012), increasing the number of injected cells (Pearson, Barber 
et al. 2012), introducing scleral punctures (Pearson, Barber et al. 2012), pre-detaching the 
injection site (Pearson, Barber et al. 2012), dual injections (Pearson, Barber et al. 2012) and so 
on. All these have contributed to increase the integration efficiency to such an extent that at 
present up to 26,000 cells can be integrated into a wildtype host retina (Pearson, Barber et al. 
2012). With an optimized number of 200,000 donor cells in 1 µl injection buffer to inject, this 
gives a maximum integration efficiency of 16% (Pearson, Barber et al. 2012). This number, 
although substantial enough to guide optokinetic head tracking and visually guided behaviour 
in a rod-deficient mouse model Gnat1-/- (Pearson, Barber et al. 2012), remains low considering 
that in an experiment with viral vector delivery of Gnat1 transgene in this model, 60,000 rod α-
transducin+ve cells cannot evoke an ERG response but 150,000 cells can after dual injection of 
AAV2/8.Rho.GNAT1 (Pearson, Barber et al. 2012). Therefore, substantial improvement of the 
integration efficiency remains to be achieved for cell transplantation therapy. Further 
refinement and characterisation of the donor population selected for transplantation as 
explored in this thesis is one strategy to improve integration levels.  
8.5.2 Cone transplantation 
Of crucial importance to human vision are the cone photoreceptor cells. However, there are 
far fewer studies in cone transplantation than in rod transplantation. Occasionally cone-like 
cells were observed after transplantation with neonatal retinal cells (MacLaren, Pearson et al. 
2006) or RPCs (Klassen, Ng et al. 2004) or ES cell derived retinal cells (Lamba, Gust et al. 2009). 
However numbers of such cells are finger countable. Some may express cone opsins (Klassen, 
Ng et al. 2004; Lamba, Gust et al. 2009), but the featured cone morphology of stubby 
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inner/outer segment, multiple heterochromatin loci, and large cone pedicle were not shown 
(Lamba, Gust et al. 2009). Lakowski and Baron et al found that cells isolated from the 
embryonic stage close to the birth peak of cones (E14.5) gave the highest percentage of cones 
after transplantation (Lakowski, Baron et al. 2010). The new cones unambiguously 
demonstrated the morphology of cone features and expressed cone markers. Up to 54 
integrated cones per eye was observed (Lakowski, Baron et al. 2010), yet taking into account 
both rods and cones formed by the transplanted cells, the integration efficiency of the 
embryonic photoreceptor precursor cells was 10-fold lower than postnatal photoreceptor cells 
which only give rise to rods. Although the ratio of the newly formed rods and cones are close 
to host retina, the degenerated cone-rich macular region of the human retina will require a 
much higher number of cones to be integrated. Therefore increasing the number of integrated 
cones remains a priority.  
The optimization of the transplantation procedure mentioned above can be adopted here for 
cone transplantation. Of particular importance is probably the preselection of cone-forming 
cells for transplantation. This thesis found that the embryonic photoreceptor precursor cells 
which form cones after transplantation contain some stage-specific genes and cone-specific 
genes which are shared with postnatal photoreceptor precursor cells. Therefore selecting cells 
which express these genes, in particular the cone-specific genes and testing them for 
transplantation could be the next step for cone transplantation. Of particular convenience, 
many cone-specific genes identified here encode cell surface molecules such as Cngb3, 
Opn1sw, Chrnb4, and Arr3, making live cell selection potentially feasible and easy, although 
the stage at which these proteins are present on the cell surface and the availability of 
antibodies to extracellular domains first needs to be established. The recipient environment 
can also be manipulated to increase cone integration. It was shown that cone yield was 
increased in the Gucy2e-/- mutant in which endogenous cones were degenerated (Lakowski, 
Baron et al. 2010).  
There is no purpose for transplantation if the injected cones don’t function. To determine if 
the newly formed cones function or not, ERG responses and behavioural tests can be assessed. 
To separate cone function from rod function in ERGs, light-adaption can be applied to saturate 
the rod system so that the ERG mainly reflects activities in the cone system which shows waves 
of small amplitude but very fast kinetics (Hood and Finkelstein 1986; Alexander, Umino et al. 
2007). If in a dark-adapted state, bright red light stimulus induces a cone-mediated ERG 
response of fast kinetics (known as X-waves) followed by a rod-mediated slow-time-to-peak 
response (Bornschein, Goodman et al. 1957; Berson and Howard 1971). This property can be 
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used to assess the function of both rods and cones after transplantation. Visual acuity can be 
assessed by measuring optomotor head-tracking responses and its ERG responses to a rotating 
grating using the OptoMotry© system (Alexander, Umino et al. 2007). Other behaviour tests 
such as the Prusky water maze system in which rodents learn to associate visual grating display 
with escape can also be used to assess visual acuity (Prusky, West et al. 2000). 
Using mice, a nocturnal species, for cone transplantation to restore photopic vision is in 
general less ideal, although the many transgenic lines greatly facilited our research. Domestic 
animals such as pig, sheep, and cattle as well as the rodent ground squirrel and nile rat are all 
diurnal species. It may be worthwhile to explore the possibility of using these species as the 
recipients for cone transplantation. Although there aren’t any cone-degenerating models in 
these species, it may still be possible to generate a cone-deficient retina to test new cone 
function after transplantation. It is found that excessive thyroid hormone or triiodothyronine 
(T3) leads to cone apoptosis in mice (Ng, Lyubarsky et al. 2010), therefore it may be worth 
injecting T3 or thyroid hormone to these diurnal species to see if their cones are eliminated or 
not.  
8.5.3 ES cells and iPS cells 
Being considered renewable and immortal cell resources, ES cells and iPS cells have been the 
focus of regenerative medicine over decades. Retinal cell transplantation studies with these 
sources have also evolved greatly. A recent breakthrough in ES cell technology showed 
spontaneous formation of optic cups and even properly layered ONL using a 3-dimentional (3D) 
culture system (Eiraku, Takata et al. 2011). Rod precursors labelled with RhoGFP transgenes 
derived from mouse ES cells using this 3D protocol successfully integrated into ONL of 
degenerating mice retina and matured into healthy OS-bearing photoreceptor cells (Gonzalez-
Cordero, West et al. 2013). These new data suggest that ES cell sources are likely to be useful 
to provide photoreceptor precursor cells for human transplantation and treatment of retinal 
diseases. The immediate next step will be to evaluate if these cells can rescue vision in these 
models with behaviour tests, ERG recordings and so on. Protocols of human ES cell and iPS 
cells differentiation into photoreceptor precursors will need to be improved to increase 
photoreceptor-precursor-forming-efficiency and similar functional assessments are needed. 
Cell surface molecules identified in the postnatal retina will need to be assessed in the human 
ES cell and iPS cell cultures to select for cells of the right type and time for transplantation, and 
so that cells can be selected without the use of transgenic markers. Last but not least, Good 
Manufacturing Practice will need to be established to ensure safe transplantation for retinal 
repair.   
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9 Appendix 
9.1 Appendix Table 2.1  
Appendix Table 2.1 RNA extraction and FACS of CrxGFP+ve vs CrxGFP-ve cells for microarray 
All extracted RNA are in 30 µl RNase-free water at -80°C. 
First set of 6 samples from CrxGFP E15.5 
Sample 
Number 
Sample 
Name 
Cell 
No. 
(106) 
A260/280 [RNA] 
ng/µl 
RNA 
Extractn 
date 
Cell sort date (million 
cells) 
#1 Crx E15.5 
GFP+tive 1 
3.02 2.09 81.1 26.5.10 31.3.10 (1.86) 
31.3.10 (0.51) 
7.4.10 (0.65) 
#2 Crx E15.5 
GFP+tive 2 
3.03 1.98 107.1 27.5.10 25.2.10 (0.78) 
 25.2.10 (0.96) 
 25.2.10 (1.29) 
#3 Crx E15.5 
GFP+tive 3 
3.97 1.96 99.4 27.5.10 29.1.10 (1.06) 
19.2.10 (1.47) 
26.2.10 (1.44) 
#4 Crx E15.5  3.02 1.98 100.7 27.5.10 31.3.10 (1.54) 
GFP-tive 1 31.3.10 (0.9) 
 7.4.10 (0.4) 
 9.4.10 (0.17) 
#5 Crx E15.5  5 2.08 76.5 1.7.10 17.6.10 (5 from 3 
litters)  GFP-tive 2 
#6 Crx E15.5  2.47 2.09 65.9 1.7.10 25.6.10 (2.47) 
 GFP-tive 3 
Second set of 6 samples from CrxGFP P4 
Sample 
Number 
Sample 
Name 
Cell 
No. 
(106) 
A260/280 [RNA] 
ng/µl 
RNA 
Extractn 
date 
Cell sort date (million) 
#7 Crx P4 5.96 2.06 81.3 2.8.10 29.7.10 (5.96) 
 GFP+tive 1 
#8 Crx P4 
GFP+tive 2 
8.09 2.06 106.9 2.8.10 29.7.10 (8.09) 
#9 Crx P4 
GFP+tive 3 
9.5 2.08 115.3 2.8.10 29.7.10 (9.5) 
#10 Crx P4 4.92 2.08 72 3.8.10 29.7.10 (2.02) 
 GFP-tive 1 2.8.10 (2.9) 
#11 Crx P4  5.4 2.07 86.4 3.8.10 29.7.10 (1.9) 
 GFP-tive 2 2.8.10 (3.5) 
#12 Crx P4 5.54 2.08 65.1 3.8.10 29.7.10 (2) 
 GFP-tive 3 2.8.10 (3.54) 
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9.2 Appendix 2.1 
Appendix 2.1 shRNA sequences for Sema7a  
shRNAsema7a1 (Target seq: TGGACGTGGCAAGGTCTACCACTTCAACT ) 
5’ - TTTG TGAGCGA  TGGACGTGGCAAGGTCTACCACTTCAATT  CTGTAAAGCCACAGATGGG 
AGTTGAAGTGGTAGACCTTGCCACGTCCA 
 CCGCCTA TTTT-3’ 
5’ – CTAGAAAA TAGGCGG TGGACGTGGCAAGGTCTACCACTTCAATT  CCCATCTGTGGCTTTACAG 
AATTGAAGTGGTAGACCTTGCCACGTCCA TCGCTCA -3’ 
 
shRNAsema7a2 (Target seq: TCTGTCTCCAAGTGGAACACCTTCCTGAA ) 
5’ - TTTG TGAGCGA  TCTGTCTCCAAGTGGAACACCTTCCTTAA  CTGTAAAGCCACAGATGGG 
TTCAGGAAGGTGTTCCACTTGGAGACAGA 
 CCGCCTA TTTT-3’ 
5’ – CTAGAAAA TAGGCGG TCTGTCTCCAAGTGGAACACCTTCCTGAA  CCCATCTGTGGCTTTACAG 
TTAAGGAAGGTGTTCCACTTGGAGACAGA TCGCTCA -3’ 
 
shRNAsema7a3 (Target seq: GAACTGTACACAAGTGATA ) 
5’ - TTTG TGAGCGA  GAACTGTACACAAGTGATA  CTGTAAAGCCACAGATGGG 
TATCACTTGTGTACAGTTC CCGCCTA TTTT-3’ 
5’ – CTAGAAAA TAGGCGG GAACTGTACACAAGTGATA  CCCATCTGTGGCTTTACAG 
TATCACTTGTGTACAGTTC TCGCTCA -3’ 
 
shRNAsema7a4 (Target seq: GCTTGGTGACATTGACAGA ) 
5’ - TTTG TGAGCGA  GCTTGGTGACATTGACAGA  CTGTAAAGCCACAGATGGG 
TCTGTCAATGTCACCAAGC CCGCCTA TTTT-3’ 
5’ – CTAGAAAA TAGGCGG GCTTGGTGACATTGACAGA  CCCATCTGTGGCTTTACAG 
TCTGTCAATGTCACCAAGC TCGCTCA -3’ 
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9.3 Appendix figure 3.1 
Appendix figure 3.1 Photoreceptor 
cell transcriptomes show very 
different properties from other 
retinal cells of the same stage. (A) 
Properties of gene sets for E15.5 
CrxGFP positive cells (green, 
photoreceptor precursors) vs CrxGFP 
negative cells (blue, other retinal 
cells). (Bottom row) Main properties 
of gene sets for P4 CrxGFP positive 
cells (green, photoreceptor 
precursors) vs CrxGFP negative cells 
(blue, other retinal cells). X-axis: 
percentage of the genes annotated 
under each GO term out of the 
whole input gene lists. Y-axis: Gene 
ontology terms which were 
significantly enriched in the gene 
lists compared with random 
generated gene lists from the 
genome. Here only the most general GO terms merged and compressed from the original full GO lists were compared (Figure3.6 and Appendix figure 3.1 showed the full lists of GO term 
comparison). According to the size of the gene sets, the statistic thresholds were set as E15.5Crx+ve p0.01, E15.5Crx-ve p0.01, P4Crx+ve and P4Crx-ve FDR0.01. PR: photoreceptor cell.  
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9.4 Appendix table 3.1 
Appendix table 3.1 Crx+ve E15.5 specific gene list and expression fold changes 
 
E15.5+v- P4+v- Pos E15.5vP4 Neg E15.5vP4
10575227 Pmfbp1 7.40171 1.11228 11.3425 1.70448
10426385 Muc19 6.7345 1.70728 3.79409 -1.03967
10587077 Onecut1 5.34908 1.98551 6.61816 2.45658
10426383 Muc19 5.32521 1.23673 4.18323 -1.02932
10553477 Ano5 5.29653 1.11665 5.18558 1.09326
10486041 Meis2 4.25981 1.03087 -1.61024 -6.65395
10461979 Aldh1a1 4.24871 -3.32572 7.53073 -1.87632
10345016 Tcfap2b 4.24378 -1.63453 1.06917 -6.48781
10432831 Krt73 4.10624 1.16921 3.4788 -1.00954
10408798 Tcfap2a 3.4392 -1.40821 1.27202 -3.80743
10492402 Kcnab1 3.20919 -1.02407 2.05693 -1.59773
10514240 Slc24a2 2.74261 -1.99407 1.86717 -2.92901
10357339 Lypd1 2.45636 1.15356 1.65555 -1.2862
10564527 Nr2f2 2.37387 1.01021 1.7306 -1.35784
10358434 Pla2g4a 2.2837 -1.03389 3.95443 1.67483
10364402 Slc1a6 2.26781 1.23661 1.82212 -1.00646
10467319 Rbp4 2.08783 -1.16647 2.33731 -1.04196
Fold Change between copmarisonGeneSymbolGeneID
and  expression fold changes
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9.5 Appendix table 3.2 
Appendix table 3.2 Crx+ve E15.5 & P4 common gene list and expression fold changes  
  
  
GeneID GeneSymbol
E15.5+v- P4+v- Pos E15.5vP4 Neg E15.5vP4
10412882 Thrb 10.993 3.16205 3.78172 1.08778
10428376 Angpt1 11.0135 4.6791 1.75939 -1.33783
10502881 St6galnac5 5.00706 3.00236 1.64386 -1.01451
10344679 St18 3.71804 4.31443 1.52956 1.77491
10372023 Gm4792 3.49235 2.79062 1.23951 -1.00964
10462887 Pde6c 12.758 9.09732 1.07249 -1.3076
10495259 Gnat2 6.57846 6.78718 -1.04271 -1.01065
10528864 Cnpy1 2.33203 2.23657 -1.05128 -1.09615
10406817 Enc1 2.20788 2.2026 -1.09166 -1.09428
10382492 Otop3 3.04043 3.41933 -1.16554 -1.03639
10503464 Cngb3 26.0673 12.9657 -1.32521 -2.66432
10503259 Trp53inp1 2.06685 2.00654 -1.34396 -1.38435
10548118 Prmt8 2.65199 2.24071 -1.50301 -1.77889
10402020 Eml5 2.57303 2.94343 -1.51782 -1.32681
10440393 Samsn1 8.39357 12.5896 -1.53622 -1.02421
10411782 Pik3r1 2.72947 3.13696 -1.67729 -1.45941
10368970 Prdm1 8.55711 10.344 -1.70707 -1.41218
10422244 Slitrk6 28.2526 15.8267 -1.81468 -3.23941
10446334 Glcci1 2.97587 6.0902 -1.90631 1.07356
10402061 Eml5 2.91839 3.66592 -1.9167 -1.52586
10462195 Kank1 2.09994 4.2985 -1.94368 1.05314
10428004 Ankrd33b 2.11933 3.06033 -1.9743 -1.36724
10543118 Glcci1 2.65454 5.13945 -2.02176 -1.04424
10529923 Lcorl 2.44664 4.65032 -2.14844 -1.13034
10484276 Neurod1 4.60123 10.5051 -2.38507 -1.04466
10474141 Slc1a2 4.15551 8.43913 -2.41959 -1.19143
10419356 Otx2 4.11957 4.80459 -2.56417 -2.19858
10454369 Fhod3 2.97124 7.20721 -2.73701 -1.12836
10427496 Egflam 4.13253 9.67583 -2.75206 -1.1754
10480139 C1ql3 6.62908 6.34843 -2.79417 -2.91769
10560168 Crx 15.6546 20.1751 -2.83702 -2.20134
10373680 Neurod4 22.0025 14.279 -2.98079 -4.59311
10600604 Dmd 3.13276 11.581 -3.04372 1.21455
10363224 Fabp7 17.3043 26.1714 -3.16354 -2.0917
10413981 Gm626 6.58336 20.5644 -3.41173 -1.09221
10564646 Sv2b 2.75689 16.9575 -3.62394 1.69731
10408812 Mak 6.25322 22.0808 -3.82327 -1.08274
10419015 Cdhr1 4.21158 14.3479 -4.55181 -1.3361
10484237 Zfp385b 2.64113 11.0052 -4.92003 -1.18076
10531348 Ppef2 5.50396 19.2097 -5.10044 -1.46138
10407337 Hcn1 5.18522 7.23023 -5.12108 -3.67262
10414663 Rpgrip1 5.75074 21.604 -6.26463 -1.66757
10436282 Impg2 13.7527 51.4033 -6.59326 -1.764
10400904 4930403N07Rik 2.07776 17.7718 -9.09124 -1.06289
10414034 Rbp3 10.0091 35.0821 -9.55153 -2.72511
10350530 Pdc 16.5561 43.7619 -12.2548 -4.63625
Fold Change between copmarison
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9.6 Appendix table 3.3 
Appendix table 3.3 Crx+ve P4 specific gene list and expression fold changes
 
GeneID GeneSymbol
E15.5+v- P4+v- Pos E15.5vP4 Neg E15.5vP4
10436416 Gabrr3 1.56298 47.1376 -30.1713 -1.00042
10491252 Samd7 1.23482 45.9339 -78.2068 -2.10239
10352928 Rp1 1.35926 44.6873 -49.0212 -1.49109
10522366 -1.1787 42.613 -52.0424 -1.03613
10523979 Pde6b 1.06469 41.5261 -67.4317 -1.72889
10530503 Cnga1 1.11251 36.0885 -40.8715 -1.25996
10540984 Rho -1.04559 34.1121 -44.2423 -1.24041
10540991 Rho 1.06174 31.3976 -33.492 -1.13256
10587639 Nt5e 2.25786 31.1249 -17.8497 -1.29485
10459475 Cplx4 -1.04124 27.3017 -34.7447 -1.22222
10348301 Sag 1.13769 23.2779 -29.9094 -1.46181
10420013 Nrl 1.89248 18.4976 -13.1307 -1.3434
10594188 Nr2e3 -1.09344 16.6894 -23.1088 -1.26632
10484261 Cerkl 3.12629 16.1369 -4.13472 1.24837
10536209 Gngt1 1.81586 15.3593 -12.1606 -1.43769
10413993 Gm626 4.29368 15.3371 -4.15283 -1.1626
10485357 1.54624 14.1963 -5.03205 1.82454
10531177 Adamts3 1.08234 14.1692 -6.7008 1.95368
10558150 Htra1 1.33505 13.6217 -14.2355 -1.3952
10475653 Slc27a2 -1.13881 12.5943 -9.69793 1.47892
10414168 Lrit2 2.02075 12.331 -6.86066 -1.1243
10541968 Ano2 1.51876 12.2319 -9.85965 -1.22422
10413979 Gm626 3.80615 11.1979 -3.80604 -1.29366
10541144 Cacna2d4 1.97631 11.1951 -7.68082 -1.35592
10413991 Gm626 3.24716 10.676 -3.94013 -1.19841
10368021 Gje1 1.05596 10.667 -8.89136 1.13613
10393793 Pde6g 1.29125 10.5799 -12.7712 -1.55869
10445293 Pla2g7 -1.27454 10.0114 -5.60963 2.27464
10595306 Impg1 1.15089 9.94632 -10.0882 -1.16732
10439483 Arhgap31 1.73977 9.85156 -7.52304 -1.32856
10529824 Prom1 1.24535 9.40123 -4.24424 1.77866
10602966 Rs1 1.07405 9.3161 -10.2494 -1.18164
10547858 Gnb3 2.78104 9.28214 -3.76594 -1.12832
10497276 Fabp12 1.12878 9.20939 -8.51571 -1.04375
10445633 Prph2 1.23823 9.1317 -8.48423 -1.15044
10408838 Elovl2 1.35792 8.63188 -4.36834 1.45518
10531179 Adamts3 -1.16794 8.61017 -7.63127 1.31776
10495712 Abca4 1.39594 8.07413 -6.2773 -1.08528
10413985 Gm626 2.14426 8.02536 -3.99514 -1.06744
10410995 Rasgrf2 2.42242 7.69304 -5.85925 -1.84499
10465833 Rom1 1.10279 7.59636 -7.09602 -1.03016
10543591 Opn1sw 1.46211 7.35149 -6.23974 -1.241
10531195 Adamts3 1.05045 7.21243 -4.63592 1.48104
10578222 Dlc1 2.22912 7.21027 -3.4664 -1.07167
10379176 Unc119 1.71948 7.19371 -3.81745 1.09593
10428124 Rgs22 2.21332 7.12397 -2.75136 1.16985
10352586 Ush2a 2.28418 7.01788 -3.4602 -1.12623
10466248 Stx3 1.61114 6.96566 -6.73011 -1.55666
10476795 4930529M08Rik 1.10935 6.95721 -4.34872 1.44213
10488804 Gm14214 1.20456 6.94072 -5.01794 1.14829
10388465 Doc2b 2.71129 6.75295 -3.03904 -1.22017
10413977 Gm626 2.04713 6.69868 -3.35515 -1.02534
10504672 Tdrd7 1.00695 6.64456 -6.68964 -1.01378
10354897 Trak2 1.85247 6.61963 -5.01534 -1.40352
10413999 Gm626 1.48267 6.55424 -4.74664 -1.07376
10578709 Wdr17 -1.25406 6.48935 -5.92946 1.37248
10593947 Cplx3 1.91689 6.21274 -4.11427 -1.26943
10590623 Cxcr6 2.07137 6.18301 -3.5795 -1.19917
10396840 Rdh12 1.013 6.16494 -6.00956 1.01269
10542738 Rassf8 1.93907 6.11243 -3.00378 1.04943
10452729 BC027072 1.08423 6.05408 -6.10163 -1.09275
10531193 Adamts3 1.09541 6.04745 -3.49286 1.58058
10402268 Lgmn 1.05821 6.0078 -6.92171 -1.21919
10597978 Fyco1 2.1969 5.97841 -3.48501 -1.28065
10482968 Pla2r1 1.15555 5.93668 -5.09318 1.00871
10366073 Cep290 1.35788 5.92009 -3.28442 1.32742
10414001 Gm626 1.62035 5.84266 -3.32439 1.08465
10461268 1810009A15Rik 1.0168 5.82991 -5.19098 1.10453
10514892 2210012G02Rik 1.93319 5.79579 -3.03297 -1.01165
10457475 Abhd3 1.64751 5.74139 -4.29229 -1.23169
10413995 Gm626 1.93989 5.7 -2.82912 1.0386
Fold Change between copmarison
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10580829 Cngb1 1.1839 5.68943 -5.41098 -1.12596
10354955 Mpp4 1.41652 5.66522 -5.1472 -1.287
10351665 Ccdc72 1.49154 5.64424 -3.48898 1.08461
10440314 Cadm2 1.65796 5.5947 -3.47506 -1.02982
10436666 Jam2 1.54415 5.52587 -2.86082 1.25089
10398459 Ppp2r5c -1.00481 5.51938 -4.45568 1.24469
10436623 Chodl 2.52038 5.51542 1.22612 2.68314
10550146 Cabp5 1.21357 5.48416 -4.7383 -1.04852
10453049 Cdc42ep3 1.49641 5.48076 -3.53911 1.0349
10472549 Bbs5 1.35512 5.47092 -4.40103 -1.09012
10420631 Ebpl 1.21116 5.36451 -5.12711 -1.15756
10449435 Tulp1 1.77893 5.36424 -3.5291 -1.17034
10598309 Cacna1f 1.21519 5.36359 -4.31375 1.02319
10531191 Adamts3 1.11941 5.31394 -4.20883 1.12789
10607064 Gucy2f 1.16859 5.25875 -5.33025 -1.18448
10523977 Gm10419 -1.00634 5.16872 -6.16471 -1.18518
10531203 Adamts3 -1.01664 5.16042 -2.85969 1.83457
10471675 Glo1 1.19349 5.1155 -5.25575 -1.22621
10531197 Adamts3 -1.04658 5.11408 -3.53137 1.51565
10514128 Ttc39b 1.59538 5.11125 -3.69123 -1.15215
10550217 Crxos1 2.61861 5.08755 -2.66619 -1.37231
10503234 Clvs1 -1.10758 5.0791 -1.98019 2.8409
10458645 Ppp2r2b -1.28521 5.07785 -4.03172 1.61869
10374578 Fam161a -1.16891 5.06097 -3.74481 1.57973
10538206 Ccdc126 1.46046 5.03828 -4.05328 -1.17493
10590445 Snrk 1.26359 5.02082 -4.01741 -1.01106
10476791 4930529M08Rik 1.43901 4.95348 -2.10477 1.63547
10419366 Gm534 1.17769 4.95253 -4.22477 -1.00464
10449644 Glo1 1.09345 4.93538 -4.9488 -1.09642
10497713 Pex5l 1.32106 4.92491 -3.46657 1.07541
10399046 Vipr2 -1.01688 4.90671 -4.45678 1.11953
10412335 Isl1 -1.59131 4.89052 1.3737 10.6906
10517731 Igsf21 2.17235 4.84819 -2.64916 -1.18702
10571657 Acsl1 1.35559 4.81671 -4.58377 -1.29003
10543791 Podxl 1.90941 4.76013 -1.97798 1.26037
10356154 Sphkap 2.37251 4.73331 -3.36976 -1.68905
10420503 Setdb2 1.2769 4.69231 -3.99343 -1.08672
10366595 Dyrk2 1.2676 4.66271 -3.4899 1.054
10473880 Lrp4 -1.18694 4.65252 -6.71325 -1.21567
10593767 Chrnb4 1.75116 4.6459 1.17311 3.11231
10373622 Olfr773 1.07792 4.5998 -4.40506 -1.03229
10570379 Grk1 1.13827 4.58825 -4.73281 -1.17414
10414003 Gm626 1.63183 4.56862 -2.55118 1.09741
10364784 Reep6 1.66124 4.55004 -3.23403 -1.18076
10531183 Adamts3 -1.09222 4.53914 -3.65957 1.35473
10531173 Adamts3 1.27644 4.53009 -3.21892 1.10255
10494509 Pias3 1.06588 4.52989 -4.01447 1.05864
10413983 Gm626 1.96447 4.42784 -2.36186 -1.04787
10493189 Mef2d 1.40113 4.39043 -3.74915 -1.19648
10387505 Atp1b2 1.84192 4.38038 -5.26182 -2.21256
10531187 Adamts3 1.15843 4.3781 -3.30351 1.14404
10363231 Smpdl3a 1.86284 4.36274 -2.27175 1.03091
10482030 Stom -1.08347 4.35805 -4.66603 1.01195
10536827 Ccdc136 1.51521 4.3569 -2.441 1.17797
10462303 Kcnv2 2.01156 4.32865 -2.71686 -1.26255
10519855 Cacna2d1 1.71996 4.32617 -1.29466 1.9428
10440621 Grik1 1.02031 4.28654 -6.07252 -1.44542
10596737 Gnat1 1.15297 4.24634 -4.09312 -1.11137
10411171 Pde8b 1.05532 4.24144 -3.85799 1.04176
10414163 Lrit1 1.63678 4.21884 -2.90364 -1.12653
10458046 D0H4S114 1.26789 4.17311 -2.26477 1.4533
10593668 Dmxl2 1.39853 4.16733 -3.16686 -1.06278
10580850 1.30427 4.15638 -3.12241 1.02061
10427159 Gm9918 1.88072 4.14065 -2.29928 -1.04435
10596982 Ccdc72 1.33164 4.093 -2.74202 1.12095
10384572 1110067D22Rik 1.32883 4.08823 -2.9098 1.05731
10350247 Kif21b -1.03458 4.07574 -1.94014 2.17339
10393166 St6galnac2 1.20908 4.07183 -3.32342 1.01333
10420532 Atp8a2 -1.66213 4.04273 -3.1637 2.12395
10528031 Zfp804b 1.21134 4.03227 -4.2329 -1.27161
10352792 Gm10124 1.01887 4.01934 -3.22902 1.22171
10429140 Ndrg1 1.38675 3.97818 -4.7455 -1.65423
10505623 D4Bwg0951e 2.16305 3.95598 -2.14892 -1.17498
10377235 Rcvrn 1.15175 3.94552 -3.04709 1.12425
10598359 Syp 1.51843 3.87938 -2.88935 -1.13093
10460157 Cpt1a -1.42002 3.8496 -2.90429 1.88222
10352781 Rd3 1.19109 3.78289 -3.55745 -1.12011
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10565360 1.01877 3.78087 -3.21852 1.15308
10454580 Bin1 1.63083 3.77643 -2.03404 1.13845
10404848 Jarid2 1.21986 3.76638 -3.58258 -1.16033
10479726 Pcmtd2 1.79527 3.76561 -2.73496 -1.30391
10344935 Kcnb2 1.06275 3.76165 -1.49339 2.37015
10380571 Gngt2 2.04152 3.75887 -2.42316 -1.31607
10560919 Atp1a3 -1.23102 3.75012 -6.15319 -1.33288
10366554 Mdm1 1.05751 3.74959 -2.79738 1.26749
10465764 C730048C13Rik 1.58344 3.72027 -2.84627 -1.21145
10593671 Dmxl2 1.31459 3.70081 -2.84735 -1.01143
10440292 Gm5488 1.19193 3.64536 -3.27652 -1.07133
10585778 Sema7a -1.05654 3.64527 -3.12341 1.23306
10344743 3110035E14Rik 2.45765 3.62666 -2.53073 -1.71498
10382376 Ttyh2 1.81247 3.58817 -3.51552 -1.77577
10558285 Zranb1 1.35197 3.58516 -3.13773 -1.18325
10386359 Guk1 1.02499 3.57025 -3.18173 1.09475
10423293 Myo10 1.15711 3.5634 -3.23297 -1.04981
10476628 Otor 1.01212 3.56107 -3.60789 -1.02543
10594144 Bbs4 1.26758 3.54791 -2.16995 1.28987
10440329 9330155M09Rik 1.36482 3.53727 -1.89354 1.36874
10413987 Gm626 1.8556 3.53418 -2.03247 -1.06714
10392415 Rgs9 1.55203 3.52891 -3.53079 -1.55286
10502696 Spata1 1.25963 3.51568 -2.7608 1.01095
10415890 Rp1l1 1.85238 3.51153 -2.27284 -1.19895
10389738 Dgke 1.14266 3.50347 -3.31513 -1.08123
10548899 Rerg 1.10718 3.49827 -3.49271 -1.10542
10531370 Naaa 1.8812 3.49207 -2.66921 -1.43792
10594747 C2cd4b 1.65077 3.48033 -2.04134 1.0328
10585484 Chrna5 1.01644 3.47781 -1.87292 1.82686
10422822 Lifr 1.28228 3.45633 -4.20741 -1.56092
10404612 Rreb1 1.7541 3.44475 -2.32251 -1.18264
10508052 Grik3 1.3637 3.44141 -2.531 -1.00294
10503866 Gabrr1 -1.04233 3.44093 -2.86596 1.25144
10588495 Dusp7 1.19357 3.4291 -2.1887 1.31264
10347073 Unc80 2.28709 3.42583 -2.24305 -1.49747
10479698 Myt1 1.10897 3.42219 -1.64882 1.8716
10503992 Tmem215 1.3805 3.4179 -2.79354 -1.12832
10476814 Insm1 1.15923 3.4161 -1.67268 1.76177
10429218 Fam135b 1.03943 3.41505 -3.53511 -1.07597
10429203 Fam135b 1.13181 3.41276 -3.85884 -1.27975
10405753 Me1 -1.59932 3.40088 -4.27204 1.27318
10554392 D330012F22Rik -1.19786 3.38468 -4.15748 -1.02543
10583847 Bbs9 -1.20228 3.37727 -4.54105 -1.11837
10398455 Ppp2r5c 1.00942 3.35747 -2.97174 1.11925
10600994 Arr3 1.03877 3.33913 -3.24265 -1.00875
10531544 Paqr3 1.1238 3.32818 -2.28076 1.29849
10589685 Lrrc2 1.1572 3.31093 -2.98485 -1.04323
10595392 Elovl4 1.10098 3.2966 -3.0154 -1.00707
10519815 Cacna2d1 1.42311 3.2895 -1.23462 1.87222
10505568 Frmd3 -1.46895 3.27672 -1.28644 3.74158
10572050 Mar 1.00628 3.27366 -3.14373 1.03483
10543572 Impdh1 1.20914 3.27104 -2.65554 1.01873
10565210 Fam154b -1.03032 3.25567 -2.66788 1.25732
10507500 Slc6a9 1.1708 3.23292 -3.23045 -1.16991
10421934 Klhl1 1.16602 3.22274 -1.05694 2.61498
10389581 Ypel2 2.17532 3.22264 -1.98577 -1.34042
10346330 Plcl1 1.55175 3.20984 -1.41739 1.4594
10400006 Ahr -1.18259 3.19761 -2.12326 1.78097
10603051 Ap1s2 1.22257 3.1968 -2.15248 1.21479
10499988 2310007A19Rik 2.26686 3.19467 -1.27402 1.10618
10481711 Stxbp1 1.29356 3.19363 -1.60619 1.5371
10552857 Slc17a7 1.32034 3.17132 -2.62905 -1.09457
10545014 Vopp1 -1.13459 3.1695 -2.84351 1.26466
10386951 Hs3st3b1 1.30514 3.15196 -2.13828 1.12943
10578477 Fam149a 1.20713 3.14455 -2.23838 1.16379
10511258 Fam132a 1.31156 3.14312 -2.22264 1.07821
10408268 Scgn 1.21635 3.13135 -2.81532 -1.09359
10531189 Adamts3 1.19495 3.12801 -2.51826 1.03948
10427428 AW549877 1.27932 3.11818 -2.5872 -1.06147
10428388 Rspo2 1.44061 3.11568 -2.29199 -1.05976
10347060 Unc80 1.59891 3.06919 -2.16611 -1.12844
10443027 A930001N09Rik 1.64011 3.06786 -2.13955 -1.14383
10494069 Celf3 1.56155 3.05124 -1.03229 1.89287
10348321 Dgkd 1.44176 3.04502 -2.07896 1.0159
10431697 Abcd2 1.6015 3.04069 -1.78767 1.06208
10415228 Cpne6 1.19314 3.02101 -3.21398 -1.26935
10346000 Gulp1 1.03064 3.01726 -2.72265 1.07526
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10471533 1.76433 3.00824 -1.45441 1.17232
10476793 4930529M08Rik 1.36797 3.00181 -1.87722 1.16893
10372745 Dyrk2 1.30078 2.99886 -1.76422 1.30678
10366196 Ppfia2 1.44206 2.99559 -2.31388 -1.11389
10370471 Agpat3 1.15365 2.9879 -3.63302 -1.40273
10496192 Tacr3 1.94921 2.98331 -3.31982 -2.16907
10557498 Fam57b 1.26172 2.98234 -2.6136 -1.10572
10357164 Epb4.1l5 1.15452 2.98192 -1.94708 1.32652
10497214 Tpd52 2.07922 2.97897 -2.69683 -1.8823
10531181 Adamts3 -1.038 2.97697 -2.86936 1.07693
10509441 Ece1 1.30382 2.97518 -2.22003 1.02787
10420637 Kpna3 -1.06575 2.96294 -2.5819 1.22304
10399337 Klhl29 1.55869 2.95826 -1.59453 1.19026
10405174 Nxnl2 1.27952 2.94979 -2.92087 -1.26698
10362186 Moxd1 -1.1496 2.94717 -5.06671 -1.49545
10503334 Gem 1.04369 2.92072 -2.59492 1.07843
10440288 Zfp654 1.33596 2.91946 -2.50776 -1.14757
10354168 Tbc1d8 1.19189 2.90283 -3.38802 -1.39111
10533026 Prkab1 1.02719 2.89211 -2.74227 1.02672
10484941 Madd 1.13194 2.88858 -2.45471 1.03958
10440206 Arl6 1.03534 2.88748 -2.53435 1.10045
10531201 Adamts3 -1.12074 2.88198 -2.81566 1.14713
10410408 Adcy2 1.70573 2.87769 -3.3475 -1.98421
10438442 A930003A15Rik 1.10558 2.87673 -2.70085 -1.03798
10506754 Slc1a7 1.19328 2.87647 -2.3181 1.03989
10363921 Pcdh15 3.09258 2.87036 -6.92572 -7.46191
10476355 Chgb 2.16377 2.86612 -1.51893 -1.14671
10376579 Lrrc48 1.08212 2.86585 -2.97611 -1.12376
10459671 Dcc 1.7565 2.86387 2.30614 3.76003
10510708 Icmt 1.13795 2.86375 -2.41985 1.03998
10385297 Gabra1 1.54053 2.85675 -10.3722 -5.59335
10538658 Herc3 -1.22121 2.84603 -3.19077 1.08927
10578504 1700029J07Rik 1.1973 2.83941 -2.52064 -1.06289
10451665 Apobec2 1.22229 2.82865 -2.01891 1.14627
10505779 Acer2 1.13593 2.82837 -2.50931 -1.00779
10458569 Nr3c1 1.19687 2.82501 -2.22422 1.0612
10512129 B4galt1 -1.39769 2.82217 -3.83449 1.02869
10504564 Dcaf10 1.12929 2.81388 -2.64939 -1.06328
10424607 Ptp4a3 -1.00227 2.81157 -2.68694 1.04876
10514133 Ttc39b 1.05217 2.80373 -2.61427 1.0193
10596051 Tmem22 1.00746 2.79934 -2.41405 1.15101
10474619 Fmn1 -1.15986 2.79725 -1.42099 2.2832
10523974 Gm10419 1.18895 2.7921 -4.54438 -1.93512
10406941 Sgtb 1.16552 2.78381 -1.82113 1.31153
10504234 Unc13b -1.23641 2.78021 -2.13542 1.60974
10558295 Zranb1 1.5612 2.77866 -2.28927 -1.28623
10382409 Kif19a 1.66908 2.76537 -1.90095 -1.14735
10607619 Cdkl5 -1.01453 2.76243 -2.35022 1.19247
10357155 Inhbb 1.96871 2.75733 -1.73812 -1.241
10592802 C2cd2l 1.00512 2.75266 -2.34036 1.17018
10456096 Pde6a 1.28197 2.74065 -2.43282 -1.13798
10415700 Mtmr6 1.00137 2.7378 -2.03351 1.3445
10568586 Fam53b 1.60333 2.73505 -1.79093 -1.04987
10457357 Mpp7 1.48422 2.73373 -2.01633 -1.09472
10427997 Ankrd33b 1.63131 2.71887 -2.01761 -1.21056
10452516 Ankrd12 -1.0798 2.71568 -2.4652 1.18951
10598586 Xk -1.42407 2.70977 -3.43488 1.12344
10474201 Lmo2 -1.05567 2.70938 1.1399 3.26034
10493177 Mef2d 1.4956 2.70611 -2.12104 -1.17225
10383819 Sec14l2 1.29941 2.69709 -2.38621 -1.14963
10485979 Gjd2 -1.1969 2.69682 -4.48856 -1.39059
10405576 Fbxl21 -1.08335 2.69453 -2.08493 1.40011
10535017 Gal3st4 1.03226 2.69193 -2.22368 1.17274
10400896 2810055F11Rik 1.08203 2.68509 -2.15911 1.14933
10579976 Elmod2 1.22104 2.67817 -1.45985 1.50246
10418053 Kcnma1 -1.09801 2.67229 -4.41711 -1.50538
10440513 Cyyr1 1.10767 2.6722 -1.5343 1.57235
10475324 Ckmt1 -1.09544 2.66946 -2.92836 -1.00141
10466903 4430402I18Rik -1.00989 2.66415 -3.86708 -1.43731
10601598 3110007F17Rik 1.35392 2.65714 -1.64652 1.19194
10582464 2.0879 2.65675 -1.47599 -1.15996
10476782 4930529M08Rik -1.05079 2.65533 -1.87978 1.48432
10601595 3110007F17Rik 1.34439 2.64575 -1.63947 1.20038
10597162 Klhl18 -1.10229 2.64435 -2.84441 1.02477
10414417 Peli2 1.08565 2.64333 -1.55296 1.56785
10549849 Zfp78 1.29619 2.64314 -1.92444 1.05961
10497842 Bbs7 -1.02996 2.64062 -2.5832 1.05286
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10449971 Zfp763 1.34705 2.63689 -1.77355 1.10374
10444890 Ier3 1.16517 2.6323 -1.80359 1.25259
10397683 Ttc8 1.19381 2.63163 -2.31089 -1.04831
10595480 Me1 -1.53876 2.62763 -3.37354 1.19853
10495685 Arhgap29 1.4234 2.6274 1.06996 1.97499
10575693 Vat1l -1.32856 2.60801 -5.11672 -1.47673
10388109 Pitpnm3 1.03938 2.60227 -2.73164 -1.09104
10404059 Hist1h1c -1.08298 2.59884 -2.89983 -1.03032
10462313 Slc1a1 -1.15036 2.59651 -5.52904 -1.85107
10390080 Tmem92 -1.15972 2.59546 -2.71718 1.10776
10488497 Vsx1 1.22303 2.58552 -2.31751 -1.09625
10421293 Ppp3cc 1.15836 2.58299 -4.99214 -2.23875
10585976 Myo9a -1.07853 2.57451 -1.40664 1.97398
10407792 Gpr137b-ps 1.2761 2.56242 -1.64637 1.21966
10388884 Nlk 1.97632 2.56031 -1.45093 -1.11998
10476512 Snap25 1.25319 2.55632 -2.3121 -1.13347
10405253 Cplx2 1.39799 2.55392 -1.87899 -1.02854
10372503 Lgr5 -1.11738 2.55332 -1.77645 1.60603
10459469 1.00703 2.54678 -2.70641 -1.07015
10401997 Ptpn21 1.24906 2.54603 -3.261 -1.59981
10597575 Plcd1 1.46896 2.53973 -1.80767 -1.04555
10510422 Casz1 1.03073 2.53881 -1.98703 1.2396
10386427 Flcn 1.16211 2.53421 -2.55719 -1.17264
10437073 Ripply3 1.32277 2.53308 -1.53558 1.24707
10453178 Map4k3 1.18416 2.53214 -1.92912 1.10845
10541260 Cecr2 1.31431 2.52845 -1.68569 1.14124
10382830 Gm11744 1.35351 2.52115 -1.91253 -1.02677
10566723 Lmo1 -1.03536 2.52057 -1.6287 1.60233
10494335 Otud7b 1.06421 2.51915 -2.45023 -1.0351
10536390 Glcci1 1.6809 2.5188 -1.4647 1.02306
10470564 Ralgds -1.01054 2.51151 -2.16531 1.17211
10531185 Adamts3 -1.01479 2.51105 -2.6502 -1.04003
10584901 Dscaml1 -1.1683 2.50649 -2.68727 1.08971
10413997 Gm626 1.65771 2.50559 -1.58726 -1.05014
10448064 Prdm9 1.019 2.50297 -2.52273 -1.02704
10468517 Mxi1 1.31963 2.50087 -2.34576 -1.23778
10404380 Dusp22 1.0172 2.4953 -2.41507 1.01575
10589913 Dync1li1 1.00299 2.4947 -1.62335 1.53217
10542731 Rassf8 1.30299 2.4925 -1.62952 1.17391
10415714 Fam123a 1.64993 2.48717 -1.40519 1.07277
10516393 Eif2c4 1.44993 2.48711 -2.02748 -1.18197
10505587 Kdm4c 1.29667 2.48068 -2.32971 -1.21775
10581088 Ccdc79 1.02861 2.47912 -2.28003 1.05707
10355227 1110028C15Rik 1.4499 2.47181 -1.91011 -1.12042
10565525 1.04168 2.46806 -2.36697 1.00098
10555205 Gdpd5 -1.09979 2.46511 -2.22872 1.21644
10395805 1700047I17Rik1 -1.25084 2.45843 -2.98213 1.03117
10352867 Plxna2 2.09998 2.45662 -2.46729 -2.1091
10481349 Ntng2 1.88705 2.45379 -1.47233 -1.13228
10479765 Suv39h2 1.07371 2.44852 -1.49869 1.52162
10366038 Galnt4 1.10656 2.44791 -2.59401 -1.1726
10585980 Myo9a 1.3176 2.44732 -1.15365 1.61002
10364249 1.14195 2.44384 -2.16608 -1.01216
10423503 Gm6624 1.14011 2.44203 -1.60707 1.33282
10457359 Mpp7 1.2649 2.43801 -2.04372 -1.06033
10585974 Myo9a 1.1752 2.43166 -1.26475 1.63601
10465336 Mrpl49 1.26941 2.42919 -1.98741 -1.03855
10440186 Crybg3 -1.32496 2.42703 -1.4546 2.21071
10506274 Dnajc6 -1.05403 2.42057 -1.86679 1.36671
10582890 1.14925 2.42013 -2.07298 1.01585
10408935 Gm10786 1.09708 2.41891 -9.32868 -4.23098
10549276 Bhlhe41 1.17499 2.41634 -2.78479 -1.35416
10409265 Auh 1.03038 2.41491 -2.19766 1.06646
10456577 1.26201 2.41189 1.02853 1.96567
10573803 Cyld 1.11107 2.40853 -2.4033 -1.10866
10587655 4930422I07Rik 1.15882 2.40743 -1.92842 1.07729
10363762 Tmem26 1.47596 2.40008 -1.36817 1.18853
10514713 Wdr78 1.02061 2.39664 -1.72246 1.3633
10349208 Cntnap5a 1.11821 2.39655 -2.46587 -1.15055
10359027 Lhx4 1.34343 2.39105 -1.84029 -1.03398
10546272 Iqsec1 -1.0654 2.39032 -2.06505 1.23321
10363161 Tmem229b -1.26663 2.3814 -2.06134 1.4633
10555303 Pgm2l1 1.00793 2.38018 -1.28074 1.84382
10384566 1.09431 2.3783 -2.23159 -1.0268
10500378 Nudt17 1.19826 2.37306 -1.68756 1.17354
10503659 Epha7 -1.04798 2.37221 -2.15222 1.1551
10511984 1700003M02Rik -1.09058 2.37137 -1.47089 1.75824
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10399148 Rapgef5 -1.00601 2.36846 -1.63243 1.4596
10586971 Prtg 1.85034 2.36644 1.54169 1.97169
10417841 Ttc18 1.088 2.36636 -2.05137 1.06024
10376425 Gm12258 1.17875 2.36303 -1.94358 1.03144
10467766 Loxl4 1.36379 2.3588 -1.99434 -1.15307
10589541 Kif9 1.15006 2.35126 -2.24149 -1.09637
10366026 Poc1b 1.00025 2.34234 -1.80012 1.30088
10384179 1.14282 2.34132 -2.19547 -1.07163
10463254 D19Ertd386e 1.3349 2.33547 -1.78598 -1.02083
10533055 Srrm4 1.71307 2.33335 -1.25933 1.0816
10423593 Laptm4b -1.09566 2.33175 -2.60445 -1.01943
10554076 Lysmd4 1.15492 2.33123 -2.15199 -1.06613
10403081 Wdr60 1.04056 2.32707 -2.27688 -1.01812
10549222 Bcat1 1.28512 2.32183 -1.65279 1.09312
10513544 Zfp37 1.1335 2.31879 -1.73716 1.1776
10523297 Ccng2 1.18806 2.31875 -1.78402 1.094
10505747 Rraga -1.00205 2.31479 -2.06033 1.12581
10519607 4930420K17Rik 1.38246 2.31233 -2.16099 -1.29198
10500899 Fam19a3 1.15151 2.30366 -2.44354 -1.22143
10453900 Riok3 1.1333 2.30349 -2.02635 1.00306
10510482 Clstn1 1.00629 2.30346 -2.56083 -1.11873
10513592 Wdr31 -1.01541 2.29736 -1.98659 1.17425
10467258 Myof 1.11361 2.29186 -2.58363 -1.25538
10403796 Amph -1.1379 2.28951 -3.52346 -1.35245
10545065 Gprin3 1.29 2.28272 -2.23518 -1.26314
10436947 Kcne2 1.44492 2.27596 -1.8501 -1.17455
10411059 Zfyve16 1.40197 2.2755 -1.89514 -1.16763
10504373 Gm12472 -1.02543 2.27396 -2.50775 -1.07547
10565910 Plekhb1 1.2541 2.27326 -4.14376 -2.28601
10415784 Trim13 -1.08624 2.27324 -1.34249 1.83933
10557397 D430042O09Rik 1.02247 2.27274 -2.24411 -1.00959
10390841 Krt12 2.68669 2.27203 1.24205 1.05036
10360349 Cadm3 1.68219 2.27022 -1.57632 -1.16802
10585956 Myo9a -1.07383 2.27005 -1.47266 1.65528
10380289 Mmd -1.15768 2.26916 -1.65084 1.59128
10379410 Rhot1 -1.05858 2.26584 -2.2992 1.04322
10531437 Scarb2 1.01393 2.26162 -2.18803 1.01943
10533304 Trafd1 1.18001 2.26052 -1.62718 1.17729
10439114 Iqcg 1.0811 2.25812 -1.50637 1.3866
10521757 1.02461 2.24788 -2.00027 1.09679
10573472 Rtbdn 1.20968 2.24604 -1.85841 -1.00091
10604922 BC023829 -1.00888 2.23622 -2.26447 -1.00371
10420899 Gulo 1.56687 2.23377 -1.48563 -1.04209
10585978 Myo9a 1.13842 2.22944 -1.24585 1.57192
10383564 Fn3k 1.30148 2.22889 -1.92774 -1.12564
10595805 Rasa2 1.2491 2.22509 -1.53475 1.16069
10536949 Fam40b 1.20194 2.22505 -2.29755 -1.24111
10567964 Cln3 1.0286 2.22478 -2.16838 -1.00253
10570573 Agpat5 1.08463 2.22385 -2.17805 -1.06229
10601588 3110007F17Rik 1.29496 2.21928 -1.43976 1.19032
10476482 6330527O06Rik 1.04855 2.21879 -4.22842 -1.99825
10402997 LOC630837 -1.02872 2.21805 -1.85338 1.23114
10535532 Tecpr1 1.37514 2.21479 -1.58918 1.01347
10546152 Podxl2 -1.08348 2.2104 -2.29707 1.04261
10465770 -1.041 2.20845 -2.17928 1.05493
10561337 1700049G17Rik -1.10437 2.2077 -2.07049 1.17756
10603598 Rpgr -1.098 2.20675 -2.0735 1.16856
10388098 Aipl1 1.07247 2.20669 -2.13161 -1.03598
10461311 Eml3 -1.00388 2.20492 -2.22045 -1.00315
10460468 Ctsf 1.61068 2.19978 -1.7328 -1.26875
10485562 Hipk3 -1.01041 2.19735 -2.28409 -1.02877
10344624 Lypla1 1.33908 2.19673 -1.59739 1.02697
10422962 1110020G09Rik 1.07829 2.19593 -1.85069 1.1004
10375343 Rnf145 -1.09035 2.19571 -2.43642 -1.01768
10565532 Ankrd42 1.00715 2.19203 -1.1651 1.86805
10503835 Rragd 1.18228 2.19164 1.03103 1.91126
10517521 Epha8 1.38766 2.19087 -1.71495 -1.08622
10474371 Gm16488 1.36197 2.19081 -1.54407 1.04176
10400948 Six6os1 1.28714 2.18967 -1.88958 -1.11073
10571647 4933411K20Rik 1.05066 2.18522 -1.70932 1.21677
10515242 Nsun4 1.24089 2.18252 -1.74716 1.00668
10512949 Abca1 1.20781 2.17968 -8.58166 -4.7553
10544148 Jhdm1d 1.43131 2.17772 -1.1825 1.28667
10367775 Stxbp5 1.69705 2.17653 -2.03053 -1.58321
10548905 Eps8 1.43357 2.17568 -1.90381 -1.25443
10577792 Plekha2 1.28646 2.17432 -1.902 -1.12534
10566714 Ric3 1.08115 2.17347 -1.86949 1.07533
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10577922 Hook3 1.01113 2.17237 -1.68917 1.2719
10350341 Mir181b-1 -1.07804 2.17122 -3.19297 -1.36413
10465742 Gm5631 1.04453 2.17028 -2.17622 -1.04738
10573939 Lpcat2 1.27082 2.17007 -3.69117 -2.16159
10593628 Rab39 1.32043 2.16936 -1.23456 1.33077
10427494 1.79659 2.16521 -1.25686 -1.04288
10578207 Lonrf1 -1.02076 2.16451 -1.87362 1.17924
10426292 Alg10b -1.08455 2.16388 -1.59711 1.46943
10458122 Nme5 1.61234 2.16355 -3.32809 -2.48019
10395770 Ppp2r3c -1.19096 2.16173 -2.50351 1.02838
10395780 Ppp2r3c -1.19096 2.16173 -2.50351 1.02838
10544150 Jhdm1d 1.39405 2.16103 -1.21453 1.27637
10535739 Usp12 1.03475 2.15935 -1.61905 1.28892
10529858 Tapt1 1.12817 2.15877 -2.40475 -1.25672
10518726 Slc25a33 1.17505 2.15779 -2.06038 -1.122
10579872 Tpd52 1.58348 2.15388 -2.1913 -1.61099
10504169 4933409K07Rik -1.4825 2.1537 -1.84143 1.7339
10520043 Lhfpl3 -1.28171 2.15023 -3.16497 -1.1484
10346678 Carf 1.1419 2.14812 -2.51364 -1.3362
10402630 Stk30 -1.15501 2.14303 -2.38694 1.03698
10549813 Zfp444 1.11829 2.13958 -1.88343 1.01583
10481827 Zbtb34 -1.01796 2.1378 -1.96002 1.11029
10516823 Epb4.1 1.07544 2.13485 -1.75052 1.13401
10555946 Smpd1 -1.07388 2.13465 -2.45271 -1.06995
10585972 Myo9a 1.12797 2.12991 -1.20818 1.56291
10571634 Lrp2bp 1.20479 2.12887 -1.77923 -1.00692
10407040 Esco1 1.40538 2.12829 -1.90666 -1.25904
10593589 1.05284 2.12803 -1.93685 1.04357
10365344 Tcp11l2 1.6286 2.12286 -3.7141 -2.84936
10587194 Gnb5 1.03198 2.11965 -2.63795 -1.28433
10504137 4933409K07Rik -1.35551 2.1182 -1.74545 1.64499
10504201 4933409K07Rik -1.35551 2.1182 -1.74545 1.64499
10512350 4933409K07Rik -1.35551 2.1182 -1.74545 1.64499
10512352 4933409K07Rik -1.35551 2.1182 -1.74545 1.64499
10401829 Gm8300 1.12387 2.11714 -1.5146 1.24376
10595126 Fbxo9 1.13091 2.11614 -2.36893 -1.266
10523670 Aff1 1.49592 2.11355 -1.2643 1.11752
10472562 Kbtbd10 1.37807 2.11335 -1.36929 1.11997
10527982 A330021E22Rik -1.05632 2.11288 -2.43777 -1.09225
10585990 Myo9a 1.25857 2.11235 -1.2234 1.37189
10406598 Serinc5 2.7583 2.11145 -1.47936 -1.93256
10366337 Nap1l1 -1.04725 2.10939 -1.66763 1.32467
10580852 1.17064 2.10871 -1.83421 -1.01825
10403193 Sp4 1.04901 2.10842 -1.56748 1.28227
10457959 Sft2d3 1.22832 2.10826 -1.44233 1.18999
10525741 Snrnp35 1.00125 2.10802 -1.95643 1.07613
10479379 Slco4a1 1.01852 2.10709 -1.77365 1.16639
10531342 U90926 1.23034 2.10705 -1.90332 -1.11138
10482434 Gtdc1 1.1703 2.10282 -2.15118 -1.19721
10487945 Gpcpd1 1.20501 2.10052 -2.05652 -1.17978
10378271 1200014J11Rik 1.19733 2.10007 -1.37081 1.27951
10426991 Ankrd33 1.2135 2.09874 -1.80867 -1.04578
10413967 Gm626 1.42072 2.0948 -1.73369 -1.17581
10350046 Kdm5b 1.34336 2.09329 -1.51746 1.02688
10449401 Tcp11 1.36504 2.09174 -1.58381 -1.03358
10584067 Zbtb44 1.2467 2.09105 -2.02224 -1.20568
10451851 Armcx3 -1.04473 2.0904 -2.06491 1.05763
10585970 Myo9a 1.18676 2.09 -1.26566 1.39144
10452613 Arhgap28 1.50142 2.08688 -1.36591 1.01759
10424370 Trib1 1.25436 2.08665 -2.35639 -1.4165
10374553 Tmem17 -1.05783 2.08652 -1.82436 1.20984
10363894 Ipmk 1.00121 2.08431 -2.1167 -1.01677
10556812 Lyrm1 -1.11394 2.0824 -2.04802 1.13264
10467110 AI747699 1.32044 2.07825 -1.08335 1.45282
10353036 Gm10567 1.04938 2.07801 -2.10224 -1.06162
10372139 Nts 1.07829 2.07593 -2.05189 -1.06581
10596072 Ppp2r3a 1.05744 2.07572 -1.76189 1.11412
10515924 Rimkla 1.00017 2.07436 -1.59674 1.29889
10553301 Ldha -1.11543 2.07221 -2.21213 1.04488
10588509 Pcbp4 1.11088 2.07071 -1.49086 1.25031
10429222 Fam135b -1.00237 2.0661 -2.13955 -1.0331
10566488 Trim3 1.04975 2.06475 -2.01297 -1.02343
10592001 St14 1.05532 2.06456 -1.85796 1.05295
10469335 Stam 1.25798 2.06329 -1.46586 1.11891
10397541 Gm8300 1.09855 2.06098 -1.46251 1.28279
10431140 1810041L15Rik -1.02246 2.05893 -1.69905 1.23902
10590487 Zfp660 1.38539 2.05885 -1.40033 1.06126
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10454632 Camk4 1.26742 2.05865 -2.04904 -1.2615
10506134 Atg4c -1.02451 2.0582 -2.59715 -1.23166
10422259 Tgds 1.22912 2.05705 -1.95866 -1.17033
10531175 Adamts3 1.018 2.05251 -1.67641 1.20269
10397543 Gm8300 1.09322 2.05233 -1.55773 1.20517
10554650 1700010L04Rik 1.14587 2.05169 -1.96922 -1.09982
10595573 Snx14 -1.0674 2.04777 -2.22153 -1.01635
10563820 Svip 1.52172 2.04565 -1.34358 1.00054
10451613 Foxp4 1.35316 2.04212 -1.13202 1.33314
10459193 Ppargc1b -1.05391 2.04047 -2.16289 -1.00578
10511139 Ssu72 1.02821 2.03801 -1.89689 1.04492
10487021 Slc30a4 1.09468 2.03749 -2.06522 -1.10957
10429216 Fam135b 1.05881 2.03702 -2.10378 -1.09351
10446763 Lbh 1.3168 2.0365 -1.73979 -1.12495
10585992 Myo9a -1.14623 2.03649 -1.40658 1.65953
10467102 Rnls 1.35423 2.03633 -1.49501 1.00581
10496387 Dnajb14 1.13824 2.03496 -1.65085 1.08296
10553324 Tmem86a 1.13331 2.03479 -2.04523 -1.13913
10376778 Mfap4 1.39867 2.03456 -1.05358 1.38066
10525487 4932422M17Rik 1.35421 2.03417 -1.45005 1.03591
10603627 Bcor 1.14635 2.03376 -1.48152 1.1975
10369738 Sirt1 1.19377 2.03305 -1.64817 1.03329
10437023 Morc3 1.09707 2.03101 -1.78815 1.03532
10519069 Plch2 1.28334 2.0309 -1.96427 -1.24124
10430770 Tob2 1.06923 2.02825 -2.10573 -1.11008
10529801 Fbxl5 1.15052 2.02786 -2.10563 -1.19464
10365199 Gm10778 1.24651 2.02748 -1.42394 1.14226
10445909 Kat2b 1.16198 2.0266 -2.38149 -1.36546
10491695 Bbs12 1.07234 2.02639 -1.54232 1.22523
10512301 Arid3c 1.21719 2.02191 -1.77027 -1.0657
10483822 Ttc30a2 -1.07089 2.02147 -2.19464 -1.0138
10562486 Rgs9bp -1.13057 2.02123 -2.02237 1.12994
10383353 Tspan10 1.04183 2.02104 -2.06699 -1.06552
10599335 Mcts1 1.16614 2.01959 -1.67971 1.03104
10446756 Ypel5 1.44447 2.01913 -1.8708 -1.33836
10369783 Zfp365 1.10912 2.01435 -1.70094 1.06775
10580870 Zfp319 1.01706 2.0115 -1.54536 1.27981
10435345 Mylk 1.1583 2.00958 1.09541 1.90047
10353135 Ncoa2 -1.08333 2.00934 -1.80923 1.20316
10474477 Gm13961 1.24295 2.00862 -1.39656 1.15714
10379795 Synrg 1.13049 2.00754 -1.74904 1.0153
10439362 Stxbp5l -1.31005 2.00723 -2.06766 1.27177
10531126 Igj 1.15894 2.00508 -1.92729 -1.11398
10376096 Acsl6 1.01149 2.00453 -2.08545 -1.05233
10419216 Gnpnat1 1.26108 2.00387 -1.29288 1.22904
10557481 Ypel3 1.36552 2.00212 -1.93489 -1.31967
10358991 BC034090 1.38022 2.00117 -1.31056 1.10632
10456296 Malt1 1.0351 2.00077 -1.87827 1.0291
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9.7 Appendix table 3.4 
Appendix table 3.4 Gene ontology terms enriched in the annotations of photoreceptor gene sets and classified here as encoding cell surface and cilium proteins 
 
 
Cell surface protein Cilium protein Cell surface protein Cilium protein Cell surface protein Cilium protein
'cell projection' 'cilium' 'cell projection' 'cilium' 'cell projection' 'cilium'
 'plasma membrane'  'cilium part'  'synapse'  'nonmotile primary cilium'  'cell projection membrane'  'cilium membrane'
 'plasma membrane part'  'nonmotile primary cilium'  'photoreceptor outer segment'  'plasma membrane'  'cilium part'
  'apical plasma membrane'  'stereocilium bundle'  'cilium'  'plasma membrane part'  'nonmotile primary cilium'
 'basolateral plasma membrane'  'stereocilium'  'nonmotile primary cilium'  'extrinsic to plasma membrane'  'stereocilium bundle'
 'extrinsic to plasma membrane'  'cilium axoneme'  'intrinsic to plasma membrane'  'photoreceptor connecting cilium'
 'cilium'  'motile secondary cilium'  'integral to plasma membrane'
 'cilium part'  'photoreceptor connecting cilium'  'cilium'
 'intrinsic to plasma membrane'  'cilium membrane'  'cilium membrane'
 'nonmotile primary cilium'  'cilium part'
 'photoreceptor outer segment'  'nonmotile primary cilium'
 'apical plasma membrane'  'stereocilium bundle'
 'cell projection membrane'  'photoreceptor connecting cilium'
 'stereocilium bundle'  'photoreceptor outer segment'
 'stereocilium'  'synapse'
 'cilium axoneme'  'synapse part'
 'motile secondary cilium'  'neuron projection'
 'photoreceptor connecting cilium'
 'photoreceptor inner segment'
 'cilium membrane'
 'synapse'
 'synapse part'
 'cell projection part'
NrlGFP+ve P4 CrxGFP+ve E15.5 CrxGFP+ve P4
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9.8 Appendix table 3.5 
Appendix table 3.5 Gene lists comparsion between Crx and Nrl array 
 
 
 
CrxE15.5 only 
(16) CrxP4 only (172)
CrxE15.5&P4 
common (17)
common to all 
three (27)
CrxE15.5 and 
NrlP4 common 
(0)
CrxP4 and NrlP4 
common (322) NrlP4 only (531)
Pmfbp1 Gabrr3 Slitrk6 Cngb3 Samd7 Rp1h
Muc19 Rp1 Neurod4 Pdc Pde6b ---
Onecut1 Gje1 Fabp7 Crx Cnga1 Pcdh21
Ano5 Arhgap31 Angpt1 Impg2 Rho 1700008G05Rik
Meis2 Fabp12 St6galnac5 Pde6c Nt5e Llgl2
Aldh1a1 Gm14214 Cdhr1 Thrb Cplx4 434166
Tcfap2b Cxcr6 Otx2 Rbp3 Sag 4930430E16Rik
Krt73 Chodl St18 Prdm1 Nrl D230044M03Rik
Tcfap2a Gm10419 Gm4792 Samsn1 Nr2e3 EG432988
Kcnab1 Clvs1 Glcci1 C1ql3 Cerkl Gucy2e
Slc24a2 Fam161a Pik3r1 Gm626 Gngt1 Abhd14b
Lypd1 Gm534 Prmt8 Gnat2 Adamts3 Gm1614
Nr2f2 Vipr2 Lcorl Mak Htra1 Vtn
Pla2g4a Isl1 Cnpy1 Rpgrip1 Slc27a2 BC016201
Slc1a6 Sphkap Enc1 Ppef2 Lrit2 OTTMUSG00000003947
Rbp4 Smpdl3a Ankrd33b Hcn1 Ano2 Nxnl1
Cacna2d1 Trp53inp1 Neurod1 Cacna2d4 Rxrg
Grik1 Slc1a2 Pde6g Peli3
D0H4S114 Egflam Pla2g7 1500016O10Rik
Gm9918 Dmd Impg1 Ubxn11
Zfp804b Otop3 Prom1 Guca1a
Gm10124 Fhod3 Rs1 Camkk1
Gm5488 Eml5 Gnb3 BC042720
3110035E14Rik Sv2b Prph2 Hspb6
Otor Zfp385b Elovl2 RP23-433P19.11
C2cd4b Kank1 Abca4 Kcnb1
Gabrr1 4930403N07Rik Rasgrf2 2010001M09Rik
Unc80 Rom1 BC035537
Myt1 Opn1sw Gata3
Tmem215 Dlc1 Klc3
Fam135b Unc119 Padi2
Paqr3 Rgs22 ENSMUSG00000054339
Frmd3 Ush2a Tshz2
Fam154b Stx3 Abcg4
Plcl1 4930529M08Rik C030018G13Rik
Stxbp1 Doc2b Ephx2
Vopp1 Tdrd7 Cdgap
Fam149a Trak2 Shroom3
Fam132a Wdr17 1700020C11Rik
Scgn Cplx3 Tub
Celf3 Rdh12 C1qdc2
Abcd2 Rassf8 Bhlhb3
Cpne6 BC027072 Crb2
Tacr3 Lgmn Lrguk
Fam57b Fyco1 Fer1l3
Tpd52 Pla2r1 Dhrs3
Gem Cep290 F630110N24Rik
Adcy2 1810009A15Rik 1700007K13Rik
A930003A15Rik 2210012G02Rik Zdhhc2
Dcc Abhd3 AW146242
Known/possible cone
genes were bold
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Gabra1 Cngb1 Elfn1
Acer2 Mpp4 Osbp2
Dcaf10 Ccdc72 Pard6b
Mtmr6 Cadm2 Sez6
Fam53b Jam2 Arhgap24
Lmo2 Ppp2r5c AI118078
Gjd2 Cabp5 Phyhd1
Kcnma1 Cdc42ep3 Chchd10
Cyyr1 Bbs5 Zdhhc23
4430402I18Rik Ebpl 1190005I06Rik
3110007F17Rik Tulp1 Vps13b
Zfp763 Cacna1f Paqr4
Arhgap29 Gucy2f Crocc
Vat1l Glo1 Rage
Vsx1 Ttc39b Pip4k2c
Gpr137b-ps Crxos1 Mthfr
Nlk Ppp2r2b Adcy6
Lgr5 Ccdc126 Rhbdf2
Gm11744 Snrk Pde6h
Ralgds Pex5l BC022687
Mxi1 Igsf21 Pacrg
Fam123a Acsl1 EG628705
Kdm4c Podxl Svil
Ccdc79 Setdb2 Rhpn1
Gm6624 Dyrk2 Lass4
Crybg3 Lrp4 Itga3
Gm10786 Chrnb4 Nefh
Bhlhe41 Olfr773 Ogdhl
Cntnap5a Grk1 Rdh8
Lhx4 Reep6 Sirpa
Tmem229b Pias3 Wdtc1
Pgm2l1 Mef2d Tbc1d24
Nudt17 Atp1b2 Scube3
Epha7 Stom Ppap2c
Gm12258 Ccdc136 4932418E24Rik
Loxl4 Kcnv2 Slc24a4
Poc1b Gnat1 Rabepk
Srrm4 Pde8b Plekhb2
Lysmd4 Lrit1 Pitpnm1
Bcat1 Dmxl2 Fance
Zfp37 1110067D22Rik Krt18
Ccng2 Kif21b Nphp4
Fam19a3 St6galnac2 A930008G19Rik
Riok3 Atp8a2 C030014K22Rik
Myof Ndrg1 Obox6
Amph D4Bwg0951e Ndrg3
Zfyve16 Rcvrn Synpo2
Gm12472 Syp Tmem176a
Trim13 Cpt1a Ttc30b
Krt12 Rd3 Bcar3
Cadm3 Bin1 Slc11a1
Scarb2 Jarid2 Rtn4rl1
Fam40b Pcmtd2 Syngr1
6330527O06Rik Kcnb2 AI427515
LOC630837 Gngt2 Pdk2
Tecpr1 Atp1a3 Slc31a2
1700049G17Rik Mdm1 Grina
Lypla1 C730048C13Rik Akna
Rnf145 Sema7a Bbs1
Rragd Ttyh2 Hnt
Gm16488 Zranb1 C79127
Six6os1 Guk1 Tln2
Abca1 Myo10 Tnfsf9
Jhdm1d Bbs4 Cst3
Eps8 9330155M09Rik Tmem135
Ric3 Rgs9 Jmjd2c
Mir181b-1 Spata1 Olfr772
Gm5631 Rp1l1 433036
Rab39 Dgke Rab27a
Alg10b Rerg D930005D10Rik
Ppp2r3c Naaa Farp2
Stk30 Chrna5 1110038D17Rik
Epb4.1 Lifr 5430407P10Rik
Lrp2bp Rreb1 Ramp3
Esco1 Grik3 Cetn4
Tcp11l2 Dusp7 2310031A18Rik
Gm8300 Insm1 6330442E10Rik
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Aff1 Me1 Uckl1
Kbtbd10 D330012F22Rik Lrit3
Serinc5 Bbs9 Tle2
Sft2d3 Arr3 Pde8a
Snrnp35 Lrrc2 Sys1
U90926 Elovl4 Slc6a2
Gtdc1 Mar-01 Sox30
Gpcpd1 Impdh1 Pdzd2
1200014J11Rik Slc6a9 6530418L21Rik
Kdm5b Klhl1 Akap1
Zbtb44 Ypel2 2210010N04Rik
Armcx3 Ahr Cckbr
Arhgap28 Ap1s2 Pnpla3
AI747699 2310007A19Rik Rorc
Gm10567 Slc17a7 Mamld1
Nts Hs3st3b1 Eno2
Ppp2r3a AW549877 Ccdc113
Rimkla Rspo2 Pomt2
Ldha A930001N09Rik Tead3
Pcbp4 Dgkd St3gal5
1810041L15Rik Gulp1 Pter
Zfp660 Ppfia2 3110001A13Rik
Camk4 Agpat3 Vasn
1700010L04Rik Epb4.1l5 4631416L12Rik
Svip Ece1 Susd2
Foxp4 Kpna3 Dynlrb2
Slc30a4 Klhl29 Zbtb4
Lbh Nxnl2 Ap1b1
Rnls Moxd1 ENSMUSG00000072890
Mfap4 Zfp654 5430411C19Rik
4932422M17Rik Tbc1d8 4930578G10Rik
Bcor Prkab1 4930546H06Rik
Sirt1 Madd Prickle1
Morc3 Arl6 Lrrc4
Fbxl5 Slc1a7 ENSMUSG00000053531
Gm10778 Pcdh15 Phlppl
Tspan10 Chgb Tect1
Mcts1 Lrrc48 Cdk2ap2
Ypel5 Icmt Ctbp2
Zfp319 Herc3 Mlf1
Gm13961 1700029J07Rik Clip4
Synrg Apobec2 1700030J22Rik
Stxbp5l Nr3c1 Mif4gd
Gnpnat1 B4galt1 Adck4
Malt1 Ptp4a3 Angel1
Tmem22 Dusp26
Fmn1 Tube1
Sgtb Mmd2
Unc13b Tmem9
Kif19a Shisa2
Cdkl5 ENSMUSG00000074917
Inhbb 1700129I04Rik
C2cd2l Hmgn2
Pde6a Syne2
Mpp7 1110012J17Rik
Ankrd12 Jag1
Xk Dixdc1
Sec14l2 Lmln
Fbxl21 Dhdh
Gal3st4 Lactb
2810055F11Rik 1110007C09Rik
Elmod2 Dlg4
Ckmt1 Mtfr1
Klhl18 Spint1
Peli2 Dnaja4
Zfp78 Slc44a1
Bbs7 Cltb
Ier3 Ccdc64
Ttc8 BC062109
Pitpnm3 Csda
Hist1h1c Cbx7
Slc1a1 3110056O03Rik
Tmem92 Txndc5
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Ppp3cc Taok3
Myo9a 6430571L13Rik
Snap25 Cc2d2a
Cplx2 Ppargc1a
Ptpn21 Morn1
Plcd1 B130055M24Rik
Casz1 A930018M24Rik
Flcn Wdr34
Ripply3 Calml4
Map4k3 Pwwp2b
Cecr2 Slc30a1
Lmo1 Gpr180
Otud7b Stard10
Dscaml1 Lrrc46
Prdm9 Apbb1
Dusp22 Sh3bgrl2
Dync1li1 Frmd4b
Eif2c4 Rxra
1110028C15Rik Arid3b
Gdpd5 Scn4a
1700047I17Rik1 Pygm
Plxna2 Accn3
Ntng2 Capns2
Suv39h2 Slc24a1
Galnt4 Cabp4
Mrpl49 Dnajc12
Dnajc6 Zfp787
Auh D10Bwg1364e
Cyld Crtc3
4930422I07Rik ENSMUSG00000055181
Tmem26 Zbtb7b
Wdr78 Tyrp1
Iqsec1 100039909
1700003M02Rik Pacsin2
Rapgef5 8030462N17Rik
Prtg Nr6a1
Ttc18 Zfp516
Kif9 Armc9
D19Ertd386e Pih1d2
Laptm4b Snta1
Wdr60 Cacnb2
Rraga Atp6v0b
4930420K17Rik Slc23a2
Clstn1 Got1
Wdr31 1110007L15Rik
Gprin3 4930466F19Rik
Kcne2 Clu
Plekhb1 Zdbf2
D430042O09Rik Baiap2
Mmd Ccdc65
Rhot1 Slc4a7
Trafd1 Scp2
Iqcg Epb4.1l2
Rtbdn 1110051M20Rik
BC023829 1810043G02Rik
Gulo Wfs1
Fn3k Cyp46a1
Rasa2 Rnf150
Cln3 Ap1gbp1
Agpat5 Lca5
Podxl2 Lrp2
Rpgr Sntb2
Aipl1 Rhbdd2
Eml3 Myo7a
Ctsf Lycat
Hipk3 Arl13b
1110020G09Rik D230014K01Rik
Ankrd42 Insm2
Epha8 Dyx1c1
4933411K20Rik ENSMUSG00000074230
Nsun4 5730557B15Rik
Stxbp5 Cnga3
Plekha2 Pgf
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Hook3 Cited1
Lpcat2 AI427122
Lonrf1 Itpk1
Nme5 Agl
Usp12 Galt
Tapt1 BC029684
Slc25a33 Hagh
4933409K07Rik 2810051F02Rik
Lhfpl3 Rdh9
Carf Slc29a2
Zfp444 Tex264
Zbtb34 Zbtb7a
Smpd1 Pla2g5
Gnb5 Xrcc4
Fbxo9 Klhdc8b
A330021E22Rik Fntb
Nap1l1 EG624121
Sp4 Bbs2
Slco4a1 Zfp715
Ankrd33 Map3k1
Tcp11 Ufsp2
Trib1 Rab28
Tmem17 Slc7a8
Ipmk Mbnl1
Lyrm1 Nfkbia
Trim3 Kifc3
St14 Fryl
Stam 4930565B19Rik
Atg4c 4833412L08Rik
Tgds 6330409N04Rik
Snx14 Ddi2
Ppargc1b Asah3l
Ssu72 Dcun1d3
Dnajb14 Nfic
Tmem86a Slc25a10
Plch2 Slc19a1
Tob2 Cacna1h
Kat2b Rab43
Bbs12 Ccdc96
Arid3c Dohh
Ttc30a2 Gpr162
Rgs9bp 4930485B16Rik
Zfp365 OTTMUSG00000005931
Mylk Ptges
Ncoa2 Ppara
Igj Tnfsf12-tnfsf13
Acsl6 Serinc3
Ypel3 Rffl
BC034090 Mzf1
Cish
Mpdz
6330512M04Rik
Ppil6
Bcl2l1
Gpr152
4930573I19Rik
Mllt6
Pde6d
Dctn1
Zdhhc16
Irf5
Nrtn
Cabc1
St3gal3
Sirt4
Ttll3
Dbndd2
Ahdc1
Nkiras2
Arhgap10
Wwc2
Atxn1
BC017158
Wdr51b
C130023O10Rik
Fbxw9
Mgat1
Klc4
Commd1
Man2a2
Dhdds
Pink1
Ccdc52
1110049F12Rik
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Perp
Sgms1
Cd8a
Cdh13
Svop
Mtnr1a
Rora
Cul4a
Btbd9
Agtpbp1
Gramd1b
Dnahc8
H6pd
Eno3
Arhgap26
Lad1
Tmem158
C030048H21Rik
Sesn1
Wdr19
D330017J20Rik
Rab3d
Scap
Lpgat1
Ppa2
Alpl
Pbx3
Zfpm1
Susd3
Chn1
4932417I16Rik
Tet3
Ddhd1
St6galnac4
Dennd3
Chchd5
2900052L18Rik
Cxxc5
BC057022
Ano10
0610037D15Rik
Oxct1
Stk11ip
Npepl1
Hfe
Dnaic2
Heatr5b
Katnal2
4930578N16Rik
4930430O22Rik
Qsox2
Sfrs2ip
Gas6
Arl4a
Tmem27
Scamp1
Synj1
AI462493
Kbtbd3
Fscn2
Acadvl
Msh5
Hist2h3c2
Ttll1
Hint3
Ift122
Gse1
Stab1
Snx25
4933432B09Rik
Bmp15
Slc12a6
Plagl2
5530400B01Rik
Dusp8
Slc26a2
BC032203
Plcxd2
2310006M14Rik
Dnajc16
Higd2a
Ofd1
Slc38a9
Smpd2
Ccl21a
EG624367
Adrb1
Ift81
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Aldh3a2
4833439L19Rik
Smarcd2
2600011E07Rik
9130008F23Rik
Lpin1
D9Ertd402e
Pnpla7
Slc4a5
Scarb1
Tmem42
Furin
Itfg2
Rnf32
Slc25a22
Akap7
D3Ertd751e
Tacc2
Otub2
Ezh1
Ercc2
Cab39l
Slc9a7
Rpl3l
Abcg1
Adam9
6430537H07Rik
Lingo3
Lrrc16a
2600009E05Rik
Phactr1
Chst12
Mknk1
Zbtb26
Lpcat1
Usp6nl
Prnp
Mreg
Akr1e1
Mpped2
Als2
Shroom2
Gm166
Dock8
Nfat5
2310047B19Rik
4930562D19Rik
Urod
Ttc30a1
Btc
Dalrd3
Pitpnc1
Ccpg1
6720456H20Rik
6620401K05Rik
Galnt7
Unc84a
Max
1110002L01Rik
Slc7a4
4930451G09Rik
Klhdc1
Pmm1
Rdh14
Als2cr4
Stk40
Punc
Tbc1d9
Ccndbp1
9630058J23Rik
Col17a1
Foxo3a
Gfpt1
7530404M11Rik
Wdr32
Zbtb22
Arfip2
Slc46a3
Mlh3
Tbc1d30
Pdgfa
Ppp1r16a
1700027N10Rik
Ptges2
Ppapdc2
EG639396
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9.9  Appendix figure 4.1 
 
 
 
 
Appendix figure 4.1 Sema7a and PlxnC1 co-
staining in adult mouse retina. (A) Sema7a 
(red) and PlxnC1 (mergenta) co-staining in 2 
month adult mouse retina. (B) Z-projection of 
Sema7a and PlxnC1 immuno-staining in the 
segment and ONL region. (C) Sema7a and 
PlxnC1 immuno-staining in INL to GCL region. 
(D) Sema7a and PlxnC1 co-labeling on a single 
photoreceptor cell in ONL. (E) Sema7a and 
PlxnC1 co-labeling on horizontal cells in OPL. 
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9.10 Appendix figure 4.2 
 
Appendix figure 4.2 Western blot of Sema7a and receptors full image. Lane 1: Sema7aGFP expression vector 
transfected HEK293 cells (for details about the vector, transfection and cells, see Appendix 4.1). Lane 2: 
untransfected HEK293 cells. Lane 3: retina lysates of 8 – 9 months CrxGFP mice. Lane 4 and lane 5: retina lysates 
of 7 weeks NrlKO+/- mice.  
9.11 Appendix 4.1 
Appendix 4.1 Sema7a shRNA knock down 
Purpose: I proposed to use shRNA to knockdown Sema7a expression in neonatal mice and 
transplant these cells into the host animals in order to examine if the migration and 
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integration efficiency of the transplanted cells might be affected. It is also possible to assess 
how the knockdown affects retina development to confirm the knockout effect I observed.  
Experimental design: I planned to use adeno-associated virus (AAV) infection which has been 
shown as the most efficient way to infect retina. This involved two-steps of sub-cloning 
(Appendix figure 4.1.1). The initial step was to construct several mU6 shRNA vectors and test 
their knock-down efficiency in cell lines. Then the most efficient mU6 shRNA vector would be 
subcloned into an AAV production vector PD10 and its effect examined in transplantation 
experiments.  
Results: I designed and synthesized four Sema7a shRNA sequences (Appendix 2.1, Appendix 
figure 4.1.2 A) and correctly inserted them into the mU6 vectors as confirmed by digestion and 
sequencing (Appendix figure 4.1.1). Initial validation of the Sema7a mU6 shRNA constructs was 
performed by visiting Erasmus student Veronika Haunerdinger under my supervision in cell 
lines by co-transfection with a Sema7a expression vector (Sema7a mouse cDNA clone ORF with 
C-terminal GFP tag, OriGene, Catalog No. MG209876). In HEK 293 cells, none of the four 
shRNAs can decrease Sema7a expression except shRNA1 which seemed to have some 
reduction although the effect was not significant (Appendix figure 4.1.2 B). Reduction in 
Sema7a expression was detected by qRTPCR and fluorescent microscopy in MC3T3 cells which 
express mouse Sema7a endogenously at low levels (Sudo, Kodama et al. 1983; Fratzl-Zelman, 
Fratzl et al. 1998; Delorme, Saltel et al. 2005). shRNA1 decreased endogenous Sema7a 
expression by around 30 – 40 % whereas the other three shRNA did not show effective 
reduction (Appendix figure 4.1.2 D left). For exogenous Sema7a expression, shRNA1, shRNA2, 
and the all four pooled shRNAs decreased the expression levels by around 50 %, 40 %, and 30 % 
(Appendix figure 4.1.2 D right) and the other two shRNA showed no reduction at all.   
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9.12 Appendix figure 4.1.1  
 
Appendix figure 4.1.1 Sema7a shRNA construction. The mU6pro vector (A) was cut with BbsI/XbaI and the 3 KB 
backbone (C) was gel purified for ligation with the Sema7a shRNA inserts which were synthesized with the cutting 
sites of BbsI/XbaI. The ligations were confirmed with AscI/SnaB1 for 400 bp products (D, black arrow). The 2nd 
colonies from five randomly chosen colonies of each shRNA ligation were mini and midi-preped and sequenced 
(D, white arrow). After validation of the mU6 shRNA in cell lines for knocking down effect of Sema7a, the most 
potent mU6 shRNA plasmid will be cut with AscI/SnaBI and the 400 bp product will be ligated with the backbone 
of PD10 (B) which will be cut with AscI/Bstz17I. 
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9.13 Appendix figure 4.1.2  
 
 
Appendix figure 4.1.2 Sema7a shRNA knockdown validation. The four shRNA sequences (A) were incubated with 
a Sema7a expression plasmid in HEK293 cells (B&C) and MC3Y3 cells (D). (B&C) 24hrs incubation for 
target:shRNA=1:20 in HEK 293 cells, images at 10X; (D) Transfection of MC3T3 cells with shRNA plasmid alone 
(Left) or shRNA plasmid and Sema7a expression plasmid (Right). no DNA: control group without transfection. 
Sema7A only: transfection with Sema7A  overexpression  plasmid  alone.  4x shRNA:  Sema7A overexpression 
plasmid and all 4 shRNAs pooled. shRNA#: one shRNA plasmid alone (left) or shRNA plasmid and Sema7A 
overexpression plasmid together (right)  
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9.14 Appendix figure 7.1 
Appendix figure 7.1 Swaroop array plot of marker candidates 
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9.15 Appendix table 7.1 
Appendix table 7.1 photoreceptor whole cell lysates 
 
Accession Entry Description mW (Da) pI (pH) PLGS Score Peptides Theoretical 
Peptides
Coverage 
(%)
Precursor RMS 
Mass Error 
(ppm)
Products Modified 
Peptides
Products RMS 
Mass Error 
(ppm)
Products RMS 
RT Error (min)
Amount 
(fmol)
Amount 
(ngrams)
Protein ID
P52480 KPY2_MOUSE Pyruvate kinase  M2 
isozyme  EC 2 7 1 40
57719 7.2131 552.8033 25 44 65.283 6.2573 173 1 17.574 0.014 56.1897 3.2453 41095
P17182 ENOA_MOUSE Alpha enolase  EC 4 2 
1 11   2 phospho D 
glycerate
46980 6.3752 735.7579 24 30 72.2864 4.3705 234 1 16.8074 0.0125 253.3919 11.9119 23162
P40142 TKT_MOUSE Transketolase  EC 2 2 
1 1   TK   P68
67587 7.2307 271.3765 22 44 44.9438 6.6353 101 0 16.4018 0.0136 15.05 1.0178 79962
P14733 LAM1_MOUSE Lamin B1 66613 4.9213 523.8222 22 68 47.7002 4.5622 149 1 18.225 0.0137 79.3386 5.2883 41701
Q04447 KCRB_MOUSE Creatine kinase  B 
chain  EC 2 7 3 2   B CK
42686 5.2866 605.1655 19 23 79.5276 4.2425 249 1 16.1442 0.0122 451.1776 19.2713 40228
P17751 TPIS_MOUSE Triosephosphate 
isomerase  EC 5 3 1 1   
TIM
26564 7.0833 238.9937 18 20 79.0323 5.3306 134 1 18.945 0.0132 10.9721 0.2917 80571
P11499 HS9B_MOUSE Heat shock protein 
HSP 90 beta  HSP 84   
Tumor spe
83142 4.775 364.1511 15 66 32.6418 5.4351 67 0 15.8408 0.0137 55.9171 4.652 35631
Q02053 UBA1_MOUSE Ubiquitin activating 
enzyme E1 1
117734 5.2956 270.6295 15 68 21.5501 6.2061 82 2 17.3191 0.0144 13.8487 1.6315 82546
P06151 LDHA_MOUSE L lactate 
dehydrogenase A 
chain  EC 1 1 1 27   LDH
36344 7.669 395.7395 15 28 59.5166 3.7905 145 1 16.1084 0.0128 118.809 4.3208 41976
P16858 G3P_MOUSE Glyceraldehyde 3 
phosphate 
dehydrogenase  EC 1 
2 1
35656 8.3507 1044.0819 13 19 58.4337 3.8951 253 0 15.673 0.0114 307.4733 10.9703 27737
P16627 HS7T_MOUSE Heat shock related 70 
kDa protein
70651 5.722 214.5654 10 51 32.1373 7.0539 50 2 14.702 0.0136 29.414 2.0794 35583
P35700 PDX1_MOUSE Peroxiredoxin 1  
Thioredoxin 
peroxidase 2   Thiore
22162 8.2344 140.6652 8 18 60.804 6.3721 44 0 19.4475 0.0136 5.217 0.1157 55598
P17183 ENOG_MOUSE Gamma enolase  EC 4 
2 1 11   2 phospho D 
glycerate
47136 4.7996 295.1113 7 30 25.4042 5.7158 45 1 13.736 0.0145 115.0281 5.4254 23174
P14206 RSP4_MOUSE 40S ribosomal protein 
SA  P40   34 67 kDa 
laminin
32698 4.5458 186.5374 7 25 39.322 5.102 35 0 12.7818 0.0143 22.8984 0.7492 71622
P17918 PCNA_MOUSE Proliferating cell 
nuclear antigen  
PCNA   Cyclin
28766 4.4643 132.3064 7 21 36.0153 6.8104 29 0 17.2591 0.0173 11.8413 0.3409 55375
Q61937 NPM_MOUSE Nucleophosmin  NPM   
Nucleolar 
phosphoprotein B23
32539 4.4242 131.7983 7 22 33.9041 3.7509 47 1 15.6858 0.0135 11.4286 0.3721 50670
P56480 ATPB_MOUSE ATP synthase beta 
chain  mitochondrial 
precursor
56344 4.9709 358.4167 6 37 25.7089 2.8273 45 0 14.6173 0.0105 44.6235 2.5159 6274
P05218 TBB5_MOUSE Tubulin beta 5 chain 49638 4.5903 1261.9083 6 31 26.8018 4.4825 123 0 13.7544 0.0116 406.6357 20.198 78289
P05213 TBA2_MOUSE Tubulin alpha 2 chain 50133 4.7622 920.6479 5 35 23.7251 3.1307 100 0 14.6719 0.0114 467.847 23.4699 78136
P20029 GR78_MOUSE 78 kDa glucose 
regulated protein 
precursor  GRP 78
72377 4.8748 313.7196 4 52 8.2443 6.8555 20 0 13.0869 0.0124 34.4199 2.4928 30757
Q9R1P3 PSB2_MOUSE Proteasome subunit 
beta type 2  EC 3 4 25 
1   Prot
22891 6.6086 129.2958 4 19 39.801 9.1596 22 1 18.2472 0.0192 4.2576 0.0975 60344
P02551 TBA1_MOUSE Tubulin alpha 1 chain 50103 4.7622 926.8679 4 35 19.9557 4.0742 95 1 13.604 0.0113 467.847 23.4559 78114
P08109 HS7C_MOUSE Heat shock cognate 
71 kDa protein
70827 5.1998 465.8573 3 50 8.8235 2.0273 39 0 13.6022 0.0119 62.6054 4.4369 35566
P26369 U2AF_MOUSE Splicing factor U2AF 
65 kDa subunit  U2 
auxiliary
53483 9.3635 146.2892 3 26 8.4211 5.6791 17 0 14.5612 0.011 16.806 0.8994 82501
Q9JJZ2 TBA8_MOUSE Tubulin alpha 8 chain  
Alpha tubulin 8
50019 4.7966 496.3186 2 35 10.9131 3.3523 53 1 14.789 0.0119 152.7005 7.6429 78163
P14701 TCTP_MOUSE Translationally 
controlled tumor 
protein  TCTP   p
19449 4.5679 135.8492 2 16 15.6977 8.9695 15 0 13.158 0.0115 16.4748 0.3206 78658
P47955 RLA1_MOUSE 60S acidic ribosomal 
protein P1
11467 4.0217 127.8643 2 7 75.4386 4.1428 29 1 14.1487 0.0141 26.0309 0.2987 67834
P53675 CLH2_HUMAN Clathrin heavy chain 2  
CLH 22
186909 5.4738 445.8013 28 133 22.3171 6.3253 100 5 18.4335 0.0151 11.9929 2.243 12981
Q04619 HS9B_CHICK Heat shock cognate 
protein HSP 90 beta
83375 4.7514 339.7942 22 68 34.4828 6.6605 112 1 18.3962 0.015 44.2634 3.6928 35629
P00924 ENO1_YEAST Enolase 1  EC 4 2 1 11   
2 phosphoglycerate 
dehydr
46642 6.1527 314.0052 22 28 64.9083 4.8703 172 2 18.3509 0.0136 50 2.3335 23153
P06576 ATPB_HUMAN ATP synthase beta 
chain  mitochondrial 
precursor
56524 5.0955 349.7532 20 38 60.8696 5.6867 131 0 17.6918 0.0131 44.6235 2.5239 6261
P70615 LAM1_RAT Lamin B1 66434 4.9711 477.9323 20 67 37.7133 6.427 117 3 14.8809 0.0141 61.0764 4.0601 41702
P11142 HS7C_HUMAN Heat shock cognate 
71 kDa protein
70854 5.1998 422.0086 19 50 38.3901 5.325 163 0 18.0179 0.0127 44.1048 3.1269 35564
Q39043 BIP2_ARATH Luminal binding 
protein 2 precursor  
BiP2   AtBP2
73515 4.9235 273.3715 17 63 34.1317 6.1609 68 0 15.719 0.0147 29.414 2.1637 7797
P00829 ATPB_BOVIN ATP synthase beta 
chain  mitochondrial 
precursor
56248 4.9759 355.17 17 36 46.5909 5.7204 71 0 13.6274 0.0145 44.6235 2.5116 6228
P49118 BIP_LYCES Luminal binding 
protein precursor  BiP   
78 kDa gl
73189 4.9078 290.8727 16 63 37.5375 4.5357 57 0 14.4983 0.0171 29.414 2.1541 7805
Q9AWL7 GIGA_ORYSA Gigantea like protein 128526 6.3582 292.1222 15 88 22.3359 7.2972 80 4 19.3741 0.0165 3.745 0.4816 29340
O19049 ROK_RABIT Heterogeneous 
nuclear 
ribonucleoprotein K  
hnRNP K
50928 5.2203 270.1672 15 39 37.581 4.3507 135 0 18.3713 0.0112 39.4178 2.0087 68581
Q9SQI2 GIGA_ARATH GIGANTEA protein 127794 6.5971 224.1116 14 83 15.0043 6.6213 65 2 17.6253 0.0164 1.7297 0.2212 29339
P20030 HS7C_TRYBB Heat shock cognate 
HSP70 protein
73649 4.9292 217.5527 14 46 30.4734 5.8369 59 0 17.2546 0.0163 29.414 2.1677 35568
P16019 HS70_THEAN Heat shock 70 kDa 
protein  HSP 70 1
70929 5.1449 255.481 14 53 40.5573 5.9387 78 3 14.8114 0.0162 29.414 2.0876 35492
P11981 KPY2_RAT Pyruvate kinase  M2 
isozyme  EC 2 7 1 40
57613 7.1938 529.2921 13 43 37.9245 6.0249 88 0 16.3264 0.015 56.1897 3.2393 41097
P29844 HS7C_DROME Heat shock 70 kDa 
protein cognate 3 
precursor  78
72190 5.0424 298.4409 13 58 31.7073 7.4544 65 2 17.6798 0.0156 34.3664 2.4825 35563
Q07437 HS70_LEIAM Heat shock 70 kDa 
protein
71153 5.2989 264.9041 13 49 26.9939 6.0661 72 1 15.2569 0.0147 29.414 2.0942 35471
Q65729 POLG_BSTVG Genome polyprotein  
Contains  Nuclear 
inclusion pr
105480 5.9213 256.6098 13 70 20.4883 7.1721 51 0 16.3606 0.0161 7.2525 0.7655 58108
P08418 HS70_SCHMA Heat shock 70 kDa 
homolog protein  
HSP70   Major s
69831 5.2527 252.8508 13 47 30.2983 5.8999 56 2 17.0747 0.0143 29.414 2.0553 35490
P40918 HS70_CLAHE Heat shock 70 kDa 
protein  Allergen Cla 
h 4   Cla
69933 4.8289 248.2131 13 56 37.014 6.2701 62 2 16.5429 0.0141 29.414 2.0583 35466
Yellow colour indicates overlap proteins between whole cell 
lysates and membrane preparations.  Proteins above the thick 
black line are mouse proteins.  Whole cell lysates data from 
Lakowski. 
The protein accession number (accession), name (description), 
molecular weight (mW), isoelectric point (pI), number of detected 
peptides (peptides) and theoretical peptides, and the amount of the 
proteins detected are given in columns.   
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P18669 PMGB_HUMAN Phosphoglycerate 
mutase  brain form  
EC 5 4 2 1
28654 6.7861 297.7026 12 20 67.5889 4.1206 94 0 17.4523 0.0123 81.6361 2.3407 57841
P48720 HS70_BLAEM Heat shock 70 kDa 
protein
70790 5.0475 293.5657 12 50 30.3544 5.8081 71 3 17.1228 0.0153 29.414 2.0835 35460
P22202 HS74_YEAST Heat shock protein 
SSA4
69477 4.8327 265.3275 12 53 25.117 7.7568 45 0 15.8954 0.0123 29.414 2.0449 35540
P22996 PAA4_ECOLI Resolvase 24145 10.3881 133.0365 12 23 49.3151 8.3028 45 1 15.7272 0.0174 33.5173 0.8098 54637
P24722 KCRT_ONCMY Creatine kinase  
testis isozyme  EC 2 7 
3 2
42976 6.2034 356.4003 12 24 38.9034 5.7931 69 0 15.2883 0.0143 124.6657 5.3612 40247
P00548 KPYK_CHICK Pyruvate kinase  
muscle isozyme  EC 2 
7 1 40
57846 7.3508 439.3006 11 43 31.38 6.9566 61 2 16.2102 0.015 49.3656 2.8575 41120
P37899 HS70_PYRSA Heat shock 70 kDa 
protein
72035 4.879 281.5872 11 59 29.8921 7.873 56 1 15.0008 0.0149 29.414 2.1202 35488
Q42434 BIP_SPIOL Luminal binding 
protein precursor  BiP   
78 kDa gl
73547 4.8398 281.3997 11 64 18.4132 4.656 46 0 15.3573 0.0148 29.414 2.1646 7807
P11147 HS7D_DROME Heat shock 70 kDa 
protein cognate 4  
Heat shock 70
71087 5.1848 275.0262 11 50 21.9662 4.7256 57 2 14.074 0.0132 29.414 2.0923 35569
P24629 HS71_LYCES Heat shock cognate 
70 kDa protein 1
71242 4.9545 258.6985 11 54 27.5385 5.1695 48 1 14.8074 0.0159 29.414 2.0968 35505
Q14103 ROD_HUMAN Heterogeneous 
nuclear 
ribonucleoprotein D0  
hnRNP
38410 7.8979 179.4634 11 24 31.2676 4.6626 55 0 16.119 0.0161 58.7947 2.2597 68567
P42897 ENO_ALLMI Enolase  EC 4 2 1 11   2 
phosphoglycerate 
dehydrat
42857 5.4666 521.7158 11 28 29.1139 3.283 74 0 13.9656 0.0135 213.1057 9.1388 23178
Q06331 TBA_OCTDO Tubulin alpha chain 50161 4.8904 424.7603 10 36 25.4989 5.9941 90 0 18.6419 0.0117 119.1692 5.9816 78188
Q01859 ATP2_ORYSA ATP synthase beta 
chain  mitochondrial 
precursor
59022 6.308 372.9282 10 39 30.6715 7.1172 64 1 17.19 0.0131 31.8105 1.8787 5837
P53459 ACT6_DIPDE Actin 6  Fragment 41496 5.1608 300.455 10 33 43.1635 4.7414 74 2 16.1758 0.0141 109.6464 4.5529 1905
P53623 HS72_PICAN Heat shock protein 70 
2
69898 4.7461 293.3205 10 53 38.0062 9.2399 50 1 17.0853 0.0159 29.414 2.0573 35523
P34933 HS73_BOVIN Heat shock 70 kDa 
protein 3
69156 5.1396 262.1818 10 49 26.149 6.3177 46 0 15.2486 0.0157 29.414 2.0354 35528
P05456 HS70_TRYCR Heat shock 70 kDa 
protein
73762 5.2678 225.9714 10 46 13.9706 6.947 41 0 15.1003 0.0144 29.414 2.171 35494
P22954 HS72_ARATH Heat shock cognate 
70 kDa protein 2  
Hsc70 2
71342 4.8344 221.3224 10 51 22.3583 7.036 43 0 12.9069 0.0164 29.414 2.0998 35515
P08734 ENO_XENLA Enolase  EC 4 2 1 11   2 
phosphoglycerate 
dehydrat
47343 5.8427 544.176 10 29 28.8684 6.356 68 0 14.3779 0.0147 213.1057 10.0955 23240
P46561 ATPB_CAEEL Probable ATP 
synthase beta chain  
mitochondrial pr
60961 5.6904 319.5997 9 41 25.0877 6.3354 61 1 15.7805 0.015 31.8105 1.9404 6232
Q01233 HS70_NEUCR Heat shock 70 kDa 
protein  HSP70
70558 4.8261 304.1837 9 53 18.7306 5.3861 41 1 14.9318 0.0159 29.414 2.0767 35478
P38482 ATP2_CHLRE ATP synthase beta 
chain  mitochondrial 
precursor
61783 4.8029 290.588 9 38 25.4355 6.6177 55 3 17.695 0.0138 18.7214 1.1574 5832
P09446 HS7A_CAEEL Heat shock 70 kDa 
protein A
69780 5.0823 271.66 9 53 26.25 6.8642 41 1 19.2901 0.0145 29.414 2.0538 35553
P16394 HS70_BRELC Heat shock 70 kDa 
protein
74041 5.1255 256.1414 9 57 18.6391 8.4455 45 2 14.8541 0.017 29.414 2.1792 35461
P27420 HS7C_CAEEL Heat shock 70 kDa 
protein C precursor
73303 4.9133 219.858 9 56 27.2315 6.6996 48 1 14.4625 0.0159 29.414 2.1575 35560
P22623 HS72_PARLI Heat shock 70 kDa 
protein II  HSP70 II   
Fragment
41321 8.3611 216.4324 9 33 29.8387 5.8897 44 2 15.9305 0.0144 29.414 1.2162 35522
P87047 HS70_PARBR Heat shock 70 kDa 
protein
70461 5.1189 204.632 9 53 35.4391 6.3925 50 3 16.459 0.0167 29.414 2.0738 35482
Q01105 SET_HUMAN SET protein  HLA DR 
associated protein II   
PHAPII
32083 3.9111 197.4204 9 16 44.4043 6.221 60 0 18.6397 0.0118 28.2188 0.9059 73379
O80585 MTHR_ARATH Probable 
methylenetetrahydro
folate reductase  EC 1
68216 5.1101 149.1151 9 50 22.9373 8.31 37 0 20.3854 0.0159 1.5378 0.105 47390
O16808 ACT_MAYDE Actin 41789 5.0709 478.6162 9 35 32.7128 2.5889 79 0 15.2199 0.0131 240.733 10.0667 2030
P09652 TBB4_CHICK Tubulin beta 4 chain  
Beta tubulin class III
50388 4.6778 716.2647 8 32 32.0713 6.1811 85 1 14.5855 0.0138 204.2637 10.2992 78277
Q91060 TBA_NOTVI Tubulin alpha chain 50061 4.7567 634.3005 8 35 28.2222 6.3971 115 0 16.4019 0.0114 266.282 13.339 78187
O18919 KPY2_RABIT Pyruvate kinase  M2 
isozyme  EC 2 7 1 40
57737 7.7569 525.4713 8 42 15.8491 6.1914 55 0 15.9018 0.0144 56.1897 3.2463 41096
Q9Y707 ACT2_SUIBO Actin 2 41636 5.1594 502.4036 8 34 38.4 6.3981 84 1 15.0447 0.0116 240.733 10.0298 1861
P08108 HS70_ONCMY Heat shock cognate 
70 kDa protein  HSP70
71239 5.0493 404.8638 8 52 26.7281 6.4875 54 0 16.3634 0.0133 44.1048 3.1439 35479
P49741 TBAA_SCHCO Tubulin alpha 1A 
chain
49413 4.9124 395.3371 8 35 27.9018 5.8999 61 1 15.4146 0.014 107.0527 5.2932 78165
P17614 ATP2_NICPL ATP synthase beta 
chain  mitochondrial 
precursor
59819 5.9019 337.4333 8 39 21.4286 6.821 50 1 19.7345 0.0119 31.8105 1.9041 5836
P06761 GR78_RAT 78 kDa glucose 
regulated protein 
precursor  GRP 78
72302 4.8748 313.7196 8 52 18.0428 5.3297 39 0 15.9867 0.0147 34.4199 2.4902 30762
P07323 ENOG_RAT Gamma enolase  EC 4 
2 1 11   2 phospho D 
glycerate
46979 4.8424 313.4042 8 29 29.5612 5.981 44 0 14.1087 0.0133 115.0281 5.4074 23175
P41797 HS71_CANAL Heat shock protein 
SSA1
70150 4.862 301.151 8 52 24.4275 7.0895 38 0 14.1924 0.0159 29.414 2.0647 35499
P47773 HS7C_ICTPU Heat shock cognate 
71 kDa protein
71296 5.0079 292.9524 8 53 20.0308 6.1125 49 3 15.5632 0.0136 29.414 2.0984 35565
P09435 HS73_YEAST Heat shock protein 
SSA3
70503 4.8563 287.8965 8 51 20.9553 7.0982 36 0 15.2719 0.0155 29.414 2.0751 35532
P15429 ENOB_RAT Beta enolase  EC 4 2 1 
11   2 phospho D 
glycerate
46800 7.6655 287.6051 8 29 26.097 6.3228 43 0 14.7072 0.0154 115.0281 5.3867 23171
Q27727 ENO_PLAFA Enolase  EC 4 2 1 11   2 
phosphoglycerate 
dehydrat
48673 6.1838 272.441 8 33 36.3229 6.2853 52 2 14.5333 0.0147 115.0281 5.6023 23223
P11143 HS70_MAIZE Heat shock 70 kDa 
protein
70559 5.0295 269.2604 8 51 18.7597 6.9825 32 0 13.0053 0.0164 29.414 2.0735 35477
P26413 HS70_SOYBN Heat shock 70 kDa 
protein
70835 5.1815 249.2893 8 51 18.2946 7.7617 42 1 17.3097 0.0164 29.414 2.0849 35491
Q43725 CYSM_ARATH Cysteine synthase  
mitochondrial 
precursor  EC 4 2
45153 8.2429 128.1766 8 35 25.2358 7.4137 42 2 14.1903 0.0136 9.585 0.4331 18138
O87862 ADCC_STRPN Zinc transport system 
ATP binding protein 
adcC
26525 7.0426 98.7626 8 16 46.5812 5.9546 26 0 16.2341 0.0176 2.2861 0.0607 2160
O17449 TBB1_MANSE Tubulin beta 1 chain  
Beta 1 tubulin
50198 4.5593 983.6111 8 31 31.3199 3.3181 98 0 13.4775 0.0107 216.9111 10.8956 78224
Q00215 ACTC_STYPL Actin  cytoplasmic 41902 5.1581 600.474 7 35 38.4 5.3355 87 2 15.4865 0.0134 258.4635 10.8374 1945
Q9W7L0 ENOA_PYTRG Alpha enolase  EC 4 2 
1 11   2 phospho D 
glycerate
47409 7.1027 537.61 7 34 33.2564 6.4352 65 2 14.4998 0.0145 213.1057 10.1096 23163
P90689 ACT_BRUMA Actin 41682 5.1478 515.4861 7 34 25.5319 4.9924 63 0 14.4976 0.0127 253.1386 10.5584 2003
P19120 HS7C_BOVIN Heat shock cognate 
71 kDa protein
71195 5.3269 422.0086 7 50 20.1538 5.8514 55 1 14.6316 0.0135 44.1048 3.142 35557
P04350 TBB5_HUMAN Tubulin beta 5 chain 49598 4.617 414.342 7 31 29.955 4.334 72 3 14.4043 0.014 206.0144 10.2247 78287
Q05524 ENOL_HUMAN Alpha enolase  lung 
specific  EC 4 2 1 11   2 
phos
49446 5.705 372.8593 7 30 26.6376 5.2429 45 1 14.799 0.0147 97.2268 4.8105 23176
P37399 ATP2_DAUCA ATP synthase beta 
chain  mitochondrial 
precursor
59098 5.5018 318.3439 7 42 20.6581 6.9267 38 0 14.3226 0.0107 31.8105 1.8811 5833
Q16956 GR78_APLCA 78 kDa glucose 
regulated protein 
precursor  GRP 78
73652 4.6066 287.3463 7 52 18.5907 5.963 42 0 15.6766 0.0127 34.3664 2.5327 30751
235 
 
 
P22953 HS71_ARATH Heat shock cognate 
70 kDa protein 1  
Hsc70 1
71313 4.8272 274.2661 7 53 16.4363 4.771 30 0 13.5203 0.0135 29.414 2.0989 35497
O57391 ENOG_CHICK Gamma enolase  EC 4 
2 1 11   2 phospho D 
glycerate
47278 4.6481 272.2957 7 29 29.4931 7.2268 49 2 15.6149 0.0148 117.7532 5.5707 23172
P27541 HS70_BRUMA Heat shock 70 kDa 
protein
70176 5.131 264.4902 7 51 29.9689 5.8174 39 3 15.9194 0.0169 29.414 2.0655 35462
P11833 TBB_PARLI Tubulin beta chain 50019 4.5416 1031.4604 7 31 31.3199 3.6016 102 1 13.1257 0.0118 293.374 14.6838 78336
P09244 TBB7_CHICK Tubulin beta 7 chain  
Tubulin beta 4
49638 4.5903 1261.9083 6 31 26.8018 3.6 124 0 13.4644 0.0117 406.6357 20.198 78298
P02554 TBB_PIG Tubulin beta chain 49828 4.5903 1184.696 6 31 23.3708 2.5977 110 0 13.0881 0.0113 347.0077 17.3022 78341
P32882 TBB2_CHICK Tubulin beta 2 chain  
Beta tubulin class II
49920 4.5903 1178.4197 6 31 23.3708 3.2098 106 0 13.1812 0.0118 347.0077 17.3342 78241
P13602 TBB2_XENLA Tubulin beta 2 chain 49691 4.6168 1175.2455 6 31 20.9932 3.501 105 0 13.4833 0.0114 347.0077 17.2546 78264
P09203 TBB1_CHICK Tubulin beta 1 chain  
Beta tubulin class I
49876 4.5903 1169.7322 6 31 23.5955 2.8998 105 0 13.4235 0.0117 347.0077 17.3189 78210
P04691 TBB1_RAT Tubulin beta chain  T 
beta 15
49930 4.5961 1164.7333 6 31 24.0449 2.6787 111 1 13.6926 0.0113 347.0077 17.3376 78232
P09206 TBB3_CHICK Tubulin beta 3 chain  
Beta tubulin class IV
49829 4.5767 982.2007 6 31 29.2135 3.8821 90 0 12.9801 0.0115 293.374 14.628 78267
P07437 TBB1_HUMAN Tubulin beta 1 chain 49726 4.5593 933.8457 6 31 27.2523 3.5076 84 0 13.6127 0.0118 216.9111 10.7933 78221
Q91240 TBB_PSEAM Tubulin beta  chain 49743 4.602 927.7854 6 31 27.191 4.3739 88 0 12.5351 0.011 293.374 14.603 78347
P04797 G3P_RAT Glyceraldehyde 3 
phosphate 
dehydrogenase  EC 1 
2 1
35682 8.3491 820.9352 6 19 44.5783 3.9963 104 2 12.8737 0.0121 303.4024 10.833 27760
P36221 TBB1_NOTCO Tubulin beta 1 chain 49773 4.5903 638.713 6 31 24.6637 6.7168 79 0 15.5237 0.0129 247.7534 12.3396 78226
P12456 TBB7_CAEEL Tubulin beta chain 49228 4.6926 612.2667 6 31 19.7279 4.9816 72 0 12.8091 0.0115 250.9069 12.3598 78297
Q25009 TBB1_HOMAM Tubulin beta 1 chain  
Beta I tubulin
50710 4.6888 575.4449 6 32 21.5078 6.1517 53 0 15.508 0.0121 107.6477 5.4624 78220
Q9XSJ4 ENOA_BOVIN Alpha enolase  EC 4 2 
1 11   2 phospho D 
glycerate
47116 6.4534 569.0612 6 31 29.3303 4.491 82 2 14.1129 0.0135 387.8564 18.2858 23159
P06733 ENOA_HUMAN Alpha enolase  EC 4 2 
1 11   2 phospho D 
glycerate
47008 7.1713 510.7335 6 31 24.7113 7.3371 64 1 14.7713 0.0143 210.3806 9.8959 23161
Q9W7L2 ENOA_SCEUN Alpha enolase  EC 4 2 
1 11   2 phospho D 
glycerate
47332 6.6982 507.2524 6 32 29.0993 6.9896 55 0 13.0621 0.0137 213.1057 10.0931 23165
P29511 TBA6_ARATH Tubulin alpha 6 chain 49506 4.743 501.9935 6 35 20.2222 1.5475 62 0 14.0185 0.0121 315.8264 15.6454 78158
P06351 H33_HUMAN Histone H3 3  H3 A   
H3 B   H3 3Q
15187 11.6797 488.1847 6 12 52.5926 6.2782 93 0 15.7912 0.0132 101.3608 1.5404 32328
P38669 TBA2_NEUCR Tubulin alpha B chain 50222 4.8345 409.081 6 37 23.0599 5.9008 52 0 15.8961 0.0128 107.0527 5.3799 78137
P10719 ATPB_RAT ATP synthase beta 
chain  mitochondrial 
precursor
56318 5.0198 395.6592 6 36 25.7089 4.8278 39 0 14.3422 0.0112 40.0093 2.2547 6303
P08238 HS9B_HUMAN Heat shock protein 
HSP 90 beta  HSP 84   
HSP 90
83081 4.7726 357.0724 6 66 11.065 5.6659 34 0 12.0904 0.0133 55.9171 4.6486 35630
P07823 GR78_MESAU 78 kDa glucose 
regulated protein 
precursor  GRP 78
72334 4.8748 311.789 6 52 17.737 5.8234 34 1 14.9562 0.0138 34.4199 2.4913 30756
P26300 ENO_LYCES Enolase  EC 4 2 1 11   2 
phosphoglycerate 
dehydrat
47768 5.5746 299.0548 6 35 32.8829 4.621 52 2 16.6988 0.0141 115.0281 5.4982 23210
P93587 ACT1_SOLTU Actin 42  Fragment 36830 5.3156 297.8023 6 30 33.1325 4.6349 45 1 14.9387 0.0136 109.6464 4.0409 1822
P29357 HS7E_SPIOL Chloroplast envelope 
membrane 70 kDa 
heat shock re
71555 5.1747 284.0978 6 53 17.1779 7.0756 39 2 16.9212 0.0155 29.414 2.106 35572
P46406 G3P_RABIT Glyceraldehyde 3 
phosphate 
dehydrogenase  EC 1 
2 1
35666 8.515 278.9782 6 18 28.012 3.6251 43 0 14.7237 0.0111 84.4838 3.0057 27758
P09189 HS7C_PETHY Heat shock cognate 
70 kDa protein
71182 4.9092 275.2816 6 54 12.1352 5.528 32 0 19.0806 0.0164 29.414 2.0951 35567
Q00043 HS70_AJECA Heat shock 70 kDa 
protein
77510 5.374 231.6771 6 57 15.461 6.4494 30 0 14.5093 0.0158 29.414 2.2813 35458
P53421 HS71_PICAN Heat shock protein 70 
1  HSP72
69963 4.9131 231.3553 6 51 14.9068 8.2286 31 0 15.4872 0.0138 29.414 2.0592 35507
P29843 HS7A_DROME Heat shock 70 kDa 
protein cognate 1  
Heat shock 70
70642 5.17 219.5867 6 47 18.2527 6.0572 35 0 13.51 0.0124 32.1355 2.2715 35554
Q09810 YABA_SCHPO Hypothetical 44 4 kDa 
protein C2G11 10c in 
chromos
44386 7.8794 158.3309 6 29 26.1845 8.7346 31 2 17.957 0.0145 8.8534 0.3932 94141
P24518 NADR_SALTY Transcriptional 
regulator nadR
47070 5.5527 143.4372 6 37 29.7561 5.539 26 1 12.9372 0.0158 36.0724 1.699 48590
P41387 TBB_ONCGI Tubulin beta chain 49920 4.7141 741.7727 5 33 23.4234 2.2127 77 1 13.3563 0.0122 320.5922 16.0144 78335
P18700 TBB_STRPU Tubulin beta chain  
Fragment
33322 4.496 617.9194 5 20 30.8219 3.724 68 0 12.0254 0.0123 254.311 8.4799 78351
P12277 KCRB_HUMAN Creatine kinase  B 
chain  EC 2 7 3 2   B CK
42617 5.2167 595.6894 5 24 18.8976 4.6797 64 0 14.3038 0.0116 449.1597 19.1541 40227
P05122 KCRB_CHICK Creatine kinase  B 
chain  EC 2 7 3 2   B CK
42843 5.902 535.2069 5 25 13.9108 5.8823 69 0 16.2265 0.01 444.8338 19.0704 40226
Q9PVK2 ENOA_ALLMI Alpha enolase  EC 4 2 
1 11   2 phospho D 
glycerate
47161 6.6953 534.1151 5 31 21.709 5.087 57 1 13.2714 0.0145 213.1057 10.0567 23157
Q00214 ACTM_STYPL Actin  muscle 42327 5.077 492.7652 5 34 21.6359 4.6288 57 0 13.1492 0.0137 253.1386 10.7215 1968
Q03342 ACT3_ECHGR Actin 3  Fragment 34742 5.0958 489.6795 5 25 30.7443 6.9534 62 0 15.2079 0.0129 253.1386 8.8004 1874
P50138 ACT_PUCGR Actin 41717 5.1594 450.1362 5 30 29.3333 7.0752 59 1 13.9674 0.0133 240.733 10.0494 2041
P05124 KCRB_CANFA Creatine kinase  B 
chain  EC 2 7 3 2   B CK
42674 5.3763 443.5303 5 23 26.7717 4.4454 56 2 14.2236 0.0133 128.9916 5.5081 40225
P04689 TBA2_SCHPO Tubulin alpha 2 chain 50547 4.6829 413.0338 5 36 21.1581 9.2095 50 1 15.1596 0.0148 107.0527 5.4147 78140
P49742 TBAB_SCHCO Tubulin alpha 1B 
chain
49331 5.0449 404.2228 5 38 18.8341 5.6318 52 1 15.8332 0.0136 107.0527 5.2844 78166
Q9BE24 LDHA_MACFA L lactate 
dehydrogenase A 
chain  EC 1 1 1 27   LDH
36511 8.3721 382.9194 5 31 22.3565 2.2703 52 0 14.8247 0.0101 118.809 4.3406 41974
P00338 LDHA_HUMAN L lactate 
dehydrogenase A 
chain  EC 1 1 1 27   LDH
36534 8.3652 381.2604 5 31 22.6586 4.4012 54 1 12.8845 0.0106 118.809 4.3434 41972
P19023 ATP2_MAIZE ATP synthase beta 
chain  mitochondrial 
precursor
59067 5.9729 363.2227 5 37 15.5515 5.7389 37 0 15.5441 0.0095 33.9353 2.0057 5835
P34058 HS9B_RAT Heat shock protein 
HSP 90 beta  HSP 84
83133 4.8671 357.7866 5 66 8.4371 4.9509 26 0 12.346 0.0108 55.9171 4.6515 35633
P00340 LDHA_CHICK L lactate 
dehydrogenase A 
chain  EC 1 1 1 27   LDH
36360 7.8153 323.0299 5 29 41.6918 5.7615 48 3 14.646 0.0136 103.0729 3.7501 41960
P08439 G3P_ZYGRO Glyceraldehyde 3 
phosphate 
dehydrogenase  EC 1 
2 1
35579 6.3382 319.9025 5 34 22.5225 6.3325 49 2 15.6706 0.012 82.2635 2.9287 27779
P11021 GR78_HUMAN 78 kDa glucose 
regulated protein 
precursor  GRP 78
72288 4.8748 318.4182 5 52 9.7859 7.8302 28 0 17.9372 0.0123 34.4199 2.4897 30754
Q9Y896 ACT2_SCHCO Actin 2 41766 5.315 302.4552 5 34 15.4667 5.2057 41 1 15.1829 0.0148 109.6464 4.5825 1858
P26197 ACT2_ABSGL Actin 2 42039 5.2359 292.8569 5 34 29.7082 7.2528 41 1 14.3434 0.015 109.6464 4.6125 1831
P00544 FGR_FSVGR Tyrosine protein 
kinase transforming 
protein FGR
61476 5.7171 289.4366 5 37 11.9266 2.3865 32 0 15.8299 0.0132 109.6464 6.7451 25497
Q9U639 HS7D_MANSE Heat shock 70 kDa 
protein cognate 4
71387 5.1482 283.0701 5 49 13.1902 5.9238 30 1 17.2803 0.0148 29.414 2.1011 35570
Q9TM41 ATPB_CYACA ATP synthase beta 
chain  EC 3 6 3 14
53244 6.5651 273.0966 5 40 19.5918 6.9577 32 1 16.0703 0.0105 18.7214 0.9974 6240
O65314 ACT_SCHDU Actin 41828 5.0599 271.7023 5 34 35.1852 5.861 45 2 16.3479 0.0148 109.6464 4.5893 2042
Q05944 HS70_HYDMA Heat shock 70 kDa 
protein
71423 5.5344 269.3019 5 52 12.9969 6.7853 36 3 15.8691 0.0152 29.414 2.1022 35469
236 
 
 
P10592 HS72_YEAST Heat shock protein 
SSA2
69296 4.7487 266.986 5 54 12.3824 5.9871 24 0 16.0218 0.0159 29.414 2.0395 35526
P50137 TKT_RAT Transketolase  EC 2 2 
1 1   TK
67600 7.2133 265.2631 5 44 15.0883 5.742 31 0 14.0356 0.0157 15.05 1.018 79968
P08106 HS70_CHICK Heat shock 70 kDa 
protein  HSP70
69707 5.3604 264.2122 5 48 9.1483 9.0065 28 0 15.153 0.0125 29.414 2.0517 35464
P11145 HS74_TRYBB Heat shock 70 kDa 
protein 4  HSP70
71391 5.0638 244.7078 5 46 15.4312 7.3351 39 2 13.6904 0.0132 29.414 2.0914 35539
P38982 RSP4_CRIGR 40S ribosomal protein 
SA  P40   34 67 kDa 
laminin
32860 4.6617 210.6422 5 26 27.7966 7.0346 29 0 14.9986 0.0157 22.8984 0.7529 71617
P07029 ROU2_HUMAN Heterogeneous 
nuclear 
ribonucleoprotein 
UP2  Fragm
24183 7.8327 160.8986 5 14 55.5556 4.6946 40 3 14.6267 0.0152 58.7947 1.4227 68615
P17132 ROC_RAT Heterogeneous 
nuclear 
ribonucleoprotein C  
hnRNP C
18008 10.0571 147.6805 5 12 39.2405 4.5801 40 0 14.5678 0.0136 58.7947 1.0595 68556
P26368 U2AF_HUMAN Splicing factor U2AF 
65 kDa subunit  U2 
auxiliary
53467 9.3635 146.2892 5 26 18.1053 5.8569 29 0 19.2939 0.0134 16.806 0.8991 82500
P13084 NPM_RAT Nucleophosmin  NPM   
Nucleolar 
phosphoprotein B23
32539 4.4242 131.7983 5 22 21.2329 4.9501 29 0 17.3049 0.013 11.4286 0.3721 50671
Q63716 PDX1_RAT Peroxiredoxin 1  
Thioredoxin 
peroxidase 2   Thiore
22095 8.2425 113.4073 5 18 38.6935 4.5117 31 0 15.7277 0.0174 5.217 0.1153 55599
P30050 RL12_HUMAN 60S ribosomal protein 
L12
17807 9.8965 84.6366 5 15 35.1515 8.1959 19 0 20.9483 0.0148 10.8617 0.1935 66070
P05209 TBA1_CRIGR Tubulin alpha 1 chain 50119 4.7622 829.1841 4 35 15.2993 3.76 83 0 14.0228 0.0104 467.847 23.4634 78105
P52273 TBA_BOMMO Tubulin alpha chain 49873 4.7864 723.8331 4 35 18.6667 7.6634 79 2 15.1349 0.012 299.8134 14.9624 78175
P18258 TBA1_PARLI Tubulin alpha 1 chain 50176 4.7194 718.2768 4 35 19.0265 2.993 75 0 15.3247 0.0113 299.8134 15.0533 78117
P02552 TBA1_CHICK Tubulin alpha 1 chain  
Fragment
45871 4.7818 713.7037 4 33 16.9903 7.5928 74 0 13.6879 0.0115 394.6305 18.1139 78103
P04764 ENOA_RAT Alpha enolase  EC 4 2 
1 11   2 phospho D 
glycerate
46955 6.1377 694.4021 4 31 18.9376 1.4724 67 0 14.259 0.0124 253.3919 11.9055 23164
P53478 ACT5_CHICK Actin  cytoplasmic 
type 5
41808 5.1537 642.4346 4 34 20.7447 2.5515 67 0 13.3118 0.014 258.4635 10.8131 1899
P53506 ACT8_XENLA Actin  cytoplasmic 
type 8
41820 5.1594 631.5379 4 35 21.2766 7.0435 66 0 12.9169 0.0138 258.4635 10.8162 1916
P10987 ACT1_DROME Actin 5C 41794 5.1535 629.274 4 34 20.7447 2.5515 67 0 13.3118 0.014 258.4635 10.8095 1798
P53485 ACT2_FUGRU Actin  cytoplasmic 2  
Beta actin 2
41739 5.1478 614.7429 4 34 17.6 4.9187 65 0 13.7237 0.0137 258.4635 10.7952 1842
P18603 ACT4_ARTSX Actin  clone 403 41810 5.1478 600.527 4 34 22.0745 4.115 64 0 13.5251 0.014 258.4635 10.8136 1889
Q94571 TBB2_HOMAM Tubulin beta 2 chain  
Beta II tubulin
50897 4.6456 593.1722 4 32 28.9823 6.1277 63 3 13.308 0.0121 134.5784 6.8542 78251
P49128 ACT1_AEDAE Actin 1 41763 5.6785 584.1883 4 36 27.3936 5.8148 69 1 13.4184 0.0141 258.4635 10.8014 1791
P20670 H2AO_HUMAN Histone H2A o  H2A o   
H2A 2   H2a 615
13955 11.3333 535.3417 4 7 49.6124 5.9353 98 0 13.9693 0.0094 72.2351 1.0087 32192
P19140 ENOA_ANAPL Alpha enolase  EC 4 2 
1 11   2 phospho D 
glycerate
47079 6.3734 533.5181 4 31 17.552 6.7777 55 1 15.484 0.0131 210.3806 9.9108 23158
Q25008 TBA1_HOMAM Tubulin alpha 1 chain  
Alpha I tubulin
50041 4.8278 533.3693 4 35 16.408 3.8857 66 1 15.5418 0.0123 152.7005 7.6463 78110
P51913 ENOA_CHICK Alpha enolase  EC 4 2 
1 11   2 phospho D 
glycerate
47144 6.1403 532.0462 4 31 14.7806 4.1129 49 0 12.9011 0.0137 210.3806 9.9245 23160
P09653 TBB5_CHICK Tubulin beta 5 chain  
Beta tubulin class V
49939 4.5842 523.5466 4 31 13.2287 3.9344 45 0 14.7192 0.0127 107.6477 5.3793 78285
P30436 TBA_ONCKE Tubulin alpha chain 49283 4.7406 508.3869 4 34 11.9369 3.6427 59 0 15.7824 0.0113 149.3157 7.3635 78190
P53466 ACT2_LYTPI Actin  cytoskeletal 2  
LPC2
41846 5.142 500.5599 4 34 18.883 2.5066 55 1 14.8182 0.0121 240.733 10.0805 1846
P53465 ACT1_LYTPI Actin  cytoskeletal 1  
LPC1
41814 5.2414 491.3668 4 34 17.0213 4.4696 56 1 15.013 0.0125 240.733 10.0728 1805
P02576 ACTA_PHYPO Actin  plasmodial 
isoform
41641 5.0771 484.4079 4 34 22.6667 8.2723 52 0 16.3958 0.0114 240.733 10.031 1922
P53470 ACT1_SCHMA Actin 1 41704 5.1537 483.5381 4 34 17.8191 5.3435 50 0 14.7766 0.0122 240.733 10.0462 1821
Q92193 ACT_CRAVI Actin  Fragment 29694 5.3216 466.5921 4 23 30.0752 4.0618 58 1 13.6104 0.0131 253.1386 7.5216 2015
P02577 ACT1_DICDI Actin 41574 5.0711 465.4265 4 34 22.9333 1.7107 51 0 13.0593 0.0126 240.733 10.0149 1797
P10986 ACT4_CAEEL Actin 4 41750 5.1478 443.0655 4 34 24.4681 3.5038 50 0 13.7365 0.0152 139.7823 5.8398 1891
O94128 TBA_MYCGR Tubulin alpha chain 49976 4.7168 415.1623 4 36 22.8889 4.2607 50 1 14.3991 0.0127 107.0527 5.3535 78185
P24633 TBA1_EMENI Tubulin alpha 1 chain 50339 4.7322 408.7271 4 36 16.4811 5.6955 48 1 15.5329 0.0136 107.0527 5.3924 78108
P08841 TBB3_DROME Tubulin beta 3 chain 50867 4.6243 399.2384 4 31 15.859 4.6202 41 1 13.4072 0.0137 78.5938 4.0005 78268
P41385 TBB_BOMMO Tubulin beta chain 50302 4.5414 365.9926 4 32 20.2222 7.2632 45 2 12.3553 0.0113 78.5938 3.956 78310
P04642 LDHA_RAT L lactate 
dehydrogenase A 
chain  EC 1 1 1 27   LDH
36427 8.3699 361.9266 4 31 18.9759 2.4322 45 0 13.1053 0.0115 118.809 4.3307 41986
Q25117 ATPB_HEMPU ATP synthase beta 
chain  mitochondrial 
precursor
56040 4.9167 352.419 4 35 17.9732 5.9095 36 1 14.0211 0.0111 31.8105 1.7838 6258
P35394 TBB_OCTDO Tubulin beta chain 50415 4.6573 333.4316 4 32 23.7136 4.6779 44 2 14.0583 0.0127 47.0857 2.3754 78334
P27131 ACT1_NAEFO Actin I 41700 5.0967 328.448 4 36 21.8667 3.5277 33 0 14.6265 0.0144 109.6464 4.5753 1807
P18602 ACT3_ARTSX Actin  clone 302  
Fragment
36867 5.2297 328.3654 4 29 16.5138 6.1575 37 0 16.0112 0.0131 109.6464 4.045 1868
P53476 ACT_TOXGO Actin 41880 4.8704 323.1953 4 39 19.4149 3.3582 34 1 15.6042 0.0137 109.6464 4.5951 2047
P13363 ACT_PHYME Actin 41960 5.4694 322.0128 4 36 20.2667 5.9022 36 0 14.6816 0.0135 109.6464 4.6039 2034
P00360 G3P1_YEAST Glyceraldehyde 3 
phosphate 
dehydrogenase 1  EC 
1 2
35596 8.5448 319.5415 4 30 33.8369 5.0807 38 1 14.2562 0.0114 82.2635 2.9301 27598
P29685 ATP2_HEVBR ATP synthase beta 
chain  mitochondrial 
precursor
60221 5.9171 318.7723 4 39 15.4804 4.8116 32 0 14.4633 0.011 31.8105 1.9169 5834
Q03341 ACT2_ECHGR Actin 2 41855 5.2408 306.5767 4 34 14.3617 8.6095 36 1 15.1214 0.012 109.6464 4.5923 1841
P30169 ACT7_SOLTU Actin 75 41900 5.1414 305.2027 4 33 22.5464 2.608 34 0 16.5251 0.0138 109.6464 4.3288 1911
O50290 ATPB_RICPR ATP synthase beta 
chain  EC 3 6 3 14
51237 4.662 304.1544 4 30 16.4557 5.3381 31 1 13.5892 0.012 22.8239 1.1702 6308
P34690 TBA2_CAEEL Tubulin alpha 2 chain 49881 4.7516 298.7104 4 34 14.0625 6.7386 37 0 15.6429 0.0137 73.8964 3.6884 78127
P25113 PMGB_RAT Phosphoglycerate 
mutase  brain form  
EC 5 4 2 1
28496 6.2014 296.352 4 20 32.8063 6.0711 36 1 13.8033 0.0127 81.6361 2.3278 57842
Q40831 TBA1_PELFA Tubulin alpha 1 chain 49905 4.7518 293.039 4 34 17.8808 5.1266 31 0 15.256 0.0148 73.8964 3.6902 78119
P22275 TBA3_MAIZE Tubulin alpha 3 chain  
Alpha 3 tubulin
49529 4.9188 290.3136 4 35 14.2222 7.8369 31 0 14.9647 0.0134 73.8964 3.6624 78148
Q9Y701 ACT1_SUIBO Actin 1 41624 5.3423 287.7543 4 35 15.7333 6.5588 37 1 13.7627 0.0131 109.6464 4.5668 1826
P20904 ACT_VOLCA Actin 41731 5.1537 283.5714 4 34 20.4244 4.6445 41 1 16.3255 0.0137 109.6464 4.5787 2050
Q92G88 ATPB_RICCN ATP synthase beta 
chain  EC 3 6 3 14
51076 4.6813 277.955 4 28 16.0677 3.1141 28 0 15.9784 0.0114 22.8239 1.1665 6307
P10591 HS71_YEAST Heat shock protein 
SSA1  Heat shock 
protein YG100
69483 4.799 273.838 4 52 12.9485 6.3276 25 1 16.9536 0.0144 29.414 2.045 35513
P04106 TBA_TRYBR Tubulin alpha chain 49755 4.7512 267.8998 4 35 11.9734 8.5535 39 0 16.0094 0.0116 78.8041 3.9235 78202
Q00715 H2B_RAT Histone H2B 13850 10.7878 263.1908 4 10 30.6452 3.1105 41 0 15.4406 0.012 548.0758 7.5958 32310
P30161 ACT_COSCS Actin  Fragment 37199 5.3551 263.1786 4 30 10.574 6.8729 27 0 15.3532 0.0126 109.6464 4.0814 2013
P02827 HS70_XENLA Heat shock 70 kDa 
protein  HSP70
70871 5.1392 252.3545 4 51 14.8377 4.7391 27 1 13.8216 0.0132 29.414 2.0859 35495
P24067 BIP2_MAIZE Luminal binding 
protein 2 precursor  
BiP2   Heat s
73039 4.9103 246.8104 4 62 9.8039 3.8877 26 1 17.1434 0.0119 29.414 2.1497 7798
P42896 ENO_RICCO Enolase  EC 4 2 1 11   2 
phosphoglycerate 
dehydrat
47882 5.4379 246.2456 4 34 18.2022 4.4923 37 1 16.6088 0.0154 115.0281 5.5113 23227
P34931 HS7H_HUMAN Heat shock 70 kDa 
protein 1 HOM  HSP70 
HOM
70355 5.6453 229.189 4 48 13.1045 7.4203 21 0 16.4024 0.0122 29.414 2.0707 35574
P08865 RSP4_HUMAN 40S ribosomal protein 
SA  P40   34 67 kDa 
laminin
32833 4.5932 206.448 4 26 28.1356 5.352 33 0 16.7333 0.0144 22.8984 0.7523 71621
237 
 
 
P38983 RSP4_RAT 40S ribosomal protein 
SA  P40   34 67 kDa 
laminin
32803 4.6022 196.1643 4 26 16.2712 4.8964 26 0 15.7664 0.0135 22.8984 0.7516 71623
Q24751 ATPB_DROVI ATP synthase beta 
chain  mitochondrial 
precursor
23949 5.7958 196.1096 4 16 26.7544 4.7995 26 0 19.5366 0.0121 18.7214 0.4487 6247
P14643 TBB_PLAFK Tubulin beta chain 49718 4.5359 170.3184 4 31 12.5843 4.747 18 0 14.6598 0.0131 32.9732 1.6405 78343
P14140 TBB_PLAFA Tubulin beta chain 49781 4.5018 169.892 4 31 12.5843 6.8777 20 0 18.1076 0.0164 32.9732 1.6425 78342
P15259 PMGM_HUMAN Phosphoglycerate 
mutase  muscle form  
EC 5 4 2 1
28616 9.2446 154.2681 4 20 26.9841 4.9358 25 0 16.9303 0.0127 48.0933 1.3772 57862
Q9ZSW1 TBB1_CYAPA Tubulin beta 1 chain  
Beta 1 tubulin
49791 4.5961 148.0945 4 31 16.3311 8.1549 21 1 16.6308 0.0144 32.9732 1.6429 78214
P12457 TBB_EUGGR Tubulin beta chain 49385 4.4242 130.49 4 31 14.2534 7.8963 18 0 19.597 0.0132 32.9732 1.6295 78320
P06748 NPM_HUMAN Nucleophosmin  NPM   
Nucleolar 
phosphoprotein B23
32554 4.444 109.0942 4 22 16.3265 2.2165 26 0 13.6549 0.0145 11.4286 0.3723 50669
Q9X767 PFLA_LISMO Pyruvate formate 
lyase activating 
enzyme  EC 1 97
28097 4.9609 103.9476 4 24 20.9677 6.4594 21 0 13.2573 0.0183 4.9016 0.1378 56248
P23358 RL12_RAT 60S ribosomal protein 
L12
17834 9.8965 81.0238 4 15 34.5455 5.988 20 1 16.4973 0.0138 10.8617 0.1938 66079
P08578 RUXE_HUMAN Small nuclear 
ribonucleoprotein E  
snRNP E   Sm pr
10796 9.7804 78.3456 4 4 72.8261 5.4146 29 2 17.3829 0.0153 11.7064 0.1265 72001
P17244 G3P_CRIGR Glyceraldehyde 3 
phosphate 
dehydrogenase  EC 1 
2 1
35594 8.4987 590.2339 3 19 20.4819 5.6523 68 1 13.5796 0.0114 233.6207 8.3208 27706
P07335 KCRB_RAT Creatine kinase  B 
chain  EC 2 7 3 2   B CK
42685 5.2004 589.0782 3 23 12.8609 1.7064 57 0 13.4363 0.011 451.1776 19.2709 40231
P80534 G3P1_JACOR Glyceraldehyde 3 
phosphate 
dehydrogenase  
muscle
39388 8.9141 573.4907 3 25 23.1405 4.405 68 1 13.8309 0.0118 233.6207 9.2078 27593
P06605 TBA3_DROME Tubulin alpha 3 chain 49858 4.8285 536.5869 3 35 12.4444 3.5436 51 0 14.4468 0.0112 152.7005 7.6183 78144
P53471 ACT2_SCHMA Actin 2 41713 5.1537 512.759 3 34 18.883 3.8913 55 1 13.9976 0.0128 253.1386 10.5662 1859
Q9NY65 TBA8_HUMAN Tubulin alpha 8 chain  
Alpha tubulin 8
50061 4.7567 503.489 3 35 10.9131 7.9814 51 0 15.3957 0.0114 152.7005 7.6493 78162
Q93131 ACTC_BRAFL Actin  cytoplasmic  
BfCA1
41693 5.1478 501.6621 3 34 14.9333 1.585 47 0 13.945 0.0116 240.733 10.0436 1937
P41339 ACTA_LIMPO Actin  acrosomal 
process isoform  
Actin 5
41747 5.2304 497.3423 3 34 12.766 8.4276 51 1 15.1575 0.0116 240.733 10.0566 1920
P92176 ACT2_LUMTE Actin 2 41812 5.2357 496.0553 3 34 18.617 2.7329 47 0 13.9393 0.0124 240.733 10.0723 1844
P07829 ACT3_DICDI Actin 3 SUB1 41757 5.0861 492.968 3 35 17.6 4.2501 53 1 13.8012 0.0123 240.733 10.059 1871
P41113 ACT3_PODCA Actin 3 41799 5.142 491.4865 3 34 21.0106 1.8821 53 1 13.8008 0.0122 240.733 10.0691 1882
O22347 TBA1_ELEIN Tubulin alpha 1 chain  
Alpha 1 tubulin
49699 4.7108 490.9277 3 35 15.0776 4.0915 50 0 13.6764 0.0125 321.528 15.99 78107
P25704 ENOB_RABIT Beta enolase  EC 4 2 1 
11   2 phospho D 
glycerate
46908 7.6827 489.8306 3 29 10.8545 3.1743 45 0 14.1112 0.0123 158.0394 7.418 23170
Q07903 ACTC_STRPU Actin  cytoskeletal IIA 41773 5.142 480.225 3 34 15.4255 2.9886 48 0 13.873 0.0124 240.733 10.0629 1944
P45886 ACT3_BACDO Actin 3  muscle 
specific
41788 5.1478 477.3292 3 34 12.5 3.2856 48 0 14.0441 0.0114 240.733 10.0665 1869
Q9Y702 ACT1_SCHCO Actin 1  Beta actin 41591 5.1537 475.8036 3 34 22.6667 5.2438 50 1 13.6086 0.0115 240.733 10.0187 1820
P45887 ACT5_BACDO Actin 5  muscle 
specific
41743 5.1478 475.4858 3 34 17.2872 5.9594 48 0 13.6414 0.0117 240.733 10.0556 1898
P12431 ACTM_STRPU Actin  muscle 41530 5.809 469.2625 3 36 15.7754 6.1926 47 0 13.7391 0.0112 240.733 9.8971 1966
P91754 ACT_LUMRU Actin  Fragment 41296 5.341 468.522 3 33 15.8602 1.7035 47 0 13.7722 0.0113 240.733 9.9479 2028
P00567 KCRB_RABIT Creatine kinase  B 
chain  EC 2 7 3 2   B CK
42636 5.2097 464.7339 3 24 14.4357 3.1151 45 1 14.3872 0.0121 128.9916 5.5032 40230
P92182 ACT1_LUMTE Actin 1 41818 5.1478 461.5403 3 34 20.2128 3.7559 55 1 13.6758 0.0134 240.733 10.0737 1803
O65316 ACT_MESVI Actin 41562 5.1537 444.1467 3 32 15.1194 7.497 47 0 14.6437 0.0118 240.733 9.9852 2031
P10984 ACT2_CAEEL Actin 2 41778 5.142 443.0655 3 34 23.9362 4.3453 51 1 14.5211 0.0153 139.7823 5.8437 1836
P09644 TBA5_CHICK Tubulin alpha 5 chain 49916 4.7567 429.9084 3 35 16.2946 4.7679 50 2 14.6072 0.0119 119.1692 5.9523 78156
P50719 TBA_HAECO Tubulin alpha chain 50078 4.8301 425.1556 3 35 10.2222 5.2341 47 1 15.5751 0.0116 119.1692 5.9717 78182
Q94572 TBA3_HOMAM Tubulin alpha 3 chain  
Alpha III tubulin
49974 4.7567 410.7083 3 35 17.2949 5.8076 47 1 15.2311 0.0107 119.1692 5.9593 78146
P24637 TBB_PNECA Tubulin beta chain 49086 4.7009 403.6846 3 29 13.3484 5.8362 38 1 16.523 0.0126 72.0362 3.5383 78345
P53372 TBA1_PNECA Tubulin alpha chain 50350 4.9951 392.6057 3 35 13.8085 5.4515 42 1 13.6134 0.0127 107.0527 5.3936 78120
P50259 TBB1_PORPU Tubulin beta 1 chain 50014 4.4899 391.6796 3 31 17.5055 5.1384 35 1 15.6538 0.0104 72.0362 3.6052 78231
Q92335 TBA_SORMA Tubulin alpha chain 49786 4.7875 389.0664 3 31 14.4766 1.7994 44 1 13.473 0.0129 107.0527 5.3332 78197
P50258 TBAD_PHYPO Tubulin alpha 1A 
chain
49821 4.823 374.4113 3 35 6.2222 7.6483 29 0 17.8458 0.0118 73.8964 3.684 78167
P04688 TBA1_SCHPO Tubulin alpha 1 chain 51119 4.7897 363.6262 3 37 12.3077 7.039 42 1 14.3549 0.0132 107.0527 5.476 78121
P41937 TBB2_CAEEL Tubulin beta chain 49767 4.6049 359.7253 3 31 18.2432 7.6623 34 1 11.9094 0.0131 45.6206 2.2719 78240
Q07244 ROK_HUMAN Heterogeneous 
nuclear 
ribonucleoprotein K  
hnRNP K
50944 5.2203 358.5522 3 39 15.1188 3.0517 43 0 14.0008 0.0109 98.4876 5.0205 68579
P17317 H2AZ_HUMAN Histone H2A z  H2A z 13413 11.0354 346.671 3 7 34.6457 4.8224 57 0 14.2596 0.011 32.8996 0.4416 32206
P33625 TBA_EUGGR Tubulin alpha chain 49860 4.8014 343.2773 3 35 15.7428 5.288 37 1 15.0966 0.0143 79.7969 3.9813 78179
P33623 TBA1_ANEPH Tubulin alpha 1 chain 49754 4.8439 334.2202 3 35 10.643 6.4639 32 0 16.5227 0.0135 73.8964 3.6708 78101
P05304 TBB_GIALA Tubulin beta chain 49924 4.6456 333.8278 3 31 10.9865 2.7695 33 1 15.9625 0.0132 99.2543 4.9584 78324
P13929 ENOB_HUMAN Beta enolase  EC 4 2 1 
11   2 phospho D 
glycerate
46826 7.658 328.5745 3 28 8.545 7.7748 28 0 15.3006 0.013 115.0281 5.3897 23168
Q9W7L1 ENOA_TRASC Alpha enolase  EC 4 2 
1 11   2 phospho D 
glycerate
47172 6.0417 324.7036 3 31 9.0069 6.4725 25 0 11.6682 0.0132 116.8358 5.5149 23166
P16106 H31_HUMAN Histone H3 1  H3 a   H3 
c   H3 d   H3 f   H3 h   H
15263 11.5404 324.0855 3 12 34.8148 6.6852 48 0 14.1068 0.0121 116.5931 1.7807 32316
P09243 TBA2_STYLE Tubulin alpha 2 chain 49326 4.8274 322.9846 3 36 11.3586 2.4447 30 0 18.8898 0.0119 73.8964 3.6474 78141
Q91883 GR78_XENLA 78 kDa glucose 
regulated protein 
precursor  GRP 78
72590 4.7635 320.6134 3 52 8.5106 5.4072 19 0 13.5908 0.0135 32.6253 2.3698 30764
Q9PW07 LDHA_COLLI L lactate 
dehydrogenase A 
chain  EC 1 1 1 27   LDH
36373 7.8116 319.4906 3 29 11.1782 6.0058 32 0 14.0871 0.0109 103.0729 3.7515 41961
P17304 ACTM_APLCA Actin  muscle 41738 5.1478 316.838 3 34 13.8298 2.477 29 0 11.9312 0.0126 143.4923 5.9931 1956
P22132 ACT2_PHYIN Actin 2 41930 5.2533 314.5078 3 36 15.2 9.4847 30 0 16.2785 0.0129 109.6464 4.6006 1855
P30171 ACTB_SOLTU Actin 97 41615 5.1583 309.4706 3 35 15.1194 6.2073 33 0 13.7594 0.0138 113.8373 4.7405 1932
Q40832 TBA2_PELFA Tubulin alpha 2 chain 49948 4.7197 296.2566 3 35 11.9205 9.3492 34 1 16.58 0.014 73.8964 3.6934 78139
Q90593 GR78_CHICK 78 kDa glucose 
regulated protein 
precursor  GRP 78
71974 4.9341 292.5913 3 52 6.2883 2.7456 19 0 13.0756 0.0121 29.414 2.1184 30752
P26182 ACT_ACHBI Actin 41823 5.1509 292.4547 3 37 21.8085 4.8973 34 1 15.568 0.0133 109.6464 4.5888 1999
P02581 ACT1_SOYBN Actin 1 41330 5.2258 286.5408 3 27 21.4854 7.2385 35 1 14.7609 0.0114 109.6464 4.498 1824
P00358 G3P2_YEAST Glyceraldehyde 3 
phosphate 
dehydrogenase 2  EC 
1 2
35693 6.5068 282.1055 3 28 16.3142 5.7169 35 1 14.9559 0.0083 82.2635 2.9381 27615
P27132 ACT2_NAEFO Actin II  Fragment 41126 5.0696 276.049 3 34 21.8329 5.7593 33 1 15.5362 0.0136 109.6464 4.5123 1848
O65719 HS73_ARATH Heat shock cognate 
70 kDa protein 3  
Hsc70 3
71103 4.7708 271.4206 3 54 8.9368 6.2769 22 1 13.6877 0.0159 29.414 2.0927 35527
Q07972 TBAA_PNECA Tubulin alpha chain  
Fragment
23819 7.164 268.722 3 16 15.566 6.1432 28 0 16.0163 0.0129 73.8964 1.7613 78164
P09643 TBA4_CHICK Tubulin alpha 4 chain  
Fragment
35912 4.5738 244.638 3 23 24.8447 8.6999 36 1 14.9225 0.0123 78.8041 2.8319 78152
P27322 HS72_LYCES Heat shock cognate 
70 kDa protein 2
70662 4.8807 221.092 3 51 9.9379 7.5663 18 0 12.2623 0.0125 29.414 2.0798 35520
P55063 HS73_RAT Heat shock 70 kDa 
protein 3  HSP70 3
70505 5.8319 219.4503 3 52 10.2964 5.5854 20 1 12.6571 0.0144 29.414 2.0751 35531
Q9JJ54 ROD_RAT Heterogeneous 
nuclear 
ribonucleoprotein D0  
hnRNP
38168 7.8979 177.8547 3 24 14.1643 1.9366 26 0 14.7249 0.0131 58.7947 2.2455 68568
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P04961 PCNA_RAT Proliferating cell 
nuclear antigen  
PCNA   Cyclin
28730 4.3755 149.9738 3 23 15.3257 4.0426 14 0 15.9288 0.0204 11.8413 0.3404 55384
Q9RSG0 LYTB_DEIRA LytB protein homolog 36294 5.1324 127.4708 3 23 11.6418 7.1055 12 0 20.0054 0.0166 1.4142 0.0514 43948
P40307 PSB2_RAT Proteasome subunit 
beta type 2  EC 3 4 25 
1   Prot
22897 7.2667 125.683 3 19 20.398 8.3605 16 1 13.269 0.0155 4.2576 0.0976 60347
P27278 NADR_ECOLI Transcriptional 
regulator nadR
47315 5.2917 125.5729 3 35 16.8293 7.4027 18 1 12.9465 0.0146 36.0724 1.7079 48587
P36255 RL7_MYCGE 50S ribosomal protein 
L7 L12
13052 4.8206 106.4994 3 10 25.4098 7.6979 19 0 15.8577 0.0129 4.2576 0.0556 67691
P55272 CDN5_RAT Cyclin dependent 
kinase 4 inhibitor B  
P14 INK4B
13739 5.3254 90.3335 3 12 18.4615 3.913 14 0 22.0112 0.0137 1.6149 0.0222 11111
P18288 TBAT_ONCMY Tubulin alpha chain  
testis specific
49961 4.7966 717.1216 3 35 15.1111 3.013 74 1 14.292 0.0113 299.8134 14.9888 78171
P29510 TBA2_ARATH Tubulin alpha 2 alpha 
4 chain
49509 4.743 498.7438 2 35 8.4444 5.143 47 1 13.3283 0.0119 315.8264 15.6464 78126
P53473 ACTB_STRPU Actin  cytoskeletal IB 41738 5.1418 496.3771 2 34 15.1596 1.7223 47 1 13.4513 0.0117 240.733 10.0544 1933
Q10453 H33_CAEEL Histone H3 3 15201 11.6797 486.5024 2 12 42.2222 6.7429 79 0 14.0841 0.0133 101.3608 1.5418 32327
P92179 ACT_BIOGL Actin 41909 5.1478 484.8539 2 34 14.8936 2.8838 51 1 13.1355 0.0121 240.733 10.0957 2001
P53458 ACT5_DIPDE Actin 5  Fragment 41156 5.4575 484.7069 2 33 15.0943 2.9737 51 2 13.7975 0.0128 240.733 9.9142 1900
P53501 ACT3_DROME Actin 57B 41807 5.0709 466.1548 2 35 11.9681 4.9647 49 1 13.6465 0.0121 240.733 10.0711 1873
P10875 TBB_CANAL Tubulin beta chain 49910 4.4381 391.2248 2 30 14.6993 6.043 35 1 15.046 0.0126 72.0362 3.5976 78312
P35432 ACT1_ECHGR Actin 1 41800 5.155 369.2443 2 32 16.8 3.9983 31 1 15.9107 0.0124 109.6464 4.5863 1799
P08985 H2AV_DROME Histone H2A variant 14841 10.6794 364.3352 2 11 27.8571 6.4026 51 0 13.0718 0.0113 32.8996 0.4886 32196
P30163 ACT2_ONCVO Actin 2 41791 5.1537 353.3517 2 34 16.7553 6.0481 34 1 15.0161 0.0139 122.0519 5.1041 1849
P08991 H2AV_STRPU Histone H2A variant  
Fragment
13156 11.0354 346.671 2 7 34.4 3.8319 51 0 13.4492 0.0114 32.8996 0.4331 32198
P11480 TBAE_PHYPO Tubulin alpha 2B 
chain  Tubulin alpha E 
chain
49607 4.8223 342.0682 2 35 6.0134 1.4085 26 0 15.2209 0.0127 73.8964 3.6682 78168
P46258 ACT3_PEA Actin 3 41607 5.1638 332.4516 2 35 12.7321 7.6142 33 1 15.1063 0.0132 111.5741 4.6454 1881
P53494 ACT4_ARATH Actin 4 41751 5.2397 324.4822 2 35 9.5491 7.1557 27 0 14.5546 0.0119 109.6464 4.5809 1888
P00359 G3P3_YEAST Glyceraldehyde 3 
phosphate 
dehydrogenase 3  EC 
1 2
35593 6.5068 323.6433 2 29 6.3444 5.7318 27 0 13.2821 0.0073 82.2635 2.9299 27622
P81228 ACT5_SOLTU Actin 66  Fragment 37171 5.4441 322.6461 2 31 10.119 2.4171 29 0 14.5409 0.0116 121.16 4.5066 1902
P30162 ACT1_ONCVO Actin 1 41744 5.1537 319.665 2 34 16.7553 5.509 35 1 15.0962 0.0133 122.0519 5.0983 1808
P93584 ACT9_SOLTU Actin 82  Fragment 37208 5.4397 315.5777 2 31 11.9048 5.566 27 0 14.6863 0.0125 109.6464 4.0824 1917
Q05825 ATPB_DROME ATP synthase beta 
chain  mitochondrial 
precursor
54105 5.0821 313.5788 2 32 13.2673 5.564 27 1 13.8353 0.0095 31.8105 1.7222 6246
P53497 ACTC_ARATH Actin 12 41767 5.2397 312.2555 2 35 16.1804 6.0725 30 1 15.4585 0.0121 109.6464 4.5827 1935
P09104 ENOG_HUMAN Gamma enolase  EC 4 
2 1 11   2 phospho D 
glycerate
47124 4.7518 307.0987 2 30 9.4688 4.6971 23 0 12.1291 0.0128 115.0281 5.4241 23173
P30167 ACT3_SOLTU Actin 58 41759 5.3458 305.6437 2 34 12.2016 3.8524 27 0 15.3462 0.0122 111.1465 4.6444 1883
Q05214 ACT1_TOBAC Actin 41711 5.3414 302.9246 2 34 9.0186 11.0981 27 0 15.854 0.0117 109.6464 4.5765 1828
O65315 ACT_COLSC Actin 41678 5.1537 301.5899 2 34 9.0186 4.3497 27 0 15.0067 0.0134 109.6464 4.5729 2011
P22131 ACT1_PHYIN Actin 1 41854 5.1568 296.0745 2 37 18.3511 4.9723 36 2 15.3512 0.0133 109.6464 4.5922 1815
P53504 ACT1_SORBI Actin 1 41835 5.3236 295.4765 2 34 10.8753 7.2842 28 0 15.1278 0.0126 109.6464 4.5901 1823
P30668 TBB_SCHCO Tubulin beta chain 49883 4.5665 291.9617 2 31 8.0899 1.7861 23 0 12.7517 0.0113 99.2543 4.9543 78349
P07304 TBA1_STYLE Tubulin alpha 1 chain 49104 4.7188 291.6006 2 34 10.1124 6.5532 28 0 14.3942 0.0137 73.8964 3.631 78122
P11139 TBA1_ARATH Tubulin alpha 1 chain 49768 4.7355 291.1344 2 31 6.2222 4.3126 25 0 14.8386 0.0125 73.8964 3.6801 78102
Q03684 BIP4_TOBAC Luminal binding 
protein 4 precursor  
BiP 4   78 kD
73477 4.8787 290.4351 2 66 10.3448 6.6865 27 3 14.869 0.0143 29.414 2.1626 7802
P30168 ACT6_SOLTU Actin 71 41755 5.2449 289.9611 2 34 18.0371 5.876 44 3 15.9418 0.014 109.6464 4.5691 1907
Q03685 BIP5_TOBAC Luminal binding 
protein 5 precursor  
BiP 5   78 kD
73699 4.8904 286.1054 2 64 7.0359 0.7109 15 0 11.6747 0.0131 29.414 2.1691 7803
Q27352 TBA_TRYCR Tubulin alpha chain 49696 4.7142 278.9905 2 34 11.3082 7.5567 34 1 14.5881 0.0119 81.7158 4.0636 78203
P14659 HS72_RAT Heat shock related 70 
kDa protein 2  Heat 
shock pr
69485 5.2674 278.5038 2 50 6.1611 5.487 15 0 13.5643 0.0164 29.414 2.0451 35524
P93375 ACT7_TOBAC Actin 104  Fragment 37120 5.4706 274.9634 2 30 7.1429 6.8865 25 0 15.3149 0.0116 109.6464 4.0728 1913
P54652 HS72_HUMAN Heat shock related 70 
kDa protein 2  Heat 
shock 70
69977 5.4073 271.6127 2 50 5.1643 1.6098 15 0 14.5999 0.0147 29.414 2.0596 35519
Q28259 G3P_CANFA Glyceraldehyde 3 
phosphate 
dehydrogenase  EC 1 
2 1
6678 6.0192 266.5935 2 3 53.9683 8.6615 29 0 14.5447 0.0089 82.2635 0.5497 27690
P30164 ACT1_PEA Actin 1 41699 5.2599 264.3018 2 35 8.5106 2.3985 27 0 14.9186 0.0121 109.6464 4.5751 1814
P02553 TBA_LYTPI Tubulin alpha chain  
Fragment
18012 4.5196 263.6154 2 15 11.8012 3.1953 23 0 14.9993 0.012 73.8964 1.3319 78184
P02279 H2B_CHICK Histone H2B 13782 10.6934 261.483 2 11 20 5.946 33 0 13.8751 0.0123 548.0758 7.5585 32295
Q01877 HS71_PUCGR Heat shock protein 
HSS1
70538 4.9391 246.2297 2 53 11.8827 6.1798 20 2 15.3496 0.0149 29.414 2.0761 35509
O24581 BIP3_MAIZE Luminal binding 
protein 3 precursor  
BiP3
73111 4.9411 245.8451 2 62 6.4857 4.4234 17 1 13.1331 0.0155 29.414 2.1518 7800
P24263 ACTD_PHYPO Actin  spherule 
isoform
40492 5.4232 241.6961 2 29 15.847 4.116 30 1 15.1206 0.0131 109.6464 4.4427 1946
P16865 H2A3_VOLCA Histone H2A III 13545 10.6395 238.3276 2 7 25.5814 6.473 31 0 11.9397 0.0137 225.23 3.0527 32178
P14834 HS70_LEIMA Heat shock 70 kDa 
protein  Fragment
56500 6.4658 202.6228 2 38 6.2016 0.7452 14 0 13.553 0.0121 29.414 1.6629 35474
P50890 RSP4_CHICK 40S ribosomal protein 
SA  P40   34 67 kDa 
laminin
33000 4.6022 196.1643 2 26 19.5946 5.7353 21 1 11.537 0.0137 22.8984 0.7561 71613
P19208 HS7C_CAEBR Heat shock 70 kDa 
protein C precursor  
Fragment
48799 5.432 194.1835 2 33 12.9252 6.1127 19 1 13.6831 0.0155 29.414 1.4363 35559
P26452 RSP4_BOVIN 40S ribosomal protein 
P40  C10 protein
32876 4.6022 173.3223 2 26 7.1186 2.7124 12 0 10.3363 0.0136 12.353 0.4064 71610
Q9N2N6 TBB_EUPFO Tubulin beta chain  
Beta tubulin
49774 4.6626 151.2619 2 31 7.2072 2.0839 12 0 14.384 0.0133 32.9732 1.6423 78322
P34108 TBB_NAEGR Tubulin beta chain 50478 4.5652 149.126 2 31 13.082 4.2679 17 1 12.8207 0.0178 32.9732 1.6655 78332
P57761 PCNA_CRIGR Proliferating cell 
nuclear antigen  
PCNA
28776 4.3755 148.848 2 23 18.0077 5.4444 15 1 16.0059 0.0199 11.8413 0.341 55366
P20365 TBB_EUPCR Tubulin beta chain  
Beta tubulin
49892 4.5593 145.3324 2 31 8.9686 8.0862 11 0 16.0979 0.0093 32.9732 1.6462 78321
Q08115 TBB_EUPOC Tubulin beta chain  
Beta tubulin
49586 4.602 143.5899 2 31 11.036 5.2531 15 1 13.3429 0.0129 32.9732 1.6361 78323
Q9V1C7 Y339_PYRAB Hypothetical protein 
PAB0339
24459 5.5366 121.3101 2 17 15.5556 11.4975 11 0 17.3911 0.0086 5.1785 0.1267 91474
O02722 TIM1_HORSE Metalloproteinase 
inhibitor 1 precursor  
TIMP 1
23031 7.6326 70.824 2 13 13.5266 9.0085 10 0 18.7899 0.01 1.8269 0.0421 79815
P16105 H32_BOVIN Histone H3  H3 2 15247 11.6797 542.5127 2 12 28.1481 5.6535 66 0 13.6936 0.0111 364.5874 5.5625 32320
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9.16 Appendix table 7.2 
Appendix table 7.2 Mass Spectrometry results of membrane preparation of P4 NrlGFP sorted 
cells (Run 1) 
Appendix Table 7.2 A Mass spectrometry results of P4 NrlGFP positive cells 
 
Entry Description mW (Da) pI (pH) Theoretical 
Peptides
Coverage (%) Digest 
Peptides
Amount 
(fmol)
Amount 
(ngrams)
P16858 G3P MOUSE Glyceraldehyde 3 phosphate dehydrogenase OS Mus musculus GN Gapdh PE 1 SV 2 35787 8.3507 19 49.8498 13 292.2957 10.4671
P99024 TBB5 MOUSE Tubulin beta 5 chain OS Mus musculus GN Tubb5 PE 1 SV 1 49638 4.5903 30 68.4685 20 130.4988 6.482
P68372 TBB2C MOUSE Tubulin beta 2C chain OS Mus musculus GN Tubb2c PE 1 SV 1 49799 4.602 30 54.6067 17 24.1877 1.2053
Q7TMM9 TBB2A MOUSE Tubulin beta 2A chain OS Mus musculus GN Tubb2a PE 1 SV 1 49874 4.5903 30 47.4157 13 2.8681 0.1431
P17742 PPIA MOUSE Peptidyl prolyl cis trans isomerase A OS Mus musculus GN Ppia PE 1 SV 2 17959 8.003 12 53.6585 6 74.5241 1.3393
P68369 TBA1A MOUSE Tubulin alpha 1A chain OS Mus musculus GN Tuba1a PE 1 SV 1 50103 4.7622 34 56.0976 19 25.2345 1.2651
P05213 TBA1B MOUSE Tubulin alpha 1B chain OS Mus musculus GN Tuba1b PE 1 SV 2 50119 4.7622 34 53.2151 19 161.4343 8.0962
Q64467 G3PT MOUSE Glyceraldehyde 3 phosphate dehydrogenase testis specific OS Mus musculus GN Gapdhs PE 1 47626 7.8001 30 7.0455 4 1.9385 0.0924
Q9ERD7 TBB3 MOUSE Tubulin beta 3 chain OS Mus musculus GN Tubb3 PE 1 SV 1 50386 4.6326 30 25.5556 11 0
Q04447 KCRB MOUSE Creatine kinase B type OS Mus musculus GN Ckb PE 1 SV 1 42686 5.2866 23 41.2073 12 72.1535 3.0819
P17182 ENOA MOUSE Alpha enolase OS Mus musculus GN Eno1 PE 1 SV 3 47111 6.3752 30 21.4286 10 54.6878 2.578
P63260 ACTG MOUSE Actin cytoplasmic 2 OS Mus musculus GN Actg1 PE 1 SV 1 41765 5.1594 34 30.4 17 79.84 3.33
P00924 ENO1 YEAST Enolase 1 EC 4 2 1 11 2 phosphoglycerate dehydr 46642 6.1527 28 22.2477 12 50 2.3335
Q922F4 TBB6 MOUSE Tubulin beta 6 chain OS Mus musculus GN Tubb6 PE 1 SV 1 50058 4.5903 31 19.2394 7 36.5173 1.8292
P26645 MARCS MOUSE Myristoylated alanine rich C kinase substrate OS Mus musculus GN Marcks PE 1 SV 2 29643 4.1239 25 26.5372 8 18.29 0.5425
P68033 ACTC MOUSE Actin alpha cardiac muscle 1 OS Mus musculus GN Actc1 PE 1 SV 1 41991 5.0709 34 8.4881 10 22.4112 0.9417
O89086 RBM3 MOUSE Putative RNA binding protein 3 OS Mus musculus GN Rbm3 PE 1 SV 1 16594 7.6776 13 20.915 2 47.5206 0.7891
P10126 EF1A1 MOUSE Elongation factor 1 alpha 1 OS Mus musculus GN Eef1a1 PE 1 SV 3 50082 9.3417 32 12.987 9 34.7412 1.741
P18760 COF1 MOUSE Cofilin 1 OS Mus musculus GN Cfl1 PE 1 SV 3 18547 8.2196 19 16.8675 4 13.5565 0.2516
P47955 RLA1 MOUSE 60S acidic ribosomal protein P1 OS Mus musculus GN Rplp1 PE 1 SV 1 11467 4.0217 7 14.0351 1 44.287 0.5082
Q91XV3 BASP1 MOUSE Brain acid soluble protein 1 OS Mus musculus GN Basp1 PE 1 SV 3 22073 4.2828 22 15.9292 4 5.3663 0.1185
P68254 1433T MOUSE 14 3 3 protein theta OS Mus musculus GN Ywhaq PE 1 SV 1 27760 4.4934 24 4.898 8 14.9078 0.4141
Q61171 PRDX2 MOUSE Peroxiredoxin 2 OS Mus musculus GN Prdx2 PE 1 SV 3 21765 5.0387 17 4.0404 6 22.7988 0.4965
P61979 HNRPK MOUSE Heterogeneous nuclear ribonucleoprotein K OS Mus musculus GN Hnrnpk PE 1 SV 1 50944 5.2203 38 7.5594 10 33.4423 1.7048
P01942 HBA MOUSE Hemoglobin subunit alpha OS Mus musculus GN Hba PE 1 SV 2 15075 8.6376 9 8.4507 1 44.4156 0.67
P14733 LMNB1 MOUSE Lamin B1 OS Mus musculus GN Lmnb1 PE 1 SV 3 66744 4.9213 69 2.7211 13 31.5536 2.1073
P28667 MRP MOUSE MARCKS related protein OS Mus musculus GN Marcksl1 PE 1 SV 2 20153 4.3993 15 2 4.4322 0.0894
Q60932 VDAC1 MOUSE Voltage dependent anion selective channel protein 1 OS Mus musculus GN Vdac1 PE 1 SV 3 32331 8.6711 21 6 20.6201 0.6671
P52480 KPYM MOUSE Pyruvate kinase isozymes M1 M2 OS Mus musculus GN Pkm2 PE 1 SV 4 57808 7.2131 45 12 22.4032 1.2959
P63101 1433Z MOUSE 14 3 3 protein zeta delta OS Mus musculus GN Ywhaz PE 1 SV 1 27753 4.5273 25 7 8.3832 0.2328
P63158 HMGB1 MOUSE High mobility group protein B1 OS Mus musculus GN Hmgb1 PE 1 SV 2 24878 5.4465 17 4 13.321 0.3316
P51880 FABP7 MOUSE Fatty acid binding protein brain OS Mus musculus GN Fabp7 PE 1 SV 2 14883 5.2996 12 2 17.6197 0.2624
P56480 ATPB MOUSE ATP synthase subunit beta mitochondrial OS Mus musculus GN Atp5b PE 1 SV 2 56265 5.0259 37 8 11.4701 0.6458
Q9D0J8 PTMS MOUSE Parathymosin OS Mus musculus GN Ptms PE 2 SV 3 11423 3.9613 9 1 1.9717 0.0225
O88569 ROA2 MOUSE Heterogeneous nuclear ribonucleoproteins A2 B1 OS Mus musculus GN Hnrnpa2b1 PE 1 SV 2 37379 9.1939 29 2.8329 6 25.3172 0.9469
Q37595 COX2 PERFA Cytochrome c oxidase subunit 2 OS Perognathus flavus GN MT CO2 PE 3 SV 1 25630 4.3949 11 2 0
P06151 LDHA MOUSE L lactate dehydrogenase A chain OS Mus musculus GN Ldha PE 1 SV 3 36475 7.669 28 4 7.9637 0.2907
P62827 RAN MOUSE GTP binding nuclear protein Ran OS Mus musculus GN Ran PE 1 SV 3 24407 7.312 17 3 11.3994 0.2784
P11499 HS90B MOUSE Heat shock protein HSP 90 beta OS Mus musculus GN Hsp90ab1 PE 1 SV 2 83273 4.775 67 9 16.3153 1.3595
P62259 1433E MOUSE 14 3 3 protein epsilon OS Mus musculus GN Ywhae PE 1 SV 1 29155 4.4355 29 4 9.7774 0.2852
P07724 ALBU MOUSE Serum albumin OS Mus musculus GN Alb PE 1 SV 3 68647 5.6752 54 3 27.355 1.8791
P14206 RSSA MOUSE 40S ribosomal protein SA OS Mus musculus GN Rpsa PE 1 SV 4 32817 4.6022 25 4 6.9119 0.227
P07901 HS90A MOUSE Heat shock protein HSP 90 alpha OS Mus musculus GN Hsp90aa1 PE 1 SV 4 84734 4.7357 91 4 3.804 0.3225
O35737 HNRH1 MOUSE Heterogeneous nuclear ribonucleoprotein H OS Mus musculus GN Hnrnph1 PE 1 SV 3 49168 5.8513 27 6 12.3296 0.6066
Q8BG05 ROA3 MOUSE Heterogeneous nuclear ribonucleoprotein A3 OS Mus musculus GN Hnrnpa3 PE 1 SV 1 39627 9.2212 32 6 16.3854 0.6497
P49312 ROA1 MOUSE Heterogeneous nuclear ribonucleoprotein A1 OS Mus musculus GN Hnrnpa1 PE 1 SV 2 34175 9.5198 29 3 5.2826 0.1806
P09411 PGK1 MOUSE Phosphoglycerate kinase 1 OS Mus musculus GN Pgk1 PE 1 SV 4 44521 7.9043 32 4 8.783 0.3913
P17183 ENOG MOUSE Gamma enolase OS Mus musculus GN Eno2 PE 1 SV 2 47267 4.7996 30 4 10.4937 0.4963
Q62433 NDRG1 MOUSE Protein NDRG1 OS Mus musculus GN Ndrg1 PE 1 SV 1 42980 5.6483 20 3 8.0218 0.345
P35564 CALX MOUSE Calnexin OS Mus musculus GN Canx PE 1 SV 1 67235 4.2949 44 3 12.1988 0.8207
P28656 NP1L1 MOUSE Nucleosome assembly protein 1 like 1 OS Mus musculus GN Nap1l1 PE 1 SV 2 45316 4.1589 25 3 10.6917 0.4848
Q9CQV8 1433B MOUSE 14 3 3 protein beta alpha OS Mus musculus GN Ywhab PE 1 SV 3 28068 4.5745 22 3 0.543 0.0153
P70459 ERF MOUSE ETS domain containing transcription factor ERF OS Mus musculus GN Erf PE 2 SV 1 59013 6.9192 31 1 10.9955 0.6493
P61027 RAB10 MOUSE Ras related protein Rab 10 OS Mus musculus GN Rab10 PE 1 SV 1 22526 8.5735 18 4 3.2215 0.0726
P63017 HSP7C MOUSE Heat shock cognate 71 kDa protein OS Mus musculus GN Hspa8 PE 1 SV 1 70827 5.1998 50 9 6.0082 0.4258
Q6P5F9 XPO1 MOUSE Exportin 1 OS Mus musculus GN Xpo1 PE 1 SV 1 123013 5.6552 88 6 12.9072 1.5888
P56695 WFS1 MOUSE Wolframin OS Mus musculus GN Wfs1 PE 1 SV 1 100514 7.8706 52 3 12.8751 1.295
P55258 RAB8A MOUSE Ras related protein Rab 8A OS Mus musculus GN Rab8a PE 1 SV 2 23653 9.4319 17 3 1.3939 0.033
P70168 IMB1 MOUSE Importin subunit beta 1 OS Mus musculus GN Kpnb1 PE 1 SV 1 97090 4.4865 62 5 6.8265 0.6632
P60335 PCBP1 MOUSE Poly rC binding protein 1 OS Mus musculus GN Pcbp1 PE 1 SV 1 37473 6.7136 24 3 4.9154 0.1843
O08553 DPYL2 MOUSE Dihydropyrimidinase related protein 2 OS Mus musculus GN Dpysl2 PE 1 SV 2 62238 5.9229 43 5 2.4237 0.1509
Appendix Table 7.2 A Mass spectrometry results of P4 NrlGFP positive cells
Red indicates plasma membrane proteins. Note P00924 ENO1 Yeast is a positive control that added during Mass  
Spec mapping. 
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Appendix Table 7.2 B Mass spectrometry results of P4 NrlGFP negative cells 
 
 
 
Entry Description mW (Da) pI (pH) Theoretical 
Peptides
Coverage (%) Digest 
Peptides
Amount 
(fmol)
Amount 
(ngrams)
Q8CGP6 H2A1H MOUSE Histone H2A type 1 H OS Mus musculus GN Hist1h2ah PE 1 SV 3 13941 11.454 7 37.5 2 683.5786 9.5361
Q64523 H2A2C MOUSE Histone H2A type 2 C OS Mus musculus GN Hist2h2ac PE 1 SV 3 13979 11.333 7 14.7287 2 0
P62806 H4 MOUSE Histone H4 OS Mus musculus GN Hist1h4a PE 1 SV 2 11360 11.767 11 48.5437 6 113.2583 1.2874
P16858 G3P MOUSE Glyceraldehyde 3 phosphate dehydrogenase OS Mus musculus GN Gapdh PE 1 SV 2 35787 8.3507 19 47.4474 11 235.7324 8.4416
P10853 H2B1F MOUSE Histone H2B type 1 F J L OS Mus musculus GN Hist1h2bf PE 1 SV 2 13927 10.739 11 28.5714 3 409.44 5.71
P99024 TBB5 MOUSE Tubulin beta 5 chain OS Mus musculus GN Tubb5 PE 1 SV 1 49638 4.5903 30 43.018 15 166.0173 8.2462
P68372 TBB2C MOUSE Tubulin beta 2C chain OS Mus musculus GN Tubb2c PE 1 SV 1 49799 4.602 30 32.809 12 15.8904 0.7918
Q9CWF2 TBB2B MOUSE Tubulin beta 2B chain OS Mus musculus GN Tubb2b PE 1 SV 1 49920 4.5903 30 30.1124 12 2.2063 0.1102
P68369 TBA1A MOUSE Tubulin alpha 1A chain OS Mus musculus GN Tuba1a PE 1 SV 1 50103 4.7622 34 33.2594 16 28.1914 1.4134
P68373 TBA1C MOUSE Tubulin alpha 1C chain OS Mus musculus GN Tuba1c PE 1 SV 1 49877 4.7856 34 33.4076 16 186.3768 9.302
P05213 TBA1B MOUSE Tubulin alpha 1B chain OS Mus musculus GN Tuba1b PE 1 SV 2 50119 4.7622 34 27.2727 16 0
P47955 RLA1 MOUSE 60S acidic ribosomal protein P1 OS Mus musculus GN Rplp1 PE 1 SV 1 11467 4.0217 7 14.0351 1 46.4574 0.5331
P63260 ACTG MOUSE Actin cytoplasmic 2 OS Mus musculus GN Actg1 PE 1 SV 1 41765 5.1594 34 9.0667 9 0
P17742 PPIA MOUSE Peptidyl prolyl cis trans isomerase A OS Mus musculus GN Ppia PE 1 SV 2 17959 8.003 12 27.439 4 53.3011 0.9579
P68433 H31 MOUSE Histone H3 1 OS Mus musculus GN Hist1h3a PE 1 SV 2 15394 11.54 12 23.5294 5 66.3964 1.0228
Q9ERD7 TBB3 MOUSE Tubulin beta 3 chain OS Mus musculus GN Tubb3 PE 1 SV 1 50386 4.6326 30 3.1111 8 0
P00924 ENO1 YEAST Enolase 1 EC 4 2 1 11 2 phosphoglycerate dehydr 46642 6.1527 28 8.945 11 50 2.3335
Q04447 KCRB MOUSE Creatine kinase B type OS Mus musculus GN Ckb PE 1 SV 1 42686 5.2866 23 7.874 6 118.6838 5.0694
Q922F4 TBB6 MOUSE Tubulin beta 6 chain OS Mus musculus GN Tubb6 PE 1 SV 1 50058 4.5903 31 3.132 8 1.5514 0.0777
P17182 ENOA MOUSE Alpha enolase OS Mus musculus GN Eno1 PE 1 SV 3 47111 6.3752 30 10.8295 8 56.9848 2.6863
P10126 EF1A1 MOUSE Elongation factor 1 alpha 1 OS Mus musculus GN Eef1a1 PE 1 SV 3 50082 9.3417 32 5 46.8196 2.3463
P63268 ACTH MOUSE Actin gamma enteric smooth muscle OS Mus musculus GN Actg2 PE 2 SV 1 41849 5.1594 33 6 21.6764 0.9077
P84228 H32 MOUSE Histone H3 2 OS Mus musculus GN Hist1h3b PE 1 SV 2 15378 11.68 12 5 8.9884 0.1383
P02088 HBB1 MOUSE Hemoglobin subunit beta 1 OS Mus musculus GN Hbb b1 PE 1 SV 2 15830 7.4969 13 4 28.5083 0.4516
P07759 SPA3K MOUSE Serine protease inhibitor A3K OS Mus musculus GN Serpina3k PE 1 SV 2 46850 4.8693 31 2 16.5039 0.7737
Q91XV3 BASP1 MOUSE Brain acid soluble protein 1 OS Mus musculus GN Basp1 PE 1 SV 3 22073 4.2828 22 2 4.2734 0.0944
P11499 HS90B MOUSE Heat shock protein HSP 90 beta OS Mus musculus GN Hsp90ab1 PE 1 SV 2 83273 4.775 67 5 11.2115 0.9342
P63158 HMGB1 MOUSE High mobility group protein B1 OS Mus musculus GN Hmgb1 PE 1 SV 2 24878 5.4465 17 2 8.9752 0.2234
Q3V132 ADT4 MOUSE ADP ATP translocase 4 OS Mus musculus GN Slc25a31 PE 2 SV 1 35235 9.8932 34 2 32.1351 1.133
P01942 HBA MOUSE Hemoglobin subunit alpha OS Mus musculus GN Hba PE 1 SV 2 15075 8.6376 9 3 33.0378 0.4984
P00405 COX2 MOUSE Cytochrome c oxidase subunit 2 OS Mus musculus GN Mtco2 PE 1 SV 1 25959 4.4103 11 4 0
P07901 HS90A MOUSE Heat shock protein HSP 90 alpha OS Mus musculus GN Hsp90aa1 PE 1 SV 4 84734 4.7357 91 6 6.7891 0.5756
P26645 MARCS MOUSE Myristoylated alanine rich C kinase substrate OS Mus musculus GN Marcks PE 1 SV 2 29643 4.1239 25 4 10.3172 0.306
Q60932 VDAC1 MOUSE Voltage dependent anion selective channel protein 1 OS Mus musculus GN Vdac1 PE 1 SV 3 32331 8.6711 21 3 11.4354 0.37
P14733 LMNB1 MOUSE Lamin B1 OS Mus musculus GN Lmnb1 PE 1 SV 3 66744 4.9213 69 6 20.2837 1.3547
P61979 HNRPK MOUSE Heterogeneous nuclear ribonucleoprotein K OS Mus musculus GN Hnrnpk PE 1 SV 1 50944 5.2203 38 5 25.4271 1.2962
Q9R0M8 S35A2 MOUSE UDP galactose translocator OS Mus musculus GN Slc35a2 PE 2 SV 1 40740 10.133 18 2 8.7346 0.3561
O88319 NTR1 MOUSE Neurotensin receptor type 1 OS Mus musculus GN Ntsr1 PE 2 SV 1 47186 9.4257 21 1 44.2043 2.0872
P56480 ATPB MOUSE ATP synthase subunit beta mitochondrial OS Mus musculus GN Atp5b PE 1 SV 2 56265 5.0259 37 5 12.2702 0.6908
Q64692 SIA8D MOUSE CMP N acetylneuraminate poly alpha 2 8 sialyltransferase OS Mus musculus GN St8sia4 PE 2 41229 10.156 27 1 3.8582 0.1592
Red indicates plasma membrane proteins. Note P00924 ENO1 Yeast is a positive control that added during Mass  Spec mapping.
Red indicates plasma membrane proteins. Note P00924 ENO1 Yeast is a positive control that added during Mass  
Spec mapping. 
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9.17 Appendix table 7.3  
Appendix table 7.3 Mass Spectrometry results of membrane preparation of P4 NrlGFP sorted 
cells (Run 2) 
 
Accession Entry Description mW (Da) pI (pH)
Theoretical 
Peptides
Coverage 
(%)
Digest 
Peptides
Amount 
(fmol)
Amount 
(ngrams)
ENO1_YEAST P00924 Enolase 1 OS Saccharomyces cerevisiae GN ENO1 PE 1 SV 2 46773 6.1527 28 51.9451 29 100 4.6802
Q64426 tr Q64426 MOUSE Histone H2A Fragment OS Mus musculus domesticus GN Hist2h2aa1 PE 2 SV 1 14737 11.0358 8 34.3066 3 0
Q8CGP4 tr Q8CGP4 MOUSE Histone H2A OS Mus musculus GN Hist1h2aa PE 2 SV 1 14047 11.6213 9 50.3876 3 2.2004 0.0309
Q6IWE2 tr Q6IWE2 MOUSE Beta actin Fragment OS Mus musculus GN Actb PE 2 SV 1 8588 4.2336 9 45.4545 2 1.9972 0.0172
A2A513 tr A2A513 MOUSE Keratin 10 OS Mus musculus GN Krt10 PE 3 SV 1 57006 4.8127 37 7.4866 4 2.1369 0.1219
Q8CIT7 tr Q8CIT7 MOUSE Retinoblastoma binding protein 1 Fragment OS Mus musculus GN Arid4a PE 2 SV 1 4025 9.9765 2 45.9459 1 0.348 0.0014
LMNB1_MOUSE P14733 Lamin B1 OS Mus musculus GN Lmnb1 PE 1 SV 3 66744 4.9213 69 25.1701 11 1.7757 0.1186
K2C1_MOUSE P04104 Keratin type II cytoskeletal 1 OS Mus musculus GN Krt1 PE 1 SV 4 65565 8.1526 47 5.9655 4 1.7558 0.1152
Q08EK4 tr Q08EK4 MOUSE Keratin 77 OS Mus musculus GN Krt77 PE 2 SV 1 61264 8.2932 47 14.711 7 3.8485 0.2359
Q99NC5 tr Q99NC5 MOUSE Beta actin FE 3 Fragment OS Mus musculus GN Actb PE 2 SV 1 14973 5.5602 11 21.6418 2 0
UCP1_MOUSE P12242 Mitochondrial brown fat uncoupling protein 1 OS Mus musculus GN Ucp1 PE 2 SV 2 33226 9.3928 25 8.7948 2 17.6048 0.5853
VDAC1_MOUSE Q60932 Voltage dependent anion selective channel protein 1 OS Mus musculus GN Vdac1 PE 1 SV 3 32331 8.6711 21 40.2027 7 2.11 0.0648
ROA2_MOUSE O88569 Heterogeneous nuclear ribonucleoproteins A2 B1 OS Mus musculus GN Hnrnpa2b1 PE 1 SV 2 37379 9.1939 29 11.6147 3 0
AT1A1_MOUSE Q8VDN2 Sodium potassium transporting ATPase subunit alpha 1 OS Mus musculus GN Atp1a1 PE 1 SV 1 112909 5.1374 72 10.4594 7 0
AT1A3_MOUSE Q6PIC6 Sodium potassium transporting ATPase subunit alpha 3 OS Mus musculus GN Atp1a3 PE 1 SV 1 111620 5.0881 66 19.2498 13 1.022 0.1141
HNRPK_MOUSE P61979 Heterogeneous nuclear ribonucleoprotein K OS Mus musculus GN Hnrnpk PE 1 SV 1 50944 5.2203 38 23.1102 7 1.1821 0.0574
Q8R3A9 tr Q8R3A9 MOUSE Atp1a2 protein Fragment OS Mus musculus GN Atp1a2 PE 2 SV 1 53815 4.9867 34 26.9547 8 0
KRT35_MOUSE Q497I4 Keratin type I cuticular Ha5 OS Mus musculus GN Krt35 PE 2 SV 1 50497 4.7047 40 7.033 2 1.9649 0.0993
D3YZY0 tr D3YZY0 MOUSE Uncharacterized protein OS Mus musculus GN Actg2 PE 3 SV 1 30045 4.7576 24 20 4 0
D3YV05 tr D3YV05 MOUSE Uncharacterized protein OS Mus musculus GN Atp1b2 PE 3 SV 1 25564 8.6801 18 30.3571 5 0.3241 0.0083
Q80ZV2 tr Q80ZV2 MOUSE Tubb5 protein Fragment OS Mus musculus GN Tubb5 PE 2 SV 1 21440 4.5701 13 15.5914 2 0
AT1A2_MOUSE Q6PIE5 Sodium potassium transporting ATPase subunit alpha 2 OS Mus musculus GN Atp1a2 PE 1 SV 1 112145 5.2291 77 16.2745 11 0
Q61272 tr Q61272 MOUSE Alpha actin Aa 40 375 Fragment OS Mus musculus GN Acta1 PE 2 SV 1 37787 5.326 30 16.0714 4 0
CRYM_MOUSE O54983 Mu crystallin homolog OS Mus musculus GN Crym PE 1 SV 1 33502 5.3161 22 13.738 1 1.1092 0.0372
B1AQ77 tr B1AQ77 MOUSE Keratin 15 OS Mus musculus GN Krt15 PE 3 SV 1 49463 4.593 42 7.2368 3 1.8835 0.0932
ACTBL_MOUSE Q8BFZ3 Beta actin like protein 2 OS Mus musculus GN Actbl2 PE 1 SV 1 41977 5.1535 35 11.4362 3 0
AT1B2_MOUSE P14231 Sodium potassium transporting ATPase subunit beta 2 OS Mus musculus GN Atp1b2 PE 1 SV 2 33322 8.3441 22 25.1724 5 0
Q8BK71 tr Q8BK71 MOUSE Putative uncharacterized protein Fragment OS Mus musculus GN Tpr PE 2 SV 1 47597 5.1226 44 11.1922 3 2.5077 0.1194
Q3U9U3 tr Q3U9U3 MOUSE Putative uncharacterized protein OS Mus musculus GN Tubb6 PE 2 SV 1 42127 4.5709 25 8.5333 2 0
D7URW5 tr D7URW5 MOUSE Vomeronasal 2 receptor p5 OS Mus musculus domesticus GN V2Rp5 PE 2 SV 1 97640 7.0688 52 11.4486 4 1.9876 0.1942
D7URW2 tr D7URW2 MOUSE Vomeronasal 2 receptor p2 OS Mus musculus domesticus GN V2Rp2 PE 2 SV 1 97583 7.1554 48 9.8016 4 0
K2C71_MOUSE Q9R0H5 Keratin type II cytoskeletal 71 OS Mus musculus GN Krt71 PE 1 SV 1 57346 6.626 45 15.458 5 0
Accession Entry Description mW (Da) pI (pH)
Theoretical 
Peptides
Coverage 
(%)
Digest 
Peptides
Amount 
(fmol)
Amount 
(ngrams)
ENO1_YEAST P00924 Enolase 1 OS Saccharomyces cerevisiae GN ENO1 PE 1 SV 2 46773 6.1527 28 55.6064 21 100 4.6802
MARCS_MOUSE P26645 Myristoylated alanine rich C kinase substrate OS Mus musculus GN Marcks PE 1 SV 2 29643 4.1239 25 86.0841 13 4.1355 0.1227
LMNB1_MOUSE P14733 Lamin B1 OS Mus musculus GN Lmnb1 PE 1 SV 3 66744 4.9213 69 46.5986 26 19.1796 1.2809
K2C74_MOUSE Q6IFZ9 Keratin type II cytoskeletal 74 OS Mus musculus GN Krt74 PE 2 SV 1 54712 5.3787 46 17.3737 5 0
K2C71_MOUSE Q9R0H5 Keratin type II cytoskeletal 71 OS Mus musculus GN Krt71 PE 1 SV 1 57346 6.626 45 23.6641 8 0
K2C1_MOUSE P04104 Keratin type II cytoskeletal 1 OS Mus musculus GN Krt1 PE 1 SV 4 65565 8.1526 47 16.0126 9 11.6692 0.7656
HNRPL_MOUSE Q8R081 Heterogeneous nuclear ribonucleoprotein L OS Mus musculus GN Hnrnpl PE 1 SV 2 63923 8.042 34 13.4812 3 2.9811 0.1907
H4_MOUSE P62806 Histone H4 OS Mus musculus GN Hist1h4a PE 1 SV 2 11360 11.7665 11 30.0971 4 1.201 0.0137
BASP1_MOUSE Q91XV3 Brain acid soluble protein 1 OS Mus musculus GN Basp1 PE 1 SV 3 22073 4.2828 22 44.6903 8 0.8403 0.0186
ACTB_MOUSE P60710 Actin cytoplasmic 1 OS Mus musculus GN Actb PE 1 SV 1 41709 5.142 34 21.3333 6 6.4839 0.2706
ROA2_MOUSE O88569 Heterogeneous nuclear ribonucleoproteins A2 B1 OS Mus musculus GN Hnrnpa2b1 PE 1 SV 2 37379 9.1939 29 31.728 8 3.2446 0.1214
VDAC1_MOUSE Q60932 Voltage dependent anion selective channel protein 1 OS Mus musculus GN Vdac1 PE 1 SV 3 32331 8.6711 21 16.5541 4 9.4427 0.3055
ACTA_MOUSE P62737 Actin aortic smooth muscle OS Mus musculus GN Acta2 PE 1 SV 1 41981 5.077 34 17.2414 6 0
K1C10_MOUSE P02535 Keratin type I cytoskeletal 10 OS Mus musculus GN Krt10 PE 1 SV 3 57734 4.8534 38 12.807 5 7.6891 0.4442
ACTBL_MOUSE Q8BFZ3 Beta actin like protein 2 OS Mus musculus GN Actbl2 PE 1 SV 1 41977 5.1535 35 20.2128 4 0
HNRPK_MOUSE P61979 Heterogeneous nuclear ribonucleoprotein K OS Mus musculus GN Hnrnpk PE 1 SV 1 50944 5.2203 38 22.4622 7 4.8244 0.2459
ATPB_MOUSE P56480 ATP synthase subunit beta mitochondrial OS Mus musculus GN Atp5b PE 1 SV 2 56265 5.0259 37 22.8733 7 4.7696 0.2685
PGRC1_MOUSE O55022 Membrane associated progesterone receptor component 1 OS Mus musculus GN Pgrmc1 PE 1 SV 4 21680 4.3422 19 15.8974 1 7.2572 0.1574
TBB2B_MOUSE Q9CWF2 Tubulin beta 2B chain OS Mus musculus GN Tubb2b PE 1 SV 1 49920 4.5903 30 38.6517 13 2.7463 0.1372
TBA1C_MOUSE P68373 Tubulin alpha 1C chain OS Mus musculus GN Tuba1c PE 1 SV 1 49877 4.7856 34 38.5301 9 0
RANDOM4525 RANDOM4525 Random Sequence 4525 54700 5.4809 34 10.7071 2 5.0781 0.278
TBB5_MOUSE P99024 Tubulin beta 5 chain OS Mus musculus GN Tubb5 PE 1 SV 1 49638 4.5903 30 35.1351 13 0
Q8R5E7 tr Q8R5E7 MOUSE Tmem106b protein Fragment OS Mus musculus GN Tmem106b PE 2 SV 1 12153 5.5521 6 76.6355 4 1.4954 0.0182
Q2NKW2 tr Q2NKW2 MOUSE Olfr847 protein Fragment OS Mus musculus GN Olfr847 PE 2 SV 1 34585 8.1442 9 31.5113 6 36.2647 1.2551
D3YU91 tr D3YU91 MOUSE Uncharacterized protein OS Mus musculus GN C87414 PE 4 SV 1 31706 6.6694 19 18.705 4 1.8201 0.0577
Q9R0U5 tr Q9R0U5 MOUSE Matrin3 OS Mus musculus GN Matr3 PE 2 SV 1 34083 6.4517 29 13.3987 3 2.3795 0.0812
D3YX94 tr D3YX94 MOUSE Uncharacterized protein OS Mus musculus GN Gm6205 PE 4 SV 1 41713 9.3898 26 13.0919 3 0
Q3T9Y9 tr Q3T9Y9 MOUSE Putative uncharacterized protein Fragment OS Mus musculus GN Ptpn1 PE 2 SV 1 28612 5.805 28 42.5703 7 0.4141 0.0119
VAPA_MOUSE Q9WV55 Vesicle associated membrane protein associated protein A OS Mus musculus GN Vapa PE 1 SV 2 27837 8.5909 21 6.4257 1 1.2341 0.0344
Q3TNH0 tr Q3TNH0 MOUSE Putative uncharacterized protein OS Mus musculus GN Tmpo PE 1 SV 1 46021 9.6059 36 28.1553 7 1.7539 0.0808
Accession Entry Description mW (Da) pI (pH)
Theoretical 
Peptides
Coverage 
(%)
Digest 
Peptides
Amount 
(fmol)
Amount 
(ngrams)
ENO1_YEAST P00924 Enolase 1 OS Saccharomyces cerevisiae GN ENO1 PE 1 SV 2 46773 6.1527 28 55.8352 23 100 4.6802
LMNB1_MOUSE P14733 Lamin B1 OS Mus musculus GN Lmnb1 PE 1 SV 3 66744 4.9213 69 41.3265 18 11.782 0.7869
MARCS_MOUSE P26645 Myristoylated alanine rich C kinase substrate OS Mus musculus GN Marcks PE 1 SV 2 29643 4.1239 25 64.7249 9 2.1255 0.063
ROA3_MOUSE Q8BG05 Heterogeneous nuclear ribonucleoprotein A3 OS Mus musculus GN Hnrnpa3 PE 1 SV 1 39627 9.2212 32 29.8153 7 4.3662 0.1731
K1C10_MOUSE P02535 Keratin type I cytoskeletal 10 OS Mus musculus GN Krt10 PE 1 SV 3 57734 4.8534 38 7.193 4 4.5484 0.2628
G3P_MOUSE P16858 Glyceraldehyde 3 phosphate dehydrogenase OS Mus musculus GN Gapdh PE 1 SV 2 35787 8.3507 19 20.7207 3 2.0879 0.0748
HNRPK_MOUSE P61979 Heterogeneous nuclear ribonucleoprotein K OS Mus musculus GN Hnrnpk PE 1 SV 1 50944 5.2203 38 15.1188 4 2.8757 0.1396
Accession Entry Description mW (Da) pI (pH)
Theoretical 
Peptides
Coverage 
(%)
Digest 
Peptides
Amount 
(fmol)
Amount 
(ngrams)
ENO1_YEAST P00924 Enolase 1 OS Saccharomyces cerevisiae GN ENO1 PE 1 SV 2 46773 6.1527 28 52.4027 22 100 4.6802
LMNB1_MOUSE P14733 Lamin B1 OS Mus musculus GN Lmnb1 PE 1 SV 3 66744 4.9213 69 37.2449 17 9.6148 0.6421
MARCS_MOUSE P26645 Myristoylated alanine rich C kinase substrate OS Mus musculus GN Marcks PE 1 SV 2 29643 4.1239 25 79.6117 8 2.3784 0.0705
ACTB_MOUSE P60710 Actin cytoplasmic 1 OS Mus musculus GN Actb PE 1 SV 1 41709 5.142 34 31.2 8 6.5801 0.2746
ACTBL_MOUSE Q8BFZ3 Beta actin like protein 2 OS Mus musculus GN Actbl2 PE 1 SV 1 41977 5.1535 35 31.9149 6 0
TBA1C_MOUSE P68373 Tubulin alpha 1C chain OS Mus musculus GN Tuba1c PE 1 SV 1 49877 4.7856 34 32.7394 7 4.4704 0.2231
HNRH1_MOUSE O35737 Heterogeneous nuclear ribonucleoprotein H OS Mus musculus GN Hnrnph1 PE 1 SV 3 49168 5.8513 27 25.6125 7 2.9709 0.1462
CALX_MOUSE P35564 Calnexin OS Mus musculus GN Canx PE 1 SV 1 67235 4.2949 44 14.5516 4 1.0114 0.068
HNRH2_MOUSE P70333 Heterogeneous nuclear ribonucleoprotein H2 OS Mus musculus GN Hnrnph2 PE 1 SV 1 49248 5.8511 27 12.6949 4 0
ROA3_MOUSE Q8BG05 Heterogeneous nuclear ribonucleoprotein A3 OS Mus musculus GN Hnrnpa3 PE 1 SV 1 39627 9.2212 32 12.4011 3 3.5508 0.1408
BASP1_MOUSE Q91XV3 Brain acid soluble protein 1 OS Mus musculus GN Basp1 PE 1 SV 3 22073 4.2828 22 58.4071 9 0.4424 0.0098
ROA2_MOUSE O88569 Heterogeneous nuclear ribonucleoproteins A2 B1 OS Mus musculus GN Hnrnpa2b1 PE 1 SV 2 37379 9.1939 29 20.3966 5 1.1189 0.0418
VDAC1_MOUSE Q60932 Voltage dependent anion selective channel protein 1 OS Mus musculus GN Vdac1 PE 1 SV 3 32331 8.6711 21 13.1757 2 6.1123 0.1977
PGRC1_MOUSE O55022 Membrane associated progesterone receptor component 1 OS Mus musculus GN Pgrmc1 PE 1 SV 4 21680 4.3422 19 29.7436 3 4.7642 0.1034
K1C10_MOUSE P02535 Keratin type I cytoskeletal 10 OS Mus musculus GN Krt10 PE 1 SV 3 57734 4.8534 38 10.3509 3 5.0049 0.2891
ATPB_MOUSE P56480 ATP synthase subunit beta mitochondrial OS Mus musculus GN Atp5b PE 1 SV 2 56265 5.0259 37 17.7694 4 3.9583 0.2229
HNRPK_MOUSE P61979 Heterogeneous nuclear ribonucleoprotein K OS Mus musculus GN Hnrnpk PE 1 SV 1 50944 5.2203 38 12.527 4 1.6616 0.0847
TBB5_MOUSE P99024 Tubulin beta 5 chain OS Mus musculus GN Tubb5 PE 1 SV 1 49638 4.5903 30 17.7928 6 1.0231 0.0508
Appendix Table 7.3 A Mass spectrometry results of P4 NrlGFP positive cells 2nd run
Appendix Table 7.3 B Mass spectrometry results of P4 NrlGFP negative cells 2nd run
Red indicates plasma membrane proteins;Proteins from technichal replicates were presented  separately. 
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9.18 Appendix table 7.4 
Appendix table 7.4 Mass Spectrometry results of membrane preparation of P4 NrlGFP sorted 
cells (Run 3) 
 
Accession Entry Description mW (Da) pI (pH)
Theoretical 
Peptides
Coverage 
(%)
Digest 
Peptides
Amount 
(fmol)
Amount 
(ngrams)
P00924 ENO1_YEAST Enolase 1 EC 4 2 1 11 2 phosphoglycerate dehydr 46642 6.1527 28 45.4128 20 100 4.6671
LMNB1_MOUSE P14733 Lamin B1 OS Mus musculus GN Lmnb1 PE 1 SV 3 66744 4.9213 69 35.2041 16 21.4516 1.4327
AT1B2_MOUSE P14231 Sodium potassium transporting ATPase subunit beta 2 OS Mus musculus GN Atp1b2 PE 1 SV 2 33322 8.3441 22 24.1379 3 10.6499 0.3551
ROA2_MOUSE O88569 Heterogeneous nuclear ribonucleoproteins A2 B1 OS Mus musculus GN Hnrnpa2b1 PE 1 SV 2 37379 9.1939 29 25.4958 7 0
MARCS_MOUSE P26645 Myristoylated alanine rich C kinase substrate OS Mus musculus GN Marcks PE 1 SV 2 29643 4.1239 25 25.5663 4 1.3756 0.0408
ATPA_MOUSE Q03265 ATP synthase subunit alpha mitochondrial OS Mus musculus GN Atp5a1 PE 1 SV 1 59715 9.5021 46 31.4647 12 7.0848 0.4233
ADT2_MOUSE P51881 ADP ATP translocase 2 OS Mus musculus GN Slc25a5 PE 1 SV 3 32910 10.0303 31 31.8792 7 6.2345 0.2053
AT1A3_MOUSE Q6PIC6 Sodium potassium transporting ATPase subunit alpha 3 OS Mus musculus GN Atp1a3 PE 1 SV 1 111620 5.0881 66 22.2113 15 11.2294 1.2542
A2BDV8 tr A2BDV8 MOUSE Heterogeneous nuclear ribonucleoprotein H2 OS Mus musculus GN Hnrnph2 PE 4 SV 1 49248 5.8511 27 30.2895 10 7.2114 0.3554
F6ZQM8 tr F6ZQM8 MOUSE Uncharacterized protein Fragment OS Mus musculus PE 4 SV 1 35556 8.0825 19 42.2492 12 18.2757 0.6502
TBA8_MOUSE Q9JJZ2 Tubulin alpha 8 chain OS Mus musculus GN Tuba8 PE 1 SV 1 50019 4.7966 34 23.608 6 0
ACTBL_MOUSE Q8BFZ3 Beta actin like protein 2 OS Mus musculus GN Actbl2 PE 1 SV 1 41977 5.1535 35 28.4574 7 0
ATPB_MOUSE P56480 ATP synthase subunit beta mitochondrial OS Mus musculus GN Atp5b PE 1 SV 2 56265 5.0259 37 17.5803 6 7.2057 0.4057
ENOA_MOUSE P17182 Alpha enolase OS Mus musculus GN Eno1 PE 1 SV 3 47111 6.3752 30 26.0369 8 1.1967 0.0564
HNRPF_MOUSE Q9Z2X1 Heterogeneous nuclear ribonucleoprotein F OS Mus musculus GN Hnrnpf PE 1 SV 3 45700 5.1652 26 4.8193 1 0
ADT1_MOUSE P48962 ADP ATP translocase 1 OS Mus musculus GN Slc25a4 PE 1 SV 4 32883 10.0181 31 25.1678 6 0.5776 0.019
H4_MOUSE P62806 Histone H4 OS Mus musculus GN Hist1h4a PE 1 SV 2 11360 11.7665 11 46.6019 6 5.7579 0.0655
TBB2C_MOUSE P68372 Tubulin beta 2C chain OS Mus musculus GN Tubb2c PE 1 SV 1 49799 4.602 30 29.2135 9 6.808 0.3393
KCRB_MOUSE Q04447 Creatine kinase B type OS Mus musculus GN Ckb PE 1 SV 1 42686 5.2866 23 19.685 5 5.5526 0.2372
TBB5_MOUSE P99024 Tubulin beta 5 chain OS Mus musculus GN Tubb5 PE 1 SV 1 49638 4.5903 30 22.5225 7 0
Q3TFP8 tr Q3TFP8 MOUSE Uncharacterized protein OS Mus musculus GN Pgrmc1 PE 2 SV 1 19733 4.4806 19 14.8571 2 2.611 0.0516
Q3TQ70 tr Q3TQ70 MOUSE Beta1 subnuit of GTP binding protein OS Mus musculus GN Gnb1 PE 2 SV 1 37353 5.5351 21 33.2353 7 5.4029 0.2019
E9Q9J0 tr E9Q9J0 MOUSE Uncharacterized protein OS Mus musculus GN Uba52 PE 4 SV 1 10906 8.2344 7 26.0417 2 0.7498 0.0082
F2Z471 tr F2Z471 MOUSE Uncharacterized protein OS Mus musculus GN Vdac1 PE 4 SV 1 28139 7.2405 17 31.1024 6 2.1967 0.0619
PHB_MOUSE P67778 Prohibitin OS Mus musculus GN Phb PE 1 SV 1 29801 5.4293 21 14.3382 2 5.0522 0.1507
E9Q7H5 tr E9Q7H5 MOUSE Uncharacterized protein OS Mus musculus GN Gm8991 PE 4 SV 1 32554 8.482 28 24 8 4.338 0.1413
COX2_MOUSE P00405 Cytochrome c oxidase subunit 2 OS Mus musculus GN Mtco2 PE 1 SV 1 25959 4.4103 11 29.5154 4 4.3326 0.1125
VDAC2_MOUSE Q60930 Voltage dependent anion selective channel protein 2 OS Mus musculus GN Vdac2 PE 1 SV 2 31712 7.372 20 29.8305 8 3.8052 0.1207
Q3TNH0 tr Q3TNH0 MOUSE Uncharacterized protein OS Mus musculus GN Tmpo PE 2 SV 1 46021 9.6059 36 24.2718 6 2.1125 0.0973
GBB4_MOUSE P29387 Guanine nucleotide binding protein subunit beta 4 OS Mus musculus GN Gnb4 PE 2 SV 4 37355 5.6975 22 14.7059 3 0
QCR2_MOUSE Q9DB77 Cytochrome b c1 complex subunit 2 mitochondrial OS Mus musculus GN Uqcrc2 PE 1 SV 1 48205 9.5676 26 5.9603 2 2.7056 0.1305
F7C5V8 tr F7C5V8 MOUSE Uncharacterized protein Fragment OS Mus musculus GN Ncam1 PE 4 SV 1 118069 4.5053 68 16.6365 9 1.165 0.1376
K1C10_MOUSE P02535 Keratin type I cytoskeletal 10 OS Mus musculus GN Krt10 PE 1 SV 3 57734 4.8534 38 17.0175 7 1.8954 0.1095
PGRC2_MOUSE Q80UU9 Membrane associated progesterone receptor component 2 OS Mus musculus GN Pgrmc2 PE 1 SV 2 23319 4.8098 25 11.5207 3 0
F6UTR6 tr F6UTR6 MOUSE Uncharacterized protein Fragment OS Mus musculus GN Shox2 PE 4 SV 1 26010 9.8201 18 4.5833 1 16.1676 0.419
DX39B_MOUSE Q9Z1N5 Spliceosome RNA helicase Ddx39b OS Mus musculus GN Ddx39b PE 1 SV 1 49004 5.3124 37 12.1495 2 2.7805 0.1363
THOC4_MOUSE O08583 THO complex subunit 4 OS Mus musculus GN Thoc4 PE 1 SV 3 26923 11.5563 18 13.3333 2 2.0199 0.0544
TMX3_MOUSE Q8BXZ1 Protein disulfide isomerase TMX3 OS Mus musculus GN Tmx3 PE 1 SV 2 51815 4.8246 46 8.3333 2 2.9089 0.1508
HNRPU_MOUSE Q8VEK3 Heterogeneous nuclear ribonucleoprotein U OS Mus musculus GN Hnrnpu PE 1 SV 1 87862 5.8418 53 19.125 11 3.8375 0.3374
RANDOM32305 RANDOM32305 Random Sequence 32305 23294 6.6923 13 19.2488 3 4.0383 0.0941
GNAI2_MOUSE P08752 Guanine nucleotide binding protein G i subunit alpha 2 OS Mus musculus GN Gnai2 PE 1 SV 5 40463 5.1172 29 10.4225 3 3.5965 0.1456
A2RTD1 tr A2RTD1 MOUSE Interleukin 6 OS Mus musculus GN Il6 PE 2 SV 1 24368 7.2167 18 17.0616 2 0
D3Z4C7 tr D3Z4C7 MOUSE MCG20459 isoform CRA a OS Mus musculus GN Dus2l PE 4 SV 1 42641 6.4949 36 10 2 1.5406 0.0657
A2AH75 tr A2AH75 MOUSE Kinesin family member 1B OS Mus musculus GN Kif1b PE 3 SV 1 129969 8.3945 116 10.6957 11 6.9699 0.9064
E9Q664 tr E9Q664 MOUSE Uncharacterized protein OS Mus musculus GN Ube4b PE 4 SV 1 133402 5.7237 99 10.7234 7 1.532 0.2045
A2ACG7 tr A2ACG7 MOUSE Ribophorin II OS Mus musculus GN Rpn2 PE 4 SV 1 67460 5.7918 39 13.4959 7 0
DIDO1_MOUSE Q8C9B9 Death inducer obliterator 1 OS Mus musculus GN Dido1 PE 1 SV 4 247022 7.7889 179 1.7287 4 20.1923 4.9911
F6UYF1 tr F6UYF1 MOUSE Uncharacterized protein Fragment OS Mus musculus GN Ppfia3 PE 4 SV 1 115093 5.5847 94 17.8917 12 1.3224 0.1523
Accession Entry Description mW (Da) pI (pH)
Theoretical 
Peptides
Coverage 
(%)
Digest 
Peptides
Amount 
(fmol)
Amount 
(ngrams)
P00924 ENO1_YEAST Enolase 1 EC 4 2 1 11 2 phosphoglycerate dehydr 46642 6.1527 28 23.6239 9 100 4.6671
B1ATY0 tr B1ATY0 MOUSE Actin gamma cytoplasmic 1 OS Mus musculus GN Actg1 PE 3 SV 1 32599 4.9788 27 30.5085 4 0
TBA1A_MOUSE P68369 Tubulin alpha 1A chain OS Mus musculus GN Tuba1a PE 1 SV 1 50103 4.7622 34 20.8426 5 16.6004 0.8323
LMNB1_MOUSE P14733 Lamin B1 OS Mus musculus GN Lmnb1 PE 1 SV 3 66744 4.9213 69 6.8027 2 26.2848 1.7554
HNRH1_MOUSE O35737 Heterogeneous nuclear ribonucleoprotein H OS Mus musculus GN Hnrnph1 PE 1 SV 3 49168 5.8513 27 7.5724 2 17.1212 0.8424
Accession Entry Description mW (Da) pI (pH)
Theoretical 
Peptides
Coverage 
(%)
Digest 
Peptides
Amount 
(fmol)
Amount 
(ngrams)
P00924 ENO1_YEAST Enolase 1 EC 4 2 1 11 2 phosphoglycerate dehydr 46642 6.1527 28 28.211 11 100 4.6671
LMNB1_MOUSE P14733 Lamin B1 OS Mus musculus GN Lmnb1 PE 1 SV 3 66744 4.9213 69 39.6259 21 79.612 5.3169
ROA2_MOUSE O88569 Heterogeneous nuclear ribonucleoproteins A2 B1 OS Mus musculus GN Hnrnpa2b1 PE 1 SV 2 37379 9.1939 29 17.2805 7 23.2192 0.8654
VDAC1_MOUSE Q60932 Voltage dependent anion selective channel protein 1 OS Mus musculus GN Vdac1 PE 1 SV 3 32331 8.6711 21 49.3243 8 53.8539 1.7423
HNRPF_MOUSE Q9Z2X1 Heterogeneous nuclear ribonucleoprotein F OS Mus musculus GN Hnrnpf PE 1 SV 3 45700 5.1652 26 17.3494 4 1.2509 0.0572
HNRH1_MOUSE O35737 Heterogeneous nuclear ribonucleoprotein H OS Mus musculus GN Hnrnph1 PE 1 SV 3 49168 5.8513 27 24.9443 8 43.4083 2.1357
TBA1A_MOUSE P68369 Tubulin alpha 1A chain OS Mus musculus GN Tuba1a PE 1 SV 1 50103 4.7622 34 35.9202 9 29.374 1.4727
ACTC_MOUSE P68033 Actin alpha cardiac muscle 1 OS Mus musculus GN Actc1 PE 1 SV 1 41991 5.0709 34 35.0133 11 0
H4_MOUSE P62806 Histone H4 OS Mus musculus GN Hist1h4a PE 1 SV 2 11360 11.7665 11 29.1262 3 10.2123 0.1161
SYN1_MOUSE O88935 Synapsin 1 OS Mus musculus GN Syn1 PE 1 SV 2 74051 10.1462 38 16.4306 5 68.2297 4.7785
TBA8_MOUSE Q9JJZ2 Tubulin alpha 8 chain OS Mus musculus GN Tuba8 PE 1 SV 1 50019 4.7966 34 14.0312 4 0
ATPB_MOUSE P56480 ATP synthase subunit beta mitochondrial OS Mus musculus GN Atp5b PE 1 SV 2 56265 5.0259 37 13.0435 4 37.1476 2.0914
VDAC2_MOUSE Q60930 Voltage dependent anion selective channel protein 2 OS Mus musculus GN Vdac2 PE 1 SV 2 31712 7.372 20 19.661 4 16.5292 0.5245
D3Z6F5 tr D3Z6F5 MOUSE ATP synthase subunit alpha OS Mus musculus GN Atp5a1 PE 3 SV 1 54560 8.4943 44 7.7535 3 24.5487 1.3402
E9Q9J0 tr E9Q9J0 MOUSE Uncharacterized protein OS Mus musculus GN Uba52 PE 4 SV 1 10906 8.2344 7 41.6667 4 20.4005 0.2226
F6ZQM8 tr F6ZQM8 MOUSE Uncharacterized protein Fragment OS Mus musculus PE 4 SV 1 35556 8.0825 19 26.1398 5 34.4755 1.2266
E9Q8D6 tr E9Q8D6 MOUSE Uncharacterized protein OS Mus musculus GN Hnrnpk PE 4 SV 1 49847 5.5633 40 31.1111 10 24.7583 1.2349
STXB1_MOUSE O08599 Syntaxin binding protein 1 OS Mus musculus GN Stxbp1 PE 1 SV 2 67525 6.509 48 3.7037 2 33.1267 2.2383
GTR1_MOUSE P17809 Solute carrier family 2 facilitated glucose transporter member 1 OS Mus musculus GN Slc2a1 PE 1 SV 53949 9.0406 19 14.6341 5 12.0599 0.651
ADT1_MOUSE P48962 ADP ATP translocase 1 OS Mus musculus GN Slc25a4 PE 1 SV 4 32883 10.0181 31 11.4094 3 13.6549 0.4493
E0CZ27 tr E0CZ27 MOUSE Histone H3 OS Mus musculus GN H3f3a PE 3 SV 1 13314 11.4359 10 5.8824 1 13.8015 0.1839
E9Q3T0 tr E9Q3T0 MOUSE Uncharacterized protein OS Mus musculus GN Gm10073 PE 4 SV 1 11425 4.0849 7 43.8596 3 18.6066 0.2127
F6QXX3 tr F6QXX3 MOUSE Uncharacterized protein Fragment OS Mus musculus GN Tmpo PE 4 SV 1 30568 10.3727 19 25.8993 4 11.9151 0.3644
E9PVI9 tr E9PVI9 MOUSE Uncharacterized protein OS Mus musculus GN Gm17695 PE 4 SV 1 63342 10.3176 43 23.3096 9 38.6237 2.4481
PHB_MOUSE P67778 Prohibitin OS Mus musculus GN Phb PE 1 SV 1 29801 5.4293 21 20.2206 4 13.1861 0.3932
TBB4_MOUSE Q9D6F9 Tubulin beta 4 chain OS Mus musculus GN Tubb4 PE 1 SV 3 49553 4.5903 30 3.1532 1 0
TBB2C_MOUSE P68372 Tubulin beta 2C chain OS Mus musculus GN Tubb2c PE 1 SV 1 49799 4.602 30 13.4831 5 0
ZBTB3_MOUSE Q91X45 Zinc finger and BTB domain containing protein 3 OS Mus musculus GN Zbtb3 PE 2 SV 3 55865 4.9343 35 20.8494 4 5.9341 0.3317
E9Q754 tr E9Q754 MOUSE Uncharacterized protein OS Mus musculus GN Vrk3 PE 4 SV 1 18284 9.1172 18 27.6471 3 9.239 0.169
GBB1_MOUSE P62874 Guanine nucleotide binding protein G I G S G T subunit beta 1 OS Mus musculus GN Gnb1 PE 1 SV 3 37353 5.5351 21 35 5 9.9462 0.3718
F6YPY4 tr F6YPY4 MOUSE Uncharacterized protein Fragment OS Mus musculus PE 4 SV 1 32725 11.7314 24 40.3846 8 17.4456 0.5712
Q71S36 tr Q71S36 MOUSE TAGL M splice variant OS Mus musculus GN Pglyrp2 PE 2 SV 1 40540 5.5474 18 6.8602 1 4.3011 0.1745
Appendix Table 7.4 A Mass spectrometry results of P4 NrlGFP positive cells 3rd run
Appendix Table 7.4 B Mass spectrometry results of P4 NrlGFP negative cells 3rd run
Red indicates plasma membrane proteins; Proteins from technichal replicates were presented  separately. 
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